WorldWideScience

Sample records for therapeutic radioisotope 165er

  1. Radioisotope instruments

    CERN Document Server

    Cameron, J F; Silverleaf, D J

    1971-01-01

    International Series of Monographs in Nuclear Energy, Volume 107: Radioisotope Instruments, Part 1 focuses on the design and applications of instruments based on the radiation released by radioactive substances. The book first offers information on the physical basis of radioisotope instruments; technical and economic advantages of radioisotope instruments; and radiation hazard. The manuscript then discusses commercial radioisotope instruments, including radiation sources and detectors, computing and control units, and measuring heads. The text describes the applications of radioisotop

  2. Radioisotope Power Supply Project

    Data.gov (United States)

    National Aeronautics and Space Administration — Between 1998 and 2003, Hi-Z Technology developed and built a 40 mW radioisotope power supply (RPS) that used a 1 watt radioisotope heater unit (RHU) as the energy...

  3. Power from Radioisotopes (Rev.)

    Energy Technology Data Exchange (ETDEWEB)

    Corliss, William R; Mead, Robert L

    1971-01-01

    This booklet discusses Systems for Nuclear Auxiliary Power (SNAP), called isotope power generators, that are based on using heat from the decay of radioisotopes to produce electricity. These are the SNAP systems with odd-numbered designators. The basics of radioisotope thermoelectric generators (RTGs) are discussed and their uses as power sources in space exploration and on earth are described. Various radioisotope heat sources are discussed and a table of RTGs built under the SNAP program listing their uses, electrical power, weight, the radioisotope used, the radioisotope's half-life, and the generator life is given.

  4. Medical application of radioisotopes

    Energy Technology Data Exchange (ETDEWEB)

    Choi, Chang Woon; Lim, S. M.; Kim, E. H. [and others

    2000-05-01

    In this project, we studied following subjects: 1. Clinical research for radionuclide therapy 2. Development of in vitro assay method with radioisotope 3. Development of binary therapy; Boron neutron capture therapy and photodynamic therapy 4. Development of diagnostic methods in radionuclide imaging. The results can be applied for the following objectives: (1) Radionuclide therapy will be applied in clinical practice to treat the cancer patients or other diseases in multi-center trial (2) The newly developed monoclonal antibodies and biomolecules can be used in biology, chemistry or other basic life science research (3) The new methods for the analysis of therapeutic effects, such as dosimetry, and quantitative analysis methods of radioactivity, can be applied in basic research, such as radiation oncology and radiation biology (4) The result of the project will be expected to develop the new radioimmunoassay for drug monitoring following the clinical experiments (5) Boron porphyrin has been successfully labeled with iodine. This enables the pharmacodynamic study of the boron compound in human body (6) A method to evaluate the biological effect of neutrons on tumor cells has been developed (7) The establishment of macro- and microscopic dose assessment using alpha-track autoradiography (8) Clinical application of PDT in bladder cancers, oropharyngeal cancer and skin cancer (9) Radionuclide imaging of estrogen receptor in breast cancer, lipid metabolism, gene therapy, cancers, brain function and heart disease.

  5. Production and utilization of radioisotopes

    Energy Technology Data Exchange (ETDEWEB)

    Sekine, Toshiaki [Japan Atomic Energy Research Inst., Tokai, Ibaraki (Japan). Tokai Research Establishment; Matsuoka, Hiromitsu

    1999-03-01

    A plan of developing radioisotopes with a high power proton accelerator of the Neutron Science Project is presented. The status of production and utilization of radioisotopes in Japan is briefly discussed. The radioisotopes to be produced for biomedical use are discussed together with the facility for production of those radioisotopes and for research with the products. (author)

  6. Economical Radioisotope Power Project

    Data.gov (United States)

    National Aeronautics and Space Administration — Almost all robotic space exploration missions and all Apollo missions to the moon used Radioisotopic Thermoelectric Generators (RTGs) to provide electrical power to...

  7. Radioisotopes in Industry

    Energy Technology Data Exchange (ETDEWEB)

    Baker, Philip S. [Oak Ridge National Laboratory; Fuccillo, Jr., Domenic A. [Oak Ridge National Laboratory; Gerrard, Martha W. [Oak Ridge National Laboratory; Lafferty, Jr., Robert H. [Oak Ridge National Laboratory

    1967-05-01

    Radioisotopes, man-made radioactive elements, are used in industry primarily for measuring, testing and processing. How and why they are useful is the subject of this booklet. The booklet discusses their origin, their properties, their uses, and how they may be used in the future.

  8. Radioisotopes for medical applications

    Energy Technology Data Exchange (ETDEWEB)

    Carr, S. [Australian Nuclear Science and Technology Organisation, Lucas Heights, NSW (Australia). Radiopharmaceuticals Division

    1998-03-01

    For more than 3 decades, the Australian Nuclear Science and Technology Organisation has been the country`s main supplier of radioisotopes for medical applications. The use of radioisotopes in medicine has revolutionised the diagnosis, management and treatment of many serious diseases such as cancer, heart disease and stroke. It is also beginning to play a key role in neurological disorders such as Parkinson and Alzheimers disease and epilepsy. More recently there has been considerable growth in the application of nuclear medicine to treat sport-related injuries - especially wrist, ankle and knees where more common techniques do not always enable accurate diagnosis. Australia is a recognised leader in nuclear medicine. This can be partially attributed to the close relationship between ANSTO and the medical community in providing opportunities to develop and evaluate new agents to support more effective patient care. A list of commercial isotopes produced in the reactor or the cyclotron and used in medical applications is given. Nuclear medicine plays an important role in the clinical environment and the timely supply of radioisotopes is a key element. ANSTO will continue to be the premier supplier of currently available and developing isotopes to support the health and well being of the Australian community 2 tabs., 1 fig.

  9. Taming Highly Charged Radioisotopes

    Science.gov (United States)

    Chowdhury, Usman; Eberhardt, Benjamin; Jang, Fuluni; Schultz, Brad; Simon, Vanessa; Delheij, Paul; Dilling, Jens; Gwinner, Gerald

    2012-10-01

    The precise and accurate mass of short-lived radioisotopes is a very important parameter in physics. Contribution to the improvement of nuclear models, metrological standard fixing and tests of the unitarity of the Caibbibo-Kobayashi-Maskawa (CKM) matrix are a few examples where the mass value plays a major role. TRIUMF's ion trap for atomic and nuclear physics (TITAN) is a unique facility of three online ion traps that enables the mass measurement of short-lived isotopes with high precision (˜10-8). At present TITAN's electron beam ion trap (EBIT) increases the charge state to increase the precision, but there is no facility to significantly reduce the energy spread introduced by the charge breeding process. The precision of the measured mass of radioisotopes is linearly dependent on the charge state while the energy spread of the charged radioisotopes affects the precision adversely. To boost the precision level of mass measurement at TITAN without loosing too many ions, a cooler Penning trap (CPET) is being developed. CPET is designed to use either positively (proton) or negatively (electron) charged particles to reduce the energy spread via sympathetic cooling. Off-line setup of CPET is complete. Details of the working principles and updates are presented

  10. Radioisotope Power System Pool Concept

    Science.gov (United States)

    Rusick, Jeffrey J.; Bolotin, Gary S.

    2015-01-01

    Advanced Radioisotope Power Systems (RPS) for NASA deep space science missions have historically used static thermoelectric-based designs because they are highly reliable, and their radioisotope heat sources can be passively cooled throughout the mission life cycle. Recently, a significant effort to develop a dynamic RPS, the Advanced Stirling Radioisotope Generator (ASRG), was conducted by NASA and the Department of Energy, because Stirling based designs offer energy conversion efficiencies four times higher than heritage thermoelectric designs; and the efficiency would proportionately reduce the amount of radioisotope fuel needed for the same power output. However, the long term reliability of a Stirling based design is a concern compared to thermoelectric designs, because for certain Stirling system architectures the radioisotope heat sources must be actively cooled via the dynamic operation of Stirling converters throughout the mission life cycle. To address this reliability concern, a new dynamic Stirling cycle RPS architecture is proposed called the RPS Pool Concept.

  11. Radioisotope production in Malaysia

    Energy Technology Data Exchange (ETDEWEB)

    Wan Anuar Wan Awang [Medical Technology Div., Malaysian Inst. for Nuclear Technology Research (MINT) (Malaysia)

    1998-10-01

    Production of Mo-99 by neutron activation of Mo-99 in Malaysia began as early as 1984. Regular supply of the Tc-99m extracted from it to the hospitals began in early 1988 after going through formal registration with the Malaysian Ministry of Health. Initially, the weekly demand was about 1.2 Ci of Mo-99 which catered the needs of 3 nuclear medicine centres. Sensitive to the increasing demand of Tc-99m, we have producing our own Tc-99m generator from imported TeO{sub 2} because irradiation TeO{sub 2} with our reactor give low yield of I-131. We have established the production of radioisotope for industrial use. By next year, Sm-153 EDTMP will be produce after we have license from our competent authority. (author)

  12. Milliwatt Radioisotope Stirling Convertor Project

    Data.gov (United States)

    National Aeronautics and Space Administration — Studies of potential space missions have highlighted the need for very small electric power supplies for a variety of applications. The light weight radioisotope...

  13. Recent progress in radioisotope production in Vietnam

    Energy Technology Data Exchange (ETDEWEB)

    Le Van So [Radioisotope Dept., Nuclear Research Institute, Dalat (Viet Nam)

    1998-10-01

    This is a report on the recent progress in radioisotope production in Vietnam. Using a nuclear research reactor of 500 KW with continuous operation cycles of 100 hours a month, the production of some important radioisotopes used in nuclear medicine and research was routinely carried out. More than 80 per cent of irradiation capacity of reactor for radioisotope production were exploited. The radioactivity of more than 150 Ci of {sup 131}I, {sup 99}Mo-{sup 99m}Tc, {sup 32}P, {sup 51}Cr, {sup 153}Sm, {sup 46}Sc, {sup 192}Ir was produced annually. Radiopharmaceuticals such as {sup 131}I-Hippuran and in-vivo Kits for {sup 99m}Tc labelling were also prepared routinely and regularly. More than 10 in-vivo Kits including modern radiopharmaceuticals such as HmPAO kit were supplied to hospitals in Vietnam. The research on the improvement of dry distillation technology for production of {sup 131}I was carried out. As a result obtained a new distillation apparatus made from glass was successfully put to routine use in place of expensive quartz distillation furnace. We have also continued the research programme on the development of {sup 99m}Tc generators using low power research reactors. Gel technology using Zr- and Ti- molybdate gel columns for {sup 99m}Tc generator production was developed and improved continually. Portable {sup 99m}Tc generator using Zr-({sup 99}Mo) molybdate gel column and ZISORB adsorbent column for {sup 99m}Tc concentration were developed. The ZISORB adsorbent of high adsorption capacity for {sup 99}Mo and other parent radionuclides was also studied for the development purpose of alternative technology of {sup 99m}Tc and other different radionuclide generator systems. The studies on the preparation of therapeutic radiopharmaceuticals labelling with {sup 153}Sm and {sup 131}I such as {sup 153}Sm-EDTMP, {sup 131}I-MIBG were carried out. (author)

  14. List of DOE radioisotope customers with summary of radioisotope shipments, FY 1985

    Energy Technology Data Exchange (ETDEWEB)

    Baker, D.A.

    1986-08-01

    This document describes radioisotope distribution from DOE facilities to private firms including foreign and other DOE facilities. The information is divided into five sections: (1) isotope suppliers, facility contacts, and isotopes or services supplied; (2) customers, suppliers, and isotopes purchased; (3) isotopes purchased cross-referenced with customer numbers; (4) geographic locations of radioisotope customers; and (5) radioisotope sales and transfer - FY 1985.

  15. KAERI's challenge to steady production of radioisotopes and radiopharmaceuticals

    Energy Technology Data Exchange (ETDEWEB)

    Park, J.H.; Han, H.S.; Park, K.B. [Korea Atomic Energy Research Institute, Taejon (Korea)

    2000-10-01

    The Korea Atomic Energy Research Institute (KAERI) is a national organization in Korea, and has been doing many research and development works in radioisotope production and applications for more than 30 years. Now KAERI regularly produces radioisotopes (I-131, Tc-99m, Ho-166) for medical use and Ir-192 for industrial use. Various I-131 labeled compounds and more than 10 kinds of Tc-99m cold kits are also produced. Our multi-purpose reactor, named HANARO, has been operative since April of 1995. HANAKO is an open tank type reactor with 30 MW thermal capacity. This reactor was designed not only for research on neutron utilization but for production of radioisotopes. KAERI intended to maximize the radioisotope production capability. For this purpose, radioisotope production facilities (RIPF) have been constructed adjacent to the HANARO reactor building. There are four banks of hot cells equipped with manipulators and some of the hot cells were installed according to the KGMP standards and with clean rooms. In reviewing our RI production plan intensively, emphasis was placed on the development of new radiopharmaceuticals, development of new radiation sources for industrial and therapeutic use, and steady production of selected radioisotopes and radiopharmaceuticals. The selected items are Ho-166 based pharmaceuticals, fission Mo-99/Tc-99m generators. solution and capsules of I-131, and Ir-192 and Co-60 for industrial use. The status and future plan of KAERI's research and development program will be introduced, and will highlight programs for steady production. (author)

  16. NASA's Radioisotope Power Systems - Plans

    Science.gov (United States)

    Hamley, John A.; Mccallum, Peter W.; Sandifer, Carl E., II; Sutliff, Thomas J.; Zakrajsek, June F.

    2015-01-01

    NASA's Radioisotope Power Systems (RPS) Program continues to plan and implement content to enable planetary exploration where such systems could be needed, and to prepare more advanced RPS technology for possible infusion into future power systems. The 2014-2015 period saw significant changes, and strong progress. Achievements of near-term objectives have enabled definition of a clear path forward in which payoffs from research investments and other sustaining efforts can be applied. The future implementation path is expected to yield a higher-performing thermoelectric generator design, a more isotope-fuel efficient system concept design, and a robust RPS infrastructure maintained effectively within both NASA and the Department of Energy. This paper describes recent work with an eye towards the future plans that result from these achievements.

  17. BEST medical radioisotope production cyclotrons

    Energy Technology Data Exchange (ETDEWEB)

    Sabaiduc, Vasile; Milton, Bruce; Suthanthiran, Krishnan; Johnson, Richard R. [Best Cyclotron Systems Inc., 7-8765 Ash Street, Vancouver, British Columbia, V6P 6T3 (Canada); Gelbart, W. Z. [Advanced System Designs Inc., 5295 Bear Bay Road, Garden Bay, BC, V0N 1S1 (Canada)

    2013-04-19

    Best Cyclotron Systems Inc (BCSI) is currently developing 14 MeV, 25 MeV, 35MeV and 70MeV cyclotrons for radioisotope production and research applications as well as the entire spectrum of targets and nuclear synthesis modules for the production of Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT) and radiation therapy isotopes. The company is a subsidiary of Best Medical International, renowned in the field of medical instrumentation and radiation therapy. All cyclotrons have external negative hydrogen ion sources, four radial sectors with two dees in opposite valleys, cryogenic vacuum system and simultaneous beam extraction on opposite lines. The beam intensity ranges from 400 {mu}A to 1000 {mu}A, depending on the cyclotron energy and application.

  18. Twenty years of Korea radioisotope association history

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2005-09-15

    This contents has two parts. The first part describes the present and post of Korea radioisotope association which are about the foundation of the association, organization, main projects and vision of the association. The second part is about the use and the prospect of radiation and radioisotope in Korea, which shows the plan of expansion of use of radiation and radioisotope, the prospect and present condition in fields such as medical, industry and farming, product and distribution, research and development of human resources, system and management of safety of radiation.

  19. List of DOE radioisotope customers with summary of radioisotope shipments, FY 1986

    Energy Technology Data Exchange (ETDEWEB)

    Lamar, D.A.

    1987-10-01

    This document describes radioisotope distribution from DOE facilities to private firms including foreign and other DOE facilities. The information is divided into five sections: (1)isotope suppliers, facility contact, and isotopes or services supplied; (2) customers, suppliers, and isotopes purchased; (3) isotopes purchased cross-referenced with customer numbers; (4) geographic locations of radioisotope customers; and (5) radioisotope sales and transfers for fiscal year 1986.

  20. List of DOE radioisotope customers with summary of radioisotope shipments, FY 1984

    Energy Technology Data Exchange (ETDEWEB)

    Baker, D.A.

    1985-08-01

    This edition of the radioisotope customer list was prepared at the request of the Office of Health and Environmental Research (ER-73), Office of Energy Research, Department of Energy (DOE). This document describes radioisotope distribution from DOE facilities to private firms including foreign and other DOE facilities. The information is divided into five sections: (1) isotope suppliers, facility contacts, and isotopes or services supplied; (2) customers, suppliers, and isotopes purchased; (3) isotopes purchased cross-referenced with customer numbers; (4) geographic locations of radioisotope customers; and (5) radioisotope sales and transfers - FY 1984.

  1. Radioisotope Power Systems Technology Development Project

    Data.gov (United States)

    National Aeronautics and Space Administration — Radioisotope Power Systems (RPS) is a multicenter, multiagency (with the Department of Energy (DOE)) program whose purpose is to manage the Science Mission...

  2. Medical Radioisotopes Production Without A Nuclear Reactor

    Energy Technology Data Exchange (ETDEWEB)

    Van der Keur, H.

    2010-05-15

    This report is answering the key question: Is it possible to ban the use of research reactors for the production of medical radioisotopes? Chapter 2 offers a summarized overview on the history of nuclear medicine. Chapter 3 gives an overview of the basic principles and understandings of nuclear medicine. The production of radioisotopes and its use in radiopharmaceuticals as a tracer for imaging particular parts of the inside of the human body (diagnosis) or as an agent in radiotherapy. Chapter 4 lists the use of popular medical radioisotopes used in nuclear imaging techniques and radiotherapy. Chapter 5 analyses reactor-based radioisotopes that can be produced by particle accelerators on commercial scale, other alternatives and the advantages of the cyclotron. Chapter 6 gives an overview of recent developments and prospects in worldwide radioisotopes production. Chapter 7 presents discussion, conclusions and recommendations, and is answering the abovementioned key question of this report: Is it possible to ban the use of a nuclear reactor for the production of radiopharmaceuticals? Is a safe and secure production of radioisotopes possible?.

  3. Development of radioisotope tracer technology

    Energy Technology Data Exchange (ETDEWEB)

    Jin, Joon Ha; Lee, Myun Joo; Jung, Sung Hee; Park, Soon Chul; Lim, Dong Soon; Kim, Jae Ho; Lee, Jae Choon; Lee, Doo Sung; Cho, Yong Suk; Shin, Sung Kuan

    2000-04-01

    The purpose of this study is to develop the radioisotope tracer technology, which can be used in solving industrial and environmental problems and to build a strong tracer group to support the local industries. In relation to the tracer technology in 1999, experiments to estimate the efficiencies of a sludge digester of a waste water treatment plant and a submerged biological reactor of a dye industry were conducted. As a result, the tracer technology for optimization of facilities related to wastewater treatment has been developed and is believed to contribute to improve their operation efficiency. The quantification of the experimental result was attempted to improve the confidence of tracer technology by ECRIN program which basically uses the MCNP simulation principle. Using thin layer activation technique, wear of tappet shim was estimated. Thin layer surface of a tappet shim was irradiated by proton beam and the correlation between the measured activity loss and the amount of wear was established. The equipment was developed to adjust the energy of proton which collides with the surface of tappet. The tracer project team has participated into the tracer test for estimating the efficiency of RFCC system in SK cooperation. From the experiment the tracer team has obtained the primary elements to be considered for judging the efficiency of RFCC unit. By developing the tracer techniques to test huge industrial units like RFCC, the tracer team will be able to support the local industries that require technical services to solve any urgent trouble. (author)

  4. Early radioisotope uses in Mexico

    Energy Technology Data Exchange (ETDEWEB)

    Segovia, N.; Tejera, A.; Bulbulian, S.; Palma, F

    1991-10-15

    Mexico is traditionally a mining country and the first information about the presence of uranium is related to mine exploitation. Around 1945 when uranium became economically important, a rumor had spread that large amounts of black ceramics from Oaxaca were being purchased and sent abroad because of its assumed high uranium content. It was only in 1949 when minerals containing thorium and uranium were declared by law as 'National Reserves'. In those years a radium emanation plant was installed at the 'Hospital General' in Mexico City with the main purpose of carrying out radon seed implantation in tumors. In the fifties a radium dial painting facility was operating in the city of Toluca some 70 km from Mexico City. In 1955, when the National Commission of Nuclear Energy (CNEN) was founded by a government decree, two main activities were in sight: a training program on 'Radioisotope Techniques and Nuclear Instrumentation' and the creation of specialized laboratories. In this paper a general description of these events and undertakings spanning the decades 1940 to 1970 is given. (Author)

  5. Radioisotope Production for Medical and Physics Applications

    Science.gov (United States)

    Mausner, Leonard

    2012-10-01

    Radioisotopes are critical to the science and technology base of the US. Discoveries and applications made as a result of the availability of radioisotopes span widely from medicine, biology, physics, chemistry and homeland security. The clinical use of radioisotopes for medical diagnosis is the largest sector of use, with about 16 million procedures a year in the US. The use of ^99Mo/^99mTc generator and ^18F make up the majority, but ^201Tl, ^123I, ^111In, and ^67Ga are also used routinely to perform imaging of organ function. Application of radioisotopes for therapy is dominated by use of ^131I for thyroid malignancies, ^90Y for some solid tumors, and ^89Sr for bone cancer, but production of several more exotic species such as ^225Ac and ^211At are of significant current research interest. In physics ^225Ra is of interest for CP violation studies, and the actinides ^242Am, ^249Bk, and ^254Es are needed as targets for experiments to create superheavy elements. Large amounts of ^252Cf are needed as a fission source for the CARIBU experiment at ANL. The process of radioisotope production is multidisciplinary. Nuclear physics input based on nuclear reaction excitation function data is needed to choose an optimum target/projectile in order to maximize desired isotope production and minimize unwanted byproducts. Mechanical engineering is needed to address issues of target heating, induced mechanical stress and material compatibility of target and claddings. Radiochemists are involved as well since chemical separation to purify the desired final radioisotope product from the bulk target and impurities is also usually necessary. Most neutron rich species are produced at a few government and university reactors. Other radioisotopes are produced in cyclotrons in the commercial sector, university/hospital based facilities, and larger devices at the DOE labs. The landscape of US facilities, the techniques involved, and current supply challenges will be reviewed.

  6. NASA's Radioisotope Power Systems Program Status

    Science.gov (United States)

    Dudzinski, Leonard A.; Hamley, John A.; McCallum, Peter W.; Sutliff, Thomas J.; Zakrajsek, June F.

    2013-01-01

    NASA's Radioisotope Power Systems (RPS) Program began formal implementation in December 2010. The RPS Program's goal is to make available RPS for the exploration of the solar system in environments where conventional solar or chemical power generation is impractical or impossible to meet mission needs. To meet this goal, the RPS Program manages investments in RPS system development and RPS technologies. The current keystone of the RPS Program is the development of the Advanced Stirling Radioisotope Generator (ASRG). This generator will be about four times more efficient than the more traditional thermoelectric generators, while providing a similar amount of power. This paper provides the status of the RPS Program and its related projects. Opportunities for RPS generator development and targeted research into RPS component performance enhancements, as well as constraints dealing with the supply of radioisotope fuel, are also discussed in the context of the next ten years of planetary science mission plans.

  7. Diffusion of Implanted Radioisotopes in Solids

    CERN Multimedia

    2002-01-01

    Implantation of radioisotopes into metal and semiconductor samples is performed. The implanted isotope or its decay-product should have a half-life long enough for radiotracer diffusion experiments. Such radioisotopes are utilized to investigate basic diffusion properties in semiconductors and metals and to improve our understanding of the atomic mechanisms of diffusion. For suitably chosen systems the combination of on-line production and clean implantation of radioisotopes at the ISOLDE facility opens new possibilities for diffusion studies in solids. \\\\ \\\\ The investigations are concentrated on diffusion studies of $^{195}$Au in amorphous materials. The isotope $^{195}$Au was obtained from the mass 195 of the mercury beam. $^{195}$Hg decays into $^{195}$Au which is a very convenient isotope for diffusion experiments. \\\\ \\\\ It was found that $^{195}$Au is a slow diffusor in amorphous Co-Zr alloys, whereas Co is a fast diffusor in the same matrix. The ``asymmetry'' in the diffusion behaviour is of considerab...

  8. Commercial Superconducting Electron Linac for Radioisotope Production

    Energy Technology Data Exchange (ETDEWEB)

    Grimm, Terry Lee [Niowave, Inc., Lansing, MI (United States); Boulware, Charles H. [Niowave, Inc., Lansing, MI (United States); Hollister, Jerry L. [Niowave, Inc., Lansing, MI (United States); Jecks, Randall W. [Niowave, Inc., Lansing, MI (United States); Mamtimin, Mayir [Niowave, Inc., Lansing, MI (United States); Starovoitova, Valeriia [Niowave, Inc., Lansing, MI (United States)

    2015-08-13

    The majority of radioisotopes used in the United States today come from foreign suppliers or are generated parasitically in large government accelerators and nuclear reactors. Both of these restrictions limit the availability of radioisotopes and discourage the development and evaluation of new isotopes and for nuclear medicine, science, and industry. Numerous studies have been recommending development of dedicated accelerators for production of radioisotopes for over 20 years (Institute of Medicine, 1995; Reba, et al, 2000; National Research Council, 2007; NSAC 2009). The 2015 NSAC Long Range Plan for Isotopes again identified electron accelerators as an area for continued research and development. Recommendation 1(c) from the 2015 NSAC Isotope report specifically identifies electron accelerators for continued funding for the purpose of producing medical and industrial radioisotopes. Recognizing the pressing need for new production methods of radioisotopes, the United States Congress passed the American Medical Isotope Production Act of 2012 to develop a domestic production of 99Mo and to eliminate the use of highly enriched uranium (HEU) in the production of 99Mo. One of the advantages of high power electron linear accelerators (linacs) is they can create both proton- and neutron-rich isotopes by generating high energy x-rays that knock out protons or neutrons from stable atoms or by fission of uranium. This allows for production of isotopes not possible in nuclear reactors. Recent advances in superconducting electron linacs have decreased the size and complexity of these systems such that they are economically competitive with nuclear reactors and large, high energy accelerators. Niowave, Inc. has been developing a radioisotope production facility based on a superconducting electron linac with liquid metal converters.

  9. List of DOE radioisotope customers with summary of radioisotope shipments, FY 1982

    Energy Technology Data Exchange (ETDEWEB)

    Richards, M.P.

    1983-08-01

    The radioisotope production and distribution activities by facilities at Argonne National Laboratory, Pacific Northwest Laboratory, Brookhaven National Laboratory, Hanford Engineering Development Laboratory, Idaho Operations Office, Los Alamos Scientific Laboratory, Oak Ridge National Laboratory, Savannah River Laboratory, and UNC Nuclear Industries, Inc. are listed. The information is divided into five sections: isotope suppliers, facility, contacts, and isotopes or services supplied; alphabetical list of customers, and isotopes purchased; alphabetical list of isotopes cross-referenced to customs numbers; geographical location of radioisotope customers; and radioisotope sales and transfers-FY 1982. (MHR)

  10. List of DOE radioisotope customers with summary of radioisotope shipments, FY 1980

    Energy Technology Data Exchange (ETDEWEB)

    Burlison, J.S. (comp.)

    1981-08-01

    The sixteenth edition of the radioisotope customer list was prepared at the request of the Office of Health and Environmental Research, Office of energy Research, Department of Energy (DOE). This document lists DOE's radioisotope production and distribution activities by its facilities at Argonne National Laboratory; Pacific Northwest Laboratory; Brookhaven National Laboraory; Hanford Engineering Development Laboratory; Idaho Operations Office; Los Alamos Scientific Laboratory; Mound Facility; Oak Ridge National Laboratory; Savannah River Laboratory; and UNC Nuclear Industries, Inc. The information is divided into five sections: (1) isotope suppliers, facility, contracts and isotopes or services supplied; (2) alphabetical list of customers, and isotopes purchased; (3) alphabetical list of isotopes cross-referenced to customer numbers; (4) geographical location of radioisotope customers; and (5) radioisotope sales and transfers-FY 1980.

  11. List of DOE radioisotope customers with summary of radioisotope shipments, FY 1981

    Energy Technology Data Exchange (ETDEWEB)

    Burlison, J.S. (comp.)

    1982-09-01

    The seventeenth edition of the radioisotope customer list was prepared at the request of the Office of Health and Environmental Research, Office of Energy Research, Department of Energy (DOE). This document lists DOE's radioisotope production and distribution activities by its facilities at Argonne National Laboratory: Pacific Northwest Laboratory; Brookhaven National Laboratory; Hanford Engineering Development Laboratory; Idaho Operations Office; Los Alamos Scientific Laboratory; Mound Facility; Oak Ridge National Laboratory; Savannah River Laboratory; and UNC Nuclear Industries, Inc. The information is divided into five sections: (1) isotope suppliers, facility, contracts and isotopes or services supplied; (2) alphabetical list of customers, and isotopes purchased; (3) alphabetical list of isotopes cross-referenced to customer numbers; (4) geographical location of radioisotope customers; and (5) radioisotope sales and transfers-FY 1980.

  12. Development of radioisotope production in the Philippines

    Energy Technology Data Exchange (ETDEWEB)

    Cabalfin, E.G. [Philippine Nuclear Research Institute, Quezon (Philippines)

    1998-10-01

    The Philippine Nuclear Research Institute (PNRI) started its activities on radioisotope production more than three decades ago, when the Philippine Research Reactor (PRR-1) started operating at its full rated power of 1 MW. Since then, several radionuclides in different chemical forms, were routinely produced and supplied for use in nuclear medicine, industry, agriculture, research and training, until the conversion of the PRR-1 to a 3 MW TRIGA type reactor. After the criticality test of the upgraded reactor, a leak was discovered in the pool liner. With the repair of the reactor still ongoing, routine radioisotope production activities have been reduced to dispensing of imported bulk {sup 131}I. In the Philippines, radioisotopes are widely used in nuclear medicine, with {sup 131}I and {sup 99m}Tc as the major radionuclides of interest. Thus the present radioisotope production program of PNRI is directed to meet this demand. With the technical assistance of the International Atomic Energy Agency (IAEA), PNRI is setting up a new {sup 131}I production facility. The in-cell equipment have been installed and tested using both inactive and active target, obtained from BATAN, Indonesia. In order to meet the need of producing {sup 99}Mo-{sup 99m}Tc generators, based on low specific activity reactor-produced {sup 99}Mo, research and development work on the preparation of {sup 99m}Tc gel generators is ongoing. (author)

  13. Radioisotopes in management of metastatic prostate cancer

    Directory of Open Access Journals (Sweden)

    Amar Raval

    2016-01-01

    Full Text Available Introduction: Metastatic prostate cancer continues to be a leading cause of morbidity and mortality in men with prostate cancer. Over the last decade, the treatment landscape for patients with castrate-resistant disease has drastically changed, with several novel agents demonstrating an improvement in overall survival in large, multi-institutional randomized trials. Traditional treatment with radioisotopes has largely been in the palliative setting. However, the first in class radiopharmaceutical radium-223 has emerged as the only bone-directed treatment option demonstrating an improvement in overall survival. Methods: Medline publications from 1990 to 2016 were searched and reviewed to assess the use of currently approved radioisotopes in the management of prostate cancer including emerging data regarding integration with novel systemic therapies. New positron emission tomography-based radiotracers for advanced molecular imaging of prostate cancer were also queried. Results: Radioisotopes play a crucial role in the diagnosis and treatment of prostate cancer in the definitive and metastatic setting. Molecular imaging of prostate cancer and theranostics are currently being investigated in the clinical arena. Conclusions: The use of modern radioisotopes in selected patients with mCRPC is associated with improvements in overall survival, pain control, and quality of life.

  14. Radioisotopes as Political Instruments, 1946–1953

    Science.gov (United States)

    Creager, Angela N. H.

    2009-01-01

    The development of nuclear “piles,” soon called reactors, in the Manhattan Project provided a new technology for manufacturing radioactive isotopes. Radioisotopes, unstable variants of chemical elements that give off detectable radiation upon decay, were available in small amounts for use in research and therapy before World War II. In 1946, the U.S. government began utilizing one of its first reactors, dubbed X-10 at Oak Ridge, as a production facility for radioisotopes available for purchase to civilian institutions. This program of the U.S. Atomic Energy Commission was meant to exemplify the peacetime dividends of atomic energy. The numerous requests from scientists outside the United States, however, sparked a political debate about whether the Commission should or even could export radioisotopes. This controversy manifested the tension in U.S. politics between scientific internationalism as a tool of diplomacy, associated with the aims of the Marshall Plan, and the desire to safeguard the country’s atomic monopoly at all costs, linked to American anti-Communism. This essay examines the various ways in which radioisotopes were used as political instruments—both by the U.S. federal government in world affairs, and by critics of the civilian control of atomic energy—in the early Cold War. PMID:20725612

  15. Studies of radioisotope production with an AVF cyclotron in TIARA

    Energy Technology Data Exchange (ETDEWEB)

    Sekine, Toshiaki [Japan Atomic Energy Research Inst., Takasaki, Gunma (Japan). Takasaki Radiation Chemistry Research Establishment

    1997-03-01

    The production of radioisotopes to be used mainly for nuclear medicine and biology is studied with an AVF cyclotron in TIARA. A production method of no-carrier-added {sup 186}Re with the {sup 186}W(p,n){sup 186}Re reaction has been developed; this product may be used as a therapeutic agent in radioimmunotherapy due to the adequate nuclear and chemical properties. For the study of the function of plants using a positron-emitter two-dimensional imaging system, a simple method of producing the positron emitter {sup 18}F in water was developed by taking advantage of a highly-energetic {alpha} beam from the AVF cyclotron. (author)

  16. The use of radioisotopes in medicine and medical research, Australia 1947-73

    Energy Technology Data Exchange (ETDEWEB)

    Korszniak, N

    1994-12-01

    On March 31, 1994, an article appeared in the Melbourne Age claiming that after the Second World War `hundreds of people were injected with radioactive materials in medical experiments that continued in Australian hospitals until the 1960s. Similar reports subsequently appeared in other newspapers and on the television and radio news. The archival records held at the Australian Radiation Laboratory (ARL) pertaining to the medical uses of radioisotopes during the period 1947-1973 have been examined to ascertain the nature of radioisotope use, and in the case of experimental procedures, any ethical considerations. The material examined indicates that the distribution and medical use of radioactive isotopes was stringently controlled by the Radio-isotope Standing Committee (established by the National Health and Medical Research Council (NHMRC) in 1947 to oversee this area) until its disbandment in 1973, when the responsibility for regulation of the use of radioactive isotopes for medical purposes in Australia passed to the Therapeutic Goods Administration. A database, showing details of over 500 radioisotope use in Australia between 1947-1973 is given in Appendix III . (author) refs., tabs.

  17. Advanced Stirling Radioisotope Generator Life Certification Plan

    Science.gov (United States)

    Rusick, Jeffrey J.; Zampino, Edward J.

    2013-01-01

    An Advanced Stirling Radioisotope Generator (ASRG) power supply is being developed by the Department of Energy (DOE) in partnership with NASA for potential future deep space science missions. Unlike previous radioisotope power supplies for space exploration, such as the passive MMRTG used recently on the Mars Curiosity rover, the ASRG is an active dynamic power supply with moving Stirling engine mechanical components. Due to the long life requirement of 17 years and the dynamic nature of the Stirling engine, the ASRG project faced some unique challenges trying to establish full confidence that the power supply will function reliably over the mission life. These unique challenges resulted in the development of an overall life certification plan that emphasizes long-term Stirling engine test and inspection when analysis is not practical. The ASRG life certification plan developed is described.

  18. Visualization of Radioisotope Detectability Over Time.

    Energy Technology Data Exchange (ETDEWEB)

    Huynh, Brady [Sandia National Lab. (SNL-NM), Albuquerque, NM (United States)

    2017-02-01

    A radioactive isotope is an atom that has an unstable nucleus. The isotope can undergo radioactive decay, the process in which excessive nuclear energy is emitted from the nucleus in many different forms, such as gamma radiation, alpha particles, or beta particles. The important thing to note is that these emissions act as a signature for the isotope. Each radioisotope has a particular emission spectrum, emitting radiation at different energies and at different rates.

  19. Reactors are indispensable for radioisotope production.

    Science.gov (United States)

    Mushtaq, Ahmad

    2010-12-01

    Radioisotopes can be produced by reactors and accelerators. For certain isotopes there could be an advantage to a certain production method. However, nowadays many reports suggest, that useful isotopes needed in medicine, industry and research could be produced efficiently and dependence on reactors using enriched U-235 may be eliminated. In my view reactors and accelerators will continue to play their role side by side in the supply of suitable and economical sources of isotopes.

  20. Markets for reactor-produced non-fission radioisotopes

    Energy Technology Data Exchange (ETDEWEB)

    Bennett, R.G.

    1995-01-01

    Current market segments for reactor produced radioisotopes are developed and reported from a review of current literature. Specific radioisotopes studied in is report are the primarily selected from those with major medical or industrial markets, or those expected to have strongly emerging markets. Relative market sizes are indicated. Special emphasis is given to those radioisotopes that are best matched to production in high flux reactors such as the Advanced Test Reactor (ATR) at the Idaho National Engineering Laboratory or the High Flux Isotope Reactor (HFIR) at the Oak Ridge National Laboratory. A general bibliography of medical and industrial radioisotope applications, trends, and historical notes is included.

  1. Efficient, Long-Lived Radioisotope Power Generator Project

    Data.gov (United States)

    National Aeronautics and Space Administration — Radiation Monitoring Devices, Inc., (RMD) proposes to develop an alternative very long term, radioisotope power source with thermoelectric power conversion with...

  2. Vitrified chemically bonded phosphate ceramics for immobilization of radioisotopes

    Science.gov (United States)

    Wagh, Arun S.

    2016-04-05

    A method of immobilizing a radioisotope and vitrified chemically bonded phosphate ceramic (CBPC) articles formed by the method are described. The method comprises combining a radioisotope-containing material, MgO, a source of phosphate, and optionally, a reducing agent, in water at a temperature of less than 100.degree. C. to form a slurry; curing the slurry to form a solid intermediate CBPC article comprising the radioisotope therefrom; comminuting the intermediate CBPC article, mixing the comminuted material with glass frits, and heating the mixture at a temperature in the range of about 900 to about 1500.degree. C. to form a vitrified CBPC article comprising the radioisotope immobilized therein.

  3. Development of radioisotope preparation and application technology

    Energy Technology Data Exchange (ETDEWEB)

    Han, Hyon Soo; Park, K. B.; Bang, H. S. [and others

    2000-04-01

    The purpose of this project is to develop RI production technology utility 'HANARO' and to construct a sound infra-structure for mass production and supply to domestic users. The developed contents and results are as follows: two types of rig for irradiation in reactor core were designed and manufactured. The safety of OR rig during irradiation was identified through various test and it is used for RI production. The prepared IR rig will be used to performance tests for safety. We prepared two welders and welding jigs for production of sealed sources, and equipments for quality control of the welded materials. Production processes and apparatus Cr-51, P-32, I-125 and Sr-89, were developed. Developed results would be used for routine production and supply of radioisotopes. The automatic Tc-99m extraction apparatus was supplied to Libya under IAEA support. For approval on special form radioactive material of the developed Ir-192 source assembly and projector documents were prepared and submitted to MOST. The high dose rate Ir-192 source(diameter 1.1 mm, length 5.2 mm) for RALS and the laser welding system for its fabrication were developed. Production technologies of Ir-192 sources for destructive test and medical therapy were transferred to private company for commercial supply. The chemical immobilization method based on the self-assemble monolayer of {omega}-functionalized thiol and the sensing scheme based on the beta-emitter labeling method were developed for the fabrication radioimmuno-sensors. Results of this study will be applied to mass production of radioisotopes 'HANARO' and are to contribute the advance of domestic medicine and industry related to radioisotopes.

  4. Analysis of a Radioisotope Thermal Rocket Engine

    Science.gov (United States)

    Machado-Rodriguez, Jonathan P.; Landis, Geoffrey A.

    2017-01-01

    The Triton Hopper is a concept for a vehicle to explore the surface of Neptunes moon Triton, which uses a radioisotope heated rocket engine and in-situ propellant acquisition. The initial Triton Hopper conceptual design stores pressurized Nitrogen in a spherical tank to be used as the propellant. The aim of the research was to investigate the benefits of storing propellant at ambient temperature and heating it through a thermal block during engine operation, as opposed to storing gas at a high temperature.

  5. Medical Radioisotope Data Survey: 2002 Preliminary Results

    Energy Technology Data Exchange (ETDEWEB)

    Siciliano, Edward R.

    2004-06-23

    A limited, but accurate amount of detailed information about the radioactive isotopes used in the U.S. for medical procedures was collected from a local hospital and from a recent report on the U.S. Radiopharmaceutical Markets. These data included the total number of procedures, the specific types of procedures, the specific radioisotopes used in these procedures, and the dosage administered per procedure. The information from these sources was compiled, assessed, pruned, and then merged into a single, comprehensive and consistent set of results presented in this report. (PIET-43471-TM-197)

  6. Preparing for Harvesting Radioisotopes from FRIB

    Energy Technology Data Exchange (ETDEWEB)

    Peaslee, Graham F. [Hope College, Holland, MI (United States); Lapi, Suzanne E. [Washington Univ., St. Louis, MO (United States)

    2015-02-02

    The Facility for Rare Isotope Beams (FRIB) is the next generation accelerator facility under construction at Michigan State University. FRIB will produce a wide variety of rare isotopes by a process called projectile fragmentation for a broad range of new experiments when it comes online in 2020. The accelerated rare isotope beams produced in this facility will be more intense than any current facility in the world - in many cases by more than 1000-fold. These beams will be available to the primary users of FRIB in order to do exciting new fundamental research with accelerated heavy ions. In the standard mode of operation, this will mean one radioisotope will be selected at a time for the user. However, the projectile fragmentation process also yields hundreds of other radioisotopes at these bombarding energies, and many of these rare isotopes are long-lived and could have practical applications in medicine, national security or the environment. This project developed new methods to collect these long-lived rare isotopes that are by-products of the standard FRIB operation. These isotopes are important to many areas of research, thus this project will have a broad impact in several scientific areas including medicine, environment and homeland security.

  7. High purity materials as targets for radioisotope production: Needs ...

    Indian Academy of Sciences (India)

    Artificial transmutation of an element employing thermal neutrons in a reactor or high energy particle accelerators (cyclotrons) are the routes of radioisotope production world over. Availability of high purity target materials, natural or enriched, are crucial for any successful radioisotope programme. Selection of stable ...

  8. Assessment of radioisotope heaters for remote terrestrial applications

    Energy Technology Data Exchange (ETDEWEB)

    Uherka, K.L.

    1987-05-01

    This paper examines the feasibility of using radioisotope byproducts for special heating applications at remote sites in Alaska and other cold regions. The investigation included assessment of candidate radioisotope materials for heater applications, identification of the most promising cold region applications, evaluation of key technical issues and implementation constraints, and development of conceptual heater designs for candidate applications. Strontium-90 (Sr-90) was selected as the most viable fuel for radioisotopic heaters used in terrestrial applications. Opportunities for the application of radioisotopic heaters were determined through site visits to representative Alaska installations. Candidate heater applications included water storage tanks, sludge digesters, sewage lagoons, water piping systems, well-head pumping stations, emergency shelters, and fuel storage tank deicers. Radioisotopic heaters for water storage tank freeze-up protection and for enhancement of biological waste treatment processes at remote sites were selected as the most promising applications.

  9. Production of medical radioisotopes in the ORNL High Flux Isotope Reactor (HFIR) for cancer treatment and arterial restenosis therapy after PTCA

    Energy Technology Data Exchange (ETDEWEB)

    Knapp, F.F. Jr.; Beets, A.L.; Mirzadeh, S.; Alexander, C.W.; Hobbs, R.L.

    1998-06-01

    The High Flux Isotope Reactor (HFIR) at the Oak Ridge National Laboratory (ORNL) represents an important resource for the production of a wide variety of medical radioisotopes. In addition to serving as a key production site for californium-252 and other transuranic elements, important examples of therapeutic radioisotopes which are currently routinely produced in the HFIR for distribution include dysprosium-166 (parent of holmium-166), rhenium-186, tin-117m and tungsten-188 (parent of rhenium-188). The nine hydraulic tube (HT) positions in the central high flux region permit the insertion and removal of targets at any time during the operating cycle and have traditionally represented a major site for production of medical radioisotopes. To increase the irradiation capabilities of the HFIR, special target holders have recently been designed and fabricated which will be installed in the six Peripheral Target Positions (PTP), which are also located in the high flux region. These positions are only accessible during reactor refueling and will be used for long-term irradiations, such as required for the production of tin-117m and tungsten-188. Each of the PTP tubes will be capable of housing a maximum of eight HT targets, thus increasing the total maximum number of HT targets from the current nine, to a total of 57. In this paper the therapeutic use of reactor-produced radioisotopes for bone pain palliation and vascular brachytherapy and the therapeutic medical radioisotope production capabilities of the ORNL HFIR are briefly discussed.

  10. Integro-differential equation analysis and radioisotope imaging systems. Research proposal. [Testing of radioisotope imaging system in phantoms

    Energy Technology Data Exchange (ETDEWEB)

    Hart, H.

    1976-03-09

    Design modifications of a five-probe focusing collimator coincidence radioisotope scanning system are described. Clinical applications of the system were tested in phantoms using radioisotopes with short biological half-lives, including /sup 75/Se, /sup 192/Ir, /sup 43/K, /sup 130/I, and /sup 82/Br. Data processing methods are also described. (CH)

  11. Development of leakage monitoring system using radioisotopes

    Energy Technology Data Exchange (ETDEWEB)

    Lee, J. C.; Lee, D. S. [Seoil College, Seoul (Korea); Cho, Y. S. [Konyang University, Nonsan (Korea); Shin, S. K. [Sungkyunkwan Univ., Seoul (Korea)

    2000-04-01

    This study is to development the potable neutron back-scattering gauge for leakage and detecting liquid interface of an oil and liquid tank, using a radioisotopes. For this purpose, small sized, light weight potable gauge is to be designed as to develope neutron shielding mechanism, low power supply circuit, high voltage circuit, measurement circuit, and operating handle etc. The user will be able to set the duration of the time interval, the scale, the high voltage, the threshold, the channel window, the selection whether the data storage or not, the selection whether the scale, high voltage, threshold and window fix or not at any time. The counted pulse will be displayed with the numerical value and the line bar. The gauge will be able to connect to an IBM compatible PC via a serial port, power will be supplied by internal battery. 9 refs., 28 figs., 10 tabs. (Author)

  12. Radioisotope Power Systems Program Status and Expectations

    Science.gov (United States)

    Zakrajsek, June F.; Hamley, John A.; Sutliff, Thomas J.; Mccallum, Peter W.; Sandifer, Carl E.

    2017-01-01

    The Radioisotope Power Systems (RPS) Programs goal is to make RPS available for the exploration of the solar system in environments where conventional solar or chemical power generation is impractical or impossible to use to meet mission needs. To meet this goal, the RPS Program manages investments in RPS system development and RPS technologies. The RPS Program exists to support NASA's Science Mission Directorate (SMD). The RPS Program provides strategic leadership for RPS, enables the availability of RPS for use by the planetary science community, successfully executes RPS flight projects and mission deployments, maintains a robust technology development portfolio, manages RPS related National Environmental Policy Act (NEPA) and Nuclear Launch Safety (NLS) approval processes for SMD, maintains insight into the Department of Energy (DOE) implementation of NASA funded RPS production infrastructure operations, including implementation of the NASA funded Plutonium-238 production restart efforts. This paper will provide a status of recent RPS activities.

  13. Recent progress in development of radioisotope production

    Energy Technology Data Exchange (ETDEWEB)

    Yoon, Byung Mok [HANARO Center, Korea Atomic Energy Research Institute, Taejon (Korea, Republic of)

    1998-10-01

    The Korea multipurpose research reactor, HANARO(Hi-flux Advanced Neutron Application Reactor) is designed and constructed to obtain high density neutron flux (max. 5x10{sup 14} n/cm{sup 2}{center_dot}sec) with relatively low thermal output (30 MW) in order to utilize for various studies such as fuel and material test, radioisotope production, neutron activation analysis, neutron beam experiment, neutron transmutation doping, etc. HANARO has 32 vertical channels (3 in-core, 4 out-core, 25 reflector) and 7 horizontal channels. KAERI has constructed 4 concrete hot cells for production of Co-60, Ir-192, etc. and 6 lead hot cells for production of medical RIs(I-131, Mo-99, etc.). Other 11 lead hot cells will be completed by Feb. 1998 for production of Sm-153, Dy-165, Ho-166, etc. Clean room facilities were installed for production of radiopharmaceuticals. (author)

  14. Life atomic a history of radioisotopes in science and medicine

    CERN Document Server

    Creager, Angela N H

    2013-01-01

    After World War II, the US Atomic Energy Commission (AEC) began mass-producing radioisotopes, sending out nearly 64,000 shipments of radioactive materials to scientists and physicians by 1955. Even as the atomic bomb became the focus of Cold War anxiety, radioisotopes represented the government's efforts to harness the power of the atom for peace-advancing medicine, domestic energy, and foreign relations.             In Life Atomic, Angela N. H. Creager tells the story of how these radioisotopes, which were simultaneously scientific tools and political icons, transformed biomedicine and ecolog

  15. Radioisotope Reduction Using Solar Power for Outer Planetary Missions

    Science.gov (United States)

    Fincannon, James

    2008-01-01

    Radioisotope power systems have historically been (and still are) the power system of choice from a mass and size perspective for outer planetary missions. High demand for and limited availability of radioisotope fuel has made it necessary to investigate alternatives to this option. Low mass, high efficiency solar power systems have the potential for use at low outer planetary temperatures and illumination levels. This paper documents the impacts of using solar power systems instead of radioisotope power for all or part of the power needs of outer planetary spacecraft and illustrates the potential fuel savings of such an approach.

  16. Variable Conductance Heat Pipes for Radioisotope Stirling Systems Project

    Data.gov (United States)

    National Aeronautics and Space Administration — The overall program objective is to develop a high temperature variable conductance heat pipe (VCHP) backup radiator, and integrate it into a Stirling radioisotope...

  17. Advanced Radiative Emitters for Radioisotope Thermophotovoltaic Power Systems Project

    Data.gov (United States)

    National Aeronautics and Space Administration — Radioisotope Power Systems (RPS) are critical for future flagship exploration missions in space and on planetary surfaces. Small improvements in the RPS performance,...

  18. Advanced Radiative Emitters for Radioisotope Thermophotovoltaic Power Systems Project

    Data.gov (United States)

    National Aeronautics and Space Administration — Radioisotope Power Systems (RPS) are critical for future space and planetary exploration missions. Small improvements in the RPS performance, weight, size, and/or...

  19. A power conditioning system for radioisotope thermoelectric generator energy sources

    Science.gov (United States)

    Gillis, J. A., Jr.

    1974-01-01

    The use of radioisotope thermoelectric generators (RTG) as the primary source of energy in unmanned spacecraft is discussed. RTG output control, power conditioning system requirements, the electrical design, and circuit performance are also discussed.

  20. Work in progress: radioisotopic evaluation of gastroplasty patients

    Energy Technology Data Exchange (ETDEWEB)

    Drane, W.E.; Marks, D.S.; Simms, S.M.; Saylor, J.G.; Haas, P.A.; Kambouris, A.A.

    1983-04-01

    Radioisotopic gastric emptying studies, using technetium-99m-sulfur-colloid-labeled egg, were performed in 14 patients who had undergone gastroplasty. The radioisotopic method was found to be a good quantitative indicator of the amount of solids that empty from the stomach and a useful tool in the longterm follow-up of gastroplasty patients. It was particularly helpful in evaluating the efficacy of surgery in patients with poor postsurgical weight reduction.

  1. Work in progress: radioisotopic evaluaton of gastroplasty patients

    Energy Technology Data Exchange (ETDEWEB)

    Drane, W.E.; Marks, D.S.; Simms, S.M.; Saylor, J.G.; Haas, P.A.; Kambouris, A.H.

    1983-04-01

    Radioisotopic gastric emptying studies, using technetium-99m-sulfur-colloid-labeled egg, were performed in 14 patients who had undergone gastroplasty. The radioisotopic method was found to be a good quantitative indicator of the amount of solids that empty from the stomach and a useful tool in the long-term follow-up of gastroplasty patients. It was particularly helpful in evaluating the efficacy of surgery in patients with poor postsurgical weight reduction.

  2. Production of medical radioisotopes in the ORNL high flux isotope reactor (HFIR) for cancer treatment and arterial restenosis therapy after PICA

    Science.gov (United States)

    Knapp, F. F.; Beets, A. L.; Mirzadeh, S.; Alexander, C. W.; Hobbs, R. L.

    1999-01-01

    The High Flux Isotope Reactor ( HFIR) at the Oak Ridge National Laboratory ( ORNL) represents an important resource for the production of a wide variety of medical radioisotopes. First beginning operation in 1965, the high thermal neutron flux (2.5×1015 neutrons/cm2/sec at 85 MW) and versatile target irradiation and handling facilities provide the opportunity for production of a wide variety of neutron-rich medical radioisotopes of current interest for therapy. In addition to serving as a key production site for californium-252 and other transuranic elements, important examples of therapeutic radioisotopes which are currently routinely produced in the HFIR for distribution include dysprosium-166 (parent of holmium-166), rhenium-186, tin-117 m and tungsten-188 (parent of rhenium-188). The nine hydraulic tube ( HT) positions in the central high flux region permit the insertion and removal of targets at any time during the operating cycle (22-24 days) and have traditionally represented a major site for production of medical radioisotopes. To increase the irradiation capabilities of the HFIR, special target holders have recently been designed and fabricated which will be installed in the six Peripheral Target Positions ( PTP), which are also located in the high flux region. These positions are only accessible during reactor refueling and will be used for long-term irradiations, such as required for the production of tin-117 m and tungsten-188. Each of the PTP tubes will be capable of housing a maximum of eight HT targets, thus increasing the total maximum number of HT targets from the current nine, to a total of 57. In this paper the therapeutic use of reactor-produced radioisotopes for bone pain palliation and vascular brachytherapy and the therapeutic medical radioisotope production capabilities of the ORNL HFIR are briefly discussed.

  3. The monoclonal antibodies as radioisotope vectors; Les anticorps monoclonaux vecteurs de radioisotopes

    Energy Technology Data Exchange (ETDEWEB)

    Barbet, J. [IMMUNOTECH, 13 - Marseille (France)

    1994-07-01

    The radioisotope targetting wants to show that only a reflection integrating the whole parameters which can interfere after the vector molecule injection, may give real success chances in the conception and the implementation of the targetting technologies. About 20 years later, the discovery of monoclonal antibodies, the balance, estimated on the product number placed at disposal of the clinicians remains very poor. Nevertheless it is undeniable that the immunoscintigraphy, the immunoradio-controlled surgery and radioimmunotherapy proved their clinical efficiency on experimental level. 6 refs., 3 tabs., 3 figs.

  4. Accidental radioisotope burns - Management of late sequelae

    Directory of Open Access Journals (Sweden)

    Varghese Bipin

    2010-10-01

    Full Text Available Accidental radioisotope burns are rare. The major components of radiation injury are burns, interstitial pneumonitis, acute bone marrow suppression, acute renal failure and adult respiratory distress syndrome. Radiation burns, though localized in distribution, have systemic effects, and can be extremely difficult to heal, even after multiple surgeries. In a 25 year old male who sustained such trauma by accidental industrial exposure to Iridium192 the early presentation involved recurrent haematemesis, pancytopenia and bone marrow suppression. After three weeks he developed burns in contact areas in the left hand, left side of the chest, abdomen and right inguinal region. All except the inguinal wound healed spontaneously but the former became a non-healing ulcer. Pancytopenia and bone marrow depression followed. He was treated with morphine and NSAIDs, epidural buprinorphine and bupivicaine for pain relief, steroids, antibiotics followed by wound excision and reconstruction with tensor fascia lata(TFL flap. Patient had breakdown of abdominal scar later and it was excised with 0.5 cm margins up to the underlying muscle and the wound was covered by a latissimis dorsi flap. Further scar break down and recurrent ulcers occurred at different sites including left wrist, left thumb and right heel in the next two years which needed multiple surgical interventions.

  5. Comparative analysis of 11 different radioisotopes for palliative treatment of bone metastases by computational methods

    Energy Technology Data Exchange (ETDEWEB)

    Guerra Liberal, Francisco D. C., E-mail: meb12020@fe.up.pt, E-mail: adriana-tavares@msn.com; Tavares, Adriana Alexandre S., E-mail: meb12020@fe.up.pt, E-mail: adriana-tavares@msn.com; Tavares, João Manuel R. S., E-mail: tavares@fe.up.pt [Instituto de Engenharia Mecânica e Gestão Industrial, Faculdade de Engenharia, Universidade do Porto, Rua Dr. Roberto Frias s/n, Porto 4200-465 (Portugal)

    2014-11-01

    Purpose: Throughout the years, the palliative treatment of bone metastases using bone seeking radiotracers has been part of the therapeutic resources used in oncology, but the choice of which bone seeking agent to use is not consensual across sites and limited data are available comparing the characteristics of each radioisotope. Computational simulation is a simple and practical method to study and to compare a variety of radioisotopes for different medical applications, including the palliative treatment of bone metastases. This study aims to evaluate and compare 11 different radioisotopes currently in use or under research for the palliative treatment of bone metastases using computational methods. Methods: Computational models were used to estimate the percentage of deoxyribonucleic acid (DNA) damage (fast Monte Carlo damage algorithm), the probability of correct DNA repair (Monte Carlo excision repair algorithm), and the radiation-induced cellular effects (virtual cell radiobiology algorithm) post-irradiation with selected particles emitted by phosphorus-32 ({sup 32}P), strontium-89 ({sup 89}Sr), yttrium-90 ({sup 90}Y ), tin-117 ({sup 117m}Sn), samarium-153 ({sup 153}Sm), holmium-166 ({sup 166}Ho), thulium-170 ({sup 170}Tm), lutetium-177 ({sup 177}Lu), rhenium-186 ({sup 186}Re), rhenium-188 ({sup 188}Re), and radium-223 ({sup 223}Ra). Results: {sup 223}Ra alpha particles, {sup 177}Lu beta minus particles, and {sup 170}Tm beta minus particles induced the highest cell death of all investigated particles and radioisotopes. The cell survival fraction measured post-irradiation with beta minus particles emitted by {sup 89}Sr and {sup 153}Sm, two of the most frequently used radionuclides in the palliative treatment of bone metastases in clinical routine practice, was higher than {sup 177}Lu beta minus particles and {sup 223}Ra alpha particles. Conclusions: {sup 223}Ra and {sup 177}Lu hold the highest potential for palliative treatment of bone metastases of all

  6. Use of copper radioisotopes in investigating disorders of copper metabolism

    Energy Technology Data Exchange (ETDEWEB)

    Camakaris, J.; Voskoboinik, I.; Brooks, H.; Greenough, M. [University of Melbourne, Parkville, VIC (Australia). Department of Genetics; Smith, S. [Australian Nuclear Science and Technology Organisation (ANSTO), Lucas Heights, NSW (Australia). Radiopharmaceuticals Division; Mercer, J. [Deakin University, Rusden Campus, Clayton, VIC (Australia). Centre of Cellular and Molecular Biology

    1998-12-31

    Full text: Copper is an essential trace element for life as a number of vital enzymes require it. Copper deficiency can lead to neurological disorders, osteoporosis and weakening of arteries. However Cu is also highly toxic and homeostatic mechanisms have evolved to maintain Cu at levels which satisfy requirements but do not cause toxicity. Toxicity is mediated by the oxidative capacity of Cu and its ability to generate toxic free radicals. There are several acquired and inherited diseases due to either Cu toxicity or Cu deficiency. The study of these diseases facilitates identification of genes and proteins involved in copper homeostasis, and this in turn will provide rational therapeutic approaches. Our studies have focused on Menkes disease in humans which is an inherited and usually lethal copper deficiency. Using copper radioisotopes {sup 64}Cu (t 1/2 = 12.8 hr) and {sup 67}Cu (t 1/2 = 61 hr) we have studied the protein which is mutated in Menkes disease. This is a transmembrane copper pump which is responsible for absorption of copper into the body and also functions to pump out excess Cu from cells when Cu is elevated. It is therefore a vital component of normal Cu homeostasis. We have provided the first biochemical evidence that the Menkes protein functions as a P-type ATPase Cu pump (Voskoboinik et al., FEBS Letters, in press) and these data will be discussed. The assay involved pumping of radiocopper into purified membrane vesicles. Furthermore we have transfected normal and mutant Menkes genes into cells and are carrying out structure-function studies. We are also studying the role of amyloid precursor protein (APP) as a Cu transport protein in order to determine how Cu regulates this protein and its cleavage products. These studies will provide vital information on the relationship between Cu and APP and processes which lead to Alzheimers disease

  7. Studies of copper transport in mammalian cells using copper radioisotopes

    Energy Technology Data Exchange (ETDEWEB)

    Camakaris, J.; Voskoboinik, I.; Brooks, H.; Greenough, M. [University of Melbourne, Parkville, VIC (Australia). Department of Genetics; Smith, S. [Australian Nuclear Science and Technology Organisation, Lucas Heights, NSW (Australia). Radiopharmaceuticals Division; Mercer, J. [Deakin University, Clayton, VIC (Australia). Centre of Cellular and Molecular Biology

    1998-12-31

    The trace element copper poses a major problem for all organisms. It is essential as a number of vital enzymes require it. Copper deficiency can lead to neurological disorders, osteoporosis and weakening of arteries. However Cu is also highly toxic and homeostatic mechanisms have evolved to maintain Cu at levels which satisfy requirements but do not cause toxicity. Toxicity is mediated by the oxidative capacity of Cu and its ability to generate toxic free radicals. There are several acquired and inherited diseases due to either Cu toxicity or Cu deficiency. The study of these diseases facilitates identification of genes and proteins involved in copper homeostasis, and this in turn will provide rational therapeutic approaches. Using the copper radioisotopes {sup 64}Cu (t1/2 = 12.8 hr) and {sup 67}Cu (t1/2 = 61 hr) we have developed a number of systems for studying copper transport in mammalian cells. These include investigation of copper uptake, copper efflux and ligand blot assays for Cu-binding proteins. Our studies have focused on Menkes disease which is an inherited and usually lethal copper deficiency disorder in humans. We have demonstrated that the Menkes protein is directly involved as a copper efflux pump in mammalian cells. Using cells overexpressing the Menkes protein we have provided the first biochemical evidence that this functions as a Cu translocating (across the membrane) P-type ATPase (Voskoboinik et al., FEBS Letters, in press). These studies were carried out using purified plasma membrane vesicles. We are now carrying out structure- function studies on this protein using targeted mutations and assaying using the radiocopper vesicle assay. Recently we have commenced studies on the role of amyloid precursor protein (APP) in copper transport and relationship of this to Alzheimers disease

  8. Chemistry of Cosmogenic Radioisotopes in the Stratosphere

    Science.gov (United States)

    Rowland, F. S.

    2003-12-01

    Bombardment of Earth's atmosphere by Gev cosmic ray protons produces two neutrons/cm2/second, which react with 14N nuclei to form 14C. The initial stratospheric reaction of the bare 14C atom with O2 forms 14CO, which is subsequently oxidized to 14CO2 by HO. The 14CO2 is then the basis for age-dating studies of inorganic carbon, and of organic carbon after incorporation by photosynthesis. Proton spallation of light nuclei (chiefly 14N, 16O) produces various isotopic fragments, many of them radioactive, containing 8 or fewer protons and 10 or fewer neutrons. For geophysical studies, the most important of the radioisotopes so produced are 3H, 7Be, and 10Be. Proton spallation of 40Ar produces many isotopes with atomic weight less than 40, including 34Cl, 36Cl, 38Cl, 39Cl, 35S, 38S, 22Na, 24Na, 32Si, 32P, and 33P, all of which have been detected in the atmosphere. The "million year" isotopes (10Be, 36Cl) are useful for geological dating. The short-lived isotopes were collected both from rainwater captured at ground level, and on filter paper at 18 kilometers altitude carried by an RB-57 aircraft (1970, J. A. Young, C. W. Thomas, N. A. Wogman and R. W. Perkins, JGR, 75, 2385). The radioisotopes were measured with multidimensional gamma ray spectroscopy, which was able to detect 24Na and 38Cl without prior chemical separation. Count rates as low as 0.1 count/minute were monitored, even in the presence of 107 counts/minute of fallout fission products from nuclear testing in the atmosphere. This fallout background is now greatly reduced because of the four decades old ban on nuclear testing in the atmosphere. The stratospheric collection of 24Na (15 hour half-life) was interpreted as scavenging of the radiosodium by particulate matter, and retention on filter paper with an efficiency of 100 percent within the statistical accuracy in comparison with its production in argon tanks carried on the aircraft. The efficiency of collection of radiochlorine atoms was only about 1

  9. Radioisotopes present in building materials of workplaces

    Science.gov (United States)

    Del Claro, F.; Paschuk, S. A.; Corrêa, J. N.; Denyak, V.; Kappke, J.; Perna, A. F. N.; Martins, M. R.; Santos, T. O.; Rocha, Z.; Schelin, H. R.

    2017-11-01

    The isotope 222Rn is responsible for approximately half of the effective annual dose received by the world population. The decay products of 222Rn interacting with the cells of biological tissue of lungs have very high probability to induce cancer. The present survey was focused in the evaluation of activity concentration of 222Rn and other radioisotopes related to the building materials at workplaces at Curitiba - Paraná State. For this purpose, the instant radon detector AlphaGUARD (Saphymo GmbH) was used to measure the average concentrations of 222Rn in building materials, which were also submitted to gamma spectrometry analysis for qualitative and quantitative evaluation of the radionuclides present in samples of sand, mortar, blue crushed stone (Gneissic rock), red crushed stone (Granite), concrete and red bricks. The main radionuclides evaluated by gamma spectrometry in building material samples were 238U/226Ra, 232Th and 40K. These measurements were performed at the Laboratory of Applied Nuclear Physics of the Federal University of Technology - Paraná in collaboration with the Center of Nuclear Technology Development (CDTN - CNEN). The results of the survey present the concentration values of 222Rn related to construction materials in a range from 427±40.52 Bq/m³ to 2053±90.06 Bq/m³. The results of gamma spectroscopy analysis show that specific activity values for the mentioned isotopes are similar to the results indicated by the literature. Nevertheless, the present survey is showing the need of further studies and indicates that building materials can contribute significantly to indoor concentration of 222Rn.

  10. High Efficiency Thermoelectric Radioisotope Power Systems

    Science.gov (United States)

    El-Genk, Mohamed; Saber, Hamed; Caillat, Thierry

    2004-01-01

    The work performed and whose results presented in this report is a joint effort between the University of New Mexico s Institute for Space and Nuclear Power Studies (ISNPS) and the Jet Propulsion Laboratory (JPL), California Institute of Technology. In addition to the development, design, and fabrication of skutterudites and skutterudites-based segmented unicouples this effort included conducting performance tests of these unicouples for hundreds of hours to verify theoretical predictions of the conversion efficiency. The performance predictions of these unicouples are obtained using 1-D and 3-D models developed for that purpose and for estimating the actual performance and side heat losses in the tests conducted at ISNPS. In addition to the performance tests, the development of the 1-D and 3-D models and the development of Advanced Radioisotope Power systems for Beginning-Of-Life (BOM) power of 108 We are carried out at ISNPS. The materials synthesis and fabrication of the unicouples are carried out at JPL. The research conducted at ISNPS is documented in chapters 2-5 and that conducted at JP, in documented in chapter 5. An important consideration in the design and optimization of segmented thermoelectric unicouples (STUs) is determining the relative lengths, cross-section areas, and the interfacial temperatures of the segments of the different materials in the n- and p-legs. These variables are determined using a genetic algorithm (GA) in conjunction with one-dimensional analytical model of STUs that is developed in chapter 2. Results indicated that when optimized for maximum conversion efficiency, the interfacial temperatures between various segments in a STU are close to those at the intersections of the Figure-Of-Merit (FOM), ZT, curves of the thermoelectric materials of the adjacent segments. When optimizing the STUs for maximum electrical power density, however, the interfacial temperatures are different from those at the intersections of the ZT curves, but

  11. Hair radioactivity as a measure of exposure to radioisotopes

    Science.gov (United States)

    Strain, W. H.; Pories, W. J.; Fratianne, R. B.; Flynn, A.

    1972-01-01

    Since many radioisotopes accumulate in hair, this tropism was investigated by comparing the radioactivity of shaved with plucked hair collected from rats at various time intervals up to 24 hrs after intravenous injection of the ecologically important radioisotopes, iodine-131, manganese-54, strontium-85, and zinc-65. The plucked hair includes the hair follicles where biochemical transformations are taking place. The data indicate a slight surge of each radioisotpe into the hair immediately after injection, a variation of content of each radionuclide in the hair, and a greater accumulation of radioactivity in plucked than in shaved hair. These results have application not only to hair as a measure of exposure to radioisotopes, but also to tissue damage and repair at the hair follicle.

  12. KAERI charged particle cross section library for radioisotope production

    CERN Document Server

    Chang, J H; Kim, D H; Lee, Y O; Zhuang, Y X

    2001-01-01

    This report summarized information and figures describing the 'KAERI Charged Particle Cross Section Library for Radioisotope production' The library contains proton-, deutron-, He-3-, and alpha-induced monitor cross sections, and gamma- and positron-emitter production cross sections. Experimental data and evaluation methods are described, and the evaluated cross sections are compared with those of the IAEA, MENDL, and LA150. The library has cross sections and emission spectra suitable for the transport analysis in the design of radioisotope production system, and are available at http://atom.kaeri.re.kr/ in ENDF-6 format.

  13. Results with radioisotope techniques in veterinary science in Hungary

    Energy Technology Data Exchange (ETDEWEB)

    Pethes, G. (Allatorvostudomanyi Egyetem, Budapest (Hungary))

    1983-09-01

    Radioisotopes have been applied to veterinary science in Hungary since the fifties. A short chronologic review on the development of isotope technology is given emphasizing the possibilities offered by the application of closed and open radiation sources, of instrumental neutron activation analysis and atomic absorption spectroscopy, and in vitro nuclear procedures which include competitive protein-binding analysis and radioimmunoassay. The progesterone test, applicable to diagnose the pregnancy of cattles, is carried out generally by RIA. Radioisotopic methods are applied also to determine the thyroid function of cattles, swines and domestic fowls.

  14. Radioisotope diagnosis of the insufficient femoropatellar joint

    Energy Technology Data Exchange (ETDEWEB)

    Popko, J.; Mnich, Z.; Wasilewski, A. (Akademia Medyczna, Bialystok (Poland))

    1984-01-01

    In 14 patients suffering from chondromalacia patellae as well as in 6 patients with a femoropatellar arthrosis the perfusion of the kneecap was measured scintigraphically by means of /sup 125/I-iodoantipirin. A retarded elimination of the isotopes could be found both with the chondromalacia and with the arthrosis. The course of the curve of secretion of /sup 125/I-iodoantipirin as well as the calculated half-life-period of the decline of activity give valuable diagnostic and therapeutic hints.

  15. 78 FR 1848 - Plutonium-238 Production for Radioisotope Power Systems for National Aeronautics and Space...

    Science.gov (United States)

    2013-01-09

    ... Plutonium-238 Production for Radioisotope Power Systems for National Aeronautics and Space Administration...-238 (Pu-238) for radioisotope power systems (RPSs) to support the National Aeronautics and Space... Radioisotope Power Systems (Draft Consolidation EIS) in 2005 to consolidate the nuclear operations related to...

  16. Current status of the production and research of radioisotopes in JAERI

    Energy Technology Data Exchange (ETDEWEB)

    Takahashi, Hidetake [Japan Atomic Energy Research Inst., Tokai, Ibaraki (Japan). Tokai Research Establishment; Sekine, Toshiaki [Japan Atomic Energy Research Inst., Takasaki, Gunma (Japan). Takasaki Radiation Chemistry Research Establishment

    2000-10-01

    Status of the radioisotope production and application in Japan is described, emphasizing that of reactor-produced radioisotopes for medicine. Some new application of reactor-produced radioisotopes to therapy are discussed together with those of positron emitters for medicine and plant physiology. (author)

  17. Cyclic irradiation method for production of radioisotope tracers using ...

    African Journals Online (AJOL)

    Cyclic Irradiation Method (CIM) involving repeated irradiation of samples at regular time intervals to build up activity has been adopted for the production of 82 Br, 72 Ga, 140La, 24 Na and 46 Sc isotopes using the low power Ghana Research Reactor-1. The results indicate that the specific activities of radioisotopes from ...

  18. Future Supply of Medical Radioisotopes for the UK Report 2014

    CERN Document Server

    Neilly, Brian; Ballinger, Jim; Buscombe, John; Clarke, Rob; Ellis, Beverley; Flux, Glenn; Fraser, Louise; Hall, Adrian; Owen, Hywel; Paterson, Audrey; Perkins, Alan; Scarsbrook, Andrew

    2015-01-01

    The UK has no research nuclear reactors and relies on the importation of 99Mo and other medical radioisotopes (e.g. Iodine-131) from overseas (excluding PET radioisotopes). The UK is therefore vulnerable not only to global shortages, but to problems with shipping and importation of the products. In this context Professor Erika Denton UK national Clinical Director for Diagnostics requested that the British Nuclear Medicine Society lead a working group with stakeholders including representatives from the Science & Technology Facilities Council (STFC) to prepare a report. The group had a first meeting on 10 April 2013 followed by a working group meeting with presentations on 9th September 2013 where the scope of the work required to produce a report was agreed. The objectives of the report are: to describe the status of the use of medical radioisotopes in the UK; to anticipate the potential impact of shortages for the UK; to assess potential alternative avenues of medical radioisotope production for the UK m...

  19. Applications of radioisotopes in industry and healthcare in Vietnam

    Energy Technology Data Exchange (ETDEWEB)

    Dien, N.N.; Quang, N.H. [Nucealr Research Institute, Dalat, (Viet Nam)

    1997-10-01

    Nowadays, in Vietnam radioisotopes have been used very widely in various socio-economic branches, especially in industry and healthcare. Applications of radioisotopes have significant meaning in economic development, people health protection, as well as in scientific research. In this paper, the present status and main applications of radiation and radioactive isotopes in industry and healthcare in Vietnam are reported. In order to control and monitor industrial processes, nucleonic control systems and radioactive tracer techniques have been utilized. Actually, sealed source applications are popular in Vietnam industry. A number of nuclear control devices and gauges have been used in the various industrial factories, such as liquid level gauges in steel industry, cement and beverage factories; density and moisture gauges in paper industry, etc. Tracer technique and sealed source applications have also been utilized in industrial production plants and in trouble-shooting in the petroleum industry. For medicine purposes, two departments of nuclear medicine were primarily established at the beginning of the 1970s. At the present time, a number of nuclear medicine departments have been set up and they have been equipped with advanced equipment. Main activities are focused on thyroid function studies, nuclear cardiology, brain scans, gastrointestinal studies, bone scans, etc. Since march 1984 Dalat nuclear research reactor of nominal power of 500 kW has been reconstructed and put into operation. This reactor is unique in Vietnam and has become an important scientific tool for development of nuclear techniques and radioisotope applications for socio-economic progress. Thanks to this important scientific tool, a variety of radioisotopes for medicine and industry applications as well as for scientific research has been produced. Utilization of the Dalat research reactor for radioisotope production is also summarized in this paper

  20. Production capabilities in US nuclear reactors for medical radioisotopes

    Energy Technology Data Exchange (ETDEWEB)

    Mirzadeh, S.; Callahan, A.P.; Knapp, F.F. Jr. (Oak Ridge National Lab., TN (United States)); Schenter, R.E. (Westinghouse Hanford Co., Richland, WA (United States))

    1992-11-01

    The availability of reactor-produced radioisotopes in the United States for use in medical research and nuclear medicine has traditionally depended on facilities which are an integral part of the US national laboratories and a few reactors at universities. One exception is the reactor in Sterling Forest, New York, originally operated as part of the Cintichem (Union Carbide) system, which is currently in the process of permanent shutdown. Since there are no industry-run reactors in the US, the national laboratories and universities thus play a critical role in providing reactor-produced radioisotopes for medical research and clinical use. The goal of this survey is to provide a comprehensive summary of these production capabilities. With the temporary shutdown of the Oak Ridge National Laboratory (ORNL) High Flux Isotope Reactor (HFIR) in November 1986, the radioisotopes required for DOE-supported radionuclide generators were made available at the Brookhaven National Laboratory (BNL) High Flux Beam Reactor (HFBR). In March 1988, however, the HFBR was temporarily shut down which forced investigators to look at other reactors for production of the radioisotopes. During this period the Missouri University Research Reactor (MURR) played an important role in providing these services. The HFIR resumed routine operation in July 1990 at 85 MW power, and the HFBR resumed operation in June 1991, at 30 MW power. At the time of the HFBR shutdown, there was no available comprehensive overview which could provide information on status of the reactors operating in the US and their capabilities for radioisotope production. The obvious need for a useful overview was thus the impetus for preparing this survey, which would provide an up-to-date summary of those reactors available in the US at both the DOE-funded national laboratories and at US universities where service irradiations are currently or expected to be conducted.

  1. Development of the cyclotron radioisotope production technology

    Energy Technology Data Exchange (ETDEWEB)

    Suh, Yong Sup; Chun, K.S.; Yang, S.D.; Lee, J.D.; Ahn, S.H.; Yun, Y.K.; Park, H.; Lee, J.S.; Chai, J.S.; Kim, U.S.; Hong, S.S.; Lee, M.Y.; Park, C.W.; Baik, S. K.; Kim, E. H.; Kim, T. K.; Kim, K. S.; Kim, J. H

    1999-04-01

    The purpose of this study is to contribute the advance of nuclear medicine and to the improvement of human health through the development of various accelerator radionuclides and mass production with automization of production. The results obtained from this study are following: 1) In order to introduce 30 MeV high current cyclotron, the specification of cyclotron has been made, the building site was selected and we drew the draw-up of cyclotron. The cyclotron installation contract was postponed until the financial resources could be secured. 2) For a development high purity 1-123 producing system, a Xe-124 target system, a temperature measurement system of the inner part of the target and a target window were fabricated. A Xe-124 gas target recovery system and a full production system of 1-123 was drew up. 3) For a development of a therapeutic nuclide At-211, a target for the production of At-211 via {sup 209}Bi(alpha, 2n) reaction was fabricated. Produced At-211 was separated by distillation method. 4) For development of beta-emitting nuclides, Ti-45, C-11, F{sub 2}-18, beam irradiation system suitable for each target were fabricated. 5) For automatic production of Ga-67, automated module and PLC program was made 6) For the quality control of radiopharmaceuticals, analytical method of thallium and copper by polarography was investigated and established.

  2. Environmental assessment for radioisotope heat source fuel processing and fabrication

    Energy Technology Data Exchange (ETDEWEB)

    1991-07-01

    DOE has prepared an Environmental Assessment (EA) for radioisotope heat source fuel processing and fabrication involving existing facilities at the Savannah River Site (SRS) near Aiken, South Carolina and the Los Alamos National Laboratory (LANL) near Los Alamos, New Mexico. The proposed action is needed to provide Radioisotope Thermoelectric Generators (RTG) to support the National Aeronautics and Space Administration's (NASA) CRAF and Cassini Missions. Based on the analysis in the EA, DOE has determined that the proposed action does not constitute a major Federal action significantly affecting the quality of the human environment within the meaning of the National Environmental Policy Act (NEPA) of 1969. Therefore, an Environmental Impact Statement is not required. 30 refs., 5 figs.

  3. Investigation of Insulation Materials for Future Radioisotope Power Systems

    Science.gov (United States)

    Cornell, Peggy A.; Hurwitz, Frances I.; Ellis, David L.; Schmitz, Paul C.

    2013-01-01

    NASA's Radioisotope Power Systems (RPS) Technology Advancement Project is developing next generation high-temperature insulation materials that directly benefit thermal management and improve performance of RPS for future science missions. Preliminary studies on the use of multilayer insulation (MLI) for Stirling convertors used on the Advanced Stirling Radioisotope Generator (ASRG) have shown the potential benefits of MLI for space vacuum applications in reducing generator size and increasing specific power (W/kg) as compared to the baseline Microtherm HT (Microtherm, Inc.) insulation. Further studies are currently being conducted at NASA Glenn Research Center on candidate MLI foils and aerogel composite spacers. This paper presents the method of testing of foils and spacers and experimental results to date.

  4. Investigation of Insulation Materials for Future Radioisotope Power Systems (RPS)

    Science.gov (United States)

    Cornell, Peggy A.; Hurwitz, Frances I.; Ellis, David L.; Schmitz, Paul C.

    2013-01-01

    NASA's Radioisotope Power System (RPS) Technology Advancement Project is developing next generation high temperature insulation materials that directly benefit thermal management and improve performance of RPS for future science missions. Preliminary studies on the use of multilayer insulation (MLI) for Stirling convertors used on the Advanced Stirling Radioisotope Generator (ASRG) have shown the potential benefits of MLI for space vacuum applications in reducing generator size and increasing specific power (W/kg) as compared to the baseline Microtherm HT (Microtherm, Inc.) insulation. Further studies are currently being conducted at NASA Glenn Research Center (GRC) on candidate MLI foils and aerogel composite spacers. This paper presents the method of testing of foils and spacers and experimental results to date.

  5. Emitted radiation characteristics of plutonium dioxide radioisotope thermoelectric generators

    Science.gov (United States)

    Gingo, P. J.; Steyn, J. J.

    1971-01-01

    The nuclear and emitted radiation characteristics of the radioisotope elements and impurities in commercial grade plutonium dioxide are presented in detail. The development of the methods of analysis are presented. Radioisotope thermoelectric generators (RTG) of 1575, 3468 and 5679 thermal watts are characterized with respect to neutron and gamma photon source strength as well as spatial and number flux distribution. The results are presented as a function of detector position and light element contamination concentration for fuel age ranging from 'fresh' to 18 years. The data may be used to obtain results for given O-18 and Pu-236 concentrations. The neutron and gamma photon flux and dose calculations compare favorably with reported experimental values for SNAP-27.

  6. Safety evaluation on use and waste of medical radioisotopes

    Energy Technology Data Exchange (ETDEWEB)

    Kim, Jang Hee; Chung, Y. Y.; Chun, J. H.; Ahn, H. Y.; Lee, G. B.; Park, J. O.; Oh, G. B.; Hong, C. S.; Kim, G. S. [Korea Cancer Center Hospital, Seoul (Korea, Republic of)

    2001-03-15

    This study was performed a survey of many hospitals using radioisotopes in order to check the amount of use and used radioisotopes, radioactive waste, status of radiation safety and control and the exposure of radiation workers who are working at department of nuclear medicine. At the time of the survey, this study is provided as a guide to the safe handling radionuclides. It will prove helpful all users. The basic objective of radiation safety technique and national standardization of safe handling radioactive materials are to keep the radiation dose to man as low as are under any regulation within the annual dose limits recommended by Most. Further routine monitoring of I-131 high dose therapy ward was carried out the effectiveness of safety precautions taken to prevent undue release of I-131 to the environment.

  7. Analysis of status of radiation/radioisotopes utilization

    Energy Technology Data Exchange (ETDEWEB)

    Park, Chan Hee; Lee, Seung Hyun; Kim, Na Kyung; Kim, Kon Wuk [Business Innovation Office, Korean Association for Radiation Application, Seoul (Korea, Republic of)

    2017-03-15

    The use of radiation and radioisotopes in Korea has been increasing each year, and its impact on economy and industry is expected to be increasing progressively following the development of industrial technology and the expansion of their usage. To establish and supporting policies for industries using radiation and radioisotopes, it is necessary to check the status of related industries accurately, as well as to gather data required to establish plans for industrial development by studying both revenues and economic scale (contributing to revenue). o analyze the status of utilization, surveys were carried out on 6,621 organizations engaged in nuclear operations handling radiation and radioisotopes pursuant to the Nuclear Safety Act as of end 2014, on 33,471 medical institutions using radiation generators for medical and diagnostic purposes pursuant to the Medical Service Act, and on 2,218 organizations using radiation generators for animal diagnostics pursuant to the Veterinary License Act. he overall status of the domestic radiation market including the number of user organizations, that of employees, and the size of distributions (imports, productions, and exports) with which the scale of domestic radiation market can be judged showed a growth trend compared to the previous year, though the number of employees for radiation operation in industrial sector, research sector, education sector, military sector, and power plants (nuclear power plants) and the size of imports was reduced somewhat. t is expected that data acquired through periodic surveys on the status of utilization would be utilized practically in establishing governmental policies related to the promotion of usage of radiation and radioisotopes, and also be utilized widely in cultivating and developing the industry efficiently to invigorate the related industries.

  8. Radioisotope Electric Propulsion Centaur Orbiter Spacecraft Design Overview

    Science.gov (United States)

    Oleson, Steve; McGuire, Melissa; Sarver-Verhey, Tim; Juergens, Jeff; Parkey, Tom; Dankanich, John; Fiehler, Doug; Gyekenyesi, John; Hemminger, Joseph; Gilland, Jim; hide

    2009-01-01

    Radioisotope electric propulsion (REP) has been shown in past studies to enable missions to outerplanetary bodies including the orbiting of Centaur asteroids. Key to the feasibility for REP missions are long life, low power electric propulsion (EP) devices, low mass radioisotope power systems (RPS) and light spacecraft (S/C) components. In order to determine what are the key parameters for EP devices to perform these REP missions a design study was completed to design an REP S/C to orbit a Centaur in a New Frontiers cost cap. The design shows that an orbiter using several long lived (approximately 200 kg Xenon throughput), low power (approximately 700 W) Hall thrusters teamed with six (150 W each) Advanced Stirling Radioisotope Generators (ASRG) can deliver 60 kg of science instruments to a Centaur in 10 yr within the New Frontiers cost cap. Optimal specific impulses for the Hall thrusters were found to be around 2000 sec with thruster efficiencies over 40%. Not only can the REP S/C enable orbiting a Centaur (when compared to an all chemical mission only capable of flybys) but the additional power from the REP system can be reused to enhance science and simplify communications.

  9. NASA's Radioisotope Power Systems Planning and Potential Future Systems Overview

    Science.gov (United States)

    Zakrajsek, June F.; Woerner, Dave F.; Cairns-Gallimore, Dirk; Johnson, Stephen G.; Qualls, Louis

    2016-01-01

    The goal of NASA's Radioisotope Power Systems (RPS) Program is to make RPS ready and available to support the exploration of the solar system in environments where the use of conventional solar or chemical power generation is impractical or impossible to meet the needs of the missions. To meet this goal, the RPS Program, working closely with the Department of Energy, performs mission and system studies (such as the recently released Nuclear Power Assessment Study), assesses the readiness of promising technologies to infuse in future generators, assesses the sustainment of key RPS capabilities and knowledge, forecasts and tracks the Program's budgetary needs, and disseminates current information about RPS to the community of potential users. This process has been refined and used to determine the current content of the RPS Program's portfolio. This portfolio currently includes an effort to mature advanced thermoelectric technology for possible integration into an enhanced Multi-Mission Radioisotope Generator (eMMRTG), sustainment and production of the currently deployed MMRTG, and technology investments that could lead to a future Stirling Radioisotope Generator (SRG). This paper describes the program planning processes that have been used, the currently available MMRTG, and one of the potential future systems, the eMMRTG.

  10. NASA's Radioisotope Power Systems Planning and Potential Future Systems Overview

    Science.gov (United States)

    Zakrajsek, June F.; Woerner, Dave F.; Cairns-Gallimore, Dirk; Johnson, Stephen G.; Qualis, Louis

    2016-01-01

    The goal of NASA's Radioisotope Power Systems (RPS) Program is to make RPS ready and available to support the exploration of the solar system in environments where the use of conventional solar or chemical power generation is impractical or impossible to meet the needs of the missions. To meet this goal, the RPS Program, working closely with the Department of Energy, performs mission and system studies (such as the recently released Nuclear Power Assessment Study), assesses the readiness of promising technologies to infuse in future generators, assesses the sustainment of key RPS capabilities and knowledge, forecasts and tracks the Programs budgetary needs, and disseminates current information about RPS to the community of potential users. This process has been refined and used to determine the current content of the RPS Programs portfolio. This portfolio currently includes an effort to mature advanced thermoelectric technology for possible integration into an enhanced Multi-Mission Radioisotope Generator (eMMRTG), sustainment and production of the currently deployed MMRTG, and technology investments that could lead to a future Stirling Radioisotope Generator (SRG). This paper describes the program planning processes that have been used, the currently available MMRTG, and one of the potential future systems, the eMMRTG.

  11. Detection and tracing of the medical radioisotope 131I in the Canberra environment

    Science.gov (United States)

    Gilfillan, Nathan R.; Timmers, Heiko

    2012-10-01

    The transport and radioecology of the therapeutical radioisotope 131I has been studied in Canberra, Australia. The isotope has been detected in water samples and its activity quantified via characteristic J-ray photo peaks. A comparison of measurements on samples from upstream and downstream of the Canberra waste water treatment plant shows that 131I is discharged from the plant outflow into the local Molonglo river. This is consistent with observations in other urban environments. A time-correlation between the measured activities in the outflow and the therapeutical treatment cycle at the hospital identifies the medical treatment as the source of the isotope. Enhanced activity levels of 131I have been measured for fish samples. This may permit conclusions on 131I uptake by the biosphere. Due to the well-defined and intermittent input of 131I into the sewage, the Canberra situation is ideally suited for radioecological studies. Furthermore, the 131I activity may be applied in tracer studies of sewage transport to and through the treatment plant and as an indicator of outflow dilution following discharge to the environment.

  12. Radioisotope synoviorthesis in paediatric and adolescent patients with haemophilia.

    Science.gov (United States)

    Martínez-Esteve, A; Álvarez-Pérez, R M; Núñez-Vázquez, R; Tirado-Hospital, J L; García-Jiménez, R; Povedano-Gómez, J; Borrego-Dorado, I

    2016-01-01

    To assess the outcome and adverse-effects of the radioisotope synoviorthesis in paediatric and adolescent patients with haemophilia. Prospective study of historical cohort was conducted. A total of 20 consecutive haemophiliacs with a mean age of 13.1 years (range 4-17) were included with a mean follow-up of 64.9 months (range 18-109). The diagnosis of synovitis was established on the basis of clinical follow-up including radiological images (radiography and/or MRI). For evaluation, the classification proposed by Fernandez-Palazzi was used. Patients aged less than 18 years old with haemophilia and more than one haemarthrosis in less than 3 months remaining a chronic synovitis despite prophylactic therapy intensification. Any contraindication for radionuclide synoviorthesis. Twenty-seven radioisotope synoviorthesis with (90)Y-citrate-colloid and/or (186)Re-sulphide-colloid were done. The effectiveness of the procedure was assessed through pre and posttreatment clinical comparison at 6 months after radioisotope synoviorthesis. Nineteen of the 27 synoviorthesis (70.3%) had a good or excellent response and 8 joints (29.7%) had partial response. It was necessary to repeat the procedure in 3 joints in 3 different patients, obtaining in all cases a good or excellent response. We appreciated inflammatory reaction after procedure in 4 cases (14.8%), which improved with analgesics and nonsteroidal anti-inflamatory drugs. None of the patients presented malignant or premalignant lesions during the follow-up. The radionuclide synoviorthesis is a very effective procedure in paediatric and adolescent patients with hemophilia, being a minimally invasive procedure, easy to perform, safe and with minimal side effects. Copyright © 2015 Elsevier España, S.L.U. and SEMNIM. All rights reserved.

  13. Joint Radioisotope Electric Propulsion Studies - Neptune System Explorer

    Science.gov (United States)

    Khan, M. Omair; Amini, Rashied; Ervin, Joan; Lang, Jared; Landau, Damon; Oleson, Steven; Spilker, Thomas; Strange, Nathan

    2011-01-01

    The Neptune System Explorer (NSE) mission concept study assessed opportunities to conduct Cassini-like science at Neptune with a radioisotope electric propulsion (REP) based spacecraft. REP is based on powering an electric propulsion (EP) engine with a radioisotope power source (RPS). The NSE study was commissioned under the Joint Radioisotope Electric Propulsion Studies (JREPS) project, which sought to determine the technical feasibility of flagship class REP applications. Within JREPS, special emphasis was given toward identifying tall technology tent poles, as well as recommending any new RPS technology developments that would be required for complicated REP missions. Based on the goals of JREPS, multiple RPS (e.g. thermoelectric and Stirling based RPS) and EP (e.g. Hall and ion engines) technology combinations were traded during the NSE study to determine the most favorable REP design architecture. Among the findings from the study was the need for >400We RPS systems, which was driven by EP operating powers and the requirement for a long-lived mission in the deep solar system. Additionally multiple development and implementation risks were identified for the NSE concept, as well as REP missions in general. Among the strengths of the NSE mission would be the benefits associated with RPS and EP use, such as long-term power (approx. 2-3kW) at Neptune and flexible trajectory options for achieving orbit or tours of the Neptune system. Although there are still multiple issues to mitigate, the NSE concept demonstrated distinct advantages associated with using REP for deep space flagship-class missions.

  14. Energy-Recovery Linacs for Commercial Radioisotope Production

    Energy Technology Data Exchange (ETDEWEB)

    Johnson, Rolland Paul [Muplus, Inc., Newport News, VA (United States)

    2016-11-19

    Most radioisotopes are produced by nuclear reactors or positive ion accelerators, which are expensive to construct and to operate. Photonuclear reactions using bremsstrahlung photon beams from less-expensive electron linacs can generate isotopes of critical interest, but much of the beam energy in a conventional electron linac is dumped at high energy, making unwanted radioactivation. The largest part of this radioactivation may be completely eliminated by applying energy recovery linac technology to the problem with an additional benefit that the energy cost to produce a given amount of isotope is reduced. Consequently, a Superconducting Radio Frequency (SRF) Energy Recovery Linac (ERL) is a path to a more diverse and reliable domestic supply of short-lived, high-value, high-demand isotopes at a cost lower than that of isotopes produced by reactors or positive-ion accelerators. A Jefferson Lab approach to this problem involves a thin photon production radiator, which allows the electron beam to recirculate through rf cavities so the beam energy can be recovered while the spent electrons are extracted and absorbed at a low enough energy to minimize unwanted radioactivation. The thicker isotope photoproduction target is not in the beam. MuPlus, with Jefferson Lab and Niowave, proposed to extend this ERL technology to the commercial world of radioisotope production. In Phase I we demonstrated that 1) the ERL advantage for producing radioisotopes is at high energies (~100 MeV), 2) the range of acceptable radiator thickness is narrow (too thin and there is no advantage relative to other methods and too thick means energy recovery is too difficult), 3) using optics techniques developed under an earlier STTR for collider low beta designs greatly improves the fraction of beam energy that can be recovered (patent pending), 4) many potentially useful radioisotopes can be made with this ERL technique that have never before been available in significant commercial quantities

  15. ADVANCED RADIOISOTOPE HEAT SOURCE AND PROPULSION SYSTEMS FOR PLANETARY EXPLORATION

    Energy Technology Data Exchange (ETDEWEB)

    R. C. O' Brien; S. D. Howe; J. E. Werner

    2010-09-01

    The exploration of planetary surfaces and atmospheres may be enhanced by increasing the range and mobility of a science platform. Fundamentally, power production and availability of resources are limiting factors that must be considered for all science and exploration missions. A novel power and propulsion system is considered and discussed with reference to a long-range Mars surface exploration mission with in-situ resource utilization. Significance to applications such as sample return missions is also considered. Key material selections for radioisotope encapsulation techniques are presented.

  16. REVISS / MAYAK: A new partnership in radioisotope supply

    Energy Technology Data Exchange (ETDEWEB)

    Bennett, N. [REVISS Services Limited, Chesham (United Kingdom); Chikshov, A.I.; Malykh, Y.A. [MAYAK Production Association, Ozyorsk (Russian Federation)

    1997-10-01

    REVISS Services (UK) Limited, the joint venture company formed between Amersham International plc, Production Association MAYAK and Techsnabexport brings together the scientific, manufacturing, marketing and distribution skills and facilities which enable REVISS to be not just a major supplier of radioisotopes and other associated products and services, but the supplier with the largest product range. The paper describes the history and the development of MAYAK and reviews its manufacturing facilities and capabilities and also how MAYAK has moved from being a secret military organisation to become a major and successful commercial organisation

  17. Parametric System Model for a Stirling Radioisotope Generator

    Science.gov (United States)

    Schmitz, Paul C.

    2015-01-01

    A Parametric System Model (PSM) was created in order to explore conceptual designs, the impact of component changes and power level on the performance of the Stirling Radioisotope Generator (SRG). Using the General Purpose Heat Source (GPHS approximately 250 Wth) modules as the thermal building block from which a SRG is conceptualized, trade studies are performed to understand the importance of individual component scaling on isotope usage. Mathematical relationships based on heat and power throughput, temperature, mass, and volume were developed for each of the required subsystems. The PSM uses these relationships to perform component- and system-level trades.

  18. Sodium Variable Conductance Heat Pipe for Radioisotope Stirling Systems

    Science.gov (United States)

    Tarau, Calin; Anderson, William G.; Walker, Kara

    2009-01-01

    In a Stirling radioisotope system, heat must continually be removed from the General Purpose Heat Source (GPHS) modules to maintain the modules and surrounding insulation at acceptable temperatures. Normally, the Stirling convertor provides this cooling. If the converter stops in the current system, the insulation is designed to spoil, preventing damage to the GPHS, and also ending the mission. An alkali-metal Variable Conductance Heat Pipe (VCHP) has been designed to allow multiple stops and restarts of the Stirling convertor in an Advanced Stirling Radioisotope Generator (ASRG). When the Stirling convertor is turned off, the VCHP will activate when the temperatures rises 30 C above the setpoint temperature. A prototype VCHP with sodium as the working fluid was fabricated and tested in both gravity aided and against gravity conditions for a nominal heater head temperature of 790 C. The results show very good agreement with the predictions and validate the model. The gas front was located at the exit of the reservoir when heater head temperature was 790 C while cooling was ON, simulating an operating Advanced Stirling Converter (ASC). When cooling stopped, the temperature increased by 30 C, allowing the gas front to move past the radiator, which transferred the heat to the case. After resuming the cooling flow, the front returned at the initial location turning OFF the VCHP. The against gravity working conditions showed a colder reservoir and faster transients.

  19. GRC Supporting Technology for NASA's Advanced Stirling Radioisotope Generator (ASRG)

    Science.gov (United States)

    Schreiber, Jeffrey G.; Thieme, Lanny G.

    2008-01-01

    From 1999-2006, the Glenn Research Center (GRC) supported a NASA project to develop a high-efficiency, nominal 110-We Stirling Radioisotope Generator (SRG110) for potential use on NASA missions. Lockheed Martin was selected as the System Integration Contractor for the SRG110, under contract to the Department of Energy (DOE). The potential applications included deep space missions, and Mars rovers. The project was redirected in 2006 to make use of the Advanced Stirling Convertor (ASC) that was being developed by Sunpower, Inc. under contract to GRC, which would reduce the mass of the generator and increase the power output. This change would approximately double the specific power and result in the Advanced Stirling Radioisotope Generator (ASRG). The SRG110 supporting technology effort at GRC was replanned to support the integration of the Sunpower convertor and the ASRG. This paper describes the ASRG supporting technology effort at GRC and provides details of the contributions in some of the key areas. The GRC tasks include convertor extended-operation testing in air and in thermal vacuum environments, heater head life assessment, materials studies, permanent magnet characterization and aging tests, structural dynamics testing, electromagnetic interference and electromagnetic compatibility characterization, evaluation of organic materials, reliability studies, and analysis to support controller development.

  20. The radioisotope osteogram: Kinetic studies of skeletal disorders in humans

    Energy Technology Data Exchange (ETDEWEB)

    MacDonald, N.S.

    1959-10-16

    Radioactive strontium can serve as a tracer to gain information concerning calcium metabolism in human subjects. Gamma-emitting Sr{sup 85} is used rather than the much more hazardous, beta-emitting Sr{sup 89} and Sr{sup 90}. (ca{sup 47} -- the ideal tracer for normal calcium -- is quite expensive and difficult to procure.) Very significant information may be obtained merely by measuring and recording the changes in radioactivity in various body areas during the first hour after intravenous injection of the bone-seeking radioisotope. This is accomplished by placing a lead-shielded gamma-scintillation detector in contact with the skin over the sites of interest and recording the activities on a scaler or ratemeter. The activity versus time curves so obtained are called radioisotope osteograms. Data were presented which indicated that Sr{sup 85} osteograms for patients afflicted with osteoporosis, Paget`s disease, tumor metastases to bone, and possibly multiple myeloma, differ significantly from those obtained from subjects with no skeletal abnormalities. Some interpretations of these deviations were discussed. The value of conducting double-tracer tests (e.g. -- Sr{sup 85} plus radio-iodinated serum albumin) was demonstrated, and correlations with excretion data were made. With further refinements the technique may ultimately become useful for certain diagnostic problems in the clinic and.for evaluating the efficacy of treatment of these disorders.

  1. Science Instrument Sensitivities to Radioisotope Power System Environment

    Science.gov (United States)

    Bairstow, Brian; Lee, Young; Smythe, William; Zakrajsek, June

    2016-01-01

    Radioisotope Power Systems (RPS) have been and will be enabling or significantly enhancing for many missions, including several concepts identified in the 2011 Planetary Science Decadal Survey. Some mission planners and science investigators might have concerns about possible impacts from RPS-induced conditions upon the scientific capabilities of their mission concepts. To alleviate these concerns, this paper looks at existing and potential future RPS designs, and examines their potential radiation, thermal, vibration, electromagnetic interference (EMI), and magnetic fields impacts on representative science instruments and science measurements. Radiation impacts from RPS on science instruments are of potential concern for instruments with optical detectors and instruments with high-voltage electronics. The two main areas of concern are noise effects on the instrument measurements, and long-term effects of instrument damage. While RPS by their nature will contribute to total radiation dose, their addition for most missions should be relatively small. For example, the gamma dose rate from one Multi-Mission Radioisotope Thermoelectric Generator (MMRTG) would be an order of magnitude lower than the environmental dose rate at Mars, and would have a correspondingly lower contribution to instrument noise and to any permanent damage to payload sensors. Increasing the number of General Purpose Heat Source (GPHS) modules used in an RPS would be expected to increase the generated radiation proportionally; however, the effect of more GPHS modules is mitigated from a strictly linear relationship by self-shielding effects. The radiation field of an RPS is anisotropic due to the deviation of the modules from a point-source-geometry. For particularly sensitive instruments the total radiation dose could be mitigated with separation or application of spot shielding. Though a new, higher-power RPS could generate more heat per unit than current designs, thermal impact to the flight

  2. Assessment of myocardial pathogenesis with new radioisotopic tracers

    Energy Technology Data Exchange (ETDEWEB)

    Yamabe, Hiroshi; Yokoyama, Mitsuhiro (Kobe Univ. (Japan). School of Medicine)

    1994-08-01

    In the field of nuclear cardiology, various new radioisotopic tracers have been commercially available since 1993 in Japan. These tracers can be divided into (1) [sup 99m]Tc-labeled myocardial perfusion imaging agents ([sup 99m]Tc-MIBI, [sup 99m]Tc-tetrofosimin, and [sup 99m]Tc-teboroxime); (2) [sup 123]I-labeled myocardial fatty acid imaging agents ([sup 123]-BMIPP and [sup 123]I-IPPA); (3) [sup 123]I-labeled myocardial sympathetic imaging agent ([sup 123]I-MIBG); (4) [sup 111]In-labeled imaging agents for myocardial cell damage ([sup 111]In-monoclonal antimyosin antibody); and (5) [sup 67]Ga thrombosis imaging agent ([sup 67]Ga-fibrinogen). This article outlines these new tracers, focussing on their potential in assessing myocardial pathogenesis. (N.K.) 64 refs.

  3. Radioisotope-Powered Hopper Design for Europan Mission

    Science.gov (United States)

    Dekany, Justin; Guzman, Melissa; Jagadevan, Karthikeyan; McCulley, Jonathan; Shipley, Kevin; Howe, Steven

    2010-10-01

    NASA and ESA have prioritized an outer planet flagship mission to Jupiter and its four largest moons. The constant cycling of material from Europa's surface to the global ocean below allows the potential for organic life similar to the eco-systems surrounding geothermal vents on Earth. The Europa Hopper model utilizes a radioisotope core, in-situ materials and a subsurface ice probe in order to minimize mass and power needs. A hopping distance of 10km was chosen to maximize the surface area coverage of Europa and increasing the potential for organic sampling and geological imaging of Europa's surface. The hopper design has mid-range power and mass needs while maintaining a substantial instrumentation package in comparison to smaller, low-power competitive designs. This mission could provide vital information both on early solar system formation and the potential existence of organic life in the Jovian system.

  4. Advanced Stirling Convertor Development for NASA Radioisotope Power Systems

    Science.gov (United States)

    Wong, Wayne A.; Wilson, Scott D.; Collins, Josh

    2015-01-01

    Sunpower Inc.'s Advanced Stirling Convertor (ASC) initiated development under contract to the NASA Glenn Research Center and after a series of successful demonstrations, the ASC began transitioning from a technology development project to a flight development project. The ASC has very high power conversion efficiency making it attractive for future Radioisotope Power Systems (RPS) in order to make best use of the low plutonium-238 fuel inventory in the United States. In recent years, the ASC became part of the NASA and Department of Energy (DOE) Advanced Stirling Radioisotope Generator (ASRG) Integrated Project. Sunpower held two parallel contracts to produce ASCs, one with the DOE and Lockheed Martin to produce the ASC-F flight convertors, and one with NASA Glenn for the production of ASC-E3 engineering units, the initial units of which served as production pathfinders. The integrated ASC technical team successfully overcame various technical challenges that led to the completion and delivery of the first two pairs of flightlike ASC-E3 by 2013. However, in late fall 2013, the DOE initiated termination of the Lockheed Martin ASRG flight development contract driven primarily by budget constraints. NASA continues to recognize the importance of high-efficiency ASC power conversion for RPS and continues investment in the technology including the continuation of ASC-E3 production at Sunpower and the assembly of the ASRG Engineering Unit #2. This paper provides a summary of ASC technical accomplishments, overview of tests at Glenn, plans for continued ASC production at Sunpower, and status of Stirling technology development.

  5. Pathway of radioisotopes from land surface to sewage sludge

    Science.gov (United States)

    Fischer, Helmut W.; Yokoo, Yoshiyuki

    2014-05-01

    Radioactive surface contaminations will only partially remain at the original location - a fraction of the inventory will take part in (mainly terrestrial and aquatic) environmental transport processes. The probably best known and most important process comprises the food chain. Besides, the translocation of dissolved and particle-bound radioisotopes with surface waters plays an important role. These processes can have the effect of displacing large radioisotope amounts over considerable distances and of creating new sinks and hot spots, as it is already known for sewage sludge. We are reporting on a combined modeling and experimental project concerning the transport of I-131 and Cs-134/Cs-137 FDNPP 2011 depositions in the Fukushima Prefecture. Well-documented experimental data sets are available for surface deposition and sewage sludge concentrations. The goal is to model the pathway in between, involving surface runoff, transport in the sewer system and processes in the sewage treatment plant. Watershed runoff and sewer transport will be treated with models developed recently by us in other projects. For sewage treatment processes a new model is currently being constructed. For comparison and further validation, historical data from Chernobyl depositions and tracer data from natural and artificial, e.g. medical, isotopes will be used. First results for 2011 data from Fukushima Prefecture will be presented. The benefits of the study are expected to be two-fold: on one hand, the abundant recent and historical data will help to develop and improve environmental transport models; on the other hand, both data and models will help in identifying the most critical points in the envisaged transport pathways in terms of radiation protection and waste management.

  6. Long Life 600W Hall Thruster System for Radioisotope Electric Propulsion Project

    Data.gov (United States)

    National Aeronautics and Space Administration — Radioisotope Electric Propulsion (REP) offers the prospect for a variety of new science missions by enabling use of Hall Effect propulsion in the outer solar system,...

  7. Radioisotope electric propulsion (REP): A near-term approach to nuclear propulsion

    Science.gov (United States)

    Schmidt, George R.; Manzella, David H.; Kamhawi, Hani; Kremic, Tibor; Oleson, Steven R.; Dankanich, John W.; Dudzinski, Leonard A.

    2010-02-01

    Studies over the last decade have shown radioisotope-based nuclear electric propulsion to be enhancing and, in some cases, enabling for many potential robotic science missions. Also known as radioisotope electric propulsion (REP), the technology offers the performance advantages of traditional reactor-powered electric propulsion (i.e., high specific impulse propulsion at large distances from the Sun), but with much smaller, affordable spacecraft. Future use of REP requires development of radioisotope power sources with system specific powers well above that of current systems. The US Department of Energy and NASA have developed an advanced Stirling radioisotope generator (ASRG) engineering unit, which was subjected to rigorous flight qualification-level tests in 2008, and began extended lifetime testing later that year. This advancement, along with recent work on small ion thrusters and life extension technology for Hall thrusters, could enable missions using REP sometime during the next decade.

  8. Iron Oxide Nanoradiomaterials: Combining Nanoscale Properties with Radioisotopes for Enhanced Molecular Imaging

    Directory of Open Access Journals (Sweden)

    Juan Pellico

    2017-01-01

    Full Text Available The combination of the size-dependent properties of nanomaterials with radioisotopes is emerging as a novel tool for molecular imaging. There are numerous examples already showing how the controlled synthesis of nanoparticles and the incorporation of a radioisotope in the nanostructure offer new features beyond the simple addition of different components. Among the different nanomaterials, iron oxide-based nanoparticles are the most used in imaging because of their versatility. In this review, we will study the different radioisotopes for biomedical imaging, how to incorporate them within the nanoparticles, and what applications they can be used for. Our focus is directed towards what is new in this field, what the nanoparticles can offer to the field of nuclear imaging, and the radioisotopes hybridized with nanomaterials for use in molecular imaging.

  9. Development of Kabila rocket: A radioisotope heated thermionic plasma rocket engine

    OpenAIRE

    Mboyi, Kalomba; Ren, Junxue; Liu, Yu

    2015-01-01

    A new type of plasma rocket engine, the Kabila rocket, using a radioisotope heated thermionic heating chamber instead of a conventional combustion chamber or catalyst bed is introduced and it achieves specific impulses similar to the ones of conventional solid and bipropellant rockets. Curium-244 is chosen as a radioisotope heat source and a thermal reductive layer is also used to obtain precise thermionic emissions. The self-sufficiency principle is applied by simultaneously heating up the e...

  10. Clouds, airplanes, trucks and people : carrying radioisotopes to and across Mexico

    OpenAIRE

    Mateos, Gisela

    2015-01-01

    The aim of this paper is to describe the early stages of Mexican nuclearization that took place in contact with radioisotopes. This history requires a multilayered narrative with an emphasis in North-South asymmetric relations, and in the value of education and training in the creation of international asymmetrical networks. Radioisotopes were involved in exchanges with the United States since the late 1940s, but also with Canada. We also describe the context of implementation of Eisenhower´s...

  11. First ECR-Ionized Noble Gas Radioisotopes at ISOLDE

    CERN Document Server

    Wenander, F; Gaubert, G; Jardin, P; Lettry, Jacques

    2004-01-01

    The production of light noble gas radioisotopes with high ionization potentials has been hampered by modest ionization efficiencies for standard plasma ion-sources. However, the decay losses are minimal as the lingering time of light noble gases within plasma ion-sources is negligible when compared to its diffusion out of the target material. Previous singly charged ECRIS have shown a higher efficiency but also a lingering time of the order of 1 s and a total weight that prevents remote handling by the ISOLDE robot. The compact MINIMONO efficiently addressed the lingering time and weight issues. In addition, the MINIMONO maintained the high off-line ionization efficiency for light noble gases. This paper describes a standard ISOLDE target unit equipped with a MINIMONO ion-source and the first tests. The ion-source has been tested off-line and equipped with a CaO target for on-line tests. Valuable information was gained about high current (100-500 muA) transport through the ISOLDE mass separators designed for ...

  12. Radioisotope Power Systems Reference Book for Mission Designers and Planners

    Science.gov (United States)

    Lee, Young; Bairstow, Brian

    2015-01-01

    The RPS Program's Program Planning and Assessment (PPA) Office commissioned the Mission Analysis team to develop the Radioisotope Power Systems (RPS) Reference Book for Mission Planners and Designers to define a baseline of RPS technology capabilities with specific emphasis on performance parameters and technology readiness. The main objective of this book is to provide RPS technology information that could be utilized by future mission concept studies and concurrent engineering practices. A progress summary from the major branches of RPS technology research provides mission analysis teams with a vital tool for assessing the RPS trade space, and provides concurrent engineering centers with a consistent set of guidelines for RPS performance characteristics. This book will be iterated when substantial new information becomes available to ensure continued relevance, serving as one of the cornerstone products of the RPS PPA Office. This book updates the original 2011 internal document, using data from the relevant publicly released RPS technology references and consultations with RPS technologists. Each performance parameter and RPS product subsection has been reviewed and cleared by at least one subject matter representative. A virtual workshop was held to reach consensus on the scope and contents of the book, and the definitions and assumptions that should be used. The subject matter experts then reviewed and updated the appropriate sections of the book. The RPS Mission Analysis Team then performed further updates and crosschecked the book for consistency. Finally, a second virtual workshop was held to ensure all subject matter experts and stakeholders concurred on the contents.

  13. Development of radioisotope tracer technology and nucleonic control system

    Energy Technology Data Exchange (ETDEWEB)

    Jin, Joon Ha; Lee, Myun Joo; Jung, Sung Hee and others

    1999-04-01

    The purpose of this study is to develop the radioisotope tracer technology, which can be used in solving industrial and environmental problems and basic technology of nuclear control systems that are widely used for automation of industrial plants, and to build a strong tracer group to support the local industries. In relation to the tracer technology, the data acquisition system, the column scanning equipment and the detection pig for a leakage test have been developed. In order to use in analyzing data of tracer experiments, a computer program for the analysis of residence time distribution has been created as well. These results were utilized in developing the tracer technologies, such as the column scanning, the flow measurement using the dilution method, the simultaneous monitoring rotational movement of piston rings and the optimization of a waste water treatment facility, and the technologies were successfully demonstrated in the local industrial. The stripper of RFCC reactor has been examined to find an unwanted structure in it by imminent request from the industry. Related to the development of nucleonic control system, the state of art report on the technology has been written and an equipment for the analysis of asphalt content has been developed. (author)

  14. Toward high performance radioisotope thermophotovoltaic systems using spectral control

    Energy Technology Data Exchange (ETDEWEB)

    Wang, Xiawa, E-mail: xiawaw@mit.edu [Electrical Engineering Department, Massachusetts Institute of Technology, Cambridge, MA02139 (United States); Institute for Soldier Nanotechnologies, Massachusetts Institute of Technology, Cambridge, MA02139 (United States); Chan, Walker [Institute for Soldier Nanotechnologies, Massachusetts Institute of Technology, Cambridge, MA02139 (United States); Stelmakh, Veronika [Electrical Engineering Department, Massachusetts Institute of Technology, Cambridge, MA02139 (United States); Institute for Soldier Nanotechnologies, Massachusetts Institute of Technology, Cambridge, MA02139 (United States); Celanovic, Ivan [Institute for Soldier Nanotechnologies, Massachusetts Institute of Technology, Cambridge, MA02139 (United States); Fisher, Peter [Institute for Soldier Nanotechnologies, Massachusetts Institute of Technology, Cambridge, MA02139 (United States); Physics Department, Massachusetts Institute of Technology, Cambridge, MA02139 (United States)

    2016-12-01

    This work describes RTPV-PhC-1, an initial prototype for a radioisotope thermophotovoltaic (RTPV) system using a two-dimensional photonic crystal emitter and low bandgap thermophotovoltaic (TPV) cell to realize spectral control. We validated a system simulation using the measurements of RTPV-PhC-1 and its comparison setup RTPV-FlatTa-1 with the same configuration except a polished tantalum emitter. The emitter of RTPV-PhC-1 powered by an electric heater providing energy equivalent to one plutonia fuel pellet reached 950 °C with 52 W of thermal input power and produced 208 mW output power from 1 cm{sup 2} TPV cell. We compared the system performance using a photonic crystal emitter to a polished flat tantalum emitter and found that spectral control with the photonic crystal was four times more efficient. Based on the simulation, with more cell areas, better TPV cells, and improved insulation design, the system powered by a fuel pellet equivalent heat source is expected to reach an efficiency of 7.8%.

  15. Neptune Orbiters Utilizing Solar and Radioisotope Electric Propulsion

    Science.gov (United States)

    Fiehler, Douglas I.; Oleson, Steven R.

    2004-01-01

    In certain cases, Radioisotope Electric Propulsion (REP), used in conjunction with other propulsion systems, could be used to reduce the trip times for outer planetary orbiter spacecraft. It also has the potential to improve the maneuverability and power capabilities of the spacecraft when the target body is reached as compared with non-electric propulsion spacecraft. Current missions under study baseline aerocapture systems to capture into a science orbit after a Solar Electric Propulsion (SEP) stage is jettisoned. Other options under study would use all REP transfers with small payloads. Compared to the SEP stage/Aerocapture scenario, adding REP to the science spacecraft as well as a chemical capture system can replace the aerocapture system but with a trip time penalty. Eliminating both the SEP stage and the aerocapture system and utilizing a slightly larger launch vehicle, Star 48 upper stage, and a combined REP/Chemical capture system, the trip time can nearly be matched while providing over a kilowatt of science power reused from the REP maneuver. A Neptune Orbiter mission is examined utilizing single propulsion systems and combinations of SEP, REP, and chemical systems to compare concepts.

  16. Radioisotope Power System Delivery, Ground Support and Nuclear Safety Implementation: Use of the Multi-Mission Radioisotope Thermoelectric Generator for the NASA's Mars Science Laboratory

    Energy Technology Data Exchange (ETDEWEB)

    S.G. Johnson; K.L. Lively; C.C. Dwight

    2014-07-01

    Radioisotope power systems have been used for over 50 years to enable missions in remote or hostile environments. They are a convenient means of supplying a few milliwatts up to a few hundred watts of useable, long-term electrical power. With regard to use of a radioisotope power system, the transportation, ground support and implementation of nuclear safety protocols in the field is a complex process that requires clear identification of needed technical and regulatory requirements. The appropriate care must be taken to provide high quality treatment of the item to be moved so it arrives in a condition to fulfill its missions in space. Similarly it must be transported and managed in a manner compliant with requirements for shipment and handling of special nuclear material. This presentation describes transportation, ground support operations and implementation of nuclear safety and security protocols for a radioisotope power system using recent experience involving the Multi-Mission Radioisotope Thermoelectric Generator for National Aeronautics and Space Administration’s Mars Science Laboratory, which launched in November of 2011.

  17. The Texas A&M Radioisotope Production and Radiochemistry Program

    Energy Technology Data Exchange (ETDEWEB)

    Akabani, Gamal [Texas A & M Univ., College Station, TX (United States). Dept. of Nuclear Engineering. Dept. of Veterinary Integrative Biosciences

    2016-10-28

    The main motivation of the project at Texas A&M University was to carry out the production of critically needed radioisotopes used in medicine for diagnostics and therapy, and to establish an academic program in radionuclide production and separation methods. After a lengthy battle with the Texas A&M University Radiation Safety Office, the Texas Department of State Health Services granted us a license for the production of radionuclides in July 2015, allowing us to work in earnest in our project objectives. Experiments began immediately after licensing, and we started the assembly and testing of our target systems. There were four analytical/theoretical projects and two experimental target systems. These were for At-211 production and for Zn-62/Cu-62 production. The theoretical projects were related to the production of Mo-99/Tc-99m using a) a subcritical aqueous target system and b) production of Tc-99m from accelerator-generated Mo-99 utilizing a photon-neutron interaction with enriched Mo-100 targets. The two experimental projects were the development of targetry systems and production of At-211 and Zn-62/Cu-62 generator. The targetry system for At-211 has been tested and production of At-211 is chronic depending of availability of beam time at the cyclotron. The installation and testing of the targetry system for the production of Zn-62/Cu-62 has not been finalized. A description of the systems is described. The academic program in radionuclide production and separation methods was initiated in the fall of 2011 and, due to the lack of a radiochemistry laboratory, it was suspended. We expect to re-start the academic program at the Texas A&M Institute for Preclinical Studies under the Molecular Imaging Program.

  18. The Texas A&M Radioisotope Production and Radiochemistry Program

    Energy Technology Data Exchange (ETDEWEB)

    Akabani, Gamal [Texas A & M Univ., College Station, TX (United States)

    2016-08-31

    The main motivation of the project at Texas A&M University was to carry out the production of critically needed radioisotopes used in medicine for diagnostic and therapy, and to establish an academic program in radionuclide production and separation methods. After a lengthy battle with the Texas A&M University Radiation Safety Office, the Texas Department of State Health Services granted us a license for the production of radionuclides in July 2015, allowing us to work in earnest in our project objectives. Experiments began immediately after licensing, and we started the assembly and testing of our target systems. There were four analytical/theoretical projects and two experimental target systems. These were for At-211 production and for Zn- 62/Cu-62 production. The theoretical projects were related to the production of Mo-99/Tc-99m using (a) a subcritical aqueous target system and (b) production of Tc-99m from accelerator-generated Mo-99 utilizing a photon-neutron interaction with enriched Mo-100 targets. The two experimental projects were the development of targetry systems and production of At-211 and Zn-62/Cu-62 generator. The targetry system for At-211 has been tested and production of At-211 is chronic depending of availability of beam time at the cyclotron. The installation and testing of the targetry system for the production of Zn-62/Cu-62 has not been finalized. A description of the systems is described. The academic program in radionuclide production and separation methods was initiated in the fall of 2011; due to the lack of a radiochemistry laboratory, it was suspended. We expect to re-start the academic program at the Texas A&M Institute for Preclinical Studies under the Molecular Imaging Program.

  19. Small Radioisotope Power System Testing at NASA Glenn Research Center

    Science.gov (United States)

    Dugala, Gina; Bell, Mark; Oriti, Salvatore; Fraeman, Martin; Frankford, David; Duven, Dennis

    2013-01-01

    In April 2009, NASA Glenn Research Center (GRC) formed an integrated product team (IPT) to develop a Small Radioisotope Power System (SRPS) utilizing a single Advanced Stirling Convertor (ASC) with passive balancer. A single ASC produces approximately 80 We making this system advantageous for small distributed lunar science stations. The IPT consists of Sunpower, Inc., to provide the single ASC with a passive balancer, The Johns Hopkins University Applied Physics Laboratory (JHUAPL) to design an engineering model Single Convertor Controller (SCC) for an ASC with a passive balancer, and NASA GRC to provide technical support to these tasks and to develop a simulated lunar lander test stand. The single ASC with a passive balancer, simulated lunar lander test stand, and SCC were delivered to GRC and were tested as a system. The testing sequence at GRC included SCC fault tolerance, integration, electromagnetic interference (EMI), vibration, and extended operation testing. The SCC fault tolerance test characterized the SCCs ability to handle various fault conditions, including high or low bus power consumption, total open load or short circuit, and replacing a failed SCC card while the backup maintains control of the ASC. The integrated test characterized the behavior of the system across a range of operating conditions, including variations in cold-end temperature and piston amplitude, including the emitted vibration to both the sensors on the lunar lander and the lunar surface. The EMI test characterized the AC and DC magnetic and electric fields emitted by the SCC and single ASC. The vibration test confirms the SCCs ability to control the single ASC during launch. The extended operation test allows data to be collected over a period of thousands of hours to obtain long term performance data of the ASC with a passive balancer and the SCC. This paper will discuss the results of each of these tests.

  20. Radioisotope Productions for Medical Use with Accelerator Neutrons

    Science.gov (United States)

    Minato, Futoshi; Nagai, Yasuki; Iwamoto, Nobuyuki; Iwamoto, Osamu

    2014-09-01

    Various kinds of radioactive isotopes (RIs) are widely used in nuclear medicine for diagnostics and therapy. Since the RIs are not usually present in the nature, they must be produced by nuclear reactors and accelerators. For instance, 99mTc, which is the most common RI used in diagnosis, is mainly produced by fission of highly enriched 235U (HEU) in nuclear reactors. However, use of the HEU is unfavorable in terms of nuclear security. Therefore, many methods without 235U have been studied in order to produce RIs for medical use; for example, thermal neutron capture, gamma disintegration, and proton induced reactions. We also have proposed an alternative method using accelerator neutrons besides the above methods. Technique producing high intense accelerator neutron beam as much as 1015 n/s is being developed and RI productions with the accelerator neutron have been done recently. The major advantages of the use of accelerator neutron are followings. 1) A wide variety of carrier-added and carrier-free radioisotopes can be produced using the neutrons, because a charge exchange reaction of a sample nucleus has a sizable cross section of 50 to 500 mb. 2) High transparency of neutron allows us to use a large amount of sample to co-produce other RIs by putting other samples behind the main sample in the beam direction. In this talk, we will show the features of RI productions with accelerator neutron which we have ever investigated and found, along with numerical results of RI yields calculated with Japanese Evaluated Nuclear Data Library (JENDL-4.0).

  1. Evaluation of a group of health professionals on the physics and toxicological concepts of the radiopharmaceuticals that uses {sup 123}I e {sup 131}I radioisotopes; Avaliacao de um grupo de profissionais de saude sobre os conceitos fisicos e toxicologicos dos radiofarmacos que utilizam os radioisotopos {sup 123}I e {sup 131}I

    Energy Technology Data Exchange (ETDEWEB)

    Luiz, L.C. [Faculdade Bezerra de Araujo (FABA), Rio de Janeiro, RJ (Brazil); Universidade do Estado do Rio de Janeiro (DFAT-UERJ), RJ (Brazil). Inst. de Fisica Armando Dias Tavares; Brandao, D.L. [Faculdade Bezerra de Araujo (FABA), Rio de Janeiro, RJ (Brazil); Batista, R.T., E-mail: leandro.dfnae@bol.com.br, E-mail: brandao.dl@oi.com.br, E-mail: batistartb@hotmail.com [Universidade do Estado do Rio de Janeiro (DFAT-UERJ), RJ (Brazil). Inst. de Fisica Armando Dias Tavares

    2011-07-01

    In order to evaluate the level of knowledge of a group of health professionals in the area west of the city of Rio de Janeiro, a survey of nurses, nursing technicians, doctors and graduate students in pharmacy, concerning production, radiation emitted, applications and toxicities of radiopharmaceuticals using {sup 123}I radioisotopes and {sup 131}I. These radioisotopes are widely used in Nuclear Medicine to aid in the diagnostic imaging and therapeutic procedures. In this paper is presented an approach on radiopharmaceuticals using radioisotopes mentioned above so that it has knowledge of what was asked to group of professionals here. With this work, it is expected to contribute to the knowledge of these professionals, as well as the general public, in Nuclear Physics and radiation protection concepts for the subject in question. (author)

  2. Radiation dosimetry in developing a radioactive stent for therapeutic use

    Energy Technology Data Exchange (ETDEWEB)

    Kim, Eun Hee; Kim, Jang Hee; Chung, Wee Sup; Woo, Kwang Sun [Korea Cancer Center Hospital , Seoul (Korea, Republic of)

    1997-09-01

    Research Goal: A new radioation therapy protocol of the esophageal carcinoma has been proposed. A metal stent coated with beta-emitting radioisotope would be inserted into the lesion of malignant esophageal obstruction and irradiate it. In this study, dose to the esophageal wall is estimated to suggest the selection of radioisotope, total activity, and the activity distribution pattern over the stent. Result: Dose distribution of the esophageal wall is determined by the energy spectrum of beta particles emitted from the radioisotope used in the stent activation. The endpoint energy of the beta spectrum corresponds to a range in liquid water, which determines the depth into the esophageal wall where the dose is significant. With a stent of constant areal activity density, dose to the esophageal wall increases with an increasing stent height until reaching a saturation value. Dose is maximum at the esophageal wall surface. The degree of dose decreasing as the target moves into the esophageal wall varies among different radioisotopes. However, dose decreases by similar degree among different radioisotopes as the target moves from the stent central height toward the stent end. For a stent of 2 cm in diameter, more than 4 cm in heigh, and 10 {mu}Ci/cm{sup 2} in activity, dose at the esophageal wall surface and at the stent central height is {approx}70 Gy, {approx}60 Gy, {approx}50 Gy, {approx}50 Gy, {approx}25 Gy, and {approx}15 Gy for {sup 90}Y, {sup 188}Re, {sup 166}Ho, {sup 32}P, {sup 186}Re, and {sup 192}Ir, respectively. Applications: Dose estimates provided in this study and the experimental results from the researchers at Yonsei University, who applied the radioactive stent to animals, will be used to analyze the relationship between the stent design and the corresponding therapeutic effect. This helps utilizing the new protocol of treating the esophageal carcinoma. 37 refs., 18 tabs., 27 figs. (author)

  3. Development of Kabila rocket: A radioisotope heated thermionic plasma rocket engine

    Directory of Open Access Journals (Sweden)

    Kalomba Mboyi

    2015-04-01

    Full Text Available A new type of plasma rocket engine, the Kabila rocket, using a radioisotope heated thermionic heating chamber instead of a conventional combustion chamber or catalyst bed is introduced and it achieves specific impulses similar to the ones of conventional solid and bipropellant rockets. Curium-244 is chosen as a radioisotope heat source and a thermal reductive layer is also used to obtain precise thermionic emissions. The self-sufficiency principle is applied by simultaneously heating up the emitting material with the radioisotope decay heat and by powering the different valves of the plasma rocket engine with the same radioisotope decay heat using a radioisotope thermoelectric generator. This rocket engine is then benchmarked against a 1 N hydrazine thruster configuration operated on one of the Pleiades-HR-1 constellation spacecraft. A maximal specific impulse and power saving of respectively 529 s and 32% are achieved with helium as propellant. Its advantages are its power saving capability, high specific impulses and simultaneous ease of storage and restart. It can however be extremely voluminous and potentially hazardous. The Kabila rocket is found to bring great benefits to the existing spacecraft and further research should optimize its geometric characteristics and investigate the physical principals of its operation.

  4. Planning For Multiple NASA Missions With Use Of Enabling Radioisotope Power

    Energy Technology Data Exchange (ETDEWEB)

    S.G. Johnson; K.L. Lively; C.C. Dwight

    2013-02-01

    Since the early 1960’s the Department of Energy (DOE) and its predecessor agencies have provided radioisotope power systems (RPS) to NASA as an enabling technology for deep space and various planetary missions. They provide reliable power in situations where solar and/or battery power sources are either untenable or would place an undue mass burden on the mission. In the modern era of the past twenty years there has been no time that multiple missions have been considered for launching from Kennedy Space Center (KSC) during the same year. The closest proximity of missions that involved radioisotope power systems would be that of Galileo (October 1989) and Ulysses (October 1990). The closest that involved radioisotope heater units would be the small rovers Spirit and Opportunity (May and July 2003) used in the Mars Exploration Rovers (MER) mission. It can be argued that the rovers sent to Mars in 2003 were essentially a special case since they staged in the same facility and used a pair of small launch vehicles (Delta II). This paper examines constraints on the frequency of use of radioisotope power systems with regard to launching them from Kennedy Space Center using currently available launch vehicles. This knowledge may be useful as NASA plans for its future deep space or planetary missions where radioisotope power systems are used as an enabling technology. Previous descriptions have focused on single mission chronologies and not analyzed the timelines with an emphasis on multiple missions.

  5. Progress on 241Am Production for Use in Radioisotope Power Systems

    Science.gov (United States)

    Baker, S. R.; Bell, K. J.; Brown, J.; Carrigan, C.; Carrott, M. J.; Gregson, C.; Clough, M.; Maher, C. J.; Mason, C.; Rhodes, C. J.; Rice, T. G.; Sarsfield, M. J.; Stephenson, K.; Taylor, R. J.; Tinsley, T. P.; Woodhead, D. A.; Wiss, T.

    2014-08-01

    Electrical power sources used in outer planet missions are a key enabling technology for data acquisition and communications. Power sources generate electricity from the thermal energy from alpha decay of the radioisotope 238Pu via thermo-electric conversion. Production of 238Pu requires specialist facilities including a nuclear reactor and reprocessing plants that are expensive to build and operate, so naturally, a more economical alternative is attractive to the industry. Within Europe 241Am is a feasible alternative to 238Pu that can provide a heat source for radioisotope thermoelectric generators (RTGs) and radioisotope heating units (RHUs). As a daughter product of 241Pu decay, 241Am is present at 1000s kg levels within the UK civil plutonium stockpile.A chemical separation process is required to extract the 241Am in a pure form and this paper describes such a process, successfully developed to the proof of concept stage.

  6. OXavidin for Tissue Targeting Biotinylated Therapeutics

    Directory of Open Access Journals (Sweden)

    Rita De Santis

    2009-01-01

    Full Text Available Avidin is a glycoprotein from hen egg white that binds biotin with very high affinity. Here we describe OXavidin, a product containing aldehyde groups, obtained by ligand-assisted sugar oxidation of avidin by sodium periodate. OXavidin chemically reacts with cellular and tissue proteins through Schiff's base formation thus residing in tissues for weeks while preserving the biotin binding capacity. The long tissue residence of OXavidin as well as that of OXavidin/biotinylated agent complex occurs in normal and neoplastic tissues and immunohistochemistry shows a strong and homogenous stromal localization. Once localized in tissue/tumor, OXavidin becomes an “artificial receptor” for intravenous injected biotin allowing tumor targeting with biotinylated therapeutics like radioisotopes or toxins. Moreover, present data also suggest that OXavidin might be useful for the homing of biotinylated cells. Overall, OXavidin exhibits a remarkable potential for many different therapeutic applications.

  7. Radioisotope Thermophotovoltaic (RTPV) Generator and Its Application to the Pluto Fast Flyby Mission

    Energy Technology Data Exchange (ETDEWEB)

    Schock, Alfred; Mukunda, Meera; Or, Chuen T; Kumar, Vasanth; Summers, G.

    1994-01-16

    This paper describes the results of a DOE-sponsored design study of a radioisotope thermophotovoltaic generator. Instead of conducting a generic study, it was decided to focus the design by directing it at a specific space mission, Pluto Fast Flyby (PFF). That mission, under study by JPL, envisages a direct eight-year flight to Pluto (the only unexplored planet in the solar system), followed by comprehensive mapping, surface composition, and atmospheric structure measurements during a brief flyby of the planet and its moon Charon, and transmission of the recorded science data to Earth during a one-year post-encounter cruise. Because of Pluto's long distance from the sun (30-50 A.U.) and the mission's large energy demand, JPL has baselined the use of a radioisotope power system for the PFF spacecraft. The chief advantage of Radioisotope Thermophotovoltaic (RTPV) power systems over current Radioisotope Thermoelectric Generators (RTGs) is their much higher conversion efficiency, which greatly reduces the mass and cost of the required radioisotope heat source. Those attributes are particularly important for the PFF mission, which - like all NASA missions under current consideration - is severely mass- and cost-limited. The paper describes the design of the radioisotope heat source, the thermophotovoltaic converter, and the heat rejection system; and presents the results of the thermal, electrical, and structural analysis and the design optimization of the integrated RTPV system. It briefly summarizes the RTPV system's current technology status, and lists a number of factors that my greatly reduce the need for long-term tests to demonstrate generator lifetime. Our analytical results show very substantial performance improvements over an RTG designed for the same mission, and suggest that the RTPV generator, when developed by DOE and/or NASA, would be quite valuable not only for the PFF mission but also for other future missions requiring small, long

  8. Implementation of nanoparticles in therapeutic radiation oncology

    Science.gov (United States)

    Beeler, Erik; Gabani, Prashant; Singh, Om V.

    2017-05-01

    Development and progress of cancer is a very complex disease process to comprehend because of the multiple changes in cellular physiology, pathology, and pathophysiology resulting from the numerous genetic changes from which cancer originates. As a result, most common treatments are not directed at the molecular level but rather at the tissue level. While personalized care is becoming an increasingly aim, the most common cancer treatments are restricted to chemotherapy, radiation, and surgery, each of which has a high likelihood of resulting in rather severe adverse side effects. For example, currently used radiation therapy does not discriminate between normal and cancerous cells and greatly relies on the external targeting of the radiation beams to specific cells and organs. Because of this, there is an immediate need for the development of new and innovative technologies that help to differentiate tumor cells and micrometastases from normal cells and facilitate the complete destruction of those cells. Recent advancements in nanoscience and nanotechnology have paved a way for the development of nanoparticles (NPs) as multifunctional carriers to deliver therapeutic radioisotopes for tumor targeted radiation therapy, to monitor their delivery, and improve the therapeutic index of radiation and tumor response to the treatment. The application of NPs in radiation therapy has aimed to improve outcomes in radiation therapy by increasing therapeutic effect in tumors and reducing toxicity on normal tissues. Because NPs possess unique properties, such as preferential accumulation in tumors and minimal uptake in normal tissues, it makes them ideal for the delivery of radiotherapy. This review provides an overview of the recent development of NPs for carrying and delivering therapeutic radioisotopes for systemic radiation treatment for a variety of cancers in radiation oncology.

  9. Contributions and Future of Radioisotopes in Medical, Industrial and Space Applications

    Science.gov (United States)

    Tingey, G. L.; Dix, G. P.; Wahlquist, E. J.

    1990-11-01

    There are 333 isotopes that have a half-life between 1 day and 100,000 years that have a wide variety of applications including public health, medicine,industrial technology, food technology and packaging, agriculture, energy supply, and national security. This paper provides an overview of some of the most extensive applications of radioisotopes including some observations of future uses. Examples are discussed that indicate that the use of radioisotopes is almost unlimited and will continue to grow. There is a growing need for future applications development and production. 12 refs., 1 tab. (BM)

  10. Solid targets for production of radioisotopes with cyclotron; Blancos solidos para produccion de radioisotopos con ciclotron

    Energy Technology Data Exchange (ETDEWEB)

    Paredes G, L.; Balcazar G, M. [Instituto Nacional de Investigaciones Nucleares, Direccion de Investigacion Tecnologica, A.P. 18-1027, 11801 Mexico D.F. (Mexico)

    1999-07-01

    The design of targets for production of radioisotopes and radiopharmaceuticals of cyclotron to medical applications requires a detailed analysis of several variables such as: cyclotron operation conditions, choice of used materials as target and their physicochemical characteristics, activity calculation, the yielding of each radioisotope by irradiation, the competition of nuclear reactions in function of the projectiles energy and the collision processes amongst others. The objective of this work is to determine the equations for the calculation for yielding of solid targets at the end of the proton irradiation. (Author)

  11. An Adjunct Galilean Satellite Orbiter Using a Small Radioisotope Power Source

    Science.gov (United States)

    Abelson, Robert Dean; Randolph, J.; Alkalai, L.; Collins, D.; Moore, W.

    2005-01-01

    This is a conceptual mission study intended to demonstrate the range of possible missions and applications that could be enabled were a new generation of Small Radioisotope Power Systems to be developed by NASA and DOE. While such systems are currently being considered by NASA and DOE, they do not currently exist. This study is one of several small RPS-enabled mission concepts that were studied and presented in the NASA/JPL document "Enabling Exploration with Small Radioisotope Power Systems" available at: http://solarsystem.nasa.gov/multimedia/download-detail.cfm?DL_ID=82

  12. Contributions and future of radioisotopes in medical, industrial and space applications

    Energy Technology Data Exchange (ETDEWEB)

    Tingey, G.L.; Dix, G.P.; Wahlquist, E.J.

    1990-11-01

    There are 333 isotopes that have a half-life between 1 day and 100,000 years that have a wide variety of applications including public health, medicine,industrial technology, food technology and packaging, agriculture, energy supply, and national security. This paper provides an overview of some of the most extensive applications of radioisotopes including some observations of future uses. Examples are discussed that indicate that the use of radioisotopes is almost unlimited and will continue to grow. There is a growing need for future applications development and production. 12 refs., 1 tab. (BM)

  13. Actual and future situations of the use of radioisotopes; Situacion actual y futura del empleo de radioisotopos

    Energy Technology Data Exchange (ETDEWEB)

    Paredes G, L.C. [ININ, 52045 Ocoyoacac, Estado de Mexico (Mexico)

    2005-07-01

    It is anticipated to medium term, an increase in the demand of the radioisotopes for medicine, industry and research, as well as the application of new radioisotopes derived from the development of new radiopharmaceuticals products for diagnosis and therapy applications. The personal and clinical dosimetry will have to be prepared for the new challenges. (Author)

  14. The assessment of testosterone and radioisotopic index of bone metabolism and bone mineral density in men with testosterone deficiency after one year of testosterone therapy.

    Science.gov (United States)

    Tryniszewski, Wieslaw; Kamiński, Grzegorz; Maziarz, Zbigniew; Nowak, Michal; Gadzicki, Mariusz; Radek, Maciej

    2018-01-10

    a positive correlation between IBM and BMD before treatment (r = 0.7991), however, its strength decreased after one-year therapy (r = 0.6757). In our opinion, IBM is more sensitive than other methods of the assessment of changes occurring in bone system under the influence of testosterone therapy. The observed changes in IBM were proportional to changes in testosterone concentration. Testosterone level, TDS and radioisotopic assessment of bone metabolism may be used as prognostic and therapeutic factors of osteoporosis and bone fractures in elderly men.

  15. Fabrication of the Prototype Target Stack and Test Mock-up for the PEFP Radioisotope Production Facility

    Energy Technology Data Exchange (ETDEWEB)

    Yoon, S. P.; Park, B. S.; Kim, H. S.; Kwon, H. J.; Cho, Y. S. [Korea Atomic Energy Research Institute, Daejeon (Korea, Republic of)

    2011-05-15

    The Proton Engineering Frontier Project have a plan to construct 100-MeV Proton Linear accelerator and also, will construct radioisotope production facility using 100MeV proton beam for medical application. Sr- 82, Cu-67 and Ge-68 were selected as the objective radioisotope in this facility. They are promising radioisotope for the PET imaging and cancer therapy. To produce Sr-82, Cu-67 and Ge-68, RbCl, Zn metal and Ga metal were chosen as a target materials which they have claddings of stainless steel or Inconel. and also to produce these radioisotopes at the same time, we have introduced target stack in tandem. Table 1 indicated the general characteristics of the designated radioisotopes

  16. Brachytherapy on restenosis. {sup 32}P radioisotope in animal model

    Energy Technology Data Exchange (ETDEWEB)

    Bergoc, R.; Rivera, E.; Cocca, C.; Martin, G.; Cricco, G. [Buenos Aires Univ. (Argentina). School of Pharmacy and Biochemistry; Croci, M.; Guzman, L.

    2000-05-01

    Despite a notorious decline in age-adjusted death rates for cardiovascular pathologies, coronary artery disease still remains as the main cause of mortality above the age of 40 in men and 60 in women. More than 25% of death in persons over the age of 35 are due to coronary disease. In about 50% of men and 30% of women, the first manifestation of the disease is an acute myocardial infarction and 10% a sudden cardiac death. In Argentina it is estimated that in 1998 about 100.000-115.000 people suffered as first manifestation of coronary illness a myocardial acute infarct. Angioplasty has an important and well established site in the treatment of the coronary illness and restenosis represents the principal complication of this method for myocardial re-vascularization. About a 35-40% of treated arteries present restenosis within the first six month the intervention with the concomitant need of re-interventions, re-hospitalizations, by-pass surgery, work discontinuity and the high cost for the health system. A number of drugs were tested as anti-restenosis: anticoagulants, aspirin, antispasmodics and lipid-lowering agents but none was clearly efficient; also, experimental studies in which intravascular irradiation with different source types and energies, radiation doses and doses rate to prevent restenosis was utilized; however, there is no consensus in many aspects of this intravascular brachytherapy. The first step in this work was to induce the experimental model in rabbits. Afterwards, by means of the balloon methodology and stent implantation, brachytherapy experiments were carried out to evaluate the biological effect on different layers of arteries, with different Doses using a beta particle emitting radioisotope ({sup 32}P). The arteriosclerotic lesions were induced in New Zealand rabbits through the administration of a diet with high cholesterol content. Angioplastic interventions on femoral arteries were done with balloon methodology and controlled by

  17. Dose estimate of exposure to radioisotopes in molecular and cellular biology

    Energy Technology Data Exchange (ETDEWEB)

    Onado, C.; Faretta, M.; Ubezio, P. [Unitadi Biofisica, Istituto di Ricerche Farmacologiche ' Mario Negri' , Milano (Italy)

    1999-06-01

    A method for prospectively evaluating the annual equivalent doses and effective dose to biomedical researchers working with unsealed radioisotopes, and their classification, is presented here. Simplified formulae relate occupational data to a reasonable overestimate of the annual effective dose, and the equivalent doses to the hands and to the skin. The procedure, up to the classification of personnel and laboratories, can be made fully automatic, using a common spreadsheet on a personal computer. The method is based on occupational data, accounting for the amounts of each radioisotope used by a researcher, the time of exposure and the overall amounts employed in the laboratories where experiments are performed. The former data serve to forecast a contribution to the dose arising from a researcher's own work, the latter to a forecast of an 'environmental' contribution deriving simply from the presence in a laboratory where other people are working with radioisotopes. The estimates of the doses due to one's own radioisotope handling and to 'environment' were corrected for accidental exposure, considered as a linear function of the manipulated activity or of the time spent in the laboratories respectively, and summed up to give the effective dose. The effective dose associated with some common experiments in molecular and cellular biology is pre-evaluated by this method. (author)

  18. Clouds, airplanes, trucks and people: carrying radioisotopes to and across Mexico.

    Science.gov (United States)

    Mateos, Gisela; Suárez-Díaz, Edna

    2015-01-01

    The aim of this paper is to describe the early stages of Mexican nuclearization that took place in contact with radioisotopes. This history requires a multilayered narrative with an emphasis in North-South asymmetric relations, and in the value of education and training in the creation of international asymmetrical networks. Radioisotopes were involved in exchanges with the United States since the late 1940s, but also with Canada. We also describe the context of implementation of Eisenhower's Atoms for Peace initiative in Mexico that opened the door to training programs at both the Comisión Nacional de Energía Nuclear and the Universidad Nacional Autónoma de México. Radioisotopes became the best example of the peaceful applications of atomic energy, and as such they fitted the Mexican nuclearization process that was and still is defined by its commitment to pacifism. In 1955 Mexico became one of the 16 members of the atomic fallout network established by the United Nations. As part of this network, the first generation of Mexican (women) radio-chemists was trained. By the end of the 1960s, radioisotopes and biological markers were being produced in a research reactor, prepared and distributed by the CNEN within Mexico. We end up this paper with a brief reflection on North-South nuclear exchanges and the particularities of the Mexican case.

  19. The study on the adaptation for regulation - the permission of a radioisotope

    Energy Technology Data Exchange (ETDEWEB)

    Park, Byoung Il; Choi, Won Seok; Jung, Yong Moon [Gallup Korea, Seoul (Korea, Republic of)

    2003-08-15

    The restriction -the permission of a radioisotope keeps satisfaction with almost parts for example, awareness, observance and so on. Moreover two concepts are considered fully -too strict about certain specific control rules and needed more discriminated application standards to each organization related to KINS, it's preserved and controlled properly even if the penalties are downsized.

  20. Summary, the 20th quality control survey for radioisotopes in vitro tests in Japan, 1998

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1999-11-01

    For advancement of radioisotope in vitro tests such as radioimmunoassay and immunoradiometric assay, the Subcommittee for Radioisotope in vitro Test in Medical and Pharmaceutical Committee of Japan Radioisotope Association has conducted the yearly quality control survey for the test facilities in Japan since 1978. This is the summary of the 20th survey in 1998 where non-radioisotope tests like enzyme-immunoassay were involved as well. The survey was done for 143 facilities: 20 national and public university hospitals, 18 private university hospitals, 8 national hospitals, 13 public hospitals, 21 private hospitals, 41 hygienic laboratories and 22 manufacturers of reagents. Facilities examined intra- and between day-reproducibility, freeze-thaw effect and time change of the measured values on the same samples. Assays were for: growth hormone (h), somatomedin C, follicle stimulating h, luteinizing h, prolactin, thyroid stimulating h, triiodothyronines, thyroxines, thyroxine binding protein, calcitonin, insulin, C-peptide, glucagons, gastrin, testosterones, estradiol, progesterone, gonadotropin, 17{alpha}-hydroxyprogesterone, aldosterone, cortisol, dehydroepiandorosterone sulfate, renin, IgE, digoxin, {alpha}-fetoprotein, carcinoembryonic antigen, tissue polypeptide antigen, CA (125, 19-9 and 15-3), prostatic acid phosphatase, prostate specific antigen, {beta}2-microglobulin, ferritin, and neuron specific enolase. There was no great difference between this and last survey results although tendency of improvement was recognized. There were problems to be solved from the standpoint of clinical practice. (K.H.)

  1. Fractal Dimensions for Radioisotope Pollution Patterns by Nuclear Power Plant Accidents

    Science.gov (United States)

    Saito, K.; Ogawa, S.

    2015-04-01

    The radioisotope pollution shows two types of patterns: dry and wet deposits for nuclear power plant accidents. Two surface pollution patterns were analysed by fractal. In Fukushima nuclear power plant accident, surface pollution by wet deposits was estimated to occur. However, actually it was no rain and white crystals were observed on the surface. Then, fractal analysis was carried out for the spatial distribution patterns of radio isotopes on the surface to judge the types of deposits. As a reference, Chernobyl nuclear power plant accident was checked for the spatial distribution patterns of radioisotopes on the surface. The objective patterns by fractal analysis were the surface pollution maps in Fukushima and Chernobyl, Abukuma river watershed map, and NOAA/AVHRR. The calculation of fractal dimensions was carried out with the box counting for binarized images. Fractal analysis results suggested the next conclusions. The radioisotope pollution in Fukushima might occur in both dry and wet deposits. The dry deposit might make the pollution pattern similar to the watershed, while the wet deposit might make the pollution pattern similar to cloud images. Moreover, most radioisotope contaminants might flow on the road in the forest valley and deposit on forest with and without rainfall in Fukushima.

  2. The radioisotope complex project “RIC-80” at the Petersburg Nuclear Physics Institute

    Energy Technology Data Exchange (ETDEWEB)

    Panteleev, V. N., E-mail: vnp@pnpi.spb.ru; Barzakh, A. E.; Batist, L. Kh.; Fedorov, D. V.; Ivanov, V. S.; Moroz, F. V.; Molkanov, P. L.; Orlov, S. Yu.; Volkov, Yu. M. [NRC “Kurchatov Institute” PNPI, 188300 Gatchina (Russian Federation)

    2015-12-15

    The high current cyclotron C-80 capable of producing 40-80 MeV proton beams with a current of up to 200 μA has been constructed at Petersburg Nuclear Physics Institute. One of the main goals of the C-80 is the production of a wide spectrum of medical radionuclides for diagnostics and therapy. The project development of the radioisotope complex RIC-80 (radioisotopes at the cyclotron C-80) at the beam of C-80 has been completed. The RIC-80 complex is briefly discussed in this paper. The combination of the mass-separator with the target-ion source device, available at one of the new target stations for on-line or semi on-line production of a high purity separated radioisotopes, is explored in greater detail. The results of target and ion source tests for a mass-separator method for the production of high purity radioisotopes {sup 82}Sr and {sup 223,224}Ra are also presented.

  3. Preparation of the Nanostructured Radioisotope Metallic Oxide by Neutron Irradiation for Use as Radiotracers

    Directory of Open Access Journals (Sweden)

    Sang-Ei Seo

    2017-10-01

    Full Text Available Metallic oxides manganese dioxide (MnO2, samarium oxide (Sm2O3, and dysprosium oxide (Dy2O3 with nanorod-like structures were synthesized by the hydrothermal synthesis method, respectively. Subsequently, the nanostructured radioisotopes MnO2 with Mn-56, Sm2O3 with Sm-153, and Dy2O3 with Dy-165 were prepared by neutron irradiation from the HANARO research reactor, respectively. The three different elements, Mn, Sm, and Dy, were selected as radiotracers because these elements can be easily gamma-activated from neutrons (activation limits: 1 picogram (Dy, 1–10 picogram (Mn, 10–100 picogram (Sm. Furthermore, the synthesized radioisotopes can be used as radiotracers in Prompt Gamma Neutron Activation Analysis as the rare earth metals Dy and Sm were not present in the Korean environment. The successful synthesis of the radioisotope metallic oxides was confirmed by Transmission Electron Microscopy (TEM, Energy Dispersive X-ray Spectrometry (EDS, X-ray Diffraction (XRD analysis, and gamma spectroscopy analysis. The synthesized nanostructured radioisotope metallic oxides may be used as radiotracers in scientific, environmental, engineering, and industrial fields.

  4. Planetary Protection Concerns During Pre-Launch Radioisotope Power System Final Integration Activities

    Science.gov (United States)

    Chen, Fei; McKay, Terri; Spry, James A.; Colozza, Anthony J.; DiStefano, Salvador

    2012-01-01

    The Advanced Stirling Radioisotope Generator (ASRG) is a next-generation radioisotope-based power system that is currently being developed as an alternative to the Multi-Mission Radioisotope Thermoelectric Generator (MMRTG). Power sources such as these may be needed for proposed missions to solar system planets and bodies that have challenging Planetary Protection (PP) requirements (e.g. Mars, Europa, Enceladus) that may support NASA s search for life, remnants of past life, and the precursors of life. One concern is that the heat from the ASRG could potentially create a region in which liquid water may occur. As advised by the NASA Planetary Protection Officer, when deploying an ASRG to Mars, the current COSPAR/NASA PP policy should be followed for Category IVc mission. Thus, sterilization processing of the ASRG to achieve bioburden reduction would be essential to meet the Planetary Protection requirements. Due to thermal constraints and associated low temperature limits of elements of the ASRG, vapor hydrogen peroxide (VHP) was suggested as a candidate alternative sterilization process to complement dry heat microbial reduction (DHMR) for the assembled ASRG. The following proposed sterilization plan for the ASRG anticipates a mission Category IVc level of cleanliness. This plan provides a scenario in which VHP is used as the final sterilization process. Keywords: Advanced Stirling Radioisotope Generator (ASRG), Planetary Protection (PP), Vapor hydrogen peroxide (VHP) sterilization.

  5. 76 FR 63668 - Guidelines for Preparing and Reviewing Licensing Applications for the Production of Radioisotopes

    Science.gov (United States)

    2011-10-13

    ... construction and operating license for a radioisotope production facility and the Research and Test Reactor... Reactors Licensing Branch, Division of Policy and Rulemaking, Office of Nuclear Reactor Regulation, U.S... the Nuclear Regulatory Commission. Patricia A. Silva, Chief, Research and Test Reactors Projects...

  6. Application of radioisotopes Au -198 to radiometrical field investigation of spraying machine

    Energy Technology Data Exchange (ETDEWEB)

    Goraczko, W.; Kocorowska, E. [Technical Univeristy, Poznan (Poland). Radio and Photo-Chemistry Department

    1997-10-01

    The poster shows application of radioisotope {sup 198}Au to radiometrical field testing of spraying machine. In the research was tested the Polish suspensioned tractor OZS400 type spraying machine. The machine worked in two different variants: without and with the beam stabilisation (oscillatory stabilisation)

  7. The radioisotope complex project "RIC-80" at the Petersburg Nuclear Physics Institute.

    Science.gov (United States)

    Panteleev, V N; Barzakh, A E; Batist, L Kh; Fedorov, D V; Ivanov, V S; Moroz, F V; Molkanov, P L; Orlov, S Yu; Volkov, Yu M

    2015-12-01

    The high current cyclotron C-80 capable of producing 40-80 MeV proton beams with a current of up to 200 μA has been constructed at Petersburg Nuclear Physics Institute. One of the main goals of the C-80 is the production of a wide spectrum of medical radionuclides for diagnostics and therapy. The project development of the radioisotope complex RIC-80 (radioisotopes at the cyclotron C-80) at the beam of C-80 has been completed. The RIC-80 complex is briefly discussed in this paper. The combination of the mass-separator with the target-ion source device, available at one of the new target stations for on-line or semi on-line production of a high purity separated radioisotopes, is explored in greater detail. The results of target and ion source tests for a mass-separator method for the production of high purity radioisotopes (82)Sr and (223,224)Ra are also presented.

  8. Synthesis and evaluation of tetraphosphonates labelled with {sup 212}Bi, {sup 212}Pb and {sup 165}Er

    Energy Technology Data Exchange (ETDEWEB)

    Hassfjell, S.P

    1997-08-01

    The main goal of this work has been to achieve a synthesis of radiolabelled phosphonates for the improvement of diagnostic and therapy of osteoblastic osteosarcoma and sclerotic bone metastases. {sup 212}Bi-DOTMP is shown to be an in vivo stable bone seeking radiopharmaceutical with a potential for a {alpha}-particle therapy of the above mentioned diseases. It has biodistribution characteristics similar to {sup 153}Sm-EDTMP, which is now formally approved in several countries, most recently in the US. {sup 212}Pb-DOTMP is also a promising candidate having the advantage of increasing the effective half life of the {alpha}-emitter, although loss of some of the in vivo generated {sup 212}Bi may be a problem. A generator has been developed for the production of the {alpha}-emitting radionuclide {sup 212}Bi and its parent nuclide {sup 212}Pb. The generator is based on the emanation of {sup 220}Rn from ({sup 228}Th)barium stearate. The decay product of {sup 220}Rn, {sup 212}Pb deposits on the walls of a polyethylene bottle, and can be wasted off with distilled water. The generator shows no leakage of any long-lived parent nuclides, is easy to operate and has a high degree of radiation safety.

  9. Radioisotopes production for applications on the health; Produccion de radioisotopos para aplicaciones en la salud

    Energy Technology Data Exchange (ETDEWEB)

    Monroy G, F.; Alanis M, J., E-mail: fabiola.monroy@inin.gob.m [ININ, Departamento de Materiales Radiactivos, Carretera Mexico-Toluca s/n, 52750 Ocoyoacac, Estado de Mexico (Mexico)

    2010-07-01

    In the Radioactive Materials Department of the Instituto Nacional de Investigaciones Nucleares (ININ) processes have been studied and developed for the radioisotopes production of interest in the medicine, research, industry and agriculture. In particular five new processes have been developed in the last 10 years by the group of the Radioactive Materials Research Laboratory to produce: {sup 99}Mo/{sup 99m}Tc and {sup 188}W/{sup 188}Re generators, the radio lanthanides: {sup 151}Pm, {sup 147}Pm, {sup 161}Tb, {sup 166}Ho, {sup 177}Lu, {sup 131}I and the {sup 32}P. All these radioisotopes are artificial and they can be produced in nuclear reactors and some of them in particle accelerators. The radioisotope generators are of particular interest, as those of {sup 99}Mo/{sup 99m}Tc and {sup 188}W/{sup 188}Re presented in this work, because they are systems that allow to produce an artificial radioisotope of interest continually, in these cases the {sup 99m}Tc and the {sup 188}Re, without the necessity of having a nuclear reactor or an particle accelerator. They are compact systems armored and sure perfectly of manipulating that, once the radioactive material has decayed, they do not present radiological risk some for the environment and the population. These systems are therefore of supreme utility in places where it is not had nuclear reactors or with a continuous radioisotope supply, due to their time of decaying, for its cost or for logistical problems in their supply, like it is the case of many hospital centers, of research or industries in our country. (Author)

  10. The improvement of the education courses on radiation protection and radioisotope handling

    Energy Technology Data Exchange (ETDEWEB)

    Ko, Han Suk; Kim, Woong Ki [Korea Atomic Energy Research Institute, Daejeon (Korea, Republic of)

    2015-10-15

    About 48,000 nuclear personnel and 10,000 radioisotope personnel have participated in the KAERI-NTC's education and training programs. For the needs of personnel in radioisotope and radiation handling, KAERI-NTC has operated a class-room based full-time course for 4 weeks for applicants of a general license and 6 weeks for applicants of supervisor license. These courses educated almost 3,908 trainees for general radioisotope handling and 1,856 trainees for supervisors of radiation handling. Since the Korean Association for Radiation Application (KARA) was established in 1985 and the Korea Academy of Nuclear Safety (KANS) was established in 2002, KARA and KANS have operated with a non-classroom based correspondence course. According to this role separation in training radioisotope handling personnel, KAERI-NTC tried to improve the classroom based courses. The number of applicants of general radioisotope handling in recent years is increasing around 3,000 - 4,000 in a year. The real participants in an general license test are 2,105 to 2,841 in 2013 and 2014. The ratio of successful applicants in general isotope handling are just the 23% in 2013 and 4.2% in 2014. Addressing this low ratio of successful applicants, several proactive measures in KAERI-NTC were considered to enhance these courses for general users and supervisors. The purpose of this paper is to provide. For the further development of these courses, our measures were classified the measures in the Implementation stage of the ADDIE model. In addition to this Implementation stage, it is recommended that these actions should be applied to the other stages of ADDIE such as Analysis, Design, Development and Evaluation.

  11. Therapeutic Nanodevices

    Science.gov (United States)

    Lee, Stephen; Ruegsegger, Mark; Barnes, Philip; Smith, Bryan; Ferrari, Mauro

    Therapeutic nanotechnology offers minimally invasive therapies with high densities of function concentrated in small volumes, features that may reduce patient morbidity and mortality. Unlike other areas of nanotechnology, novel physical properties associated with nanoscale dimensionality are not the raison d'être of therapeutic nanotechnology, whereas the aggregation of multiple biochemical (or comparably precise) functions into controlled nanoarchitectures is. Multifunctionality is a hallmark of emerging nanotherapeutic devices, and multifunctionality can allow nanotherapeutic devices to perform multistep work processes, with each functional component contributing to one or more nanodevice subroutine such that, in aggregate, subroutines sum to a cogent work process. Cannonical nanotherapeutic subroutines include tethering (targeting) to sites of disease, dispensing measured doses of drug (or bioactive compound), detection of residual disease after therapy and communication with an external clinician/operator. Emerging nanotherapeutics thus blur the boundaries between medical devices and traditional pharmaceuticals. Assembly of therapeutic nanodevices generally exploits either (bio)material self-assembly properties or chemoselective bioconjugation techniques, or both. Given the complexity, composition, and the necessity for their tight chemical and structural definition inherent in the nature of nanotherapeutics, their cost of goods (COGs) might exceed that of (already expensive) biologics. Early therapeutic nanodevices will likely be applied to disease states which exhibit significant unmet patient need (cancer and cardiovascular disease), while application to other disease states well-served by conventional therapy may await perfection of nanotherapeutic design and assembly protocols.

  12. U.S. Space Radioisotope Power Systems and Applications: Past, Present and Future

    Science.gov (United States)

    Cataldo, Robert L.; Bennett, Gary L.

    2011-01-01

    Radioisotope power systems (RPS) have been essential to the U.S. exploration of outer space. RPS have two primary uses: electrical power and thermal power. To provide electrical power, the RPS uses the heat produced by the natural decay of a radioisotope (e.g., plutonium-238 in U.S. RPS) to drive a converter (e.g., thermoelectric elements or Stirling linear alternator). As a thermal power source the heat is conducted to whatever component on the spacecraft needs to be kept warm; this heat can be produced by a radioisotope heater unit (RHU) or by using the excess heat of a radioisotope thermoelectric generator (RTG). As of 2010, the U.S. has launched 41 RTGs on 26 space systems. These space systems have ranged from navigational satellites to challenging outer planet missions such as Pioneer 10/11, Voyager 1/2, Galileo, Ulysses, Cassini and the New Horizons mission to Pluto. In the fall of 2011, NASA plans to launch the Mars Science Laboratory (MSL) that will employ the new Multi-Mission Radioisotope Thermoelectric Generator (MMRTG) as the principal power source. Hundreds of radioisotope heater units (RHUs) have been launched to provide warmth to Apollo 11, used to provide heating of critical components in a seismic experiment package, Pioneer 10/11, Voyager 1/2, Galileo, Cassini, Mars Pathfinder, MER rovers, etc. to provide temperature control to critical spacecraft electronics and other mechanical devices such as propulsion system propellant valves. A radioisotope (electrical) power source or system (RPS) consists of three basic elements: (1) the radioisotope heat source that provides the thermal power, (2) the converter that transforms the thermal power into electrical power and (3) the heat rejection radiator. Figure 1 illustrates the basic features of an RPS. The idea of a radioisotope power source follows closely after the early investigations of radioactivity by researchers such as Henri Becquerel (1852-1908), Marie Curie (1867-1935), Pierre Curie (1859

  13. Regulations concerning the radionuclides uses in France; Reglementation de l'utilisation des radioisotopes en France

    Energy Technology Data Exchange (ETDEWEB)

    Vergne, J. [Commissariat a l' Energie Atomique, Saclay (France). Centre d' Etudes Nucleaires; Bugnard, L. [Institut national d' Hygiene (France)

    1955-07-01

    The progress in the uses of radioisotopes has been conditioned by increasing the number of trained workers and researchers and developing theoretical teaching in universities since 1950 in France as well as developing a national control of the distribution and uses of radioisotopes. With the large diffusion and development of radioisotopes uses and applications, new rules and regulations came to control the importation, exportation, transport and utilization of radioisotopes. In the first part, it described the different French laws since 1934 and their successive modifications which ruled on the production, manipulation and utilization of radioisotopes. An inter-ministerial committee was created in 1952 to advise and inform of all the questions related to the preparation, importation, exportation, possession and distribution of radioisotopes. The transport regulations are in constant evolution and has got to meet with international recommendations. It distinguished three different type of transport: road, river and railway transport, postal transport and finally air transport. All the different transports have their specific packaging, maximum transportable quantity, maximum material intensity and labelling requirements. The regulations about customs duties are specified as well as the administrative formalities for non natural radioisotopes importation. Since 1950, diseases caused by irradiation to natural or artificial radioactive materials are recognised as professional diseases and a table of the actual regulations is presented. (M.P.)

  14. Radioisotope Thermophotovoltaic (RTPV) Generator and Its Applicability to an Illustrative Space Mission

    Energy Technology Data Exchange (ETDEWEB)

    Schock, A.; Mukunda, M.; Or, T.; Kumar, V.; Summers, G.

    1994-02-14

    The paper describes the results of a DOE-sponsored design study of a radioisotope thermophotovoltaic generator (RTPV), to complement similar studies of Radioisotope Thermoelectric Generators (RTGs) and Stirling Generators (RSGs) previously published by the author. Instead of conducting a generic study, it was decided to focus the design effort by directing it at a specific illustrative space mission, Pluto Fast Flyby (PFF). That mission, under study by JPL, envisages a direct eight-year flight to Pluto (the only unexplored planet in the solar system), followed by comprehensive mapping, surface composition, and atmospheric structure measurements during a brief flyby of the planet and its moon Charon, and transmission of the recorded science data to Earth during a post-encounter cruise lasting up to one year.

  15. Integration of Americium Heat Source into the Advanced Stirling Radioisotope Generator

    Science.gov (United States)

    Schulze, Erich; Quinn, Richard

    2014-08-01

    The Lockheed Martin developed Advanced Stirling Radioisotope Generator (ASRG) design uses similar technology as proposed for the European Space Agency (ESA) Radioisotope Power System (RPS) development program but different isotopes. The RPS uses americium, 241Am isotope, while the ASRG uses plutonium, 238Pu isotope. The 238Pu isotope provides four times greater thermal output per kilogram than the 241Am isotope. Lockheed Martin performed an internally funded feasibility assessment that determined integration of a 241Am fueled heat source into the ASRG is achievable with no changes to ASRG technology and only structural and volumetric design considerations required. Lockheed Martin is interested in developing collaborative partnerships with the United Kingdom (UK) for the ESA RPS development program.

  16. Light weight radioisotope heater unit (LWRHU): a technical description of the reference design

    Energy Technology Data Exchange (ETDEWEB)

    Tate, R.E.

    1982-01-01

    The Light Weight Radioisotope Heater Unit (LWRHU), a new radioisotope heater unit for use in space missions, is a /sup 238/PuO/sub 2/-fueled unit designed to provide a thermal watt in dispersed locations on a spacecraft. The LWRHU is required to maintain the temperature of a component at a level where the component will function reliably in space. Two major constraints are placed on the unit's design; it must be as light as possible and must provide enough protection to immobilize the plutonium fuel to the maximum extent in all phases of the unit's lifetime. The four components are pelletized fuel, platinum-alloy encapsulation, pyrolytic graphite thermal insulation, and high-technology graphite ablation shell. The LWRHU is a cylinder 32 mm (1.26 in.) high and 26 mm (1.02 in.) in diameter. It weighs slightly less than 40 g(.09 lb).

  17. Recent research activities and future subjects on stable- and radio-isotopes of chlorine in environment

    Energy Technology Data Exchange (ETDEWEB)

    Kushita, Kouhei [Japan Atomic Energy Research Inst., Tokai, Ibaraki (Japan). Tokai Research Establishment

    2001-12-01

    This report reviews the recent studies on the stable- and radio-isotopes of chlorine from a viewpoint of environmental science, partly including historic references on this element. First, general properties, occurrence, and utilization of chlorine are described. Secondly, current status and research works on chlorine-compounds, which attract special attention in recent years as environmentally hazardous materials, are reported. Thirdly, research works on stable chlorine isotopes, {sup 35}Cl and {sup 37}Cl, are described with a focus laid on the newly-developed techniques; isotopic ratio mass spectrometry (IRMS) and thermal ionization mass spectrometry (TIMS). Fourthly, recent research works on chlorine radioisotopes, {sup 36}Cl etc., are described, focusing on the development of accelerator mass spectrometry (AMS) and its application to geochemistry and others. Finally, taking account of the above-mentioned recent works on Cl isotopes, possible future research subjects are discussed. (author)

  18. Modelling study on production cross sections of {sup 111}In radioisotopes used in nuclear medicine

    Energy Technology Data Exchange (ETDEWEB)

    Kara, Ayhan; Korkut, Turgay [Sinop Univ. (Turkey). Faculty of Engineering; Yigit, Mustafa [Aksaray Univ. (Turkey). Faculty of Science and Arts; Tel, Eyyup [Osmaniye Korkut Ata Univ. (Turkey). Faculty of Science and Arts

    2015-07-15

    Radiopharmaceuticals are radioactive drugs used for diagnosis or treatment in a tracer quantity with no pharmacological action. The production of radiopharmaceuticals is carried out in the special research centers generally using by the cyclotron systems. Indium-111 is one of the most useful radioisotopes used in nuclear medicine. In this paper, we calculated the production cross sections of {sup 111}In radioisotope via {sup 111-114}Cd(p,xn) nuclear reactions up to 60 MeV energy. In the model calculations, ALICE/ASH, TALYS 1.6 and EMPIRE 3.2 Malta nuclear reaction code systems were used. The model calculation results were compared to the experimental literature data and TENDL-2014 (TALYS-based) data.

  19. Evaluation of radiation dose for registered users of radioisotopes at Faculty of Engineering, Hiroshima University

    Energy Technology Data Exchange (ETDEWEB)

    Shizuma, Kiyoshi; Iwatani, Kazuo; Hasai, Hiromi (Hiroshima Univ., Higashi-Hiroshima (Japan). Faculty of Engineering)

    1993-12-01

    The effective dose equivalent for registered users of radioisotopes was evaluated. The external dose was evaluated from the dose measured with the film badge. The internal dose was evaluated on the basis of the concentration of radioisotopes in air, which is calculated beforehand for each facility. The radon concentration in air was measured for all facilities. The contribution of radon daughters to the internal dose was added for users of accelerator and electron microscope of radioactive samples. The maximum effective dose was 0.22 mSv among 97 users in 1992 and the dominant dose was 0.1-0.01 mSv. Present evaluation is important for individual radiation hazard control and also for fundamental data for abbreviation of health examination of users. (author).

  20. Using radioisotope method for measuring ice layer thickness in pulp lines

    Science.gov (United States)

    Malarev, V. I.; Kopteva, A. V.

    2017-10-01

    Operating hydro-transportation systems in Russia means challenges resulting from ice formation within pipelines when idle, and even during actual operation, thus some protection of pulp lines against freezing is a must. This work is devoted to the radioisotope method for ice layer thickness measuring on pipeline walls, which is now more and more often used in practice. This is a low cost method with units and parts easily replaceable, simple by design, non-interrupting the process.

  1. COMPASS Final Report: Radioisotope Electric Propulsion (REP) Centaur Orbiter New Frontiers Mission

    Science.gov (United States)

    Oleson, Steven R.; McGuire, Melissa L.

    2011-01-01

    Radioisotope Electric Propulsion (REP) has been shown in past studies to enable missions to outer planetary bodies including the orbiting of Centaur asteroids. Key to the feasibility for REP missions are long life, low power electric propulsion (EP) devices, low mass Radioisotope Power System (RPS) and light spacecraft (S/C) components. In order to determine the key parameters for EP devices to perform these REP missions a design study was completed to design an REP S/C to orbit a Centaur in a New Frontiers (NF) cost cap. The design shows that an orbiter using several long lived (approx.200 kg xenon (Xe) throughput), low power (approx.700 W) Hall thrusters teamed with six (150 W each) Advanced Stirling Radioisotope Generators (ASRG) can deliver 60 kg of science instruments to a Centaur in 10 yr within the NF cost cap. Optimal specific impulses (Isp) for the Hall thrusters were found to be around 2000 s with thruster efficiencies over 40 percent. Not only can the REP S/C enable orbiting a Centaur (when compared to an all chemical mission only capable of flybys) but the additional power from the REP system can be used to enhance science and simplify communications. The mission design detailed in this report is a Radioisotope Power System (RPS) powered EP science orbiter to the Centaur Thereus with arrival 10 yr after launch, ending in a 1 yr science mapping mission. Along the trajectory, approximately 1.5 yr into the mission, the REP S/C does a flyby of the Trojan asteroid Tlepolemus. The total (Delta)V of the trajectory is 8.9 km/s. The REP S/C is delivered to orbit on an Atlas 551 class launch vehicle with a Star 48 B solid rocket stage

  2. Simple radio-isotopic method for the detection of bronchial inhalation during intensive care

    Energy Technology Data Exchange (ETDEWEB)

    Venot, J.; Veyriras, E.; Vandroux, J.C.; Bournaud, E.; Gastinne, H.; Beck, C.

    1984-08-01

    The high incidence of pneumopathy in intensive care units might be due to the pulmonary aspiration of gastric juice following gastro-oesophageal reflux. The paper describes a radio-isotopic method using material easy to install at the patient's bedside. This technique demonstrated aspiration of gastric juice in the lungs of 8 of 25 intensive care patients investigated. Such a method might be useful later to demonstrate that silent bronchial aspirations of gastric juice are responsible for pulmonary complications.

  3. submitter Development of a Superconducting Magnet for a Compact Cyclotron for Radioisotope Production

    CERN Document Server

    Garcia-Tabares, Luis; Calero, Jesus; Gutierrez, Jose L; Munilla, Javier; Obradors, Diego; Perez, Jose M; Toral, Fernando; Iturbe, Rafael; Minguez, Leire; Gomez, Jose; Rodilla, Elena; Bajko, Marta; Michels, Matthias; Berkowitz, Daniel; Haug, Friedrich

    2016-01-01

    The present paper describes the development process of a low critical temperature superconducting magnet to be installed in a compact cyclotron producing single-dose radioisotopes for clinical and preclinical applications. After a brief description of the accelerator, the magnet development process is described, starting from the magnetic, mechanical, quench, and thermal calculations, continuing with the designing process, particularly the support structure of the magnet and the cryogenic supply system, to finish with the fabrication and the first tests than have been performed.

  4. Radioisotope labelling of several major insect pest. Dipping the pupae in /sup 32/P solution

    Energy Technology Data Exchange (ETDEWEB)

    Sutrisno, S. (National Atomic Energy Agency, Jakarta (Indonesia). Pasar Djumat Research Centre)

    1981-12-01

    Radioisotope uptake by insects could take place through various parts i.e. mouth, cuticula, intersegmental, secretion and excretion organs. Usually insects are labelled internally by feeding them on an artificial diet containing radioisotope solution. Labelling of several insect pests of cabbage (Crocidolomia binotalis) Zell and Plutella maculipennis Curt and rice (Chilo suppressalis Walker) by dipping of the pupae in /sup 32/P solution showed a promising result. Pupae of Crocidolomia binotalis Zell dipped in 3 ml solution of /sup 32/P with specific activities of 1, 3, 5 and 7 ..mu..Ci/ml had developed labelled adults of sufficiently high radioactivity levels for ecological studies. Similar results were also obtained with Plutella maculipennis Curt and Chilo suppressalis Walker with doses of 1, 3, 5, 7 and 9 ..mu..Ci/ml /sup 32/P solution. The best doses for radioisotope labelling by dipping of the insects Crocidolomia binotalis Zell, Plutella maculipennis Curt, and Chilo suppressalis Walker were 1, 9, and 7 ..mu..Ci/ml respectivelly.

  5. Test Program for Stirling Radioisotope Generator Hardware at NASA Glenn Research Center

    Science.gov (United States)

    Lewandowski, Edward J.; Bolotin, Gary S.; Oriti, Salvatore M.

    2015-01-01

    Stirling-based energy conversion technology has demonstrated the potential of high efficiency and low mass power systems for future space missions. This capability is beneficial, if not essential, to making certain deep space missions possible. Significant progress was made developing the Advanced Stirling Radioisotope Generator (ASRG), a 140-W radioisotope power system. A variety of flight-like hardware, including Stirling convertors, controllers, and housings, was designed and built under the ASRG flight development project. To support future Stirling-based power system development NASA has proposals that, if funded, will allow this hardware to go on test at the NASA Glenn Research Center. While future flight hardware may not be identical to the hardware developed under the ASRG flight development project, many components will likely be similar, and system architectures may have heritage to ASRG. Thus, the importance of testing the ASRG hardware to the development of future Stirling-based power systems cannot be understated. This proposed testing will include performance testing, extended operation to establish an extensive reliability database, and characterization testing to quantify subsystem and system performance and better understand system interfaces. This paper details this proposed test program for Stirling radioisotope generator hardware at NASA Glenn. It explains the rationale behind the proposed tests and how these tests will meet the stated objectives.

  6. NASA Glenn Research Center Support of the Advanced Stirling Radioisotope Generator Project

    Science.gov (United States)

    Wilson, Scott D.; Wong, Wayne A.

    2015-01-01

    A high-efficiency radioisotope power system was being developed for long-duration NASA space science missions. The U.S. Department of Energy (DOE) managed a flight contract with Lockheed Martin Space Systems Company to build Advanced Stirling Radioisotope Generators (ASRGs), with support from NASA Glenn Research Center. DOE initiated termination of that contract in late 2013, primarily due to budget constraints. Sunpower, Inc., held two parallel contracts to produce Advanced Stirling Convertors (ASCs), one with Lockheed Martin to produce ASC-F flight units, and one with Glenn for the production of ASC-E3 engineering unit "pathfinders" that are built to the flight design. In support of those contracts, Glenn provided testing, materials expertise, Government-furnished equipment, inspection capabilities, and related data products to Lockheed Martin and Sunpower. The technical support included material evaluations, component tests, convertor characterization, and technology transfer. Material evaluations and component tests were performed on various ASC components in order to assess potential life-limiting mechanisms and provide data for reliability models. Convertor level tests were conducted to characterize performance under operating conditions that are representative of various mission conditions. Despite termination of the ASRG flight development contract, NASA continues to recognize the importance of high-efficiency ASC power conversion for Radioisotope Power Systems (RPS) and continues investment in the technology, including the continuation of the ASC-E3 contract. This paper describes key Government support for the ASRG project and future tests to be used to provide data for ongoing reliability assessments.

  7. Medical Radioisotope Production in a Power-Flattened ADS Fuelled with Uranium and Plutonium Dioxides

    Directory of Open Access Journals (Sweden)

    Gizem Bakır

    2016-01-01

    Full Text Available This study presents the medical radioisotope production performance of a conceptual accelerator driven system (ADS. Lead-bismuth eutectic (LBE is selected as target material. The subcritical fuel core is conceptually divided into ten equidistant subzones. The ceramic (natural U, PuO2 fuel mixture and the materials used for radioisotope production (copper, gold, cobalt, holmium, rhenium, thulium, mercury, palladium, thallium, molybdenum, and yttrium are separately prepared as cylindrical rods cladded with carbon/carbon composite (C/C and these rods are located in the subzones. In order to obtain the flattened power density, percentages of PuO2 in the mixture of UO2 and PuO2 in the subzones are adjusted in radial direction of the fuel zone. Time-dependent calculations are performed at 1000 MW thermal fission power (Pth for one hour using the BURN card. The neutronic results show that the investigated ADS has a high neutronic capability, in terms of medical radioisotope productions, spent fuel transmutation and energy multiplication. Moreover, a good quasiuniform power density is achieved in each material case. The peak-to-average fission power density ratio is in the range of 1.02–1.28.

  8. A compact and high current FFAG for the production of radioisotopes for medical application

    CERN Document Server

    Bruton, David; Edgecock, Rob; Seviour, Rebecca; Johnstone, Carol

    2017-01-01

    A low energy Fixed Field Alternating Gradient(FFAG)accelerator has been designed for the production of radioisotopes. Tracking studies have been conducted using the OPAL code, including the effects of space charge. Radioisotopes have a wide range of uses in medicine, and recent disruption to the supply chain has seen a renewed effort to find alternative isotopes and production methods. The design features separate sector magnets with non-scaling, non-linear field gradients but without the counter bends commonly found in FFAG’s. The machine is isochronous at the level of 0.3% up to at least 28MeV and hence able to operate in Continuous Wave (CW) mode. Both protons and helium ions can be used with this design and it has been demonstrated that proton beams with currents of up to 20 mA can be accelerated. An interesting option for the production of radioisotopes is the use of a thin internal target. We have shown that this design has large acceptance, ideal for allowing the beam to be recirculated through t...

  9. Technical Reviews on the Radioisotope Application for Leak Detection in Reservoirs

    Energy Technology Data Exchange (ETDEWEB)

    Kim, Jin Seop; Jung, Sung Hee; Kim, Jong Bum; Kim, Jae Ho

    2006-02-15

    The previous techniques on the detection of leaks from reservoirs are difficult to identify the leak points and leak pathways in reservoirs. Additionally the complexity and ambiguity of data analysis resulted from them can increase the failures of leak detection. While, The technique using radioisotope as a tracer is considered to be very promising. In the same context, systematic studies led by IAEA are being practiced by organizing the task force team. The detection technique using natural tracer can give information about the age of ground water and the interconnection between ground water and reservoir water and the seepage origin. On the other hand, the one using artificial tracer can identify the leak point in reservoirs directly, in which radioactive cloud migration method and radioactive tracer adsorption method are included. The former is using hydrophilic radioisotope tracer, and the latter adsorptive radioisotope tracer which is emitting gamma ray. The radiotracer are injected at a point of the reservoir near to the bottom. Afterwards, the migration of the radioactive tracer is followed by means of submerged scintillation detectors suspended from boats. Usually {sup 131}I, {sup 82}Br, {sup 46}Sc, and {sup 198}Au etc. can be used as tracer. The point reaching the maximum concentration of tracer corresponds to the leak point in reservoirs.

  10. The copper radioisotopes: a systematic review with special interest to 64Cu.

    Science.gov (United States)

    Niccoli Asabella, Artor; Cascini, Giuseppe Lucio; Altini, Corinna; Paparella, Domenico; Notaristefano, Antonio; Rubini, Giuseppe

    2014-01-01

    Copper (Cu) is an important trace element in humans; it plays a role as a cofactor for numerous enzymes and other proteins crucial for respiration, iron transport, metabolism, cell growth, and hemostasis. Natural copper comprises two stable isotopes, (63)Cu and (65)Cu, and 5 principal radioisotopes for molecular imaging applications ((60)Cu, (61)Cu, (62)Cu, and (64)Cu) and in vivo targeted radiation therapy ((64)Cu and (67)Cu). The two potential ways to produce Cu radioisotopes concern the use of the cyclotron or the reactor. A noncopper target is used to produce noncarrier-added Cu thanks to a chemical separation from the target material using ion exchange chromatography achieving a high amount of radioactivity with the lowest possible amount of nonradioactive isotopes. In recent years, Cu isotopes have been linked to antibodies, proteins, peptides, and nanoparticles for preclinical and clinical research; pathological conditions that influence Cu metabolism such as Menkes syndrome, Wilson disease, inflammation, tumor growth, metastasis, angiogenesis, and drug resistance have been studied. We aim to discuss all Cu radioisotopes application focusing on (64)Cu and in particular its form (64)CuCl2 that seems to be the most promising for its half-life, radiation emissions, and stability with chelators, allowing several applications in oncological and nononcological fields.

  11. The Copper Radioisotopes: A Systematic Review with Special Interest to 64Cu

    Directory of Open Access Journals (Sweden)

    Artor Niccoli Asabella

    2014-01-01

    Full Text Available Copper (Cu is an important trace element in humans; it plays a role as a cofactor for numerous enzymes and other proteins crucial for respiration, iron transport, metabolism, cell growth, and hemostasis. Natural copper comprises two stable isotopes, 63Cu and 65Cu, and 5 principal radioisotopes for molecular imaging applications (60Cu, 61Cu, 62Cu, and 64Cu and in vivo targeted radiation therapy (64Cu and 67Cu. The two potential ways to produce Cu radioisotopes concern the use of the cyclotron or the reactor. A noncopper target is used to produce noncarrier-added Cu thanks to a chemical separation from the target material using ion exchange chromatography achieving a high amount of radioactivity with the lowest possible amount of nonradioactive isotopes. In recent years, Cu isotopes have been linked to antibodies, proteins, peptides, and nanoparticles for preclinical and clinical research; pathological conditions that influence Cu metabolism such as Menkes syndrome, Wilson disease, inflammation, tumor growth, metastasis, angiogenesis, and drug resistance have been studied. We aim to discuss all Cu radioisotopes application focusing on 64Cu and in particular its form 64CuCl2 that seems to be the most promising for its half-life, radiation emissions, and stability with chelators, allowing several applications in oncological and nononcological fields.

  12. Integration of Radioisotope Heat Source with Stirling Engine and Cooler for Venus Internal-Structure Mission

    Energy Technology Data Exchange (ETDEWEB)

    Schock, Alfred

    1993-10-01

    The primary mission goal is to perform long-term seismic measurements on Venus, to study its largely unknown internal structure. The principal problem is that most payload components cannot long survive Venus's harsh environment, 90 bars at 500 degrees C. To meet the mission life goal, such components must be protected by a refrigerated payload bay. JPL Investigators have proposed a mission concept employing a lander with a spherical payload bay cooled to 25 degrees C by a Stirling cooler powered by a radioisotope-heated Sitrling engine. To support JPL's mission study, NASA/Lewis and MTI have proposed a conceptual design for a hydraulically coupled Stirling engine and cooler, and Fairchild Space - with support of the Department of Energy - has proposed a design and integration scheme for a suitable radioisotope heat source. The key integration problem is to devise a simple, light-weight, and reliable scheme for forcing the radioisotope decay heat to flow through the Stirling engine during operation on Venus, but to reject that heat to the external environment when the Stirling engine and cooler are not operating (e.g., during the cruise phase, when the landers are surrounded by heat shields needed for protection during subsequent entry into the Venusian atmosphere.) A design and integration scheme for achieving these goals, together with results of detailed thermal analyses, are described in this paper. There are 7 copies in the file.

  13. Analysis, Optimization, and Assessment of Radioisotope Thermophotovoltaic System Design for an Illustrative Space Mission

    Energy Technology Data Exchange (ETDEWEB)

    Schock, Alfred; Mukunda, Meera; Summers, G.

    1994-06-28

    A companion paper presented at this conference described the design of a Radioisotope Thermophotovoltaic (RTPV) Generator for an illustrative space mission (Pluto Fast Flyby). It presented a detailed design of an integrated system consisting of a radioisotope heat source, a thermophotovoltaic converter, and an optimized heat rejection system. The present paper describes the thermal, electrical, and structural analyses which led to that optimized design, and compares the computed RTPV performance to that of a Radioisotope Thermoelectric Generator (RTG) designed for the same mission. RTPV's are of course much less mature than RTGs, but our results indicate that - when fully developed - they could result in a 60% reduction of the heat source's mass, cost, and fuel loading, a 50% reduction of generator mass, a tripling of the power system's specific power, and a quadrupling of its efficiency. The paper concludes by briefly summarizing the RTPV's current technology status and assessing its potential applicability for the PFF mission. For other power systems (e.g. RTGs), demonstrating their flight readiness for a long mission is a very time-consuming process to determine the long-term effect of temperature-induced degradation mechanisms. But for the case of the described RTPV design, the paper lists a number of factors, primarily its cold (0 to 10 degrees C) converter temperature, that may greatly reduce the need for long-term tests to demonstrate generator lifetime. In any event, our analytical results suggest that the RTPV generator, when developed by DOE and/or NASA, would be quite valuable not only for the Pluto mission but also for other future missions requiring small, long-lived, low mass generators. Another copy is in the Energy Systems files.

  14. Therapeutic misadventure.

    Science.gov (United States)

    Langford, N J

    2010-10-01

    Therapeutic misadventure can be defined as an injury or an adverse event caused by medical management rather than by an underlying disease. Within the National Health Service there were over 86,000 reported adverse incidents in 2007. In the USA medication errors have been rated as the fourth highest cause of death. Unfortunately one of the greatest contributors to iatrogenic injury is human error. The potential types of misadventure are infinite. Medication errors are a major part of this, being responsible for over 70% of cases that cause serious harm. However, many medication errors caused by slips, lapses, technical errors and mistakes are preventable; intentional violations of safe operating procedures are not. While medication errors were tolerated by society in the past, the readiness to institute criminal proceedings against health-care professionals has increased greatly in the UK over the last decade. The medication process consists of writing prescriptions, dispensing the product, administering it and monitoring its effects. Prescription errors arise owing to incomplete information, lack of appropriate labelling, environmental factors and human blunders. Even with a perfect prescription the right medication must be dispensed and appropriately labelled. Dispensing errors are not uncommon and may be compounded by non-clinical considerations. Administration of a drug by injection is one of the most dangerous aspects of the medication process, especially in inexperienced hands. The final component of medication supply is monitoring the effect of the medication. With short courses of medication such monitoring is easy, but with long-term medication, particularly with potent drugs where the margin between efficacy and toxicity is small, active procedures may be required to ensure toxicity does not ensue. Despite the endeavour of health-care professions to stick to the rule of 'first, do no harm', in reality this is difficult to achieve all of the time. When

  15. Phosphate and arsenate removal efficiency by thermostable ferritin enzyme from Pyrococcus furiosus using radioisotopes

    KAUST Repository

    Sevcenco, Ana-Maria

    2015-03-13

    Oxo-anion binding properties of the thermostable enzyme ferritin from Pyrococcus furiosus were characterized with radiography. Radioisotopes 32P and 76As present as oxoanions were used to measure the extent and the rate of their absorption by the ferritin. Thermostable ferritin proved to be an excellent system for rapid phosphate and arsenate removal from aqueous solutions down to residual concentrations at the picomolar level. These very low concentrations make thermostable ferritin a potential tool to considerably mitigate industrial biofouling by phosphate limitation or to remove arsenate from drinking water.

  16. Effects of antineoplastic drugs on Lactobacillus casei and radioisotopic assays for serum folate

    Energy Technology Data Exchange (ETDEWEB)

    Carmel, R.

    1978-02-01

    Microbiologic assay, usually employing Lactobacillus casei, remains the standard assay for serum folate to date. Among its disadvantages have been falsely low results in patients receiving bacteriostatic agents such as antibiotics. This study examined whether commonly used antineoplastic drugs had similar effect. Methotrexate and 5-fluorouracil depressed microbiologic serum folate levels. No effect was found for adriamycin, bleomycin, BCNU, cyclophosphamide, cytosine arabinoside, vincristine, vinblastine, mechlorethamine, mithramycin, hydroxyurea, and hydrocortisone. None of the drugs affected radioassay except methotrexate, which produced falsely high folate results. Thus, it appears that L. casei assay for folate becomes unreliable in patients receiving 5-fluorouracil and radioisotopic assay becomes unreliable in those receiving methotrexate.

  17. MECRIS A compact ECRIS for ionization of noble gas radioisotopes at ISOLDE

    CERN Document Server

    Wenander, Fredrik

    2004-01-01

    The development of electron cyclotron resonance ion source (ECRIS) for singly charged radioactive gases at ISOLDE/CERN was analyzed. The radioisotopes were produced by fission, spallation and fragmentation reactions which were induced by high-energy protons. It was observed that Mono ECRIS (MECRIS) ISOLIDE was intended for light noble gases with low ionization efficiency in ordinary plasma ion sources. The results show that ionization efficiencies for He and Xe injected through calibrated leak were less than 0.1 and 5%-10% which were similar to standard ISOLDE plasma ion source. (Edited abstract) 11 Refs.

  18. Investigations of diffusion of 35S radioisotope in β-Ni 3S 2 polycrystals

    Science.gov (United States)

    Gilewicz-Wolter, J.; Żurek, Z.; Ochoński, A.

    1997-05-01

    The diffusion of 35S radioisotope in β-Ni 3S 2 polycrystals was studied at temperatures ranging from 848 K to 893 K and at sulphur vapour pressure interval (5.6 × 10 -6-3.2 × 10 -4) Pa. The autoradigraphy and the tracer sectioning method were used. It was found, that the bulk diffusion is the main process of sulphur transport. The activation energy of the diffusion equals (190 ± 10) kJ mol -1. Under the conditions used in the experiments the dominant anionic point defects are single-ionized vacancies and quasi-free electrons.

  19. COMPASS Final Report: Saturn Moons Orbiter Using Radioisotope Electric Propulsion (REP): Flagship Class Mission

    Science.gov (United States)

    Oleson, Steven R.; McGuire, Melissa L.

    2011-01-01

    The COllaborative Modeling and Parametric Assessment of Space Systems (COMPASS) team was approached by the NASA Glenn Research Center (GRC) In-Space Project to perform a design session to develop Radioisotope Electric Propulsion (REP) Spacecraft Conceptual Designs (with cost, risk, and reliability) for missions of three different classes: New Frontier s Class Centaur Orbiter (with Trojan flyby), Flagship, and Discovery. The designs will allow trading of current and future propulsion systems. The results will directly support technology development decisions. The results of the Flagship mission design are reported in this document

  20. NASA's Radioisotope Power Systems Program Overview - A Focus on RPS Users

    Science.gov (United States)

    Hamley, John A.; McCallum, Peter W.; Sandifer, Carl E., II; Sutliff, Thomas J.; Zakrajsek, June F.

    2016-01-01

    The goal of NASA's Radioisotope Power Systems (RPS) Program is to make RPS ready and available to support the exploration of the solar system in environments where the use of conventional solar or chemical power generation is impractical or impossible to meet potential future mission needs. To meet this goal, the RPS Program manages investments in RPS technologies and RPS system development, working closely with the Department of Energy. This paper provides an overview of the RPS Program content and status, its collaborations with potential RPS users, and the approach employed to maintain the readiness of RPS to support future NASA mission concepts.

  1. Sourceless formation evaluation. An LWD solution providing density and neutron measurements without the use of radioisotopes

    Energy Technology Data Exchange (ETDEWEB)

    Griffiths, R.; Reichel, N. [Schlumberger, Sungai Buloh (Malaysia)

    2013-08-01

    For many years the industry has been searching for a way to eliminate the logistical difficulties and risk associated with deployment of radioisotopes for formation evaluation. The traditional gamma-gamma density (GGD) measurement uses the scattering of 662-keV gamma rays from a 137Cs radioisotopic source, with a 30.17-year half-life, to determine formation density. The traditional neutron measurement uses an Am-Be source emitting neutrons with an energy around 4 MeV, with a half-life of 432 years. Both these radioisotopic sources pose health, security, and environmental risks. Pulsed-neutron generators have been used in the industry for several decades in wireline tools and more recently in logging-while-drilling tools. These generators produce 14-MeV neutrons, many of which interact with the nuclei in the formation. Elastic collisions allow a neutron porosity measurement to be derived, which has been available to the industry since 2005. Inelastic interactions are typically followed by the emission of a variety of high-energy gamma rays. Similar to the case of the GGD measurement, the transport and attenuation of these gamma rays is a strong function of the formation density. However, the gamma-ray source is now distributed over a volume within the formation, where gamma rays have been induced by neutron interactions and the source can no longer be considered to be a point as in the case of a radioisotopic source. In addition, the extent of the induced source region depends on the transport of the fast neutrons from the source to the point of gamma-ray production. Even though the physics is more complex, it is possible to measure the formation density if the fast neutron transport is taken into account when deriving the density answer. This paper briefly reviews the physics underlying the sourceless neutron porosity and recently introduced neutron-gamma density (SNGD) measurement, demonstrates how they can be used in traditional workflows and illustrates their

  2. Radioisotope thermoelectric generator package o-ring seal material validation testing

    Science.gov (United States)

    Adkins, Harold E.; Ferrell, Patrick C.; Knight, Ronald C.

    1995-01-01

    The Radioisotope Thermoelectric Generator Package O-Ring Seal Material Validation Test was conducted to validate the use of the Butyl material as a primary seal throughout the required temperature range. Three tests were performed at (I) 233 K (-40 °F), (2) a specified operating temperature, and (3) 244 K (-20 °F) before returning to room temperature. Helium leak tests were performed at each test point to determine seal performance. The two major test objectives were to establish that butyl rubber material would maintain its integrity under various conditions and within specified parameters and to evaluate changes in material properties.

  3. Inorganic, Radioisotopic, and Organic Analysis of 241-AP-101 Tank Waste

    Energy Technology Data Exchange (ETDEWEB)

    Fiskum, S.K.; Bredt, P.R.; Campbell, J.A.; Farmer, O.T.; Greenwood, L.R.; Hoppe, E.W.; Hoopes, F.V.; Lumetta, G.J.; Mong, G.M.; Ratner, R.T.; Soderquist, C.Z.; Steele, M.J.; Swoboda, R.G.; Urie, M.W.; Wagner, J.J.

    2000-10-17

    Battelle received five samples from Hanford waste tank 241-AP-101, taken at five different depths within the tank. No visible solids or organic layer were observed in the individual samples. Individual sample densities were measured, then the five samples were mixed together to provide a single composite. The composite was homogenized and representative sub-samples taken for inorganic, radioisotopic, and organic analysis. All analyses were performed on triplicate sub-samples of the composite material. The sample composite did not contain visible solids or an organic layer. A subsample held at 10 C for seven days formed no visible solids.

  4. Alpha-Energy-Deposition-Profiling of Radioisotope p-i-n Diodes for Power Generation

    Science.gov (United States)

    Cress, Cory; Raffaelle, Ryne

    2006-03-01

    The high energy density and long half-life of certain alpha-emitting radioisotopes enables viable and long-lived power supplies to be fabricated on the micro-scale. A design incorporating an InGaP p-i-n photovoltaic (PV) device that directly converts the kinetic energy of the alpha-particles into electricity represents both a scalable and efficient microsystem design. To better understand the relationship between the alpha-energy-deposition-profile (ADEP) and the maximum power conversion efficiency for this device structure, we have performed two systematic studies. In these studies, I-V characteristics for the InGaP PV device under alpha-flux are measured as a function of alpha source distance, and as function of aluminum film thickness (10 nm to 10 μm) which is deposited onto the surface of the PV device. Both techniques will alter the ADEP in relation to the active region of the PV device. These experimental results are compared to a theoretical model which utilizes Monte Carlo simulations and numerical calculations to determine the ADEP for the same device configuration. The understanding gained from this analysis has direct implications towards the fabrication of radioisotope microbatteries with structural characteristics that enable optimal power conversion efficiencies to be achieved.

  5. Computational modeling of Radioisotope Thermoelectric Generators (RTG) for interplanetary and deep space travel

    Science.gov (United States)

    Nejat, Cyrus; Nejat, Narsis; Nejat, Najmeh

    2014-06-01

    This research project is part of Narsis Nejat Master of Science thesis project that it is done at Shiraz University. The goals of this research are to make a computer model to evaluate the thermal power, electrical power, amount of emitted/absorbed dose, and amount of emitted/absorbed dose rate for static Radioisotope Thermoelectric Generators (RTG)s that is include a comprehensive study of the types of RTG systems and in particular RTG’s fuel resulting from both natural and artificial isotopes, calculation of the permissible dose radioisotope selected from the above, and conceptual design modeling and comparison between several NASA made RTGs with the project computer model pointing out the strong and weakness points for using this model in nuclear industries for simulation. The heat is being converted to electricity by two major methods in RTGs: static conversion and dynamic conversion. The model that is created for this project is for RTGs that heat is being converted to electricity statically. The model approximates good results as being compared with SNAP-3, SNAP-19, MHW, and GPHS RTGs in terms of electrical power, efficiency, specific power, and types of the mission and amount of fuel mass that is required to accomplish the mission.

  6. ARAS: an automated radioactivity aliquoting system for dispensing solutions containing positron-emitting radioisotopes.

    Science.gov (United States)

    Dooraghi, Alex A; Carroll, Lewis; Collins, Jeffrey; van Dam, R Michael; Chatziioannou, Arion F

    2016-12-01

    Automated protocols for measuring and dispensing solutions containing radioisotopes are essential not only for providing a safe environment for radiation workers but also to ensure accuracy of dispensed radioactivity and an efficient workflow. For this purpose, we have designed ARAS, an automated radioactivity aliquoting system for dispensing solutions containing positron-emitting radioisotopes with particular focus on fluorine-18 ((18)F). The key to the system is the combination of a radiation detector measuring radioactivity concentration, in line with a peristaltic pump dispensing known volumes. The combined system demonstrates volume variation to be within 5 % for dispensing volumes of 20 μL or greater. When considering volumes of 20 μL or greater, the delivered radioactivity is in agreement with the requested amount as measured independently with a dose calibrator to within 2 % on average. The integration of the detector and pump in an in-line system leads to a flexible and compact approach that can accurately dispense solutions containing radioactivity concentrations ranging from the high values typical of [(18)F]fluoride directly produced from a cyclotron (~0.1-1 mCi μL(-1)) to the low values typical of batches of [(18)F]fluoride-labeled radiotracers intended for preclinical mouse scans (~1-10 μCi μL(-1)).

  7. Development of a Power Electronics Controller for the Advanced Stirling Radioisotope Generator

    Science.gov (United States)

    Leland, Douglas K.; Priest, Joel F.; Keiter, Douglas E.; Schreiber, Jeffrey G.

    2008-01-01

    Under a U.S. Department of Energy program for radioisotope power systems, Lockheed Martin is developing an Engineering Unit of the Advanced Stirling Radioisotope Generator (ASRG). This is an advanced version of the previously reported SRG110 generator. The ASRG uses Advanced Stirling Convertors (ASCs) developed by Sunpower Incorporated under a NASA Research Announcement contract. The ASRG makes use of a Stirling controller based on power electronics that eliminates the tuning capacitors. The power electronics controller synchronizes dual-opposed convertors and maintains a fixed frequency operating point. The controller is single-fault tolerant and uses high-frequency pulse width modulation to create the sinusoidal currents that are nearly in phase with the piston velocity, eliminating the need for large series tuning capacitors. Sunpower supports this effort through an extension of their controller development intended for other applications. Glenn Research Center (GRC) supports this effort through system dynamic modeling, analysis and test support. The ASRG design arrived at a new baseline based on a system-level trade study and extensive feedback from mission planners on the necessity of single-fault tolerance. This paper presents the baseline design with an emphasis on the power electronics controller detailed design concept that will meet space mission requirements including single fault tolerance.

  8. Radioisotope penile plethysmography: A technique for evaluating corpora cavernosal blood flow during early tumescence

    Energy Technology Data Exchange (ETDEWEB)

    Schwartz, A.N.; Graham, M.M.; Ferency, G.F.; Miura, R.S.

    1989-04-01

    Radioisotope penile plethysmography is a nuclear medicine technique which assists in the evaluation of patients with erectile dysfunction. This technique attempts to noninvasively quantitate penile corpora cavernosal blood flow during early penile tumescence using technetium-99m-labeled red blood cells. Penile images and counts were acquired in a steady-state blood-pool phase prior to and after the administration of intracorporal papaverine. Penile counts, images, and time-activity curves were computer analyzed in order to determine peak corporal flow and volume changes. Peak corporal flow rates were compared to arterial integrity (determined by angiography) and venosinusoidal corporal leak (determined by cavernosometry). Peak corporal flow correlated well with arterial integrity (r = 0.91) but did not correlate with venosinusoidal leak parameters (r = 0.01). This report focuses on the methodology and the assumptions which form the foundation of this technique. The strong correlation of peak corporal flow and angiography suggests that radioisotope penile plethysmography could prove useful in the evaluation of arterial inflow disorders in patients with erectile dysfunction.

  9. A new method of measuring renal function in conscious rats without the use of radioisotopes.

    Science.gov (United States)

    Gabel, R A; Ranaei, R A; Kivlighn, S D

    1996-12-01

    The purpose of the current experiment was to develop fast and accurate assays for measuring glomerular filtration rate (GFR) and effective renal plasma flow (ERPF). An enzymatic method was developed for the determination of inulin, and a colorimetric method was developed for determination of p-aminohippurate (PAH) in the plasma and urine of rats. These assays are easily automated and do not require the use of radioisotopes or corrosive chemicals. Glomerular filtration rate was measured by the clearance of inulin, and effective renal plasma flow was measured by the clearance of PAH. Blood pressure, heart rate, and renal function (urine volume, electrolytes, GFR, and ERPF) were measured in conscious rats for 1.5 h prior to drug treatment and for 3 h after treatment. Baseline renal function was compared to historical data. Acute changes in GFR and ERPF following administration of the vasoconstrictor peptide endothelin-1 (ET-1) were accurately measured with results similar to those obtained with older methodologies. These new methods offer many advantages over previously described methods by eliminating the use of radioisotopes and harsh chemicals. In addition, these methods can be used with an automated instrument with high accuracy and precision. Therefore, these new methods can be used to accurately determine GFR and ERPF and are sensitive enough to detect acute changes in GFR and ERPF in conscious animals.

  10. Potential Applications for Radioisotope Power Systems in Support of Human Exploration Missions

    Science.gov (United States)

    Cataldo, Robert L.; Colozza, Anthony J.; Schmitz, Paul C.

    2013-01-01

    Radioisotope power systems (RPS) for space applications have powered over 27 U.S. space systems, starting with Transit 4A and 4B in 1961, and more recently with the successful landing of the Mars Science Laboratory rover Curiosity in August 2012. RPS enable missions with destinations far from the Sun with faint solar flux, on planetary surfaces with dense or dusty atmospheres, and at places with long eclipse periods where solar array sizes and energy storage mass become impractical. RPS could also provide an enabling capability in support of human exploration activities. It is envisioned that with the higher power needs of most human mission concepts, a high efficiency thermal-to-electric technology would be required such as the Advanced Stirling Radioisotope generator (ASRG). The ASRG should be capable of a four-fold improvement in efficiency over traditional thermoelectric RPS. While it may be impractical to use RPS as a main power source, many other applications could be considered, such as crewed pressurized rovers, in-situ resource production of propellants, back-up habitat power, drilling, any mobile or remote activity from the main base habitat, etc. This paper will identify potential applications and provide concepts that could be a practical extension of the current ASRG design in providing for robust and flexible use of RPS on human exploration missions.

  11. Radioisotope radiotherapy research and achievements at the University of Missouri Research Reactor

    Science.gov (United States)

    Ehrhardt, G. J.; Ketring, A. R.; Cutler, C. S.

    2003-01-01

    The University of Missouri Research Reactor (MURR) in collaboration with faculty in other departments at the University of Missouri has been involved in developing new means of internal radioisotopic therapy for cancer for many years. These efforts have centered on methods of targeting radioisotopes such as brachytherapy, embolisation of liver tumors with radioactive microspheres, small-molecule-labelled chelates for the treatment of bone cancer, and various means of radioimmunotherapy or labelled receptor agent targeting. This work has produced two radioactive agents, Sm-153 Quadramet™ and Y-90 TheraSphere™, which have U.S. Food and Drug Administration approval for the palliation of bone cancer pain and treatment of inoperable liver cancer, respectively. MURR has also pioneered development of other beta-emitting isotopes for internal radiotherapy such as Re-186, Re-188, Rh-105, Ho-166, Lu-177, and Pm-149, many of which are in research and clinical trials throughout the U.S. and the world. This important work has been made possible by the very high neutron flux available at MURR combined with MURR's outstanding reliability of operation and flexibility in meeting the needs of researchers and the radiopharmaceutical industry.

  12. Summary. The 19th quality control survey for radioisotope in vitro tests in Japan, 1997

    Energy Technology Data Exchange (ETDEWEB)

    Shishiba, Yoshimasa; Shimizu, Taeko [Toranomon Hospital, Tokyo (Japan); Ichihara, Kiyoshi; Kousaka, Tadako; Kobayashi, Hisae; Tsushima, Toshio; Hoshino, Minoru; Mori, Mikio

    1998-11-01

    This summary concerns results of the survey in the title performed by the Subcommittee for Radioisotope in vitro Test in the Medical and Pharmaceutical Committee, Japan Radioisotope Association. The survey was conducted in 161 facilities in Japan including public and private hospitals, health institutes and reagent manufacturers. Samples were sent to the facilities and subjected to examinations of intra- and inter-day reproducibility, freeze-thawing effects and periodical changes of the measured values. Methods employed were RIA, IRMA, EIA, ELISA, LPIA, PAMIA, FIA, FPIA, NIA, LAT, CLIA and ECLIA. Results were analyzed by variation coefficients in the kit and between the kits. Samples were for: growth hormone, somatomedin C, follicle stimulating hormone, luteinizing hormone, prolactin, thyroid stimulating hormone, triiodothyronine, thyroxine, thyroxine binding globulin, calcitonin, insulin, C-peptide, glucagon, gastrin, testosterone, estradiol, progesterone, {beta}human chorionic gonadotropin, 17{alpha}-hydroxyprogesterone, aldosterone, cortisol, dehydroepiandrosterone, renin, immunogloblin E, digoxin, {alpha}-fetoprotein, carcinoembryonic antigen, tissue polypeptide antigen, CA125, CA19-9, CA15-3, prostatic acid phosphatase, prostate specific antigen, {beta}{sub 2}-microgloblin and ferritin. Results were found rather unsatistactory for some products in the clinical practice, necessary for improvement of detection for some tests and needed for some kits for solving the problems of difference between kits and of matrix effect. (K.H)

  13. System-Level Testing of the Advanced Stirling Radioisotope Generator Engineering Hardware

    Science.gov (United States)

    Chan, Jack; Wiser, Jack; Brown, Greg; Florin, Dominic; Oriti, Salvatore M.

    2014-01-01

    To support future NASA deep space missions, a radioisotope power system utilizing Stirling power conversion technology was under development. This development effort was performed under the joint sponsorship of the Department of Energy and NASA, until its termination at the end of 2013 due to budget constraints. The higher conversion efficiency of the Stirling cycle compared with that of the Radioisotope Thermoelectric Generators (RTGs) used in previous missions (Viking, Pioneer, Voyager, Galileo, Ulysses, Cassini, Pluto New Horizons and Mars Science Laboratory) offers the advantage of a four-fold reduction in Pu-238 fuel, thereby extending its limited domestic supply. As part of closeout activities, system-level testing of flight-like Advanced Stirling Convertors (ASCs) with a flight-like ASC Controller Unit (ACU) was performed in February 2014. This hardware is the most representative of the flight design tested to date. The test fully demonstrates the following ACU and system functionality: system startup; ASC control and operation at nominal and worst-case operating conditions; power rectification; DC output power management throughout nominal and out-of-range host voltage levels; ACU fault management, and system command / telemetry via MIL-STD 1553 bus. This testing shows the viability of such a system for future deep space missions and bolsters confidence in the maturity of the flight design.

  14. Separation of no-carrier-added {sup 203}Pb, a surrogate radioisotope, from proton irradiated {sup nat}Tl{sub 2}CO{sub 3} target using calcium alginate hydrogel beads

    Energy Technology Data Exchange (ETDEWEB)

    Sarkar, Kangkana; Sen, Kamalika [Univ. of Calcutta, Kolkata (India). Dept. of Chemistry; Lahiri, Susanta [Saha Institute of Nuclear Physics, Kolkata (India)

    2016-07-01

    {sup 203}Pb is a promising radioisotope in the field of medical science as an imaging surrogate of {sup 212}Pb. In the present investigation {sup 203}Pb was produced by proton irradiation of natural Tl{sub 2}CO{sub 3} target and was separated from the bulk Tl target using calcium alginate (CA) hydrogel beads with a high separation factor (3.8 x 10{sup 4} at 10{sup -3} M HNO{sub 3}). During the separation process {sup 203}Pb was encapsulated in CA beads and desorption of the radioisotope could only be achieved in 1M HNO{sub 3}. Possibility of Tl uptake was also checked in Fe doped CA (Fe-CA) beads after oxidation of Tl(I) to Tl(III) by sodium bismuthate. No significant uptake of Tl(III) was noticed in the Fe-CA beads. The matrix is therefore suitable for isolation of {sup 203}Pb from the target as well as its storage in the bead for therapeutic as well as diagnostic purpose.

  15. GEANT4 simulation of cyclotron radioisotope production in a solid target.

    Science.gov (United States)

    Poignant, F; Penfold, S; Asp, J; Takhar, P; Jackson, P

    2016-05-01

    The use of radioisotopes in nuclear medicine is essential for diagnosing and treating cancer. The optimization of their production is a key factor in maximizing the production yield and minimizing the associated costs. An efficient approach to this problem is the use of Monte Carlo simulations prior to experimentation. By predicting isotopes yields, one can study the isotope of interest expected activity for different energy ranges. One can also study the target contamination with other radioisotopes, especially undesired radioisotopes of the wanted chemical element which are difficult to separate from the irradiated target and might result in increasing the dose when delivering the radiopharmaceutical product to the patient. The aim of this work is to build and validate a Monte Carlo simulation platform using the GEANT4 toolkit to model the solid target system of the South Australian Health and Medical Research Institute (SAHMRI) GE Healthcare PETtrace cyclotron. It includes a GEANT4 Graphical User Interface (GUI) where the user can modify simulation parameters such as the energy, shape and current of the proton beam, the target geometry and material, the foil geometry and material and the time of irradiation. The paper describes the simulation and presents a comparison of simulated and experimental/theoretical yields for various nuclear reactions on an enriched nickel 64 target using the GEANT4 physics model QGSP_BIC_AllHP, a model recently developed to evaluate with high precision the interaction of protons with energies below 200MeV available in Geant4 version 10.1. The simulation yield of the (64)Ni(p,n)(64)Cu reaction was found to be 7.67±0.074 mCi·μA(-1) for a target energy range of 9-12MeV. Szelecsenyi et al. (1993) gives a theoretical yield of 6.71mCi·μA(-1) and an experimental yield of 6.38mCi·μA(-1). The (64)Ni(p,n)(64)Cu cross section obtained with the simulation was also verified against the yield predicted from the nuclear database TENDL and

  16. 188W/188Re Generator System and Its Therapeutic Applications

    Directory of Open Access Journals (Sweden)

    A. Boschi

    2014-01-01

    Full Text Available The 188Re radioisotope represents a useful radioisotope for the preparation of radiopharmaceuticals for therapeutic applications, particularly because of its favorable nuclear properties. The nuclide decay pattern is through the emission of a principle beta particle having 2.12 MeV maximum energy, which is enough to penetrate and destroy abnormal tissues, and principle gamma rays (Eγ=155 keV, which can efficiently be used for imaging and calculations of radiation dose. 188Re may be conveniently produced by 188W/188Re generator systems. The challenges related to the double neutron capture reaction route to provide only modest yield of the parent 188W radionuclide indeed have been one of the major issues about the use of 188Re in nuclear medicine. Since the specific activity of 188W used in the generator is relatively low (<185 GBq/g, the eluted Re188O4- can have a low radioactive concentration, often ineffective for radiopharmaceutical preparation. However, several efficient postelution concentration techniques have been developed, which yield clinically useful Re188O4- solutions. This review summarizes the technologies developed for the preparation of 188W/188Re generators, postelution concentration of the 188Re perrhenate eluate, and a brief discussion of new chemical strategies available for the very high yield preparation of 188Re radiopharmaceuticals.

  17. Cross section calculations of medical 103Pd radioisotope using α and 3He induced reactions

    Directory of Open Access Journals (Sweden)

    Demir Bayram

    2016-01-01

    Full Text Available One of the most popular radioisotopes used in the prostate brachytherapy is Palladium-103 (103Pd. The radioactive plaque is sewn onto the eye as to cover the intraocular tumor shadow with a 2-3 mm margin. These plaques are temporary and radiation is continuously delivered over 5 to 7 days. At the end of treatment, the plaque is removed from eye. In this study, production cross–section calculations of 103Pd radionuclide used in brachytherapy produced by 101Ru(α,2n, 100Ru(α,n, 102Ru(3He,2n and 101Ru(3He,n reactions have been investigated in the different incident energy range up to 35 MeV. Twocomponent Exciton model and Generalized Superfluid model of the TALYS 1.6 code used to perform calculations and calculation results were compared with experimental results reported in the literature.

  18. Induced radioisotopes inside the treatment hall with a Linac for radiotherapy

    Energy Technology Data Exchange (ETDEWEB)

    De Leon M, H. A. [Instituto Tecnologico de Aguascalientes, Av. Adolfo Lopez Mateos 1801 Ote., Fracc. Bona Gens, 20255 Aguascalientes (Mexico); Rivera P, E.; Vega C, H. R. [Universidad Autonoma de Zacatecas, Unidad Academica de Estudios Nucleares, Cipres No. 10, Fracc. La Penuela, 98068 Zacatecas (Mexico); Gallego, E.; Lorente, A., E-mail: asa_15@hotmail.com [Universidad Politecnica de Madrid, Departamento de Ingenieria Nuclear, C. Jose Gutierrez Abascal 2, 28006 Madrid (Spain)

    2014-08-15

    When Linacs operate above 8 MV an undesirable neutron field is produced whose spectrum has three main components: the direct spectrum due to those neutrons leaking out from the Linac head, the scattered spectrum due to neutrons produced in the head that collides with the nuclei in the head losing energy and the third spectrum due to room-return effect; this last are mainly epithermal and thermal neutrons being constant at any location in the treatment hall. These neutrons induce activation mainly in the concrete walls and the Linac components. Here the induced radioisotopes have been identified in concrete samples located in the hall and in one of the wedges. The identification has been carried out using a gamma-ray spectrometer. (Author)

  19. A study on the enhancement of nuclear cooperation with African countries including utilization of radioisotope

    Energy Technology Data Exchange (ETDEWEB)

    Yang, Maeng Ho; Oh, K. B; Lee, H. M. and others

    2005-05-15

    In this study, potential countries for nuclear cooperation in African region and possible cooperation areas were investigated between Korea and African countries including radioisotopes and more fields were also analysed in depth in order to suggest the recommendations for future cooperation to be considered as follows; First, current status and perspectives of demand and supply of energy and electricity in the African countries, use and development of nuclear energy and international nuclear cooperation were analyzed. Second, current status of nuclear cooperation between Korea and African countries were investigated as well as analysis of future cooperation potential and countries having potential for nuclear cooperation and possible cooperative activities were suggested considering potential of nuclear market in mid- and long term base and step by step. Third, desirable strategies and directions for the establishment and promotion of nuclear cooperation relations between Korea and African developing countries were suggested in order to develope cooperative relations in efficient and effective manners with African developing countries.

  20. Quality Assurance Plan for Heat Source/Radioisotope Thermoelectric Generator Programs

    Energy Technology Data Exchange (ETDEWEB)

    Gabriel, D. M.; Miller, G. D.; Bohne, W. A.

    1995-03-16

    The purpose of this document is to serve as the Quality Assurance Plan for Heat Source/Radioisotope Thermoelectric Generator (HS/RTG) programs performed at EG&G Mound Applied Technologies. As such, it identifies and describes the systems and activities in place to support the requirements contained in DOE Order 5700.6C as reflected in MD-10334, Mound Quality Policy and Responsibilities and the DOE/RPSD supplement, OSA/PQAR-1, Programmatic Quality Assurance Requirements for Space and Terrestrial Nuclear Power Systems. Unique program requirements, including additions, modifications, and exceptions to these quality requirements, are contained in the appendices of this plan. Additional appendices will be added as new programs and activities are added to Mound's HS/RTG mission assignment.

  1. Automated processing of first-pass radioisotope ventriculography data to determine essential central circulation parameters

    Science.gov (United States)

    Krotov, Aleksei; Pankin, Victor

    2017-09-01

    The assessment of central circulation (including heart function) parameters is vital in the preventive diagnostics of inherent and acquired heart failures and during polychemotherapy. The protocols currently applied in Russia do not fully utilize the first-pass assessment (FPRNA) and that results in poor data formalization, while the FPRNA is the one of the fastest, affordable and compact methods among other radioisotope diagnostics protocols. A non-imaging algorithm basing on existing protocols has been designed to use the readings of an additional detector above vena subclavia to determine the total blood volume (TBV), not requiring blood sampling in contrast to current protocols. An automated processing of precordial detector readings is presented, in order to determine the heart strike volume (SV). Two techniques to estimate the ejection fraction (EF) of the heart are discussed.

  2. Cyclotron-produced radioisotopes and their clinical use at the Austin PET Centre

    Energy Technology Data Exchange (ETDEWEB)

    Tochon-Danguy, H.J. [Centre for PET, Melbourne, VIC (Australia). Austin and Repatriation Medical Centre

    1997-12-31

    A Centre for Positron Emission Tomography (PET) has been established within the Department of Nuclear Medicine at the Austin and Repatriation Medical Centre in Melbourne. PET is a non-invasive technique based on the use of biologically relevant compounds labelled with short-lived positron-emitting radionuclides such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18. The basic equipment consists of a medical cyclotron (10 MeV proton and 5 MeV deuteron), six lead-shielded hot cells with associated radiochemistry facilities and a whole body PET scanner. During its first five years of operation, the Melbourne PET Centre, has pursued a strong radiolabelling development program, leading to an ambitious clinical program in neurology, oncology and cardiology. This presentation will describe the basic principles of the PET technique and review the cyclotron-produced radioisotopes and radiopharmaceuticals. Radiolabelling development programs and clinical applications are also addressed. 30 refs., 1 tab., 1 fig.

  3. Advanced Stirling Radioisotope Generator Thermal Power Model in Thermal Desktop SINDA/FLUINT Analyzer

    Science.gov (United States)

    Wang, Xiao-Yen; Fabanich, William A.; Schmitz, Paul C.

    2012-01-01

    This paper presents a three-dimensional Advanced Stirling Radioisotope Generator (ASRG) thermal power model that was built using the Thermal Desktop SINDA/FLUINT thermal analyzer. The model was correlated with ASRG engineering unit (EU) test data and ASRG flight unit predictions from Lockheed Martin's Ideas TMG thermal model. ASRG performance under (1) ASC hot-end temperatures, (2) ambient temperatures, and (3) years of mission for the general purpose heat source fuel decay was predicted using this model for the flight unit. The results were compared with those reported by Lockheed Martin and showed good agreement. In addition, the model was used to study the performance of the ASRG flight unit for operations on the ground and on the surface of Titan, and the concept of using gold film to reduce thermal loss through insulation was investigated.

  4. Radio-Isotope Identification Algorithms for NaI γ Spectra

    Directory of Open Access Journals (Sweden)

    Michael Hamada

    2009-03-01

    Full Text Available The performance of Radio-Isotope Identification (RIID algorithms using NaI-based γ spectroscopy is increasingly important. For example, sensors at locations that screen for illicit nuclear material rely on isotope identification using NaI detectors to distinguish innocent nuisance alarms, arising from naturally occurring radioactive material, from alarms arising from threat isotopes. Recent data collections for RIID testing consist of repeat measurements for each of several measurement scenarios to test RIID algorithms. It is anticipated that vendors can modify their algorithms on the basis of performance on chosen measurement scenarios and then test modified algorithms on data for other measurement scenarios. It is therefore timely to review the current status of RIID algorithms on NaI detectors. This review describes γ spectra from NaI detectors, measurement issues and challenges, current RIID algorithms, data preprocessing steps, the role and current quality of synthetic spectra, and opportunities for improvements.

  5. Augmenting real data with synthetic data: an application in assessing radio-isotope identification algorithms

    Energy Technology Data Exchange (ETDEWEB)

    Burr, Tom L [Los Alamos National Laboratory; Hamada, Michael [Los Alamos National Laboratory; Graves, Todd [Los Alamos National Laboratory; Myers, Steve [Los Alamos National Laboratory

    2008-01-01

    The performance of Radio-Isotope Identification (RIID) algorithms using gamma spectroscopy is increasingly important. For example, sensors at locations that screen for illicit nuclear material rely on isotope identification to resolve innocent nuisance alarms arising from naturally occurring radioactive material. Recent data collections for RIID testing consist of repeat measurements for each of several scenarios to test RIID algorithms. Efficient allocation of measurement resources requires an appropriate number of repeats for each scenario. To help allocate measurement resources in such data collections for RIID algorithm testing, we consider using only a few real repeats per scenario. In order to reduce uncertainty in the estimated RIID algorithm performance for each scenario, the potential merit of augmenting these real repeats with realistic synthetic repeats is also considered. Our results suggest that for the scenarios and algorithms considered, approximately 10 real repeats augmented with simulated repeats will result in an estimate having comparable uncertainty to the estimate based on using 60 real repeats.

  6. A state of the art on coastal environmental protection using radioisotope tracer technology

    CERN Document Server

    Jung, S H; Jin, J H; Kim, J B

    2002-01-01

    Construction of artificial structures has caused a sediment process change due to the variation of hydraulic condition in Korea. Subsequently we have a serious problem of shoaling for shoreline deformation, siltation of the harbor and shipping channel. To protect those abnormal environmental changes, a large estimate has been spent for additional construction such as outer wall facilities, littoral nourishment and dredging. Systematic long-term studies should be carried out to understand the causes of environmental change. In addition, comprehensive plan is required for its monitoring and prevention. The radioisotope application studies for coastal environmental protection have not been actively performed only in the developed countries like France, Canada, and Australia etc., but also in many developing countries like Poland, India. Since KAERI has performed two experiments in costal area of Korea in 1960s, no more study has been reported. Recently the studies of radiotracer application technology is getting...

  7. External Magnetic Field Reduction Techniques for the Advanced Stirling Radioisotope Generator

    Science.gov (United States)

    Niedra, Janis M.; Geng, Steven M.

    2013-01-01

    Linear alternators coupled to high efficiency Stirling engines are strong candidates for thermal-to-electric power conversion in space. However, the magnetic field emissions, both AC and DC, of these permanent magnet excited alternators can interfere with sensitive instrumentation onboard a spacecraft. Effective methods to mitigate the AC and DC electromagnetic interference (EMI) from solenoidal type linear alternators (like that used in the Advanced Stirling Convertor) have been developed for potential use in the Advanced Stirling Radioisotope Generator. The methods developed avoid the complexity and extra mass inherent in data extraction from multiple sensors or the use of shielding. This paper discusses these methods, and also provides experimental data obtained during breadboard testing of both AC and DC external magnetic field devices.

  8. Recent Joint Studies Related to the Development of Space Radioisotope Power Systems

    Directory of Open Access Journals (Sweden)

    Kramer Daniel P.

    2017-01-01

    Full Text Available Over the last several years there has been a mutually beneficial ongoing technical interchange between the U.K and the U.S. related to various aspects of space radioisotope power systems (RPS. While this interchange has been primarily focused on materials based activities, it has also included some aspects related to safety, environmental, and lessons learned during the application of RPSs by the U.S. during the last fifty years. Recent joint technical RPS endeavors have centered on the development of a possible “cold” ceramic surrogate for 238PuO2 and 241AmOx and the irradiation of thermoelectrics and other materials at expected RPS related neutron fluences. As the U.S. continues to deploy and Europe develops RPS capability, on-going joint RPS technical interfaces will continue to enhance each entities’ endeavors in this nuclear based power technology critical for deep space exploration.

  9. On-Site Inspection RadioIsotopic Spectroscopy (Osiris) System Development

    Energy Technology Data Exchange (ETDEWEB)

    Caffrey, Gus J. [Idaho National Laboratory, Idaho Falls, ID (United States); Egger, Ann E. [Idaho National Laboratory, Idaho Falls, ID (United States); Krebs, Kenneth M. [Idaho National Laboratory, Idaho Falls, ID (United States); Milbrath, B. D. [Pacific Northwest National Lab. (PNNL), Richland, WA (United States); Jordan, D. V. [Pacific Northwest National Lab. (PNNL), Richland, WA (United States); Warren, G. A. [Pacific Northwest National Lab. (PNNL), Richland, WA (United States); Wilmer, N. G. [Lawrence Livermore National Lab. (LLNL), Livermore, CA (United States)

    2015-09-01

    We have designed and tested hardware and software for the acquisition and analysis of high-resolution gamma-ray spectra during on-site inspections under the Comprehensive Nuclear-Test-Ban Treaty (CTBT). The On-Site Inspection RadioIsotopic Spectroscopy—Osiris—software filters the spectral data to display only radioisotopic information relevant to CTBT on-site inspections, e.g.,132I. A set of over 100 fission-product spectra was employed for Osiris testing. These spectra were measured, where possible, or generated by modeling. The synthetic test spectral compositions include non-nuclear-explosion scenarios, e.g., a severe nuclear reactor accident, and nuclear-explosion scenarios such as a vented underground nuclear test. Comparing its computer-based analyses to expert visual analyses of the test spectra, Osiris correctly identifies CTBT-relevant fission product isotopes at the 95% level or better.The Osiris gamma-ray spectrometer is a mechanically-cooled, battery-powered ORTEC Transpec-100, chosen to avoid the need for liquid nitrogen during on-site inspections. The spectrometer was used successfully during the recent 2014 CTBT Integrated Field Exercise in Jordan. The spectrometer is controlled and the spectral data analyzed by a Panasonic Toughbook notebook computer. To date, software development has been the main focus of the Osiris project. In FY2016-17, we plan to modify the Osiris hardware, integrate the Osiris software and hardware, and conduct rigorous field tests to ensure that the Osiris system will function correctly during CTBT on-site inspections. The planned development will raise Osiris to technology readiness level TRL-8; transfer the Osiris technology to a commercial manufacturer, and demonstrate Osiris to potential CTBT on-site inspectors.

  10. Supramolecular Nanoparticles for Molecular Diagnostics and Therapeutics

    Science.gov (United States)

    Chen, Kuan-Ju

    Over the past decades, significant efforts have been devoted to explore the use of various nanoparticle-based systems in the field of nanomedicine, including molecular imaging and therapy. Supramolecular synthetic approaches have attracted lots of attention due to their flexibility, convenience, and modularity for producing nanoparticles. In this dissertation, the developmental story of our size-controllable supramolecular nanoparticles (SNPs) will be discussed, as well as their use in specific biomedical applications. To achieve the self-assembly of SNPs, the well-characterized molecular recognition system (i.e., cyclodextrin/adamantane recognition) was employed. The resulting SNPs, which were assembled from three molecular building blocks, possess incredible stability in various physiological conditions, reversible size-controllability and dynamic disassembly that were exploited for various in vitro and in vivo applications. An advantage of using the supramolecular approach is that it enables the convenient incorporation of functional ligands onto SNP surface that confers functionality ( e.g., targeting, cell penetration) to SNPs. We utilized SNPs for molecular imaging such as magnetic resonance imaging (MRI) and positron emission tomography (PET) by introducing reporter systems (i.e., radio-isotopes, MR contrast agents, and fluorophores) into SNPs. On the other hand, the incorporation of various payloads, including drugs, genes and proteins, into SNPs showed improved delivery performance and enhanced therapeutic efficacy for these therapeutic agents. Leveraging the powers of (i) a combinatorial synthetic approach based on supramolecular assembly and (ii) a digital microreactor, a rapid developmental pathway was developed that is capable of screening SNP candidates for the ideal structural and functional properties that deliver optimal performance. Moreover, SNP-based theranostic delivery systems that combine reporter systems and therapeutic payloads into a

  11. Radio-isotope production scale-up at the University of Wisconsin

    Energy Technology Data Exchange (ETDEWEB)

    Nickles, Robert Jerome [Univ of Wisconsin

    2014-06-19

    Our intent has been to scale up our production capacity for a subset of the NSAC-I list of radioisotopes in jeopardy, so as to make a significant impact on the projected national needs for Cu-64, Zr-89, Y-86, Ga-66, Br-76, I-124 and other radioisotopes that offer promise as PET synthons. The work-flow and milestones in this project have been compressed into a single year (Aug 1, 2012- July 31, 2013). The grant budget was virtually dominated by the purchase of a pair of dual-mini-cells that have made the scale-up possible, now permitting the Curie-level processing of Cu-64 and Zr-89 with greatly reduced radiation exposure. Mile stones: 1. We doubled our production of Cu-64 and Zr-89 during the grant period, both for local use and out-bound distribution to ≈ 30 labs nationwide. This involved the dove-tailing of beam schedules of both our PETtrace and legacy RDS cyclotron. 2. Implemented improved chemical separation of Zr-89, Ga-66, Y-86 and Sc-44, with remote, semi-automated dissolution, trap-and-release separation under LabView control in the two dual-mini-cells provided by this DOE grant. A key advance was to fit the chemical stream with miniature radiation detectors to confirm the transfer operations. 3. Implemented improved shipping of radioisotopes (Cu-64, Zr-89, Tc-95m, and Ho-163) with approved DOT 7A boxes, with a much-improved FedEx shipping success compared to our previous steel drums. 4. Implemented broad range quantitative trace metal analysis, employing a new microwave plasma atomic emission spectrometer (Agilent 4200) capable of ppb sensitivity across the periodic table. This new instrument will prove essential in bringing our radiometals into FDA compliance needing CoA’s for translational research in clinical trials. 5. Expanded our capabilities in target fabrication, with the purchase of a programmable 1600 oC inert gas tube furnace for the smelting of binary alloy target materials. A similar effort makes use of our RF induction furnace, allowing

  12. Inorganic, radioisotopic and organic analysis of 241-AP-101 tank waste

    Energy Technology Data Exchange (ETDEWEB)

    SK Fiskum; PR Bredt; JA Campbell; LR Greenwood; OT Farmer; GJ Lumetta; GM Mong; RT Ratner; CZ Soderquist; RG Swoboda; MW Urie; JJ Wagner

    2000-06-28

    Battelle received five samples from Hanford waste tank 241-AP-101, taken at five different depths within the tank. No visible solids or organic layer were observed in the individual samples. Individual sample densities were measured, then the five samples were mixed together to provide a single composite. The composite was homogenized and representative sub-samples taken for inorganic, radioisotopic, and organic analysis. All analyses were performed on triplicate sub-samples of the composite material. The sample composite did not contain visible solids or an organic layer. A subsample held at 10 C for seven days formed no visible solids. The characterization of the 241-AP-101 composite samples included: (1) Inductively-coupled plasma spectrometry for Ag, Al, Ba, Bi, Ca, Cd, Cr, Cu, Fe, K, La, Mg, Mn, Na, Nd, Ni, P, Pb, Pd, Ru, Rh, Si, Sr, Ti, U, Zn, and Zr (Note: Although not specified in the test plan, As, B, Be, Co, Li, Mo, Sb, Se, Sn, Tl, V, W, and Y were also measured and reported for information only) (2) Radioisotopic analyses for total alpha and total beta activities, {sup 3}H, {sup 14}C, {sup 60}Co, {sup 79}Se, {sup 90}Sr, {sup 99}Tc as pertechnetate, {sup 106}Ru/Rh, {sup 125}Sb, {sup 134}Cs, {sup 137}Cs, {sup 152}Eu, {sup 154}Eu, {sup 155}Eu, {sup 238}Pu, {sup 239+240}Pu, {sup 241}Am, {sup 242}Cm, and {sup 243+244}Cm; (3) Inductively-coupled plasma mass spectrometry for {sup 237}Np, {sup 239}Pu, {sup 240}Pu, {sup 99}Tc, {sup 126}Sn, {sup 129}I, {sup 231}Pa, {sup 233}U, {sup 234}U, {sup 235}U, {sup 236}U, {sup 238}U, {sup 241}AMU, {sup 242}AMU, {sup 243}AMU, As, B, Be, Ce, Co, Cs, Eu, I, Li, Mo, Pr, Rb, Sb, Se, Ta, Te, Th, Tl, V, and W; (4) total U by kinetic phosphorescence analysis; (5) Ion chromatography for Cl, F, NO{sub 2}, NO{sub 3}, PO{sub 4}, SO{sub 4}, acetate, formate, oxalate, and citrate; (6) Density, inorganic carbon and organic carbon by two different methods, mercury, free hydroxide, ammonia, and cyanide. The 241-AP-101 composite met all

  13. Cascaded Thermoelectric Conversion-Advanced Radioisotope Power Systems (CTC-ARPSs)

    Science.gov (United States)

    El-Genk, Mohamed S.; Saber, Hamed H.

    2004-02-01

    Conceptual designs of Advanced Radioisotope Power System (ARPS) with Cascaded Thermoelectric Converters (CTCs) are developed and optimized for maximum efficiency operation for End-Of Mission (EOM) electrical power of at least 100 We. These power systems each employs four General Purpose Heat Source (GPHS) bricks generating 1000 Wth at Beginning-of-Life (BOL) and 32 Cascaded Thermoelectric Modules (CTMs). Each CTM consists of a top and a bottom array of thermoelectric unicouples, which are thermally, but not electrically, coupled. The top and bottom arrays of the CTMs are connected electrically in series in two parallel strings with the same nominal voltage of > 28 VDC. The SiGe unicouples in the top array of the CTMs are optimized for nominal hot shoe temperature of 1273 K and constant cold shoe temperature of either 780 K or 980 K, depending on the thermoelectric materials of the unicouples in the bottom array. For a SiGe cold junction temperature of 780 K, the unicouples in the bottom array have p-legs of TAGS-85 and n-legs of 2N-PbTe and operate at constant hot junction temperature of 765 K and nominal cold junction temperature of 476.4 K. When the SiGe cold junction temperature is 980 K, the unicouples in the bottom arrays of CTMs have p-legs of CeFe3.5Co0.5Sb12 or CeFe3.5Co0.5Sb12 and Zn4Sb3, segments and n-legs of CoSb3 and operate at constant hot junction temperature of 965 K and nominal cold junction temperatures of 446.5 K or 493.5 K, respectively. The CTC-ARPSs have a nominal efficiency of 10.82% - 10.85% and generate BOL power of 108 We. This system efficiency is ~ 80% higher than that of State-of-the-Art (SOA) Radioisotope Thermoelectric Generators (RTGs), requiring 7 GHPS bricks and generating 105 We at BOL. The CTC-ARPSs have specific powers of 8.2 We/kg to 8.8 We/kg, which are 71% to 83% higher, respectively, than that of the SOA-RTGs, and use ~ 43% less 238PuO2 fuel.

  14. Dose Calibrator Linearity Testing: Radioisotope 99mTc or 18F? An Alternative for Reducing Costs in Nuclear Medicine Quality Control

    National Research Council Canada - National Science Library

    José Willegaignon; Marcelo Sapienza; George Coura-Filho; Alexandre Garcez; Carlos Alves; Marissa Cardona; Ricardo Gutterres; Carlos Buchpiguel

    2015-01-01

    ... routine of a nuclear medicine department, and with an impact on patient exposure. The main aims of this study were to evaluate the feasibility of substituting the radioisotope Fluorine-18 ( 18 F...

  15. Comparative analysis of taxonomic, functional, and metabolic patterns of microbiomes from 14 full-scale biogas reactors by metagenomic sequencing and radioisotopic analysis

    DEFF Research Database (Denmark)

    Luo, Gang; Fotidis, Ioannis; Angelidaki, Irini

    2016-01-01

    , and their relationships with the metabolic patterns. The present study used metagenomic sequencing and radioisotopic analysis to assess the taxonomic, functional, and metabolic patterns of microbiomes from 14 full-scale biogas reactors operated under various conditions treating either sludge or manure. Results...... The results from metagenomic analysis showed that the dominant methanogenic pathway revealed by radioisotopic analysis was not always correlated with the taxonomic and functional compositions. It was found by radioisotopic experiments that the aceticlastic methanogenic pathway was dominant, while metagenomics...... the metabolic patterns determined by metagenomic analysis and metabolic pathways determined by radioisotopic analysis was found. Besides, a clear correlation between taxonomic and functional patterns was demonstrated for biogas reactors, and also the environmental factors that shaping both taxonomic...

  16. Revealing smuggled nuclear material covered by a legitimate radioisotope shipment using CdTe-based gamma-ray spectrometry

    CERN Document Server

    Lakosi, L; Zsigrai, J; Safar, J

    2003-01-01

    Illicit trade of nuclear materials (NM) represents a serious challenge to radiation monitoring upon scenarios, when legitimate radioisotope shipments are used to obscure the weak radiation of NM. Planar and hemispherical Cd(Zn)Te detectors with a portable mini-multichannel analyzer were proven to be suitable, in measuring times of 10 min order, for revealing the presence of low-enriched or natural U-bearing reactor fuel pellets in amounts of kg order, placed beside transport containers of lead or depleted uranium, which contain high activity sup 6 sup 0 Co (10 GBq range) or sup 1 sup 9 sup 2 Ir (TBq range) radioisotope sources. Such a hand-held or portable device may help authorities combating illicit trafficking of nuclear materials.

  17. Optimization Design and Simulation of a Multi-Source Energy Harvester Based on Solar and Radioisotope Energy Sources

    Directory of Open Access Journals (Sweden)

    Hao Li

    2016-12-01

    Full Text Available A novel multi-source energy harvester based on solar and radioisotope energy sources is designed and simulated in this work. We established the calculation formulas for the short-circuit current and open-circuit voltage, and then studied and analyzed the optimization thickness of the semiconductor, doping concentration, and junction depth with simulation of the transport process of β particles in a semiconductor material using the Monte Carlo simulation program MCNP (version 5, Radiation Safety Information Computational Center, Oak Ridge, TN, USA. In order to improve the efficiency of converting solar light energy into electric power, we adopted PC1D (version 5.9, University of New South Wales, Sydney, Australia to optimize the parameters, and selected the best parameters for converting both the radioisotope energy and solar energy into electricity. The results concluded that the best parameters for the multi-source energy harvester are as follows: Na is 1 × 1019 cm−3, Nd is 3.8 × 1016 cm−3, a PN junction depth of 0.5 μm (using the 147Pm radioisotope source, and so on. Under these parameters, the proposed harvester can achieve a conversion efficiency of 5.05% for the 147Pm radioisotope source (with the activity of 9.25 × 108 Bq and 20.8% for solar light radiation (AM1.5. Such a design and parameters are valuable for some unique micro-power fields, such as applications in space, isolated terrestrial applications, and smart dust in battlefields.

  18. Operations of a Radioisotope-based Propulsion System Enabling CubeSat Exploration of the Outer Planets

    Energy Technology Data Exchange (ETDEWEB)

    Dr. Steven Howe; Nathan Jerred; Troy Howe; Adarsh Rajguru

    2014-05-01

    Exploration to the outer planets is an ongoing endeavor but in the current economical environment, cost reduction is the forefront of all concern. The success of small satellites such as CubeSats launched to Near-Earth Orbit has lead to examine their potential use to achieve cheaper science for deep space applications. However, to achieve lower cost missions; hardware, launch and operations costs must be minimized. Additionally, as we push towards smaller exploration beds with relative limited power sources, allowing for adequate communication back to Earth is imperative. Researchers at the Center for Space Nuclear Research are developing the potential of utilizing an advanced, radioisotope-based system. This system will be capable of providing both the propulsion power needed to reach the destination and the additional requirements needed to maintain communication while at location. Presented here are a basic trajectory analysis, communication link budget and concept of operations of a dual-mode (thermal and electric) radioisotope-based propulsion system, for a proposed mission to Enceladus (Saturnian icy moon) using a 6U CubeSat payload. The radioisotope system being proposed will be the integration of three sub-systems working together to achieve the overall mission. At the core of the system, stored thermal energy from radioisotope decay is transferred to a passing propellant to achieve high thrust – useful for quick orbital maneuvering. An auxiliary closed-loop Brayton cycle can be operated in parallel to the thrusting mode to provide short bursts of high power for high data-rate communications back to Earth. Additionally, a thermal photovoltaic (TPV) energy conversion system will use radiation heat losses from the core. This in turn can provide the electrical energy needed to utilize the efficiency of ion propulsion to achieve quick interplanetary transit times. The intelligent operation to handle all functions of this system under optimized conditions adds

  19. Measurement of excitation functions for production of cerium radioisotopes by deuteron induced reactions on natural cerium for nanobioscience applications

    Energy Technology Data Exchange (ETDEWEB)

    Simonelli, F.; Abbas, K.; Holzwarth, U.; Cydzik, I. [Inst. for Health and Consumer Protection, Joint Research Centre, European Commission, Ispra (Italy); Huu-Tai, Chau P. [CEA, DAM, DIF, Arpajon (France)

    2010-07-01

    Cerium based nanoparticles would play an important role in the field of nanotechnology ranging from fuel additives to sun creams, and to various medical applications. Radiolabelled cerium can be accurately and precisely traced during each step of their applications, thanks to the sensitivity of nuclear measurement techniques. This work is focused on the study of the production of cerium radioisotopes and more precisely, as few data are available, on the determination of the excitation functions for production of cerium radioisotopes by deuteron induced nuclear reactions on natural cerium. We measured the excitation functions for the nuclear reactions {sup nat}Ce(d,x){sup 139g,141,143}Ce and also for {sup nat}Ce(d,x){sup 142g}Pr in the energy range of 5 to 18.5 MeV. Theoretical simulations of these excitation functions were performed using the TALYS calculation code. We have shown that with deuteron beam irradiation, several radioisotopes of cerium can be activated and the cross section data of the relevant nuclear reactions are produced for the first time. Thick target yields of 0.1, 1.1 and 3.2 MBq/{mu}A h were reached for {sup 139g}Ce, {sup 141}Ce and {sup 143}Ce, respectively, which are sufficient for various biological studies such as cellular uptake of cerium based nanoparticles. (orig.)

  20. Preliminary evaluation of a fluorescence and radioisotope nuclear smuggling deterrence tag - final report (IL500E)

    Energy Technology Data Exchange (ETDEWEB)

    Hartenstein, S.D.; Aryaeinejad, R.; Delmastro, J.R. [and others

    1997-04-01

    This report summarizes the efforts completed in identifying candidate fluorescence compounds and radioisotopes for a developing tagging system. The tagging system is being developed as a deterrent to nuclear smuggling, by providing a means of: (1) tracing materials and pilferers to the facility of origin for any recovered special nuclear materials, (2) inventory control of long-term stored items containing special nuclear materials, and (3) tracking materials transferred between facilities. The system uses three types of materials to cover a range of applications intended to prevent the pilfering of special nuclear materials. One material, fluorescent compounds which are invisible without ultraviolet or near-infrared detection systems, is marked on controlled items with a tracking pattern that corresponds to a specified item in a specified location in the data control system. The tagging system uses an invisible, fluorescent dusting powder to mark equipment and personnel who inappropriately handle the tagged material. The tagging system also uses unique combinations of radionuclides to identify the facility of origin for any special nuclear material. This report also summarizes the efforts completed in identifying hardware that will be used for the tagging system. This hardware includes the devices for applying the tagging materials, the commercially available fluorescence detection systems, and gamma ray detection systems assembled from existing, commercially available technologies.

  1. The 11th quality control survey for radioisotopes in vitro tests in Japan, 1989

    Energy Technology Data Exchange (ETDEWEB)

    1990-10-01

    This report presents the results of the 11th quality control nationwide survey. Of 730 facilities performing radioisotopes in vitro tests in November 1989, 422 facilities (60.5%) participated in the present survey. The following 23 items were examined: adrenocorticotropic hormone (ACTH), albumin, carbohydrate antigen 125 (CA 125), carbohydrate antigen 19-9 (CA 19-9), carcinoembryonic antigen (CEA), calcitonin, cortisol, estradiol, ferritin, free thyroxine (FT{sub 4}), follicle stimulating hormone (FSH), gastrine, cholylglycine, glucagon, insulin, anti-DNA antibody, luteinizing hormone (LH), neuron specific enolase (NSE), parathyroid hormone (PTH), squamous cell carcinoma associated antigen (SCC), thyroxine (T{sub 4}), thyroxine binding globulin (TBG), and antithyroid stimulating hormone (TSH) receptor antibody. 'Within kit variation' between facilities showed large coefficient of variation for ACTH, CA125, CEA, estradiol, ferritin, FSH, glucagon, anti-DNA antibody, LH, PTH, and TSH receptor antibody. Both 'within kit variation' and 'between kit variation' showed small coefficient of variation for cortisol, free T{sub 4}, NSE, SCC, T{sub 4}, and TBG. The present survey was characterized by using immunoradiometric assay (IRMA) and non-isotope techniques, as well as radioimmunoassay. Kits for IRMA greatly varied from facility to facility. (N.K.).

  2. Experimental system to displace radioisotopes from upper to deeper soil layers: chemical research

    Directory of Open Access Journals (Sweden)

    Ghignone Stefano

    2004-05-01

    Full Text Available Abstract Background Radioisotopes are introduced into the environment following nuclear power plant accidents or nuclear weapons tests. The immobility of these radioactive elements in uppermost soil layers represents a problem for human health, since they can easily be incorporated in the food chain. Preventing their assimilation by plants may be a first step towards the total recovery of contaminated areas. Methods The possibility of displacing radionuclides from the most superficial soil layers and their subsequent stabilisation at lower levels were investigated in laboratory trials. An experimental system reproducing the environmental conditions of contaminated areas was designed in plastic columns. A radiopolluted soil sample was treated with solutions containing ions normally used in fertilisation (NO3-, NH4+, PO4--- and K+. Results Contaminated soils treated with an acid solution of ions NO3-, PO4--- and K+, undergo a reduction of radioactivity up to 35%, after a series of washes which simulate one year's rainfall. The capacity of the deepest soil layers to immobilize the radionuclides percolated from the superficial layers was also confirmed. Conclusion The migration of radionuclides towards deeper soil layers, following chemical treatments, and their subsequent stabilization reduces bioavailability in the uppermost soil horizon, preventing at the same time their transfer into the water-bearing stratum.

  3. The 21th quality control survey for radioisotope in vitro tests in Japan, 1999

    Energy Technology Data Exchange (ETDEWEB)

    Shishiba, Yoshimasa; Shimizu, Taeko [Toranomon Hospital, Tokyo (Japan); Ichihara, Kiyoshi; Kousaka, Tadako; Kobayashi, Hisae; Tachibana, Katsuhiko; Tsushima, Toshio; Hoshino, Minoru; Mori, Mikio

    2000-10-01

    The quality control survey in the title has been conducted every year from 1978 to improve the quality of the in vitro tests and this report gives the survey results done in 1999. The survey was performed in 133 facilities out of 283 in Japan, which involved 18 national and public university hospitals, 16 private university hospitals, 19 national and public hospitals, 18 private hospitals, 41 hygiene test institutes and 21 reagent manufacturers. Tests examined were on 6 substances related to functions of pituitary, 5 of thyroid function, 1 of parathyroid, 4 of digestive-pancreas, 5 of gonad-placenta, 4 of adrenal and 1 of renal-blood pressure regulation, on IgE, on digoxin and on 11 tumor-related substances. Tests were done on 2 - 3 samples supplied from the Committee and for reproducibility for within-day, between-day, effects of freeze-thaw and periodic variation after thawing. Methods involved those using non-radioisotopes like enzyme immunoassay as well as those using radioactive isotopes like radioimmunoassay. Results given by the mean, standard deviation and coefficient of variation for each kit, were analyzed for within-kit (between-facility) variation and between-kit (between-reagent) variation by one way analysis of variance. Findings were similar to those previously reported without the particular new problem; however, the committee considered that the survey should be done with human serum as a matrix especially for samples with a high matrix effect in future. (K.H.)

  4. Present status of research on Re-186 radiopharmaceuticals at Radioisotope Production Center

    Energy Technology Data Exchange (ETDEWEB)

    Mutalib, A. [Radioisotope Production Center, National Atomic Energy Agency Kawasan PUSPIPTEK, Serpong (Indonesia)

    1998-10-01

    Rhenium shows a close chemical similarity to technetium and is suitable for radiotherapy because the {beta}-emitting radionuclides {sup 186}Re (t{sub 1/2} 90 h, E{sub {beta}} = 1.1 MeV, E{sub {gamma}} = 137 keV) and {sup 188}Re (t{sub 1/2} = 17 h, E{sub {beta}} = 2.1 MeV). The {gamma}-emission associated with decay of {sup 186}Re is also useful in scintigraphy. The research on {sup 186}Re radiopharmaceuticals at Radioisotope Production Center has been carried out since April 1997. Interest in radioimmunotherapy (RIT) led us to the development of labeling antibodies with rhenium isotopes. Although there are several methods for coupling radiometal to antibody, we prefer an indirect labeling method in which a bifunctional chelating agent is used for coupling of {sup 186}Re to monoclonal antibodies. In this report we outline the study on the preparation of {sup 186}Re DMSA-TFP as precursor for labeling with monoclonal antibody. (author)

  5. Assembly and Testing of a Radioisotope Power System for the New Horizons Spacecraft

    Energy Technology Data Exchange (ETDEWEB)

    Kenneth E. Rosenberg; Stephen G. Johnson

    2006-06-01

    The Idaho National Laboratory (INL) recently fueled and assembled a radioisotope power system (RPS) that was used upon the New Horizons spacecraft which was launched in January 2006. New Horizons is the first mission to the last planet - the initial reconnaissance of Pluto-Charon and the Kuiper Belt, exploring the mysterious worlds at the edge of our solar system. The RPS otherwise known as a "space battery" converts thermal heat into electrical energy. The thermal heat source contains plutonium dioxide in the form of ceramic pellets encapsulated in iridium metal. The space battery was assembled in a new facility at the Idaho National Laboratory site near Idaho Falls, Idaho. The new facility has all the fueling and testing capabilities including the following: the ability to handle all the shipping containers currently certified to ship Pu-238, the ability to fuel a variety of RPS designs, the ability to perform vibrational testing to simulate transportation and launch environments, welding systems, a center of mass determination device, and various other support systems.

  6. Efficient Monte Carlo simulation of coincidence effects in radioisotope decays including γ-γ angular correlations

    Science.gov (United States)

    Williams, Elizabeth; Tickner, James

    2012-09-01

    Many nuclear decays lead to the emission of multiple gamma-rays or X-rays in close temporal coincidence. Nuclear polarization effects lead to angular correlations between these successive gamma-ray emissions that depend on the spins of the states involved and the multipolarities of the transitions in question. To accurately simulate the transport and detection of such coincident gamma decays, these polarization effects should be taken into account. However, most standard Monte Carlo codes either ignore coincidence effects completely, or treat the direction of each gamma-ray emitted in a decay cascade as uncorrelated and isotropic. We have developed tools to facilitate the accurate simulation of decays or arbitrary radioisotopes based on level-scheme and decay data available in the Evaluated Nuclear Structure and Decay Files (ENSDF) library. Analogue simulation of coincidence effects is inefficient in many practical cases, necessitating the use of variance reduction techniques. Implementing biased sampling in situations where coincidence effects are important is recognized as a complicated problem. We have developed a modified approach that simplifies the coding of variance reduction techniques for such cases. We demonstrate that a combination of deterministic transport and forced collision biasing allows for efficient simulation of coincidence effects in gamma-ray detection.

  7. Quantitative radio-isotope scanning of the sacroiliac joints in ankylosing spondylitis

    Energy Technology Data Exchange (ETDEWEB)

    Skaar, O.; Dale, K.; Lindegaard, M.W.; Foerre, O.; Kaass, E. (Oslo Sanitetsforening Rheumatism Hospital (Norway). Dept. of Radiology, General Dept. Norwegian Radium Hospital, Oslo (Norway). Dept. of Nuclear Medicine)

    1992-03-01

    A method for applying {sup 99m}Tc-MDP for dynamic and static quantitative radioisotope scanning (QRS) of the sacroiliac joints (SI) in early progressive sacroiliitis in ankylosing spondylitis (AS) is described. In a prospective study, 2 groups of male AS patients were investigated, one with increased elevated erythrocytic sedimentation rate (ERS) (group A, n = 7) and one with normal ERS (group B, n = 8). In both groups an increased uptake of the radiotracer was found in the static part of the study versus a control group C (n = 9). An increased uptake versus group C was also found for group A in the dynamic part of the study (p = 0.01) while there was no significant difference dynamically between group B and C. The results of the dynamic study in group A indicate ERS to be a parameter of inflammatory activity in the SI joints. The study also seems to indicate QRS to be a valuable diagnostic method in early AS without definite radiographic changes in the SI joints. (orig.).

  8. Quantitative radio-isotope scanning in ankylosing spondylitis: a clinical, laboratory and computerised tomographic study

    Energy Technology Data Exchange (ETDEWEB)

    Taylor, H.G.; Gadd, R.; Beswick, E.J.; Venkateswaran, M.; Dawes, P.T. (Staffordshire Rheumatology Centre, Haywood Hospital, Stoke-on-Trent (United Kingdom))

    1991-01-01

    Quantitative sacroiliac and lumbar spine radio-isotope (Tc-99m MDP) scans were performed in 42 patients with ankylosing spondylitis, and repeated 12 months later in 25. Clinical and laboratory assessments as well as computerised tomographic (CT) scans of the sacroiliac joints (SIJ) and lateral lumbar spine x-rays, were performed. Bone (using the L3/4 area of the lumbar spine, sacrum, SIJ's and knee) to soft tissue (ST) ratios all correlated strongly with each other. Patients with high SIJ:ST ratios had significantly greater low-back stiffness (p<0.05). Change in serum IgA levels correlated negatively with change in bone: ST ratios. There was no relationship between bone: ST ratios and any other clinical or laboratory variables. The change in SIJ:ST ratios correlated positively with change in CT erosion score (p<0.05) and negatively with change in CT ankylosis score (p<0.05). (au) 24 refs., 2 figs., 1 tbl.

  9. Study of radioisotope safety devices for electric propulsion system, Volume 1: Summary report

    Science.gov (United States)

    Bradshaw, G. B.; Homeyer, W. G.; Postula, F. D.; Steeger, E. J.

    1972-01-01

    A new reference design was prepared for the 5 kW(e) thermionic power supply. The safety equipment in this design is a passive containment system which does not rely on the operation of any mechanisms such as a launch escape rocket or deployment of parachutes. It includes: (1) a blast shield to protect against the explosion of the launch vehicle; (2) a combination of refractory thermal insulation and heat storage material to protect against a sustained launch pad fire; (3) a reentry body with a spherical nose and a large conical flare at the aft end to stabilize the reentry attitude and lower the terminal velocity in air; (4) composite graphite thermal protection to sustain the reentry heat pulse; (5) crushable honeycomb behind the nose to limit the deceleration of the radioisotope source due to impact on land at terminal velocity; (6) a double-walled secondary containment vessel surrounding the isotopic capsules; (7) neutron shielding to reduce external dose rates; (8) an auxiliary cooling system employing redundant heat pipes to remove the radioactive decay heat from the heat source and reject it to the surroundings or to a forced convection loop.

  10. Radioisotope Stirling Engine Powered Airship for Atmospheric and Surface Exploration of Titan

    Science.gov (United States)

    Colozza, Anthony J.; Cataldo, Robert L.

    2014-01-01

    The feasibility of an advanced Stirling radioisotope generator (ASRG) powered airship for the near surface exploration of Titan was evaluated. The analysis did not consider the complete mission only the operation of the airship within the atmosphere of Titan. The baseline airship utilized two ASRG systems with a total of four general-purpose heat source (GPHS) blocks. Hydrogen gas was used to provide lift. The ASRG systems, airship electronics and controls and the science payload were contained in a payload enclosure. This enclosure was separated into two sections, one for the ASRG systems and the other for the electronics and payload. Each section operated at atmospheric pressure but at different temperatures. The propulsion system consisted of an electric motor driving a propeller. An analysis was set up to size the airship that could operate near the surface of Titan based on the available power from the ASRGs. The atmospheric conditions on Titan were modeled and used in the analysis. The analysis was an iterative process between sizing the airship to carry a specified payload and the power required to operate the electronics, payload and cooling system as well as provide power to the propulsion system to overcome the drag on the airship. A baseline configuration was determined that could meet the power requirements and operate near the Titan surface. From this baseline design additional trades were made to see how other factors affected the design such as the flight altitude and payload mass and volume.

  11. Radioisotope tracer studies of inorganic carbon and Ca in microbially derived CaCO3

    Science.gov (United States)

    Yates, Kimberly K.; Robbins, Lisa L.

    1999-01-01

    Microbial calcification significantly impacts the cycling and deposition of inorganic carbon. This research employs 45Ca and 14C techniques as radioisotopic tracers to examine the role of cellular cycling of Ca2+ and inorganic carbon in CaCO3 precipitation by the unicellular green alga Nannochloris atomus. Implications of the effects of these physiological aspects on CaCO3 precipitation and the effects of microbial calcification on CaCO3 δ13C ratios are discussed. Results from pulse/chase experiments indicate that intracellular Ca2+ is incorporated into extracellular CaCO3. Intracellular inorganic carbon leaks from cells within 10 to 12 s after injection of unlabelled NaHCO3, providing a source of inorganic carbon for extracellular CaCO3. Cellular expulsion of calcium plays a key role in increasing the CaCO3 saturation state at the site of calcification. The δ13C ratios of microbial carbonates may vary depending on the amount of photorespiratory CO2 incorporated.

  12. Natural Convection Cooling of the Advanced Stirling Radioisotope Generator Engineering Unit

    Science.gov (United States)

    Lewandowski, Edward J.; Hill, Dennis

    2011-01-01

    After fueling and prior to launch, the Advanced Stirling Radioisotope Generator (ASRG) will be stored for a period of time then moved to the launch pad for integration with the space probe and mounting on the launch vehicle. During this time, which could be as long as 3 years, the ASRG will operate continuously with heat rejected from the housing and fins. Typically, the generator will be cooled by forced convection using fans. During some of the ground operations, maintaining forced convection may add significant complexity, so allowing natural convection may simplify operations. A test was conducted on the ASRG Engineering Unit (EU) to quantify temperatures and operating parameters with natural convection only and determine if the EU could be safely operated in such an environment. The results show that with natural convection cooling the ASRG EU Stirling convertor pressure vessel temperatures and other parameters had significant margins while the EU was operated for several days in this configuration. Additionally, an update is provided on ASRG EU testing at NASA Glenn Research Center, where the ASRG EU has operated for over 16,000 hr and underwent extensive testing.

  13. Deep-Ocean Crusts as Telescopes: Using Live Radioisotopes to Probe Supernova Nucleosynthesis

    CERN Document Server

    Fields, B D; Ellis, Jonathan Richard; Fields, Brian D.; Hochmuth, Kathrin A.; Ellis, John

    2005-01-01

    Live 60Fe has recently been detected in a deep-ocean ferromanganese crust, isolated in layers dating from about 3 Myr ago. Since 60Fe has a mean life of 2.2 Myr, a near-Earth supernova is the only likely source for such a signal, and we explore here the consequences of a supernova origin. We combine the 60Fe data with several supernova nucleosynthesis models to calculate the supernova distance as a function of progenitor mass, finding an allowed range of 15-120 pc. We also predict the signals expected for several other radioisotopes, which are independent of the supernova distance. Species likely to be present near or above background levels are 10Be, 26Al, 53Mn, 182Hf and 244Pu. Of these, 182Hf and 244Pu are nearly background-free, presenting the best opportunities to provide strong confirmation of the supernova origin of the 60Fe signal, and to demonstrate that at least some supernovae are the source for the r-process. The accuracies of our predictions are hampered by large uncertainties in the predicted 60...

  14. Cadmium-109 Radioisotope Adsorption onto Polypyrrole Coated Sawdust of Dryobalanops aromatic: Kinetics and Adsorption Isotherms Modelling

    Science.gov (United States)

    Olatunji, Michael Adekunle; Khandaker, Mayeen Uddin; Amin, Yusoff Mohd; Mahmud, Habibun Nabi Muhammad Ekramul

    2016-01-01

    A radiotracer study was conducted to investigate the removal characteristics of cadmium (109Cd) from aqueous solution by polypyrrole/ sawdust composite. Several factors such as solution pH, sorbent dosage, initial concentration, contact time, temperature and interfering metal ions were found to have influence on the adsorption process. The kinetics of adsorption was relatively fast, reaching equilibrium within 3 hours. A lowering of the solution pH reduced the removal efficiency from 99.3 to ~ 46.7% and an ambient temperature of 25°C was found to be optimum for maximum adsorption. The presence of sodium and potassium ions inhibited 109Cd removal from its aqueous solution. The experimental data for 109Cd adsorption showed a very good agreement with the Langmuir isotherm and a pseudo-first order kinetic model. The surface condition of the adsorbent before and after cadmium loading was investigated using BET, FESEM and FTIR. Considering the low cost of the precursor’s materials and the toxicity of 109Cd radioactive metal, polypyrrole synthesized on the sawdust of Dryobalanops aromatic could be used as an efficient adsorbent for the removal of 109Cd radioisotope from radionuclide-containing effluents. PMID:27706232

  15. Radioisotope Analyses in Determination of Time since Death from Skeletal Remains

    Directory of Open Access Journals (Sweden)

    Özge Ünlütürk

    2016-12-01

    Full Text Available Estimation of the time since death is one of the most important problems in forensic cases. It is relatively easier to estimate the time since death in such cases if the corpse is fresh or the soft tissue still exists. However, estimating postmortem interval becomes more complicated as decomposition stage of the corpse develops. While evaluating decomposition stages of a corpse, different criteria like environmental conditions, position of the body and bodily features should be studied all together. Estimation of the time since death is carried out macroscopically in the first place according to morphological changes. Nevertheless, various histological, chemical and psychical methods can be used as well to estimate the time since death particularly if long time passes after death and skeletonization begins. Of all these methods, radioisotope analyses are the most discussed method since it is not affected by environmental factors. Because of their short half-lives, the analyses especially carried out with measurement of Sr90and Pb210radionuclides have produced successful results in estimating postmortem intervals.

  16. Applicability of sodium alginate in decorporation therapy of strontium radioisotopes in human being; Aplicabilidade do alginato de sodio na terapia de decorporacao de radioisotopos de estroncio em seres humanos

    Energy Technology Data Exchange (ETDEWEB)

    Ferreira, Aloisio Cordilha

    1999-10-01

    The increasing release of fission products from nuclear weapon tests in the environment has been rising the levels of radioactive contamination of food chains caused by the fall-out of these elements. In cases of accidental exposure, human subjects could be submitted to an internal contamination, which is likely to include several radionuclides. Special concern must be given, however, to the radioactive isotopes of strontium, cesium and iodine, along with the highly radio toxic transuranium elements like cerium. It was found that sodium alginate, a polyelectrolyte commonly used in food industry and obtained from brown algae (Phaeophyceae), provides the selective suppression of absorption of radioactive strontium presented in the ingested food material with no disturbance of the electrolyte balance nor undesirable side effects, even for a long term treatment. Moreover, these patterns were maintained when alginate was associated to other decontamination additives, specially those related to the other radioisotopes mentioned above, as, in this case, losses in the effectiveness, mutual interference or adverse health effects were not detected. These conclusions ground the discussion about the present trend in the usual choice of EDTA/DTPA complex therapy rather than of alginate therapy for medical assistance of radiocontaminated patients, although they corroborate the efficiency and usefulness of alginate salts in situations related to extensive intakes of strontium radioisotopes alone or associated to other fission products. The purpose of the present work is to make a general review of the alginate therapy as well as to discuss its present and future therapeutic importance from the scientific and institutional points of view. (author)

  17. Therapeutic use exemption

    Science.gov (United States)

    Dvorak, J; Kirkendall, D; Vouillamoz, M

    2006-01-01

    Football players who have either physical symptoms or disease after injury may need to be treated with specific medicines that are on the list of prohibited substances. Therapeutic use exemption may be granted to such players, in accordance with strictly defined criteria—these are presented in this article. Procedures of how to request for an abbreviated or a standard therapeutic use exemption are explained, and data on therapeutic use exemptions (UEFA and FIFA, 2004 and 2005) are also presented. PMID:16799102

  18. Cost Comparison in 2015 Dollars for Radioisotope Power Systems -- Cassini and Mars Science Laboratory

    Energy Technology Data Exchange (ETDEWEB)

    Werner, James Elmer [Idaho National Lab. (INL), Idaho Falls, ID (United States); Johnson, Stephen Guy [Idaho National Lab. (INL), Idaho Falls, ID (United States); Dwight, Carla Chelan [Idaho National Lab. (INL), Idaho Falls, ID (United States); Lively, Kelly Lynn [Idaho National Lab. (INL), Idaho Falls, ID (United States)

    2016-07-01

    Radioisotope power systems (RPSs) have enabled missions requiring reliable, long-lasting power in remote, harsh environments such as space since the early 1960s. Costs for RPSs are high, but are often misrepresented due to the complexity of space missions and inconsistent charging practices among the many and changing participant organizations over the years. This paper examines historical documentation associated with two past successful flight missions, each with a different RPS design, to provide a realistic cost basis for RPS production and deployment. The missions and their respective RPSs are Cassini, launched in 1997, that uses the general purpose heat source (GPHS) radioisotope thermoelectric generator (RTG), and Mars Science Laboratory (MSL), launched in 2011, that uses the multi-mission RTG (MMRTG). Actual costs in their respective years are discussed for each of the two RTG designs and the missions they enabled, and then present day values to 2015 are computed to compare the costs. Costs for this analysis were categorized into two areas: development of the specific RTG technology, and production and deployment of an RTG. This latter category includes material costs for the flight components (including Pu-238 and fine weave pierced fabric (FWPF)); manufacturing of flight components; assembly, testing, and transport of the flight RTG(s); ground operations involving the RTG(s) through launch; nuclear safety analyses for the launch and for the facilities housing the RTG(s) during all phases of ground operations; DOE’s support for NEPA analyses; and radiological contingency planning. This analysis results in a fairly similar 2015 normalized cost for the production and deployment of an RTG—approximately $118M for the GPHS-RTG and $109M for the MMRTG. In addition to these two successful flight missions, the costs for development of the MMRTG are included to serve as a future reference. Note that development costs included herein for the MMRTG do not include

  19. Dose calibrator linearity test: 99mTc versus 18F radioisotopes*

    Science.gov (United States)

    Willegaignon, José; Sapienza, Marcelo Tatit; Coura-Filho, George Barberio; Garcez, Alexandre Teles; Alves, Carlos Eduardo Gonzalez Ribeiro; Cardona, Marissa Anabel Rivera; Gutterres, Ricardo Fraga; Buchpiguel, Carlos Alberto

    2015-01-01

    Objective The present study was aimed at evaluating the viability of replacing 18F with 99mTc in dose calibrator linearity testing. Materials and Methods The test was performed with sources of 99mTc (62 GBq) and 18F (12 GBq) whose activities were measured up to values lower than 1 MBq. Ratios and deviations between experimental and theoretical 99mTc and 18F sources activities were calculated and subsequently compared. Results Mean deviations between experimental and theoretical 99mTc and 18F sources activities were 0.56 (± 1.79)% and 0.92 (± 1.19)%, respectively. The mean ratio between activities indicated by the device for the 99mTc source as measured with the equipment pre-calibrated to measure 99mTc and 18F was 3.42 (± 0.06), and for the 18F source this ratio was 3.39 (± 0.05), values considered constant over the measurement time. Conclusion The results of the linearity test using 99mTc were compatible with those obtained with the 18F source, indicating the viability of utilizing both radioisotopes in dose calibrator linearity testing. Such information in association with the high potential of radiation exposure and costs involved in 18F acquisition suggest 99mTc as the element of choice to perform dose calibrator linearity tests in centers that use 18F, without any detriment to the procedure as well as to the quality of the nuclear medicine service. PMID:25798005

  20. Sintering trials of analogues of americium oxides for radioisotope power systems

    Science.gov (United States)

    Watkinson, E. J.; Ambrosi, R. M.; Kramer, D. P.; Williams, H. R.; Reece, M. J.; Chen, K.; Sarsfield, M. J.; Barklay, C. D.; Fenwick, H.; Weston, D. P.; Stephenson, K.

    2017-08-01

    European Space Agency radioisotope power systems will use americium oxide as the heat source in pellet or disc form. The oxide form is yet to be decided. Sintering trials with CeO2 and Nd2O3 as analogues for AmO2 and Am2O3 were conducted. Spark plasma sintering (SPS) and cold-press-and-sinter methods were compared. Different sintering parameters and particle characteristics were investigated with commercial and synthesised powders. The synthesised powders contained lath-shaped particles, and batches with different particle sizes and specific surface areas were made and sintered. This is the first study in the public literature to report the sintering of lath-shaped CeO2. The targeted density range of 85-90% was met using both techniques. No ball-milling was required. Cold-pressing-and-sintering CeO2 produced intact discs. Large cracking was prevalent in the SPS discs. Some powders pressed more successfully than others. Powder morphology had a significant effect on the result but it was not possible to fully quantify the effects in this study. The cold-pressed-and-sintered CeO2 discs had comparable Vickers hardness values to a nuclear ceramic (UO2). The hardness values were greater than the spark plasma sintered CeO2 sample. Efforts to SPS near-net shaped pellets using CeO2 and Nd2O3 are reported. A follow on investigation was conducted to assess how the 85-90% T.D. target could be achieved. The aspect ratio impacts the sintering parameters and behaviour. The Vickers hardness of Nd2O3 is reported for the first time and compared to the results of sintered CeO2.

  1. Development and characterization of carbon-bonded carbon fiber insulation for radioisotope space power systems

    Energy Technology Data Exchange (ETDEWEB)

    Wei, G.C.; Robbins, J.M.

    1985-06-01

    The General-Purpose Heat Source (GPHS), an improved radioisotope heat source, employs a unique thermal insulation material, carbon-bonded carbon fiber (CBCF), to protect the fuel capsule and to help achieve the highest possible specific power. The CBCF insulation is made from chopped rayon fiber about 10 ..mu..m in diameter and 250 ..mu..m long, which is carbonized and bonded with phenolic resin particles. The CBCF shapes, both tubes and plates, are formed in a multiple molding facility by vacuum molding a water slurry of the carbonized chopped-rayon fiber (54 wt %) and phenolic resin (46 wt %). The molded shapes are subsequently dried and cured. Final carbonization of the resin is at 1600/sup 0/C. Machining to close tolerances (+-0.08 mm) is accomplished by conventional tooling and fixturing. The resulting material is an excellent lightweight insulation with a nominal density of 0.2 Mg/m/sup 3/ and a thermal conductivity of 0.24 W(m.K) in vacuum at 2000/sup 0/C. Several attributes that make CBCF superior to other known high-temperature insulation materials for the GPHS application have been identified. It has the excellent attributes of light weight, low thermal conductivity, chemical compatibility, and high-temperature capabilities. The mechanical strength of CBCF insulation is satisfactory for the GPHS application; it has passed vibration tests simulating launch conditions. The basic fabrication technique was refined to eliminate undesirable large pores and cracks often present in materials fabricated by earlier techniques. Also, processing was scaled up to incease the fabrication rate by a factor of 10. The specific properties of the CBCF were tailored by adjusting material and processing variables to obtain the desired results. We report here how work on CBCF characterization and development conducted at ORNL from 1978 through 1980 has contributed to the GPHS program to meet the requirements of both the Galileo and Ulysees Missions.

  2. Assessment of the environmental fate of cycloxaprid in flooded and anaerobic soils by radioisotopic tracing

    Energy Technology Data Exchange (ETDEWEB)

    Liu, Xuanqi; Xu, Xiaoyong; Li, Chao [Shanghai Key Laboratory of Chemical Biology, School of Pharmacy, East China, University of Science and Technology, Shanghai 200237 (China); Zhang, Hanxue; Fu, Qiuguo [Institute of Nuclear Agricultural Sciences, Zhejiang University, Hangzhou 310029 (China); Shao, Xusheng [Shanghai Key Laboratory of Chemical Biology, School of Pharmacy, East China, University of Science and Technology, Shanghai 200237 (China); Ye, Qingfu, E-mail: qfye@zju.edu.cn [Institute of Nuclear Agricultural Sciences, Zhejiang University, Hangzhou 310029 (China); Li, Zhong, E-mail: lizhong@ecust.edu.cn [Shanghai Key Laboratory of Chemical Biology, School of Pharmacy, East China, University of Science and Technology, Shanghai 200237 (China)

    2016-02-01

    Cycloxaprid (CYC) is a novel broad-spectrum neonicotinoid insecticide that has been developed for agricultural pest control. The fate of the {sup 14}C-labeled racemic and enantio-pure CYC isomers in flooded and anaerobic soil was investigated using radioisotope tracing techniques. After 100 d of incubation, only a minor portion (< 1%) of the applied CYC isomers is mineralized by each of the four tested soil types. The fraction of initially applied radioactive CYC dissipated into the bound or non-extractable residues (BR) increases with increase in the length of the incubation period, reaching up to 53.0–81.6%. The dissipation of the CYC through mineralization or formation of BR is strongly influenced by soil properties, such as humic content, pH value, and retained microbial activity. Amongst the soils studied, the fluvio-marine yellow loamy soil displayed the highest tendency to mineralize CYC while the coastal saline soil exhibited the strongest tendency to form BR. The observation that the water phase retained the large portion(> 60%) of the radioactivity attributed to the total extractable residue suggested that under the experimental condition, the initially applied {sup 14}C-labeled CYC residues were readily available for leaching or offsite transport. Additionally, no enantiomer-specific behaviors are observed. The results from this study provide a framework for assessing the environmental impact resulting from the use of this pesticide. - Highlights: • Only a minor portion (<1%) of the applied CYC was mineralized. • The bound residue increased over time, reaching up to 53.0-81.6%. • CYC residues were readily available for leaching. • No enantiomer-specific behaviors were observed.

  3. Dose calibrator linearity test: {sup 99m}Tc versus {sup 18}F radioisotopes

    Energy Technology Data Exchange (ETDEWEB)

    Willegaignon, Jose; Coura-Filho, George Barberio; Garcez, Alexandre Teles, E-mail: willegaignon@hotmail.com [Instituto do Cancer do Estado de Sao Paulo Octavio Frias de Oliveira (ICESP), Sao Paulo, SP (Brazil); Sapienza, Marcelo Tatit; Buchpiguel, Carlos Alberto [Universidade de Sao Paulo (FM/USP), Sao Paulo, SP (Brazil). Fac. de Medicina; Alves, Carlos Eduardo Gonzalez Ribeiro; Cardona, Marissa Anabel Rivera; Gutterres, Ricardo Fraga [Comissao Nacional de Energia Nuclear (CNEN), Rio de Janeiro, RJ (Brazil)

    2015-01-15

    Objective: the present study was aimed at evaluating the viability of replacing {sup 18}F with {sup 99m}Tc in dose calibrator linearity testing. Materials and methods: the test was performed with sources of {sup 99m}Tc (62 GBq) and {sup 18}F (12 GBq) whose activities were measured up to values lower than 1 MBq. Ratios and deviations between experimental and theoretical {sup 99m}Tc and {sup 18}F sources activities were calculated and subsequently compared. Results: mean deviations between experimental and theoretical {sup 99m}Tc and {sup 18}F sources activities were 0.56 (± 1.79)% and 0.92 (± 1.19)%, respectively. The mean ratio between activities indicated by the device for the {sup 99m}Tc source as measured with the equipment precalibrated to measure {sup 99m}Tc and {sup 18}F was 3.42 (± 0.06), and for the {sup 18}F source this ratio was 3.39 (± 0.05), values considered constant over the measurement time. Conclusion: the results of the linearity test using {sup 99m}Tc were compatible with those obtained with the {sup 18}F source, indicating the viability of utilizing both radioisotopes in dose calibrator linearity testing. Such information in association with the high potential of radiation exposure and costs involved in {sup 18}F acquisition suggest {sup 99m}Tc as the element of choice to perform dose calibrator linearity tests in centers that use {sup 18}F, without any detriment to the procedure as well as to the quality of the nuclear medicine service. (author)

  4. Operational readiness review plan for the radioisotope thermoelectric generator materials production tasks

    Energy Technology Data Exchange (ETDEWEB)

    Cooper, R.H.; Martin, M.M.; Riggs, C.R.; Beatty, R.L.; Ohriner, E.K.; Escher, R.N.

    1990-04-19

    In October 1989, a US shuttle lifted off from Cape Kennedy carrying the spacecraft Galileo on its mission to Jupiter. In November 1990, a second spacecraft, Ulysses, will be launched from Cape Kennedy with a mission to study the polar regions of the sun. The prime source of power for both spacecraft is a series of radioisotope thermoelectric generators (RTGs), which use plutonium oxide (plutonia) as a heat source. Several of the key components in this power system are required to ensure the safety of both the public and the environment and were manufactured at Oak Ridge National Laboratory (ORNL) in the 1980 to 1983 period. For these two missions, Martin Marietta Energy Systems, Inc. (Energy Systems), will provide an iridium-alloy component used to contain the plutonia heat source and a carbon-composite material that serves as a thermal insulator. ORNL alone will continue to fabricate the carbon-composite material. Because of the importance to DOE that Energy Systems deliver these high-quality components on time, performance of an Operational Readiness Review (ORR) of these manufacturing activities is necessary. Energy Systems Policy GP-24 entitled Operational Readiness Process'' describes the formal and comprehensive process by which appropriate Energy Systems activities are to be reviewed to ensure their readiness. This Energy System policy is aimed at reducing the risks associated with mission success and requires a management-approved readiness plan'' to be issued. This document is the readiness plan for the RTG materials production tasks. 6 refs., 11 figs., 1 tab.

  5. Chicanoizing the Therapeutic Community

    Science.gov (United States)

    Aron, William S.; And Others

    1974-01-01

    Focusing on the drug addiction problem and its antecedent conditions in a Chicano population, the article examines several therapeutic interventions suggested by these conditions and indicates how they might be incorporated into a drug addiction Therapeutic Community treatment program designed to meet the needs of Chicano drug addicts. (Author/NQ)

  6. Therapeutic Crisis Intervention.

    Science.gov (United States)

    Holden, Martha J.; Powers, Jane Levine

    1993-01-01

    Describes Therapeutic Crisis Intervention (TCI) program as providing staff with skills, knowledge, and confidence to manage child in crisis to bring about a "maximum amount of lasting response." Contends that, by applying principles of TCI training, direct care worker can attain therapeutic control and maintain dignity of both adult and child…

  7. Trends in Therapeutic Recreation.

    Science.gov (United States)

    Smith, Ralph W.

    1995-01-01

    Discusses the implications of the rapid, dramatic changes taking place in therapeutic recreation for individuals with physical disabilities. The article notes the impact of changes in managed care, examines programming trends in therapeutic recreation (adventure/outdoor education, competitive sports, handcycling, health enhancement activities, and…

  8. IEA-R1 Nuclear Research Reactor: 58 Years of Operating Experience and Utilization for Research, Teaching and Radioisotopes Production

    Energy Technology Data Exchange (ETDEWEB)

    Cardenas, Jose Patricio Nahuel; Filho, Tufic Madi; Saxena, Rajendra; Filho, Walter Ricci [Nuclear and Energy Research Institute, IPEN-CNEN/SP, Instituto de Pesquisas Energeticas e Nucleares - IPEN-CNEN/SP, Av. Prof. Lineu Prestes 2242 Cid Universitaria CEP: 05508-000- Sao Paulo-SP (Brazil)

    2015-07-01

    IEA-R1 research reactor at the Instituto de Pesquisas Energeticas e Nucleares (Nuclear and Energy Research Institute) IPEN, Sao Paulo, Brazil is the largest power research reactor in Brazil, with a maximum power rating of 5 MWth. It is being used for basic and applied research in the nuclear and neutron related sciences, for the production of radioisotopes for medical and industrial applications, and for providing services of neutron activation analysis, real time neutron radiography, and neutron transmutation doping of silicon. IEA-R1 is a swimming pool reactor, with light water as the coolant and moderator, and graphite and beryllium as reflectors. The reactor was commissioned on September 16, 1957 and achieved its first criticality. It is currently operating at 4.5 MWth with a 60-hour cycle per week. In the early sixties, IPEN produced {sup 131}I, {sup 32}P, {sup 198}Au, {sup 24}Na, {sup 35}S, {sup 51}Cr and labeled compounds for medical use. During the past several years, a concerted effort has been made in order to upgrade the reactor power to 5 MWth through refurbishment and modernization programs. One of the reasons for this decision was to produce {sup 99}Mo at IPEN. The reactor cycle will be gradually increased to 120 hours per week continuous operation. It is anticipated that these programs will assure the safe and sustainable operation of the IEA-R1 reactor for several more years, to produce important primary radioisotopes {sup 99}Mo, {sup 125}I, {sup 131}I, {sup 153}Sm and {sup 192}Ir. Currently, all aspects of dealing with fuel element fabrication, fuel transportation, isotope processing, and spent fuel storage are handled by IPEN at the site. The reactor modernization program is slated for completion by 2015. This paper describes 58 years of operating experience and utilization of the IEA-R1 research reactor for research, teaching and radioisotopes production. (authors)

  9. Advanced Stirling Convertor Dual Convertor Controller Testing at NASA Glenn Research Center in the Radioisotope Power Systems System Integration Laboratory

    Science.gov (United States)

    Dugala, Gina M.; Taylor, Linda M.; Bell, Mark E.; Dolce, James L.; Fraeman, Martin; Frankford, David P.

    2015-01-01

    NASA Glenn Research Center developed a nonnuclear representation of a Radioisotope Power System (RPS) consisting of a pair of Advanced Stirling Convertors (ASCs), Dual Convertor Controller (DCC) EMs (engineering models) 2 and 3, and associated support equipment, which were tested in the Radioisotope Power Systems System Integration Laboratory (RSIL). The DCC was designed by the Johns Hopkins University Applied Physics Laboratory (JHU/APL) to actively control a pair of ASCs. The first phase of testing included a Dual Advanced Stirling Convertor Simulator (DASCS), which was developed by JHU/APL and simulates the operation and electrical behavior of a pair of ASCs in real time via a combination of hardware and software. RSIL provides insight into the electrical interactions between a representative radioisotope power generator, its associated control schemes, and realistic electric system loads. The first phase of integration testing included the following spacecraft bus configurations: capacitive, battery, and super-capacitor. A load profile, created based on data from several missions, tested the RPS's and RSIL's ability to maintain operation during load demands above and below the power provided by the RPS. The integration testing also confirmed the DCC's ability to disconnect from the spacecraft when the bus voltage dipped below 22 volts or exceeded 36 volts. Once operation was verified with the DASCS, the tests were repeated with actual operating ASCs. The goal of this integration testing was to verify operation of the DCC when connected to a spacecraft and to verify the functionality of the newly designed RSIL. The results of these tests are presented in this paper.

  10. The Mars Hopper: a radioisotope powered, impulse driven, long-range, long-lived mobile platform for exploration of Mars

    Energy Technology Data Exchange (ETDEWEB)

    Steven D. Howe; Robert C. O' Brien; William Taitano; Doug Crawford; Nathan Jerred; Spencer Cooley; John Crapeau; Steve Hansen; Andrew Klein; James Werner

    2011-02-01

    Planetary exploration mission requirements are becoming more demanding. Due to the increasing cost, the missions that provide mobile platforms that can acquire data at multiple locations are becoming more attractive. Wheeled vehicles such as the MER rovers have proven extremely capable but have very limited range and cannot traverse rugged terrain. Flying vehicles such as balloons and airplanes have been proposed but are problematic due to the very thin atmospheric pressure and the strong, dusty winds present on Mars. The Center for Space Nuclear Research has designed an instrumented platform that can acquire detailed data at hundreds of locations during its lifetime - a Mars Hopper. The Mars Hopper concept utilizes energy from radioisotopic decay in a manner different from any existing radioisotopic power sources—as a thermal capacitor. By accumulating the heat from radioisotopic decay for long periods, the power of the source can be dramatically increased for short periods. The platform will be able to "hop" from one location to the next every 5-7 days with a separation of 5-10 km per hop. Preliminary designs show a platform that weighs around 52 kgs unfueled which is the condition at deployment. Consequently, several platforms may be deployed on a single launch from Earth. With sufficient lifetime, the entire surface of Mars can be mapped in detail by a couple dozen platforms. In addition, Hoppers can collect samples from all over the planet, including gorges, mountains and crevasses, and deliver them to a central location for eventual pick-up by a Mars Sample Return mission. The status of the Mars Hopper development project at the CSNR is discussed.

  11. Annual Technical Progress Report of Radioisotope Power Systems Materials Production and Technology Program Tasks for October 1, 2006 Through September 30, 2007

    Energy Technology Data Exchange (ETDEWEB)

    King, James F [ORNL

    2008-04-01

    The Office of Radioisotope Power Systems of the Department of Energy (DOE) provides Radioisotope Power Systems (RPS) for applications where conventional power systems are not feasible. For example, radioisotope thermoelectric generators were supplied by the DOE to the National Aeronautics and Space Administration for deep space missions including the Cassini Mission launched in October of 1997 to study the planet Saturn. For the Cassini Mission, ORNL produced carbon-bonded carbon fiber (CBCF) insulator sets, iridium alloy blanks and foil, and clad vent sets (CVS) used in the generators. The Oak Ridge National Laboratory (ORNL) has been involved in developing materials and technology and producing components for the DOE for more than three decades. This report reflects program guidance from the Office of Radioisotope Power Systems for fiscal year (FY) 2007. Production activities for prime quality (prime) CBCF insulator sets, iridium alloy blanks and foil, and CVS are summarized in this report. Technology activities are also reported that were conducted to improve the manufacturing processes, characterize materials, or to develop information for new radioisotope power systems.

  12. Reporting therapeutic discourse in a therapeutic community.

    Science.gov (United States)

    Chapman, G E

    1988-03-01

    Research in nurses' communications has concentrated on nurse to patient interactions. Those few studies which focus on nurse to nurse communications seem to be generated by a pragmatic and normative concern with effective information sharing. In this paper, which describes one aspect of a larger case study of a hospital-based therapeutic community, the description and analysis of nurses' reports flows not from a normative model of professional practice, but rather an exploration of how professional practice is articulated as discourse in nurses' written accounts. Foucault's ideas about therapeutic discourse inform the theoretical framework of the research. Ethnomethodological concerns with the importance of documentary analysis provide the methodological rationale for examining nurses' 24-hour report documents, as official discourse, reflecting therapeutic practice in this setting. A content analysis of nurses' reports, collected over a period of 4 months, demonstrated the importance of domesticity and ordinary everyday activities in nurses' accounts of hospital life. Disruption to the 'life as usual' domesticity in the community seemed to be associated with admission to and discharge from the hospital when interpersonal and interactional changes between patients occur. It is suggested that nurses in general hospital wards and more orthodox psychiatric settings might usefully consider the impact of admissions and discharges on the group of patients they manage, and make this a discursive focus of their work.

  13. Advanced Stirling Convertor Control Unit Testing at NASA Glenn Research Center in the Radioisotope Power Systems System Integration Laboratory

    Science.gov (United States)

    Dugala, Gina M.; Taylor, Linda M.; Kussmaul, Michael; Casciani, Michael; Brown, Gregory; Wiser, Joel

    2017-01-01

    Future NASA missions could include establishing Lunar or Martian base camps, exploring Jupiters moons and travelling beyond where generating power from sunlight may be limited. Radioisotope Power Systems (RPS) provide a dependable power source for missions where inadequate sunlight or operational requirements make other power systems impractical. Over the past decade, NASA Glenn Research Center (GRC) has been supporting the development of RPSs. The Advanced Stirling Radioisotope Generator (ASRG) utilized a pair of Advanced Stirling Convertors (ASC). While flight development of the ASRG has been cancelled, much of the technology and hardware continued development and testing to guide future activities. Specifically, a controller for the convertor(s) is an integral part of a Stirling-based RPS. For the ASRG design, the controller maintains stable operation of the convertors, regulates the alternating current produced by the linear alternator of the convertor, provides a specified direct current output voltage for the spacecraft, synchronizes the piston motion of the two convertors in order to minimize vibration as well as manage and maintain operation with a stable piston amplitude and hot end temperature. It not only provides power to the spacecraft but also must regulate convertor operation to avoid damage to internal components and maintain safe thermal conditions after fueling. Lockheed Martin Coherent Technologies has designed, developed and tested an Engineering Development Unit (EDU) Advanced Stirling Convertor Control Unit (ACU) to support this effort. GRC used the ACU EDU as part of its non-nuclear representation of a RPS which also consists of a pair of Dual Advanced Stirling Convertor Simulator (DASCS), and associated support equipment to perform a test in the Radioisotope Power Systems System Integration Laboratory (RSIL). The RSIL was designed and built to evaluate hardware utilizing RPS technology. The RSIL provides insight into the electrical

  14. Application of radioisotope XRF and thermoluminescence (TL) dating in investigation of pottery from Tell AL-Kasra archaeological site, Syria.

    Science.gov (United States)

    Abboud, R; Issa, H; Abed-Allah, Y D; Bakraji, E H

    2015-11-01

    Statistical analysis based on chemical composition, using radioisotope X-ray fluorescence, have been applied on 39 ancient pottery fragments coming from the excavation at Tell Al-Kasra archaeological site, Syria. Three groups were defined by applying Cluster and Factor analysis statistical methods. Thermoluminescence (TL) dating was investigated on three sherds taken from the bathroom (hammam) on the site. Multiple aliquot additive dose (MAAD) was used to estimate the paleodose value, and the gamma spectrometry was used to estimate the dose rate. The average age was found to be 715±36 year. Copyright © 2015 Elsevier Ltd. All rights reserved.

  15. Ultratrace analysis and isotope ratio measurements of long-lived radioisotopes by resonance ionization mass spectrometry (RIMS).

    Science.gov (United States)

    Trautmann, N; Passler, G; Wendt, K D A

    2004-01-01

    Resonance Ionization Mass Spectrometry (RIMS) is a sensitive and selective method for ultratrace analysis of long-lived radioisotopes and isotope ratio measurements. It provides extremely high isobaric suppression and good overall efficiency. The experimental limits of detection are as low as 10(6) atoms per sample and isotopic selectivities of 5x10(12) have been obtained. The widespread potential of RIMS, using different experimental arrangements, is demonstrated for the determination of the radiotoxic isotopes Pu-238 to Pu-244 and Sr-89/Sr-90 in various environmental samples as well as for Ca-41 in nuclear reactor components and biomedical samples.

  16. Multi-Mission Radioisotope Thermoelectric Generator Heat Exchangers for the Mars Science Laboratory Rover

    Science.gov (United States)

    Mastropietro, A. J.; Beatty, John S.; Kelly, Frank P.; Bhandari, Pradeep; Bame, David P.; Liu, Yuanming; Birux, Gajanana C.; Miller, Jennifer R.; Pauken, Michael T.; Illsley, Peter M.

    2012-01-01

    The addition of the Multi-Mission Radioisotope Thermoelectric Generator (MMRTG) to the Mars Science Laboratory (MSL) Rover requires an advanced thermal control system that is able to both recover and reject the waste heat from the MMRTG as needed in order to maintain the onboard electronics at benign temperatures despite the extreme and widely varying environmental conditions experienced both on the way to Mars and on the Martian surface. Based on the previously successful Mars landed mission thermal control schemes, a mechanically pumped fluid loop (MPFL) architecture was selected as the most robust and efficient means for meeting the MSL thermal requirements. The MSL heat recovery and rejection system (HRS) is comprised of two Freon (CFC-11) MPFLs that interact closely with one another to provide comprehensive thermal management throughout all mission phases. The first loop, called the Rover HRS (RHRS), consists of a set of pumps, thermal control valves, and heat exchangers (HXs) that enables the transport of heat from the MMRTG to the rover electronics during cold conditions or from the electronics straight to the environment for immediate heat rejection during warm conditions. The second loop, called the Cruise HRS (CHRS), is thermally coupled to the RHRS during the cruise to Mars, and provides a means for dissipating the waste heat more directly from the MMRTG as well as from both the cruise stage and rover avionics by promoting circulation to the cruise stage radiators. A multifunctional structure was developed that is capable of both collecting waste heat from the MMRTG and rejecting the waste heat to the surrounding environment. It consists of a pair of honeycomb core sandwich panels with HRS tubes bonded to both sides. Two similar HX assemblies were designed to surround the MMRTG on the aft end of the rover. Heat acquisition is accomplished on the interior (MMRTG facing) surface of each HX while heat rejection is accomplished on the exterior surface of

  17. [PLURAL THERAPEUTIC ITINERARIES].

    Science.gov (United States)

    Iorio, Silvia

    2015-01-01

    This article addresses the strategies employed by Nahua community of Mexixo to deal with health problems. Drawing on qualitative research, it discusses the choice of plural therapeutic itineraries, including the use of informal and formal healthcare.

  18. Quarterly Technical Progress Report of Radioisotope Power System Materials Production and Technology Program tasks for April 2000 through June 2000

    Energy Technology Data Exchange (ETDEWEB)

    Moore, J.P.

    2000-10-23

    The Office of Space and Defense Power Systems (OSDPS) of the Department of Energy (DOE) provides Radioisotope Power Systems (RPS) for applications where conventional power systems are not feasible. For example, radioisotope thermoelectric generators were supplied by the DOE to the National Aeronautics and Space Administration for deep space missions including the Cassini Mission launched in October of 1997 to study the planet Saturn. The Oak Ridge National Laboratory (ORNL) has been involved in developing materials and technology and producing components for the DOE for more than three decades. For the Cassini Mission, for example, ORNL was involved in the production of carbon-bonded carbon fiber (CBCF) insulator sets, iridium alloy blanks and foil, and clad vent sets (CVSs) and weld shields (WSs). This quarterly report has been divided into three sections to reflect program guidance from OSDPS for fiscal year (FY) 2000. The first section deals primarily with maintenance of the capability to produce flight quality carbon-bonded carbon fiber (CBCF) insulator sets, iridium alloy blanks and foil, clad vent sets (CVSs), and weld shields (WSs). In all three cases, production maintenance is assured by the manufacture of limited quantities of flight quality (FQ) components. The second section deals with several technology activities to improve the manufacturing processes, characterize materials, or to develop technologies for two new RPS. The last section is dedicated to studies of the potential for the production of 238Pu at ORNL.

  19. Quarterly Technical Progress Report of Radioisotope Power System Materials Production and Technology Program tasks for January 2000 through March 2000

    Energy Technology Data Exchange (ETDEWEB)

    Moore, J.P.

    2000-08-18

    The Office of Space and Defense Power Systems (OSDPS) of the Department of Energy (DOE) provides radioisotope Power Systems (BPS) for applications where conventional power systems are not feasible. For example, radioisotope thermoelectric generators were supplied by the DOE to the National Aeronautics and Space Administration for deep space missions including the Cassini Mission launched in October of .I 997 to study the planet Saturn. The Oak Ridge National Laboratory (ORNL) has been involved in developing materials and technology and producing components for the DOE for more than three decades. For the Cassini Mission, for example, ORNL was involved in the production of carbon-bonded carbon fiber (CBCF) insulator sets, iridium alloy blanks and foil, and clad vent sets (CVSs) and weld shields (WSs). This quarterly report has been divided into three sections to reflect program guidance from OSDPS for fiscal year (FY) 2000. The first section deals primarily with maintenance of the capability to produce flight quality carbon-bonded carbon fiber (CBCF) insulator sets, iridium alloy blanks and foil, clad vent sets (CVSs), and weld shields (WSs). In all three cases, production maintenance is assured by the manufacture of limited quantities of flight quality (FQ) components. The second section deals with several technology activities to improve the manufacturing processes, characterize materials, or to develop technologies for two new RPS. The last section is dedicated to studies of the potential for the production of 238Pu at OBNL.

  20. Investigation of the radionuclide inventory and the production yields of the target stacks at the PEFP radioisotope production facility

    Energy Technology Data Exchange (ETDEWEB)

    Yoon, Sang-Pil; Hong, In-Seok; Cho, Yong-Sub [Korea Atomic Energy Research Institute, Daejeon (Korea, Republic of)

    2010-06-15

    The Proton Engineering Frontier Project (PEFP) will construct a radioisotope production facility by using the nuclear reaction between the 100-MeV proton beam and the solid target. For investigating the radionuclide inventory and the production yield of the radioisotope production facility, we have optimized the thickness of the prototype target stacks by using a SRIM calculation. The target stacks consist of RbCl encapsulated in inconel alloy, Zn metal, and Ga metal encapsulated in niobium. Typical beam parameters were 300 {mu}A and 95 hours. An inventory of all generated radionuclide activities is mandatory in order to prepare the operation scenario and design the hot cell. The Monte Carlo code MCNPX was used to investigate what radionuclide is generated. The obtained radionuclide inventory indicated that about 100 radionuclides were generated and that the total radioactivity of the irradiated target stacks was 1324.1 Ci at the end of the bombardment. The production yields of Sr-82, Cu-67, and Ge-68 were 3.79 Ci, 2.74 Ci, and 1.23 Ci at the end of the bombardment.

  1. Combined technetium radioisotope penile plethysmography and xenon washout: A technique for evaluating corpora cavernosal inflow and outflow during early tumescence

    Energy Technology Data Exchange (ETDEWEB)

    Schwartz, A.N.; Graham, M.M. (Univ. of Washington Medical Center, Seattle (USA))

    1991-03-01

    Combined technetium radioisotope penile plethysmography and xenon washout is a new technique that measures both corporal arterial inflow and venous sinusoidal outflow during early tumescence in patients with erectile dysfunction. Fourteen patients were studied using 99mTc-RBCs to measure inflow and 133Xe or 127Xe in saline to measure outflow. Tumescence was induced by injecting papaverine intracorporally. Peak corporal rates corrected for inflow (r = 0.88) and uncorrected for outflow (r = 0.91) and change in volume over 2 min centered around peak inflow (r = 0.96) all correlated with angiography. Outflow measurements did not correlate with intracorporal resistance. Thus, outflow rates alone could not be used to predict venous sinusoidal competence. Normal inflow rate is greater than 20 ml/min; probable normal 12-20; indeterminate inflow 7-12; and abnormal inflow less than 7 ml/min. Technetium-99m radioisotope penile plethysmography and xenon washout can be performed together and both provide a method for simultaneously evaluating the relationship between corporal inflow and outflow rates in patients with erectile dysfunction.

  2. Technical Reviews on the Petroleum Refining Industry and the Petrochemical Industry for the Development of Industrial Application of Radioisotope

    Energy Technology Data Exchange (ETDEWEB)

    Jung, Sung-Hee; Kim, Jong-Bum; Lee, Na-Young; Kwon, Taek-Yong

    2008-09-15

    Petroleum is the major energy source that supplies 35% of the total power all over the world. And the petrochemical industry generates a 120 times higher value from naphtha, and in cooperates new technology in order to keep its business prosperous. These large plant industries require in-service diagnosis technology for an optimal and efficient operation and maintenance. Since diagnosis information obtained from an on-line plant can be used for a correct operation and maintenance workplan in the case of a deteriorated product quality as well as a mechanical abnormality, this technology can contribute to a huge cost benefit and a product competitiveness. The gigantic plants equipped with heavy materials can hardly be evaluated with conventional techniques due to their harsh environment of a high temperature and a pressure. Radiation and radioisotope application technology has been studied to meet the demand of the industry, but has yet to be developed further. In spite of its usefulness, the strategic support is not enough to carry out the research activities on advanced industrial testing technology using radioisotopes. It is of importance to secure a national competitiveness by intensifying the support for the newly emerging technologies such as an industrial gamma tomography and a process visualization and validation incorporated with a CFD.

  3. Sediment Dating With Short-Lived Radioisotopes In Monterey Canyon, California Imply Episodes Of Rapid Deposition And Erosion

    Science.gov (United States)

    Lorenson, T. D.; Swarzenski, P. W.; Maier, K. L.; Gwiazda, R.; Paull, C. K.; Sumner, E.; Symons, W. O.

    2015-12-01

    Submarine canyons are a major conduit for terrestrial material to the deep sea. To better constrain the timing and rates in which sediment is transported down-canyon, we collected a series of sediment cores along the axis of Monterey Canyon, and quantified mass accumulation rates using short-lived radio-isotopes. A suite of sediment cores were carefully collected perpendicular to the canyon thalweg in water depths of approximately 300m, 500m, 800m, and 1500m using a remotely operated vehicle (ROV). We choose cores that were between 60m and 75m above the canyon thalweg on canyon side bench features for correlation with moored instrument deployments. The sediment cores reveal a complex stratigraphy that includes copious bioturbation features, sand lenses, subtle erosional surfaces, subtle graded bedding, and abrupt changes sediment texture and color. Downcore excess 210Pb and 137Cs profiles imply episodic deposition and remobilization cycles on the canyon benches. Excess 210Pb activities in cores reach depths of up to 1m, implying very rapid sedimentation. Sedimentation rates vary with water depth, generally with the highest sedimentation rate in closest to land, but vary substantially on adjacent canyon benches. Preliminary results demonstrate that sediment movement within Monterey Canyon is both dynamic and episodic on human time-scales and can be reconstructed used short-lived radio-isotopes.

  4. Theoretical dosimetry estimations for radioisotopes produced by proton-induced reactions on natural and enriched molybdenum targets

    Science.gov (United States)

    Hou, X.; Celler, A.; Grimes, J.; Bénard, F.; Ruth, T.

    2012-03-01

    This study presents a summary of the dosimetry calculations performed for three technetium agents most commonly used in nuclear medicine diagnostic studies, namely sestamibi™, phosphonates and pertechnetate, labeled with cyclotron-produced technetium. Calculated patient doses were compared to those that would be delivered by the same radiotracers labeled with technetium obtained from a generator produced in a reactor. The main difference is that technetium from a generator is pure, i.e. contains only 99mTc and its decay product 99gTc, while in a cyclotron a large number of other stable and radioactive isotopes are created. In our calculations only technetium radioisotopes (ground and isomeric states) were considered as they will be included in the radiotracer labeling process and will contribute to the patient dose. Other elements should be removed by chemical purification. These dose estimates are based on our theoretical calculations of the proton-induced reaction cross sections and radioisotope production yields. Thick targets of enriched (three different compositions) and natural molybdenum, and three initial beam energies (16, 19 and 24 MeV) were considered for irradiation times of 3, 6 and 12 h with a beam current of 200 µA. The doses were calculated for injection times corresponding to 0, 2, 8, 12 and 24 h after the end of beam.

  5. G-189A analytical simulation of the integrated waste management-water system using radioisotopes for thermal energy

    Science.gov (United States)

    Coggi, J. V.; Loscutoff, A. V.; Barker, R. S.

    1973-01-01

    An analytical simulation of the RITE-Integrated Waste Management and Water Recovery System using radioisotopes for thermal energy was prepared for the NASA-Manned Space Flight Center (MSFC). The RITE system is the most advanced concept water-waste management system currently under development and has undergone extended duration testing. It has the capability of disposing of nearly all spacecraft wastes including feces and trash and of recovering water from usual waste water sources: urine, condensate, wash water, etc. All of the process heat normally used in the system is produced from low penalty radioisotope heat sources. The analytical simulation was developed with the G189A computer program. The objective of the simulation was to obtain an analytical simulation which can be used to (1) evaluate the current RITE system steady state and transient performance during normal operating conditions, and also during off normal operating conditions including failure modes; and (2) evaluate the effects of variations in component design parameters and vehicle interface parameters on system performance.

  6. MEMPELAJARI FISIOLOGI PENCEMARAN LINGKUNGAN DENGAN TEHNIK RADIOISOTOP (Study in the Physiology of Environment Pollution Using Radiotracer Method

    Directory of Open Access Journals (Sweden)

    Razak Achmad Hamzah

    2011-11-01

    Full Text Available ABSTRAK Penelitian ini bertujuan untuk mengetahui: 1. Perbedaan kemampuan daya serap tumbuhan air Hydrilla verticillata, Enceng gondok (Eichhomia crassipes dan Kangkung terhadap residu Malathion, menggunakan akuarium (diisi dengan air + Hydrilla Verticillata + Enceng Gondok + Kangkung + Malathion radioisotope 14C. 2. Perbandingan kadar malathion dalam jaringan ikan yang mendapat makanan Hydrilla verticilata dengan yang mendapat makanan kangkung, menggunakan: (akuarium pertama diisi air + Hydrilla Vericillata + ikan mas + Malathion radioisotope 14C; akuarium ke dua diisi air + kangkung + ikan mas + malathion radiisotop 14C. 3. Perbandingan ukuran penyerapan pada jaringan mammalia (tikus yang diberi makan jaringan ikan mas dengan yang diberi makan tumbuhan air (kangkung yang terkontaminasi. Jaringan ikan mas dan kangkung dilakukan pengabuan basah, lalu diberikan masing-masing kepada 30 ekor tikus. Kadar Malathion dari semua percobaan satu, dua dan tiga, diketahui dengan menggunakan alat pencacah Sintilator cair (Liquid Scintillation Spectrometer, LSC- 753 (ALOKA”. Hasil yang didapat dibandingkan dengan menggunakan uji-t Student. Hasil penelitian memperlihatkan bahwa: 1. Hydrilla Verticillata lebih efisien dari pada Enceng Gondok dan Kangkung dalam menyerap residu insektisida malathion dalam air. 2. Ikan yang diberi makan Hydrilla verticillata mengkonsentrasikan malathion lebih tinggi dari pada ikan yang diberi makan kangkung. 3. Mammalia (tikus yang mengkonsumsi daging ikan yang terkontaminasi akan mengkonsentrasikan malathion dalam tubuhnya lebih banyak dari pada tikus yang memakan sayuran (kangkung yang terkontaminasi. ABSTRACT The aim of this study is to determine: 1.The comparison of absorption by aquatic plants Hydrilla verticillata, water hyacinth and water spinach of Malathion insecticide residues in water, (aquarium filled with water + Hydrilla verticillata + water hyacinth + water spinach + 20 mci 14C malathion radioisotope; 2

  7. Mass Properties Testing and Evaluation for the Multi-Mission Radioisotope Thermoelectric Generator

    Energy Technology Data Exchange (ETDEWEB)

    Felicione, Frank S.

    2009-12-01

    Mass properties (MP) measurements were performed for the Multi-Mission Radioisotope Thermoelectric Generator (MMRTG), serial number (S/N) 0X730401, the power system designated for the Mars Science Laboratory (MSL) mission. Measurements were made using new mounting fixtures at the mass properties testing station in the Idaho National Laboratory (INL) Space and Security Power Systems Facility (SSPSF). The objective of making mass properties measurements was to determine the generator’s flight configured mass and center of mass or center of gravity (CG). Using an extremely accurate platform scale, the mass of the as-tested generator was determined to be 100.117 ± 0.007 lb. Weight accuracy was determined by checking the platform scale with calibrated weights immediately prior to weighing the MMRTG.a CG measurement accuracy was assessed by surrogate testing using an inert mass standard for which the CG could be readily determined analytically. Repeated testing using the mass standard enabled the basic measurement precision of the system to be quantified in terms of a physical confidence interval about the measured CG position. However, repetitious testing with the MMRTG itself was not performed in deference to the gamma and neutron radiation dose to operators and the damage potential to the flight unit from extra handling operations. Since the mass standard had been specially designed to have a total weight and CG location that closely matched the MMRTG, the uncertainties determined from its testing were assigned to the MMRTG as well. On this basis, and at the 99% confidence level, a statistical analysis found the direct, as-measured MMRTG-MSL CG to be located at 10.816 ± 0.0011 in. measured perpendicular from the plane of the lower surface of the generator’s mounting lugs (Z direction), and offset from the generator’s long axis centerline in the X and Y directions by 0.0968 ± 0.0040 in. and 0.0276 ± 0.0026 in., respectively. These uncertainties are based

  8. Kant and therapeutic privilege.

    Science.gov (United States)

    Brown, Chris

    2008-08-01

    Given Kant's exceptionless moral prohibition on lying, one might suspect that he is committed to a similar prohibition on withholding diagnostic and prognostic information from patients. I confirm this suspicion by adapting arguments against therapeutic privilege from his arguments against lying. However, I show that all these arguments are importantly flawed and submit that they should be rejected. A more compelling Kantian take on informed consent and therapeutic privilege is achievable, I argue, by focusing on Kant's duty of beneficence, which requires us to aim at furthering others' ends. But I show that there are some cases in which furthering a patient's ends requires withholding material medical information from her. Although I concede that these cases are probably quite rare, I conclude that the best Kantian thinking agrees with that of therapeutic privilege's advocates.

  9. Lymphedema and Therapeutic Lymphangiogenesis

    Directory of Open Access Journals (Sweden)

    Yukihiro Saito

    2013-01-01

    Full Text Available Lymphedema is a disorder of the lymphatic vascular system characterized by impaired lymphatic return and swelling of the extremities. Lymphedema is divided into primary and secondary forms based on the underlying etiology. Despite substantial advances in both surgical and conservative techniques, therapeutic options for the management of lymphedema are limited. Although rarely lethal, lymphedema is a disfiguring and disabling condition with an associated decrease in the quality of life. The recent impressive expansion of knowledge on the molecular mechanisms governing lymphangiogenesis provides new possibilities for the treatment of lymphedema. This review highlights the lymphatic biology, the pathophysiology of lymphedema, and the therapeutic lymphangiogenesis using hepatocyte growth factor.

  10. Therapeutic development in psoriasis.

    Science.gov (United States)

    Sobell, Jeffrey M; Leonardi, Craig L

    2014-06-01

    Advances in molecular biology have provided the basis for development of new therapeutic approaches to psoriasis. New, more effective therapies target specific molecules in the inflammatory cascade involved in the pathogenesis of psoriasis.The biologic era of psoriasis therapy began with inhibitors of T-cell activation, tumor necrosis factor-α, and interleukin (IL)-12/23. Continued investigation has led to therapies and therapeutic candidates that target IL-17, IL-23, phosphodiesterase-4, and isomers of Janus kinase. 2014 by Frontline Medical Communications Inc.

  11. Therapeutic HIV Peptide Vaccine

    DEFF Research Database (Denmark)

    Fomsgaard, Anders

    2015-01-01

    Therapeutic vaccines aim to control chronic HIV infection and eliminate the need for lifelong antiretroviral therapy (ART). Therapeutic HIV vaccine is being pursued as part of a functional cure for HIV/AIDS. We have outlined a basic protocol for inducing new T cell immunity during chronic HIV-1...... infection directed to subdominant conserved HIV-1 epitopes restricted to frequent HLA supertypes. The rationale for selecting HIV peptides and adjuvants are provided. Peptide subunit vaccines are regarded as safe due to the simplicity, quality, purity, and low toxicity. The caveat is reduced immunogenicity...

  12. Carrying away and redistribution of radioisotopes on the Peyne catchment basin. Preliminary report; Entrainement et redistribution des radionucleides sur le bassin versant de la Peyne. Rapport preliminaire

    Energy Technology Data Exchange (ETDEWEB)

    Duffa, C.; Danic, F

    2006-07-01

    The transfers of radioisotopes present in soils and sediments are essentially conditioned by the mobilities of the physical vectors which constitute their supports. The water is the main vector of natural transfer, radioisotopes being associated with it under dissolved or particulate shape. The rainout and the hydrous erosion are responsible in particular for the carrying away and for the redistribution of contaminants following an atmospheric deposit on a catchment basin. However their effect is not the same in any point of the catchment basin. The work begun here aims at elaborating a classification of the grounds sensitivity towards this phenomenon of radioisotopes carrying away. The different factors of sensitivity have been identified: pluviometry, slope, soils occupation and soils nature. The Peyne catchment basin, that presents an important variability of these four parameters, constitutes the experimental site for this study. On this catchment basin, we search to identify the areas the most sensitive to the carrying away of radioisotopes, by combining a theoretical predictive approach based on the cartography and a descriptive approach basing on the sampling and the analysis of soils samples. (N.C.)

  13. Therapeutic Recombinant Monoclonal Antibodies

    Science.gov (United States)

    Bakhtiar, Ray

    2012-01-01

    During the last two decades, the rapid growth of biotechnology-derived techniques has led to a myriad of therapeutic recombinant monoclonal antibodies with significant clinical benefits. Recombinant monoclonal antibodies can be obtained from a number of natural sources such as animal cell cultures using recombinant DNA engineering. In contrast to…

  14. Therapeutic HPV DNA vaccines

    Science.gov (United States)

    Lin, Ken; Roosinovich, Elena; Ma, Barbara; Hung, Chien-Fu

    2010-01-01

    It is now well established that most cervical cancers are causally associated with HPV infection. This realization has led to efforts to control HPV-associated malignancy through prevention or treatment of HPV infection. Currently, commercially available HPV vaccines are not designed to control established HPV infection and associated premalignant and malignant lesions. To treat and eradicate pre-existing HPV infections and associated lesions which remain prevalent in the U.S. and worldwide, effective therapeutic HPV vaccines are needed. DNA vaccination has emerged as a particularly promising form of therapeutic HPV vaccines due to its safety, stability and ability to induce antigen-specific immunity. This review focuses on improving the potency of therapeutic HPV vaccines through modification of dendritic cells (DCs) by [1] increasing the number of antigen-expressing/antigen-loaded DCs, [2] improving HPV antigen expression, processing and presentation in DCs, and [3] enhancing DC and T cell interaction. Continued improvement in therapeutic HPV DNA vaccines may ultimately lead to an effective DNA vaccine for the treatment of HPV-associated malignancies. PMID:20066511

  15. Application of multi-way partial least squares calibration for simultaneous determination of radioisotopes by liquid scintillation technique

    Directory of Open Access Journals (Sweden)

    Mahani Mohamad

    2012-01-01

    Full Text Available Three-way partial last squares (3-PLS2, as a multi-way calibration method was applied for determining the 235U/238U isotope ratio to overcome problems with spectral interferences in liquid scintillation spectra of these radioisotopes. The alpha energy spectra of samples in different energy channels and different cocktail to sample ratios were used as input data for 3-PLS2. The model was applied to a prediction set and satisfactory results were obtained. The 3-way PLS2 prediction results were compared with 2-way PLS2 and it was shown that 3-way PLS2 results are more accurate than the results of PLS2. Thermal ionization-mass spectrometry was used as a reference method for calculating the accuracy of our method.

  16. High efficiency direct thermal to electric energy conversion from radioisotope decay using selective emitters and spectrally tuned solar cells

    Science.gov (United States)

    Chubb, Donald L.; Flood, Dennis J.; Lowe, Roland A.

    1993-01-01

    Thermophotovoltaic (TPV) systems are attractive possibilities for direct thermal-to-electric energy conversion, but have typically required the use of black body radiators operating at high temperatures. Recent advances in both the understanding and performance of solid rare-earth oxide selective emitters make possible the use of TPV at temperatures as low as 1200K. Both selective emitter and filter system TPV systems are feasible. However, requirements on the filter system are severe in order to attain high efficiency. A thin-film of a rare-earth oxide is one method for producing an efficient, rugged selective emitter. An efficiency of 0.14 and power density of 9.2 W/KG at 1200K is calculated for a hypothetical thin-film neodymia (Nd2O3) selective emitter TPV system that uses radioisotope decay as the thermal energy source.

  17. Radioisotope concentrations in the PRTR primary coolant and helium system during operation with a failed fuel element(s)

    Energy Technology Data Exchange (ETDEWEB)

    Perkins, R.W.; Thomas, C.W.

    1961-09-07

    Fission product measurements in the PRTR primary D{sub 2}O and helium systems during the startup tests in May 1961, showed the presence of a defective fuel elements(s). Reactor operation was discontinued during the latter part of May and during June for reactor maintenance and fuel element inspection. On resumption of operation on July 1, a sampling and analytical program was initiated to study the radioisotope concentrations resulting from this defective element(s) which were present in the primary D{sub 2}O and helium systems during the various phases of reactor operation. The data accumulated during this study are to serve as background information in future fuel element rupture identification and location studies as well as serving as a guide in setting up the rupture monitor for the individual tubes of the PRTR reactor. A summary of the analytical results from this study and their theoretical interpretation is presented in this paper.

  18. Masters Thesis- Criticality Alarm System Design Guide with Accompanying Alarm System Development for the Radioisotope Production Laboratory in Richland, Washington

    Energy Technology Data Exchange (ETDEWEB)

    Greenfield, Bryce A. [Univ. of New Mexico, Albuquerque, NM (United States)

    2009-12-01

    A detailed instructional manual was created to guide criticality safety engineers through the process of designing a criticality alarm system (CAS) for Department of Energy (DOE) hazard class 1 and 2 facilities. Regulatory and technical requirements were both addressed. A list of design tasks and technical subtasks are thoroughly analyzed to provide concise direction for how to complete the analysis. An example of the application of the design methodology, the Criticality Alarm System developed for the Radioisotope Production Laboratory (RPL) of Richland, Washington is also included. The analysis for RPL utilizes the Monte Carlo code MCNP5 for establishing detector coverage in the facility. Significant improvements to the existing CAS were made that increase the reliability, transparency, and coverage of the system.

  19. Environmental Testing of Tritium-Phosphor Glass Vials for Use in Long-Life Radioisotope Power Conversion Units

    Science.gov (United States)

    Zemcov, Michael; Cardona, Pedro; Parkus, James; Patru, Dorin; Yost, Valerie

    2017-01-01

    Power generation in extreme environments, such as the outer solar system, the night side of planets, or other low-illumination environments, currently presents a technology gap that challenges NASA's ambitious scientific goals. We are developing a radioisotope power cell (RPC) that utilizes commercially available tritium light sources and standard 1.85 eV InGaP2 photovoltaic cells to convert beta particle energy to electric energy. In the test program described here, we perform environmental tests on commercially available borosilicate glass vials internally coated with a ZnS luminescent phosphor that are designed to contain gaseous tritium in our proposed power source. Such testing is necessary to ensure that the glass containing the radioactive tritium is capable of withstanding the extreme environments of launch and space for extended periods of time.

  20. Restoration of accelerator facilities damaged by Great East Japan Earthquake at Cyclotron and Radioisotope Center, Tohoku University.

    Science.gov (United States)

    Wakui, Takashi; Itoh, Masatoshi; Shimada, Kenzi; Yoshida, Hidetomo P; Shinozuka, Tsutomu; Sakemi, Yasuhiro

    2014-08-01

    The Cyclotron and Radioisotope Center (CYRIC) of Tohoku University is a joint-use institution for education and research in a wide variety of fields ranging from physics to medicine. Accelerator facilities at the CYRIC provide opportunities for implementing a broad research program, including medical research using positron emission tomography (PET), with accelerated ions and radioisotopes. At the Great East Japan Earthquake on March 11, 2011, no human injuries occurred and a smooth evacuation was made in the CYRIC, thanks to the anti-earthquake measures such as the renovation of the cyclotron building in 2009 mainly to provide seismic strengthening, fixation of shelves to prevent the falling of objects, and securement of the width of the evacuation route. The preparation of an emergency response manual was also helpful. However, the accelerator facilities were damaged because of strong shaking that continued for a few minutes. For example, two columns on which a 930 cyclotron was placed were damaged, and thereby the 930 cyclotron was inclined. All the elements of beam transport lines were deviated from the beam axis. Some peripheral devices in a HM12 cyclotron were broken. Two shielding doors fell from the carriage onto the floor and blocked the entrances to the rooms. The repair work on the accelerator facilities was started at the end of July 2011. During the repair work, the joint use of the accelerator facilities was suspended. After the repair work was completed, the joint use was re-started at October 2012, one and a half years after the earthquake.

  1. Radiopharmaceuticals in positron emission tomography: Radioisotope productions and radiolabelling procedures at the Austin and Repatriation Medical Centre

    Energy Technology Data Exchange (ETDEWEB)

    Tochon-Danguy, H.J.; Sachinidis, J.I.; Chan, J.G.; Cook, M. [Austin and Repatriation Medical Centre, Melbourne, VIC (Australia). Centre for Positron Emission Tomography

    1997-10-01

    Positron Emission Tomography (PET) is a technique that utilizes positron-emitting radiopharmaceuticals to map the physiology, biochemistry and pharmacology of the human body. Positron-emitting radioisotopes produced in a medical cyclotron are incorporated into compounds that are biologically active in the body. A scanner measures radioactivity emitted from a patient`s body and provides cross-sectional images of the distribution of these radiolabelled compounds in the body. It is the purpose of this paper to review the variety of PET radiopharmaceuticals currently produced at the Austin and Repatriation Medical Centre in Melbourne. Radioisotope production, radiolabelling of molecules and quality control of radiopharmaceuticals will be discussed. A few examples of their clinical applications will be shown as well. During the last five years we achieved a reliable routine production of various radiopharmaceuticals labelled with the four most important positron-emitters: oxygen-15 (t,{sub 1/2}=2min), nitrogen-13 (t{sub 1/2}= 10 min), carbon-11 (t{sub 1/2}=20 min) and fluorine-18 (t{sub 1/2}= 110 min). These radiopharmaceuticals include [{sup 15}O]oxygen, [{sup 15}O]carbon monoxide, [{sup 15}O]carbon dioxide, [{sup 15}O]water, [{sup 13}N]ammonia, [{sup 11}C]flumazenil, [{sup 11}C]SCH23390, [{sup 18}F]fluoromisonidazole and [{sup 18}F]fluoro-deoxy-glucose ([{sup 18}F]FDG). In addition, since the half life of [{sup 18}F] is almost two hours, regional distribution can be done, and the Austin and Repatriation Medical Centre is currently supplying [{sup 18}F]FDG in routine to other hospitals. Future new radiopharmaceuticals development include a [{sup 18}F]thymidine analog to measure cell proliferation and a [{sup 11}C]pyrroloisoquinoline to visualize serotonergic neuron abnormalities. (authors) 23 refs., 2 tabs.

  2. Multistage vector (MSV) therapeutics

    Science.gov (United States)

    Wolfram, Joy; Shen, Haifa; Ferrari, Mauro

    2015-01-01

    One of the greatest challenges in the field of medicine is obtaining controlled distribution of systemically administered therapeutic agents within the body. Indeed, biological barriers such as physical compartmentalization, pressure gradients, and excretion pathways adversely affect localized delivery of drugs to pathological tissue. The diverse nature of these barriers requires the use of multifunctional drug delivery vehicles that can overcome a wide range of sequential obstacles. In this review, we explore the role of multifunctionality in nanomedicine by primarily focusing on multistage vectors (MSVs). The MSV is an example of a promising therapeutic platform that incorporates several components, including a microparticle, nanoparticles, and small molecules. In particular, these components are activated in a sequential manner in order to successively address transport barriers. PMID:26264836

  3. Acylation of Therapeutic Peptides

    DEFF Research Database (Denmark)

    Trier, Sofie; Henriksen, Jonas Rosager; Jensen, Simon Bjerregaard

    Oral administration of therapeutic peptides could benefit millions of chronically ill people worldwide, through easier and less stigmatized therapy, and likely improve the long-term effects of currently widespread disease mismanagement. However, oral peptide delivery is a formidable task due......, but it is not widely studied in an oral context. As acylation furthermore increases interactions with the lipid membranes of mammalian cells, it offers several potential benefits for oral delivery of therapeutic peptides, and we hypothesize that tailoring the acylation may be used to optimize intestinal translocation...... to the harsh and selective gastrointestinal system, and development has lacked far behind injection therapy. Peptide acylation is a powerful tool to alter the pharmacokinetics, biophysical properties and chemical stability of injectable peptide drugs, primarily used to prolong blood circulation...

  4. Therapeutic use of cannabis.

    Science.gov (United States)

    de Vries, Kay; Green, Anita J

    Therapeutic cannabis use raises a number of dilemmas for nurses. This article examines the legal, political and ethical challenges raised by the use of cannabis by people with life-limiting or terminal illnesses in their own homes. (Throughout this paper, the term cannabis refers to illegal cannabis unless specified.) A literature review of databases from 1996 was conducted and internet material was also examined. Evidence on the therapeutic use of cannabis suggests it may produce improvements in quality of life, which has led to increased use among people with life-limiting illnesses. The cannabis used is usually obtained illegally, which can have consequences for both those who use it and nurses who provide treatment in the community.

  5. Leech Therapeutic Applications

    OpenAIRE

    Abdualkader, A. M.; A M Ghawi; Alaama, M.; M. Awang; A Merzouk

    2013-01-01

    Hematophagous animals including leeches have been known to possess biologically active compounds in their secretions, especially in their saliva. The blood-sucking annelids, leeches have been used for therapeutic purposes since the beginning of civilization. Ancient Egyptian, Indian, Greek and Arab physicians used leeches for a wide range of diseases starting from the conventional use for bleeding to systemic ailments, such as skin diseases, nervous system abnormalities, urinary and reproduct...

  6. Thermal and resonance neutrons generated by various electron and X-ray therapeutic beams from medical linacs installed in polish oncological centers

    Science.gov (United States)

    Konefał, Adam; Orlef, Andrzej; Łaciak, Marcin; Ciba, Aleksander; Szewczuk, Marek

    2012-01-01

    Background High-energy photon and electron therapeutic beams generated in medical linear accelerators can cause the electronuclear and photonuclear reactions in which neutrons with a broad energy spectrum are produced. A low-energy component of this neutron radiation induces simple capture reactions from which various radioisotopes originate and in which the radioactivity of a linac head and various objects in the treatment room appear. Aim The aim of this paper is to present the results of the thermal/resonance neutron fluence measurements during therapeutic beam emission and exemplary spectra of gamma radiation emitted by medical linac components activated in neutron reactions for four X-ray beams and for four electron beams generated by various manufacturers’ accelerators installed in typical concrete bunkers in Polish oncological centers. Materials and methods The measurements of neutron fluence were performed with the use of the induced activity method, whereas the spectra of gamma radiation from decays of the resulting radioisotopes were measured by means of a portable high-purity germanium detector set for field spectroscopy. Results The fluence of thermal neutrons as well as resonance neutrons connected with the emission of a 20 MV X-ray beam is ∼106 neutrons/cm2 per 1 Gy of a dose in water at a reference depth. It is about one order of magnitude greater than that for the 15 MV X-ray beams and about two orders of magnitude greater than for the 18–22 MeV electron beams regardless of the type of an accelerator. Conclusion The thermal as well as resonance neutron fluence depends strongly on the type and the nominal potential of a therapeutic beam. It is greater for X-ray beams than for electrons. The accelerator accessories and other large objects should not be stored in a treatment room during high-energy therapeutic beam emission to avoid their activation caused by thermal and resonance neutrons. Half-lives of the radioisotopes originating from

  7. Frankincense--therapeutic properties.

    Science.gov (United States)

    Al-Yasiry, Ali Ridha Mustafa; Kiczorowska, Bożena

    2016-01-04

    Recently, increasing interest in natural dietary and therapeutic preparations used as dietary supplements has been observed. One of them is frankincense. This traditional medicine of the East is believed to have anti-inflammatory, expectorant, antiseptic, and even anxiolytic and anti-neurotic effects. The present study aims to verify the reported therapeutic properties of Boswellia resin and describe its chemical composition based on available scientific studies. The main component of frankincense is oil (60%). It contains mono- (13%) and diterpenes (40%) as well as ethyl acetate (21.4%), octyl acetate (13.4%) and methylanisole (7.6%). The highest biological activity among terpenes is characteristic of 11-keto-ß-acetyl-beta-boswellic acid, acetyl-11-keto-ß-boswellic acid and acetyl-α-boswellic acid. Contemporary studies have shown that resin indeed has an analgesic, tranquilising and anti-bacterial effects. From the point of view of therapeutic properties, extracts from Boswellia serrata and Boswellia carterii are reported to be particularly useful. They reduce inflammatory conditions in the course of rheumatism by inhibiting leukocyte elastase and degrading glycosaminoglycans. Boswellia preparations inhibit 5-lipoxygenase and prevent the release of leukotrienes, thus having an anti-inflammatory effect in ulcerative colitis, irritable bowel syndrome, bronchitis and sinusitis. Inhalation and consumption of Boswellia olibanum reduces the risk of asthma. In addition, boswellic acids have an antiproliferative effect on tumours. They inhibit proliferation of tumour cells of the leukaemia and glioblastoma subset. They have an anti-tumour effect since they inhibit topoisomerase I and II-alpha and stimulate programmed cell death (apoptosis).

  8. Frankincense – therapeutic properties

    Directory of Open Access Journals (Sweden)

    Ali Ridha Mustafa Al-Yasiry

    2016-01-01

    Full Text Available Recently, increasing interest in natural dietary and therapeutic preparations used as dietary supplements has been observed. One of them is frankincense. This traditional medicine of the East is believed to have anti-inflammatory, expectorant, antiseptic, and even anxiolytic and anti-neurotic effects. The present study aims to verify the reported therapeutic properties of Boswellia resin and describe its chemical composition based on available scientific studies. The main component of frankincense is oil (60%. It contains mono- (13% and diterpenes (40% as well as ethyl acetate (21.4%, octyl acetate (13.4% and methylanisole (7.6%. The highest biological activity among terpenes is characteristic of 11-keto-ß-acetyl-beta-boswellic acid, acetyl-11-keto-ß-boswellic acid and acetyl-α-boswellic acid. Contemporary studies have shown that resin indeed has an analgesic, tranquilising and anti-bacterial effects. From the point of view of therapeutic properties, extracts from Boswellia serrata and Boswellia carterii are reported to be particularly useful. They reduce inflammatory conditions in the course of rheumatism by inhibiting leukocyte elastase and degrading glycosaminoglycans. Boswellia preparations inhibit 5-lipoxygenase and prevent the release of leukotrienes, thus having an anti-inflammatory effect in ulcerative colitis, irritable bowel syndrome, bronchitis and sinusitis. Inhalation and consumption of Boswellia olibanum reduces the risk of asthma. In addition, boswellic acids have an antiproliferative effect on tumours. They inhibit proliferation of tumour cells of the leukaemia and glioblastoma subset. They have an anti-tumour effect since they inhibit topoisomerase I and II-alpha and stimulate programmed cell death (apoptosis.

  9. [Therapeutic applications of digestive endoscopy].

    Science.gov (United States)

    Ortega, J A; Pérez, L; Madureri, V

    1976-01-01

    Endoscopy has proven useful as a diagnostic tool and recently many useful therapeutic possibilities have been proposed. The authors discuss their experience with therapeutic endoscopic procedures and present new ones for treatment of Acalasia and small sliding hiatal hernia.

  10. Therapeutic approaches to cellulite.

    Science.gov (United States)

    Green, Jeremy B; Cohen, Joel L; Kaufman, Joely; Metelitsa, Andrei I; Kaminer, Michael S

    2015-09-01

    Cellulite is a condition that affects the vast majority of women. Although it is of no danger to one's overall health, cellulite can be psychosocially debilitating. Consequently, much research has been devoted to understanding cellulite and its etiopathogenesis. With additional insights into the underlying causes of its clinical presentation, therapeutic modalities have been developed that offer hope to cellulite sufferers. This review examines evidence for topical treatments, noninvasive energy-based devices, and recently developed minimally invasive interventions that may finally provide a solution. ©2015 Frontline Medical Communications.

  11. [Achievement of therapeutic objectives].

    Science.gov (United States)

    Mantilla, Teresa

    2014-07-01

    Therapeutic objectives for patients with atherogenic dyslipidemia are achieved by improving patient compliance and adherence. Clinical practice guidelines address the importance of treatment compliance for achieving objectives. The combination of a fixed dose of pravastatin and fenofibrate increases the adherence by simplifying the drug regimen and reducing the number of daily doses. The good tolerance, the cost of the combination and the possibility of adjusting the administration to the patient's lifestyle helps achieve the objectives for these patients with high cardiovascular risk. Copyright © 2014 Sociedad Española de Arteriosclerosis y Elsevier España, S.L. All rights reserved.

  12. [Is therapeutic deadlock inevitable?].

    Science.gov (United States)

    Vignat, Jean-Pierre

    2016-01-01

    Many long-term treatments appear to be an expression of therapeutic deadlock. The situation leads to a questioning of the concept of chronicity and the identification of the determining factors of situations which are apparently blocked, marked by the search for solutions taking a back seat to the taking of action. The interaction between patients' mental apparatus and the care apparatus lies at the heart of the question, interpreted from an institutional, collective and individual perspective, supported by the clinical and psychopathological approach, and the return to the prioritisation of the thought. Copyright © 2016 Elsevier Masson SAS. All rights reserved.

  13. On the Performance of X-ray Imaging Plates in Gamma Radiography employing Reactor-produced Radioisotopes

    Science.gov (United States)

    Silvani, Maria Ines; de Almeida, Gevaldo L.; Furieri, Rosanne C.; Lopes, Ricardo T.

    2011-08-01

    Gamma-radiography employing radiographic films is a well established technique for non-destructive assays. The advent of X-ray sensitive Imaging Plates opens up new possibilities to apply this technique thanks to the advantages exhibited by this new device. Indeed, besides a sensitivity about 20 times higher then the conventional photographic film, requiring thus a shorter exposure time, it does not require a dark room for a cumbersome and time-consuming chemical processing associated to the development, an can be erased to be reused many times. Moreover, its development carried out by means of a laser beam produces digitalized images which can be promptly stored in a computer. Although its resolution is still poorer than that of the conventional film, those advantages overwhelms this specific parameter when it is not an essential feature for the intended application. This work evaluates the feasibility of employing X-ray Imaging Plates as detector for higher photon energies as those emitted by reactor-produced radioisotopes. Within this frame, radioisotopes such as 198Au and 56Mn, produced at the Argonauta research reactor in the Instituto de Engenharia Nuclear-CNEN have been employed as sources to acquire radiographic images of several pieces of equipment, devices and components. In order to keep the source appearance—with regard to the detector—as punctual as possible, reducing hence the penumbra effect, the mass of the irradiated material had to be limited. Therefore, due to the low neutron flux available at the main port of the reactor, the exposure times have to be extended along several hours or even a couple of days in order to reach an image with adequate contrast. This demand, nevertheless, does not constitute a serious hindrance as the exposure process can be carried out without any intervention or surveillance. Results have shown that in spite of the higher photon energies used, surpassing the X-ray range for which the imaging plates have been

  14. The Mars Hopper: Development, Simulation and Experimental Validation of a Radioisotope Exploration Probe for the Martian Surface

    Energy Technology Data Exchange (ETDEWEB)

    Nathan D. Jerred; Spencer Cooley; Robert C. O' Brien; Steven D. Howe; James E. O' Brien

    2012-09-01

    An advanced exploration probe has been proposed by the Center for Space Nuclear Research (CSNR) to acquire detailed data from the Martian surface and subsurface, ‘hop’ large distances to multiple sites in short periods of time and perform this task repeatedly. Although several similar flying vehicles have been proposed utilizing various power sources and complex designs, e.g. solar-electric and chemical-based, the CSNR’s Mars Hopper is based on a radioisotope thermal rocket (RTR) concept. The Mars Hopper’s design relies on the high specific energies [J/kg] of radioisotopes and enhances their low specific power [W/kg] through the use of a thermal capacitance material to store thermal energy over time. During operation, the RTR transfers the stored thermal energy to a flowing gas, which is then expanded through a converging-diverging nozzle, producing thrust. Between flights, the platform will have ample time to perform in-depth science at each location while the propellant tanks and thermal capacitor recharge. Recharging the propellant tanks is accomplished by sublimation freezing of the ambient CO2 atmosphere with a cryocooler, followed by heating and pressurization to yield a liquid storage state. The proposed Mars Hopper will undergo a ballistic flight, consuming the propellant in both ascent and descent, and by using multiple hopper platforms, information can be gathered on a global scale, enabling better resource resolution and providing valuable information for a possible Mars sample-return mission. The CSNR, collaborating with the Idaho National Laboratory (INL) and three universities (University of Idaho, Utah State University and Oregon State University), has identified key components and sub-systems necessary for the proposed hopper. Current project activities include the development of a lab-scale prototypic Mars Hopper and test facility, along with computational fluid dynamics (CFD)/thermal-hydraulic models to yield a better understanding of the

  15. Mechanisms of Plasma Therapeutics

    Science.gov (United States)

    Graves, David

    2015-09-01

    In this talk, I address research directed towards biomedical applications of atmospheric pressure plasma such as sterilization, surgery, wound healing and anti-cancer therapy. The field has seen remarkable growth in the last 3-5 years, but the mechanisms responsible for the biomedical effects have remained mysterious. It is known that plasmas readily create reactive oxygen species (ROS) and reactive nitrogen species (RNS). ROS and RNS (or RONS), in addition to a suite of other radical and non-radical reactive species, are essential actors in an important sub-field of aerobic biology termed ``redox'' (or oxidation-reduction) biology. It is postulated that cold atmospheric plasma (CAP) can trigger a therapeutic shielding response in tissue in part by creating a time- and space-localized, burst-like form of oxy-nitrosative stress on near-surface exposed cells through the flux of plasma-generated RONS. RONS-exposed surface layers of cells communicate to the deeper levels of tissue via a form of the ``bystander effect,'' similar to responses to other forms of cell stress. In this proposed model of CAP therapeutics, the plasma stimulates a cellular survival mechanism through which aerobic organisms shield themselves from infection and other challenges.

  16. Therapeutic Uses of Exosomes

    Directory of Open Access Journals (Sweden)

    Zacharias E. Suntres

    2013-01-01

    Full Text Available Exosomes are membrane vesicles with a diameter of 40–100 nm that are secreted by many cell types into the extracellular milieu. Exosomes are found in cell culture supernatants and in different biological fluids and are known to be secreted by most cell types under normal and pathological conditions. Considerable research is focusing on the exploitation of exosomes in biological fluids for biomarkers in the diagnosis of disease. More recently, exosomes are being exploited for their therapeutic potential. Exosomes derived from dendritic cells, tumor cells, and malignant effusions demonstrate immunomodulatory functions and are able to present antigens to T-cells and stimulate antigen-specific T-cell responses. Exosomes have also been examined for their therapeutic potential in the treatment of infections such as toxoplasmosis, diphtheria, tuberculosis and atypical severe acute respiratory syndrome as well as autoimmune diseases. Attempts to find practical applications for exosomes continue to expand with the role of exosomes as a drug delivery system for the treatment of autoimmune/inflammatory diseases and cancers.

  17. Engineering therapeutic protein disaggregases.

    Science.gov (United States)

    Shorter, James

    2016-05-15

    Therapeutic agents are urgently required to cure several common and fatal neurodegenerative disorders caused by protein misfolding and aggregation, including amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD), and Alzheimer's disease (AD). Protein disaggregases that reverse protein misfolding and restore proteins to native structure, function, and localization could mitigate neurodegeneration by simultaneously reversing 1) any toxic gain of function of the misfolded form and 2) any loss of function due to misfolding. Potentiated variants of Hsp104, a hexameric AAA+ ATPase and protein disaggregase from yeast, have been engineered to robustly disaggregate misfolded proteins connected with ALS (e.g., TDP-43 and FUS) and PD (e.g., α-synuclein). However, Hsp104 has no metazoan homologue. Metazoa possess protein disaggregase systems distinct from Hsp104, including Hsp110, Hsp70, and Hsp40, as well as HtrA1, which might be harnessed to reverse deleterious protein misfolding. Nevertheless, vicissitudes of aging, environment, or genetics conspire to negate these disaggregase systems in neurodegenerative disease. Thus, engineering potentiated human protein disaggregases or isolating small-molecule enhancers of their activity could yield transformative therapeutics for ALS, PD, and AD. © 2016 Shorter. This article is distributed by The American Society for Cell Biology under license from the author(s). Two months after publication it is available to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).

  18. Offer/demand of the radioisotope {sup 99}MO in Brazil: a social necessity; Oferta/demanda do radioisotopo {sup 99}MO no Brasil: uma necessidade social

    Energy Technology Data Exchange (ETDEWEB)

    Souza, Bruno Luiz da Cruz Barbosa de; Pereira, Marcelo O., E-mail: brunosouza.ep@gmail.com, E-mail: marcelocefetrj@gmail.com [Centro Federal de Educacao Tecnologica Celso Suckow da Fonseca (CEFET), Nova Iguacu, RJ (Brazil). Dept. de Engenharia de Producao

    2013-07-01

    The construction of a nuclear reactor, project under way in Brazil, always generates controversy surrounding the real needs of a society to the risks of accidents. This paper proposes, using statistical data on the supply / demand of the {sup 99}Mo radioisotope, show the need to build a nuclear research reactor in the country, showing the various applications in Nuclear Medicine and needs of this input for the country.

  19. Semi-Annual Technical Progress Report of Radioisotope Power System Materials Production and Technology Program Tasks for October 1, 2001 Through March 31, 2002

    Energy Technology Data Exchange (ETDEWEB)

    J. P. Moore, JPM

    2002-05-22

    The Office of Space and Defense Power Systems of the Department of Energy (DOE) provides Radioisotope Power Systems (RPS) for applications where conventional power systems are not feasible. For example, radioisotope thermoelectric generators were supplied by the DOE to the National Aeronautics and Space Administration for deep space missions including the Cassini Mission launched in October of 1997 to study the planet Saturn. The Oak Ridge National Laboratory (ORNL) has been involved in developing materials and technology and producing components for the DOE for more than three decades. For the Cassini Mission, for example, ORNL was involved in the production of carbon-bonded carbon fiber (CBCF) insulator sets, iridium alloy blanks and foil, and clad vent sets (CVS). This report has been divided into three sections to reflect program guidance from the Office of Space and Defense Power Systems for fiscal year (FY) 2002. The first section deals primarily with maintenance of the capability to produce flight quality (FQ) CBCF insulator sets, iridium alloy blanks and foil, and CVS. In all three cases, production maintenance is assured by the manufacture of limited quantities of FQ components. The second section deals with several technology activities to improve the manufacturing processes, characterize materials, or to develop technologies for new radioisotope power systems. The last section is dedicated to studies related to the production of {sup 238}Pu.

  20. ANNUAL TECHNICAL PROGRESS REPORT OF RADIOISOTOPE POWER SYSTEMS MATERIALS PRODUCTION AND TECHNOLOGY PROGRAM TASKS FOR OCTOBER 1, 2010 THROUGH SEPTEMBER 30, 2011

    Energy Technology Data Exchange (ETDEWEB)

    King, James F [ORNL

    2012-05-01

    The Office of Space and Defense Power Systems of the Department of Energy (DOE) provides Radioisotope Power Systems (RPS) for applications where conventional power systems are not feasible. For example, radioisotope thermoelectric generators were supplied by the DOE to the National Aeronautics and Space Administration (NASA) for deep space missions including the Cassini Mission launched in October of 1997 to study the planet Saturn. For the Cassini Mission, the Oak Ridge National Laboratory (ORNL) produced carbon-bonded carbon fiber (CBCF) insulator sets, iridium alloy blanks and foil, and clad vent sets (CVS) used in the generators. These components were also produced for the Pluto New Horizons and Mars Science Lab missions launched in January 2006 and November 2011respectively. The ORNL has been involved in developing materials and technology and producing components for the DOE for nearly four decades. This report reflects program guidance from the Office of RPS for fiscal year (FY) 2011. Production activities for prime quality (prime) CBCF insulator sets, iridium alloy blanks and foil, and CVS are summarized in this report. Technology activities are also reported that were conducted to improve the manufacturing processes, characterize materials, or to develop information for new RPS. Work has also been initiated to establish fabrication capabilities for the Light Weight Radioisotope Heater Units.

  1. Semi-Annual Technical Progress Report of Radioisotope Power System Materials Production and Technology Program Tasks for April 1, 2002 Through September 20, 2002

    Energy Technology Data Exchange (ETDEWEB)

    Moore, J.P.

    2002-12-03

    The Office of Space and Defense Power Systems of the Department of Energy (DOE) provides Radioisotope Power Systems (RPS) for applications where conventional power systems are not feasible. For example, radioisotope thermoelectric generators were supplied by the DOE to the National Aeronautics and Space Administration for deep space missions including the Cassini Mission launched in October of 1997 to study the planet Saturn. The Oak Ridge National Laboratory (ORNL) has been involved in developing materials and technology and producing components for the DOE for more than three decades. For the Cassini Mission, for example, ORNL was involved in the production of carbon-bonded carbon fiber (CBCF) insulator sets, iridium alloy blanks and foil, and clad vent sets (CVS). This report has been divided into three sections to reflect program guidance from the Office of Space and Defense Power Systems for fiscal year (FY) 2002. The first section deals primarily with maintenance of the capability to produce flight quality (FQ) CBCF insulator sets, iridium alloy blanks and foil, and CVS. In all three cases, production maintenance is assured by the manufacture of limited quantities of FQ components. The second section deals with several technology activities to improve the manufacturing processes, characterize materials, or to develop technologies for new radioisotope power systems. The last section is dedicated to studies related to the production of {sup 238}Pu.

  2. Tailoring medium energy proton beam to induce low energy nuclear reactions in ⁸⁶SrCl₂ for production of PET radioisotope ⁸⁶Y.

    Science.gov (United States)

    Medvedev, Dmitri G; Mausner, Leonard F; Pile, Philip

    2015-07-01

    This paper reports results of experiments at Brookhaven Linac Isotope Producer (BLIP) aiming to investigate effective production of positron emitting radioisotope (86)Y by the low energy (86)Sr(p,n) reaction. BLIP is a facility at Brookhaven National Laboratory designed for the proton irradiation of the targets for isotope production at high and intermediate proton energies. The proton beam is delivered by the Linear Accelerator (LINAC) whose incident energy is tunable from 200 to 66 MeV in approximately 21 MeV increments. The array was designed to ensure energy degradation from 66 MeV down to less than 20 MeV. Aluminum slabs were used to degrade the proton energy down to the required range. The production yield of (86)Y (1.2+/-0.1 mCi (44.4+/-3.7) MBq/μAh) and ratio of radioisotopic impurities was determined by assaying an aliquot of the irradiated (86)SrCl2 solution by gamma spectroscopy. The analysis of energy dependence of the (86)Y production yield and the ratios of radioisotopic impurities has been used to adjust degrader thickness. Experimental data showed substantial discrepancies in actual energy propagation compared to energy loss calculations. Copyright © 2015 Elsevier Ltd. All rights reserved.

  3. Annual Technical Progress Report of Radioisotope Power System Materials Production and Technology Program Tasks for October 1, 2002 Through September 30, 2003

    Energy Technology Data Exchange (ETDEWEB)

    King, J.F.

    2004-05-18

    The Office of Space and Defense Power Systems of the Department of Energy (DOE) provides Radioisotope Power Systems (RPS) for applications where conventional power systems are not feasible. For example, radioisotope thermoelectric generators were supplied by the DOE to the National Aeronautics and Space Administration for deep space missions including the Cassini Mission launched in October of 1997 to study the planet Saturn. The Oak Ridge National Laboratory (ORNL) has been involved in developing materials and technology and producing components for the DOE for more than three decades. For the Cassini Mission, for example, ORNL was involved in the production of carbon-bonded carbon fiber (CBCF) insulator sets, iridium alloy blanks and foil, and clad vent sets (CVS). This report has been divided into three sections to reflect program guidance from the Office of Space and Defense Power Systems for fiscal year (FY) 2003. The first section deals primarily with maintenance of the capability to produce flight quality (FQ) CBCF insulator sets, iridium alloy blanks and foil, and CVS. In all three cases, production maintenance is assured by the manufacture of limited quantities of FQ components. The second section deals with several technology activities to improve the manufacturing processes, characterize materials, or to develop technologies for new radioisotope power systems. The last section is dedicated to studies related to the production of {sup 238}Pu.

  4. Annual Technical Progress Report of Radioisotope Power System Materials Production and Technical Program Tasks for October 1, 2005 through September 30, 2006

    Energy Technology Data Exchange (ETDEWEB)

    None

    2007-04-02

    The Office of Space and Defense Power Systems of the Department of Energy (DOE) provides Radioisotope Power Systems (RPS) for applications where conventional power systems are not feasible. For example, radioisotope thermoelectric generators were supplied by the DOE to the National Aeronautics and Space Administration for deep space missions including the Cassini Mission launched in October of 1997 to study the planet Saturn. For the Cassini Mission, ORNL produced carbon-bonded carbon fiber (CBCF) insulator sets, iridium alloy blanks and foil, and clad vent sets (CVS) used in the generators. The Oak Ridge National Laboratory (ORNL) has been involved in developing materials and technology and producing components for the DOE for more than three decades. This report reflects program guidance from the Office of Space and Defense Power Systems for fiscal year (FY) 2006. Production activities for prime quality (prime) CBCF insulator sets, iridium alloy blanks and foil, and CVS are summarized in this report. Technology activities are also reported that were conducted to improve the manufacturing processes, characterize materials, or to develop information for new radioisotope power systems.

  5. Annual Technical Progress Report of Radioisotope Power System Materials Production and Technology Tasks for October 1, 2003 through September 30, 2004

    Energy Technology Data Exchange (ETDEWEB)

    None listed

    2005-06-01

    The Office of Space and Defense Power Systems of the Department of Energy (DOE) provides Radioisotope Power Systems (RPS) for applications where conventional power systems are not feasible. For example, radioisotope thermoelectric generators were supplied by the DOE to the National Aeronautics and Space Administration for deep space missions including the Cassini Mission launched in October of 1997 to study the planet Saturn. For the Cassini Mission, ORNL produced carbon-bonded carbon fiber (CBCF) insulator sets, iridium alloy blanks and foil, and clad vent sets (CVS) used in the generators. The Oak Ridge National Laboratory (ORNL) has been involved in developing materials and technology and producing components for the DOE for more than three decades. This report reflects program guidance from the Office of Space and Defense Power Systems for fiscal year (FY) 2004. Production and production maintenance activities for flight quality (FQ) CBCF insulator sets, iridium alloy blanks and foil, and CVS are summarized in this report. In all three cases, production maintenance is assured by the manufacture of limited quantities of FQ components. Technology activities are also reported that were conducted to improve the manufacturing processes, characterize materials, or to develop information for new radioisotope power systems.

  6. Annual Technical Progress Report of Radioisotope Power System Materials Production and Technology Program Tasks for October 1, 2004 Through September 30, 2005

    Energy Technology Data Exchange (ETDEWEB)

    King, James F [ORNL

    2006-06-01

    The Office of Space and Defense Power Systems of the Department of Energy (DOE) provides Radioisotope Power Systems (RPS) for applications where conventional power systems are not feasible. For example, radioisotope thermoelectric generators were supplied by the DOE to the National Aeronautics and Space Administration for deep space missions including the Cassini Mission launched in October of 1997 to study the planet Saturn. For the Cassini Mission, ORNL produced carbon-bonded carbon fiber (CBCF) insulator sets, iridium alloy blanks and foil, and clad vent sets (CVS) used in the generators. The Oak Ridge National Laboratory (ORNL) has been involved in developing materials and technology and producing components for the DOE for more than three decades. This report reflects program guidance from the Office of Space and Defense Power Systems for fiscal year (FY) 2005. Production activities for prime quality (prime) CBCF insulator sets, iridium alloy blanks and foil, and CVS are summarized in this report. Technology activities are also reported that were conducted to improve the manufacturing processes, characterize materials, or to develop information for new radioisotope power systems.

  7. ANNUAL TECHNICAL PROGRESS REPORT OF RADIOISOTOPE POWER SYSTEM MATERIALS PRODUCTION AND TECHNOLOGY PROGRAM TASKS FOR OCTOBER 1, 2005 THROUGH SEPTEMBER 30, 2006

    Energy Technology Data Exchange (ETDEWEB)

    King, James F [ORNL

    2007-04-01

    The Office of Space and Defense Power Systems of the Department of Energy (DOE) provides Radioisotope Power Systems (RPS) for applications where conventional power systems are not feasible. For example, radioisotope thermoelectric generators were supplied by the DOE to the National Aeronautics and Space Administration for deep space missions including the Cassini Mission launched in October of 1997 to study the planet Saturn. For the Cassini Mission, ORNL produced carbon-bonded carbon fiber (CBCF) insulator sets, iridium alloy blanks and foil, and clad vent sets (CVS) used in the generators. The Oak Ridge National Laboratory (ORNL) has been involved in developing materials and technology and producing components for the DOE for more than three decades. This report reflects program guidance from the Office of Space and Defense Power Systems for fiscal year (FY) 2006. Production activities for prime quality (prime) CBCF insulator sets, iridium alloy blanks and foil, and CVS are summarized in this report. Technology activities are also reported that were conducted to improve the manufacturing processes, characterize materials, or to develop information for new radioisotope power systems.

  8. Annual Technical Progress Report of Radioisotope Power System Materials Production and Technology Tasks for October 1, 2004 through September 30, 2005

    Energy Technology Data Exchange (ETDEWEB)

    None listed

    2006-08-03

    The Office of Space and Defense Power Systems of the Department of Energy (DOE) provides Radioisotope Power Systems (RPS) for applications where conventional power systems are not feasible. For example, radioisotope thermoelectric generators were supplied by the DOE to the National Aeronautics and Space Administration for deep space missions including the Cassini Mission launched in October of 1997 to study the planet Saturn. For the Cassini Mission, ORNL produced carbon-bonded carbon fiber (CBCF) insulator sets, iridium alloy blanks and foil, and clad vent sets (CVS) used in the generators. The Oak Ridge National Laboratory (ORNL) has been involved in developing materials and technology and producing components for the DOE for more than three decades. This report reflects program guidance from the Office of Space and Defense Power Systems for fiscal year (FY) 2005. Production activities for prime quality (prime) CBCF insulator sets, iridium alloy blanks and foil, and CVS are summarized in this report. Technology activities are also reported that were conducted to improve the manufacturing processes, characterize materials, or to develop information for new radioisotope power systems.

  9. Semi-Annual Technical Progress Report of the Radioisotope Power System Materials Production and Technology Program Tasks for September 2000 through March 2001

    Energy Technology Data Exchange (ETDEWEB)

    Moore, J.P.

    2001-05-22

    The Office of Space and Defense Power Systems of the Department of Energy (DOE) provides Radioisotope Power Systems (RPS) for applications where conventional power systems are not feasible. For example, radioisotope thermoelectric generators were supplied by the DOE to the National Aeronautics and Space Administration for deep space missions including the Cassini Mission launched in October of 1997 to study the planet Saturn. The Oak Ridge National Laboratory (ORNL) has been involved in developing materials and technology and producing components for the DOE for more than three decades. For the Cassini Mission, for example, ORNL was involved in the production of carbon-bonded carbon fiber (CBCF) insulator sets, iridium alloy blanks and foil, and clad vent sets (CVS) and weld shields (WS). This report has been divided into three sections to reflect program guidance from the Office of Space and Defense Power Systems for fiscal year (FY) 2001. The first section deals primarily with maintenance of the capability to produce flight quality (FQ) CBCF insulator sets, iridium alloy blanks and foil, CVS, and WS. In all three cases, production maintenance is assured by the manufacture of limited quantities of FQ components. The second section deals with several technology activities to improve the manufacturing processes, characterize materials. or to develop technologies for new radioisotope power systems. The last section is dedicated to studies related to the production of {sup 238}Pu.

  10. Summary of Stirling Convertor Testing at NASA Glenn Research Center in Support of Stirling Radioisotope Power System Development

    Science.gov (United States)

    Schifer, Nicholas A.; Oriti, Salvatore M.

    2013-01-01

    The NASA Glenn Research Center (GRC) has been testing 100 We class, free-piston Stirling convertors for potential use in Stirling Radioisotope Power Systems (RPS) for space science and exploration missions. Free-piston Stirling convertors are capable of achieving a 38% conversion efficiency, making Stirling attractive for meeting future power system needs in light of the shrinking U.S. plutonium fuel supply. Convertors currently on test include four Stirling Technology Demonstration Convertors (TDCs), manufactured by the Stirling Technology Company (STC), and six Advanced Stirling Convertors (ASCs), manufactured by Sunpower, Inc. Total hours of operation is greater than 514,000 hours (59 years). Several tests have been initiated to demonstrate the functionality of Stirling convertors for space applications, including: in-air extended operation, thermal vacuum extended operation. Other tests have also been conducted to characterize Stirling performance in anticipated mission scenarios. Data collected during testing has been used to support life and reliability estimates, drive design changes and improve quality, and plan for expected mission scenarios. This paper will provide a summary of convertors tested at NASA GRC and discuss lessons learned through extended testing.

  11. The design of a source to simulate the gamma-ray spectrum emitted by a radioisotope thermoelectric generator

    Science.gov (United States)

    Reier, M.

    1972-01-01

    A simulated source was designed to duplicate the gamma spectrum of a uniform cylindrical 2200-watt Pu02 radioisotope thermoelectric generator containing 81% Pu-238 and 1.2 ppm Pu-236. Gamma rays from the decay of Pu-238, Am-241, Pu-239, and the 0-18(alpha,n)Ne-21 reaction were catalogued in broad energy groups. Two 46- and one 22-mc Th-228 sources provided simulation at various times in the life of the fuel capsule up to 18 years, which covers the time span of an outer planet mission. Emission from Th-228 represents the overwhelming contribution of the gamma spectrum after the first few years. The sources, in the form of 13-inch rods, were placed in a concentric hole in a cylinder of depleted uranium, which provided shielding equivalent to the self-shielding of the fuel capsule. The thickness of the U-238 cylinder (0.55cm) was determined by Monte Carlo calculations to insure that the spectrum emerging from the simulated source matched that of the fuel capsule.

  12. Production of Medical Radioisotopes with High Specific Activity in Photonuclear Reactions with $\\gamma$ Beams of High Intensity and Large Brilliance

    CERN Document Server

    Habs, D

    2010-01-01

    We study the production of radioisotopes for nuclear medicine in $(\\gamma,x{\\rm n}+y{\\rm p})$ photonuclear reactions or ($\\gamma,\\gamma'$) photoexcitation reactions with high flux [($10^{13}-10^{15}$)$\\gamma$/s], small diameter $\\sim (100 \\, \\mu$m$)^2$ and small band width ($\\Delta E/E \\approx 10^{-3}-10^{-4}$) $\\gamma$ beams produced by Compton back-scattering of laser light from relativistic brilliant electron beams. We compare them to (ion,$x$n$ + y$p) reactions with (ion=p,d,$\\alpha$) from particle accelerators like cyclotrons and (n,$\\gamma$) or (n,f) reactions from nuclear reactors. For photonuclear reactions with a narrow $\\gamma$ beam the energy deposition in the target can be managed by using a stack of thin target foils or wires, hence avoiding direct stopping of the Compton and pair electrons (positrons). $(\\gamma,\\gamma')$ isomer production via specially selected $\\gamma$ cascades allows to produce high specific activity in multiple excitations, where no back-pumping of the isomer to the ground st...

  13. Determination of Lactic Acid Bacteria Viability in the Small Intestine of Catfish (Pangasius djambal by Using the 32P Radioisotope

    Directory of Open Access Journals (Sweden)

    I. Sugoro

    2015-10-01

    Full Text Available The viability of probiotics is important to be determined, as is its probiotic potency in the small instestine of fish. The result can be used as a basis to determine the feeding frequency of the probiotics to the fish.The aim of this study is to gain information about the viability of lactic acid bacteria (LAB in the small intestine of fish by using the 32P isotope technique. Catfish (Pangasius djambal was used as a test fish, and the LAB with the code of P2.1 PTB was the subject of the experiment. Before its viability was tested, the LAB had been labelled with radioisotope 32P, then mixed into catfish feed. Its viability could be determined by counting the activity of 32P. The results showed that the percentage of LAB viability in the small intestine of catfish declined until day 7. The percentage of LAB viability was decreased at an amount of 30% at day 3. Based on this result, the feeding frequency of LAB P2.1 PTB is every 3 days. Received: 04 October 2014 Revised: 26 March 2015; Accepted: 05 April 2015

  14. GPHS-RTG system explosion test direct course experiment 5000. [General Purpose Heat Source-Radioisotope Thermoelectric Generator

    Energy Technology Data Exchange (ETDEWEB)

    1984-03-01

    The General Purpose Heat Source-Radioisotope Thermoelectric Generator (GPHS-RTG) has been designed and is being built to provide electrical power for spacecrafts to be launched on the Space Shuttle. The objective of the RTG System Explosion Test was to expose a mock-up of the GPHS-RTG with a simulated heat source to the overpressure and impulse representative of a potential upper magnitude explosion of the Space Shuttle. The test was designed so that the heat source module would experience an overpressure at which the survival of the fuel element cladding would be expected to be marginal. Thus, the mock-up was placed where the predicted incident overpressure would be 1300 psi. The mock-up was mounted in an orientation representative of the launch configuration on the spacecraft to be used on the NASA Galileo Mission. The incident overpressure measured was in the range of 1400 to 2100 psi. The mock-up and simulated heat source were destroyed and only very small fragments were recovered. This damage is believed to have resulted from a combination of the overpressure and impact by very high velocity fragments from the ANFO sphere. Post-test analysis indicated that extreme working of the iridium clad material occurred, indicative of intensive impulsive loading on the metal.

  15. Development of a method for multielemental determination in water by EDXRF with radioisotopic source of {sup 238}Pu

    Energy Technology Data Exchange (ETDEWEB)

    Serrano, C.; Estévez, J.; Montero, A.; Pupo, I.; Herrero, Z.; Leyva, D.; Arteche, J.; Varcárcel, L. [Centro de Aplicaciones Tecnológicas y Desarrollo Nuclear (CEADEN), (Cuba); Van Espen, P. [University of Amberes, (Belgium); Santos Júnior, J. A. dos, E-mail: cserrano@cedaen.edu.cu [Universidade Federal de Pernambuco (UFPE), Recife (Brazil)

    2017-07-01

    A method for determination of Cr, Fe, Co, Ni, Cu, Zn, Hg and Pb in waters by Energy Dispersive X Ray Fluorescence (EDXRF) was implemented, using a radioisotopic source of {sup 238}Pu. For previous concentration was employed a procedure including a coprecipitation step with ammonium pyrrolidine dithiocarbamate (APDC) as quelant agent, the separation of the phases by filtration, the measurement of filter by EDXRF and quantification by a thin layer absolute method. Sensitivity curves for K and L lines were obtained respectively. The sensitivity for most elements was greater by an order of magnitude in the case of measurement with a source of {sup 238}Pu instead of {sup 109}Cd, which means a considerable decrease in measurement times. The influence of the concentration in the precipitation efficiency was evaluated for each element. In all cases the recoveries are close to 100%, for this reason it can be affirmed that the method of determination of the studied elements is quantitative. Metrological parameters of the method such as trueness, precision, detection limit and uncertainty were calculated. A procedure to calculate the uncertainty of the method was elaborated; the most significant source of uncertainty for the thin layer EDXRF method is associated with the determination of instrumental sensitivities. The error associated with the determination, expressed as expanded uncertainty (in %), varied from 15.4% for low element concentrations (2.5-5 μg/L) to 5.4% for the higher concentration range (20-25 μg/L). (author)

  16. Removal of radioisotopes in solution and bactericidal/bacteriostatic sterilising power in activated carbon and metal silver filters.

    Science.gov (United States)

    Maioli, Claudio; Bestetti, Alberto; Mauri, Alessandro; Pozzato, Carlo; Paroni, Rita

    2009-01-01

    Activated carbon filters play an important role in water filtration and purification from contaminants of different origin. Their limit consists in bacterial proliferation, which may occur only during prolonged periods of non-use and in their ability to remove radioactive contaminants present in waste water from Industry or Nuclear Medicine departments. In this work we tested a commercially available activated carbon filter for water purification enriched with silver plated parts incubating in static condition at room temperature different micro organisms (Enterococcus faecalis, Escherichia coli, Pseudomonas aeruginosa, Salmonella enteritidis, Staphylococcus aureus, Aspergillum niger), up to 78 days. The microbial growth was in general more inhibited in the presence of metal silver into the activated carbon in respect to filters with the activated carbon alone: >4log inhibition of bacterial proliferation after 78 days of incubation the presence of silver vs. 2log without silver. When the filters were incubated empty of carbon, the sterilizing power of silver was confirmed further. The activated carbon filters proved also their ability in removing from water the principal radioisotopes used for residues liquid medical and research purposes ((131)I, (99m)Tc, (201)Tl, (67)Ga). These results contribute useful data for the use of the silver-enriched carbon filters in water filtration both for daily use at home, and professional use in a Nuclear Medicine laboratory. Copyright © 2008 Elsevier B.V. All rights reserved.

  17. Development of Paper Sludge Ash-Based Geopolymer and Application to Treatment of Hazardous Water Contaminated with Radioisotopes.

    Science.gov (United States)

    Li, Zhuguo; Ohnuki, Toshihiko; Ikeda, Ko

    2016-07-28

    Ambient temperature geopolymerization of paper sludge ashes (PS-ashes) discharged from paper mills was studied by means of scanning electron microscopy (SEM), X-ray diffraction (XRD), induction coupled plasma atomic emission spectrometry (ICP-AES), and X-ray absorption near edge structure (XANES). Two varieties of alkaline liquors were used in the PS-ash based geopolymers, corresponding to aqueous Na-metasilicate and Na-disilicate compositions. PS-ashes were found to be semi-crystalline and to have porous structures that make it possible to absorb much liquor. Flexural strengths of PS-ash-based geopolymers with liquor/filler ratios (L/F) of 1.0-1.5 ranged from 0.82 to 1.51 MPa at 4 weeks age, depending on PS-ashes and liquors used. The reaction process of the constituent minerals of the PS-ash is discussed. Furthermore, we attempted to solidify hazardous water contaminated with radioisotopes. Non-radioactive strontium and cesium nitrates were added as surrogates at a dosage of 1% into the PS-ash-based geopolymers. Generally, high immobilization ratios up to 99.89% and 98.77% were achieved for Sr(2+) and Cs⁺, respectively, depending on the source of PS-ashes, alkaline liquors, and material ages. However, in some cases, poor immobilization ratios were encountered, and we further discussed the causes of the instability of derived geopolymer gels on the basis of XANES spectra.

  18. Determination of Lactic Acid Bacteria Viability in the Small Intestine of Catfish (Pangasius djambal by Using the 32P Radioisotope

    Directory of Open Access Journals (Sweden)

    I. Sugoro

    2015-04-01

    Full Text Available The viability of probiotics is important to be determined, as is its probiotic potency in the small instestine of fish. The result can be used as a basis to determine the feeding frequency of the probiotics to the fish.The aim of this study is to gain information about the viability of lactic acid bacteria (LAB in the small intestine of fish by using the 32P isotope technique. Catfish (Pangasius djambal was used as a test fish, and the LAB with the code of P2.1 PTB was the subject of the experiment. Before its viability was tested, the LAB had been labelled with radioisotope 32P, then mixed into catfish feed. Its viability could be determined by counting the activity of 32P. The results showed that the percentage of LAB viability in the small intestine of catfish declined until day 7. The percentage of LAB viability was decreased at an amount of 30% at day 3. Based on this result, the feeding frequency of LAB P2.1 PTB is every 3 days.

  19. Therapeutic and diagnostic nanomaterials

    CERN Document Server

    Devasena T

    2017-01-01

    This brief highlights nanoparticles used in the diagnosis and treatment of prominent diseases and toxic conditions. Ecofriendly methods which are ideal for the synthesis of medicinally valued nanoparticles are explained and the characteristic features of these particles projected. The role of these particles in the therapeutic field, and the induced biological changes in some diseases are discussed. The main focus is on inflammation, oxidative stress and cellular membrane integrity alterations. The effect of nanoparticles on these changes produced by various agents are highlighted using in vitro and in vivo models. The mechanism of nanoparticles in ameliorating the biological changes is supported by relevant images and data. Finally, the brief demonstrates recent developments on the use of nanoparticles in diagnosis or sensing of some biological materials and biologically hazardous environmental materials.

  20. Antibody Engineering and Therapeutics

    Science.gov (United States)

    Almagro, Juan Carlos; Gilliland, Gary L; Breden, Felix; Scott, Jamie K; Sok, Devin; Pauthner, Matthias; Reichert, Janice M; Helguera, Gustavo; Andrabi, Raiees; Mabry, Robert; Bléry, Mathieu; Voss, James E; Laurén, Juha; Abuqayyas, Lubna; Barghorn, Stefan; Ben-Jacob, Eshel; Crowe, James E; Huston, James S; Johnston, Stephen Albert; Krauland, Eric; Lund-Johansen, Fridtjof; Marasco, Wayne A; Parren, Paul WHI; Xu, Kai Y

    2014-01-01

    The 24th Antibody Engineering & Therapeutics meeting brought together a broad range of participants who were updated on the latest advances in antibody research and development. Organized by IBC Life Sciences, the gathering is the annual meeting of The Antibody Society, which serves as the scientific sponsor. Preconference workshops on 3D modeling and delineation of clonal lineages were featured, and the conference included sessions on a wide variety of topics relevant to researchers, including systems biology; antibody deep sequencing and repertoires; the effects of antibody gene variation and usage on antibody response; directed evolution; knowledge-based design; antibodies in a complex environment; polyreactive antibodies and polyspecificity; the interface between antibody therapy and cellular immunity in cancer; antibodies in cardiometabolic medicine; antibody pharmacokinetics, distribution and off-target toxicity; optimizing antibody formats for immunotherapy; polyclonals, oligoclonals and bispecifics; antibody discovery platforms; and antibody-drug conjugates. PMID:24589717

  1. Therapeutic applications of melatonin

    Science.gov (United States)

    2013-01-01

    Melatonin is a methoxyindole synthesized within the pineal gland. The hormone is secreted during the night and appears to play multiple roles within the human organism. The hormone contributes to the regulation of biological rhythms, may induce sleep, has strong antioxidant action and appears to contribute to the protection of the organism from carcinogenesis and neurodegenerative disorders. At a therapeutic level as well as in prevention, melatonin is used for the management of sleep disorders and jet lag, for the resynchronization of circadian rhythms in situations such as blindness and shift work, for its preventive action in the development of cancer, as additive therapy in cancer and as therapy for preventing the progression of Alzheimer’s disease and other neurodegenerative disorders. PMID:23515203

  2. Microfabricated therapeutic actuators

    Science.gov (United States)

    Lee, Abraham P.; Northrup, M. Allen; Ciarlo, Dino R.; Krulevitch, Peter A.; Benett, William J.

    1999-01-01

    Microfabricated therapeutic actuators are fabricated using a shape memory polymer (SMP), a polyurethane-based material that undergoes a phase transformation at a specified temperature (Tg). At a temperature above temperature Tg material is soft and can be easily reshaped into another configuration. As the temperature is lowered below temperature Tg the new shape is fixed and locked in as long as the material stays below temperature Tg. Upon reheating the material to a temperature above Tg, the material will return to its original shape. By the use of such SMP material, SMP microtubing can be used as a release actuator for the delivery of embolic coils through catheters into aneurysms, for example. The microtubing can be manufactured in various sizes and the phase change temperature Tg is determinate for an intended temperature target and intended use.

  3. Therapeutic effects of reading

    Directory of Open Access Journals (Sweden)

    Agustín HIDALGO

    2017-06-01

    Full Text Available Reading is an act that requires isolation and loneliness, which allows rewriting the narratives through the identification between the reader and the character, the involvement in the fact narrated and singular recreation by every single reader. The act of reading allows stepping aside from reality. The reading as well as the writing perform the therapeutic effect of helping to understand the illness and to know experiences of others patients that can be useful for the accompaniment, overcoming and/or making decisions. There is not a concrete literary that could be universally recommend to every patient, but all the genre can be useful to some patient. However, poetry, novel and autobiographies are frequently referred as the manuscripts that provide help and consolation.

  4. Antiviral Polymer Therapeutics

    DEFF Research Database (Denmark)

    Smith, Anton Allen Abbotsford

    2014-01-01

    polymerized in a controlled manner with carrier monomers of historically proven biocompatible polymers. The carrier polymers, the loading of ribavirin as well as the size of the polymer were varied systematically with the aid of an automated synthesis platform. These polymers were tested in a cellular assay...... of reversible-addition-fragmentation chain transfer polymerization, which not only controls the size of polymer, but also allows the introduction of a terminal amine on the polymer which can be used for further conjugation. This has allowed for not only fluorescent labeling of the polymer, but also protein......The field of drug delivery is in essence an exercise in engineered pharmacokinetics. Methods of doing so have been developed through the introduction of a vehicle carrying the drug, either by encapsulation or covalent attachment. The emergence of polymer therapeutics in anticancer therapy has...

  5. Therapeutic Approaches in CLIPPERS.

    Science.gov (United States)

    Taieb, Guillaume; Allou, Thibaut; Labauge, Pierre

    2017-05-01

    CLIPPERS for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids, is a steroid-sensitive and steroid-dependent brainstem inflammatory disease of unknown origin. Since its first description in 2010, about 60 cases have been reported throughout the world. The mean age at onset is 50 years and men seem to be more frequently affected. In patients without chronic corticosteroid therapy or immunosuppressive agents, the disease had a relapsing remitting course, and the mean annualized relapse rate was 0.5. During attacks, although clinical and radiological improvement after high doses of corticosteroids was systematically observed, patients could display subsequent disability and hindbrain atrophy. Since no progressive course was observed, clinical and radiological sequelae were correlated with previous severe attacks. Therefore, maintaining the disease in remission may prevent the accumulation of disability. In the literature, no relapse occurred when chronic corticosteroid therapy was maintained above 20 mg per day. However, steroids side effects led to propose corticosteroid-sparing therapies. Unfortunately, no controlled therapy studies for CLIPPERS have been performed yet, and no therapeutic recommendations exist. Using the PubMed database, all articles having the following keywords "chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids" and "CLIPPERS" have been analysed. Considering that the mean annual relapse rate was 0.5, and that no relapse occurred when corticosteroid therapy was maintained above 20 mg per day, the therapeutic efficiency of corticosteroid-sparing agents was considered as "probable" when patients had a relapse-free period ≥24 months, in the absence of concomitant corticosteroid therapy. Corticosteroid-sparing agents whose efficiency is "probable" are methotrexate in two cases, cyclophosphamide in one case and hydroxychloroquine in one case. Considering the

  6. In vivo comparative study of hydroxyapatite labeled with different radioisotopes: evaluation of the scintigraphic images

    Energy Technology Data Exchange (ETDEWEB)

    Couto, Renata Martinussi; Barboza, Marycel Figols de; Souza, Adriano Aparecido de; Muramoto, Emiko; Mengatti, Jair; Araujo, Elaine Bortoleti de, E-mail: rmcouto@ipen.br [Instituto de Pesquisas Energeticas e Nucleares (IPEN/CNEN-SP), Sao Paulo, SP (Brazil). Centro de Radiofarmacia

    2008-07-01

    Rheumatoid arthritis (RA) is a chronic inflammatory disorder of joints that is characterized by the inflammation and proliferation of synovial tissues. Approximately 3% of the adult population in the world is affected by this disease which causes pain, joint immobility and disability. Adyo synovectomy (RSV) is a radiotherapeutic modality where a b--emitting radionuclide is administered locally by intra-articular injection on the form of a colloid or radiolabeled particulate. RSV is a well-accepted therapeutic procedure in inflammatory joint diseases and has been successfully employed for more than 50 years as a viable alternative to surgical and chemical synovectomy in the treatment of RA and other inflammatory arthropathies. There are several radionuclides available for this purpose such as {sup 177}Lu, {sup 90}Y, {sup 153}Sm, {sup 165}Dy, and {sup 166}Ho. Hydroxyapatite (HA) is one of the preferred particulates for this application because it is the major chemical constituent of skeletal bone and it is converted into Ca and PO4 ions in the body. In addition HA is completely eliminated over a period of six weeks. The aim of this work is to compare the in vivo stability of hydroxyapatite labeled with {sup 177}Lu, {sup 90}Y and {sup 153}Sm in order to determine the influence of the radionuclide on biological pattern. In biological studies, 100mL of labeled HAs suspended in normal saline were injected into normal knee joints of Wistar rats and the retention of the activity into the synovium was determined. Labeled particles were also injected by intravenous and intramuscular administration, to verify the biodistribution in the case of an eventual leakage of the products from the joint. Sequential scintigraphic images were acquired from 1 hour to 7 days p.i. after anesthetizing the animals with ketamine. Hydroxyapatite was radiolabeled by all radionuclides with high yield. {sup 177}Lu-HA, {sup 90}Y-HA and {sup 153}Sm-HA were retained in the joint for 7 days, showing

  7. Production of medical radioisotopes with high specific activity in photonuclear reactions with γ-beams of high intensity and large brilliance

    Science.gov (United States)

    Habs, D.; Köster, U.

    2011-05-01

    We study the production of radioisotopes for nuclear medicine in ( γ, xn+ yp) photonuclear reactions or ( γ, γ') photoexcitation reactions with high-flux [(1013-1015) γ/s], small diameter ˜(100 μm)2 and small bandwidth (Δ E/ E≈10-3-10-4) γ beams produced by Compton back-scattering of laser light from relativistic brilliant electron beams. We compare them to (ion, xn+ yp) reactions with (ion = p,d, α) from particle accelerators like cyclotrons and (n, γ) or (n,f) reactions from nuclear reactors. For photonuclear reactions with a narrow γ-beam the energy deposition in the target can be managed by using a stack of thin target foils or wires, hence avoiding direct stopping of the Compton and pair electrons (positrons). However, for ions with a strong atomic stopping only a fraction of less than 10-2 leads to nuclear reactions resulting in a target heating, which is at least 105 times larger per produced radioactive ion and often limits the achievable activity. In photonuclear reactions the well defined initial excitation energy of the compound nucleus leads to a small number of reaction channels and enables new combinations of target isotope and final radioisotope. The narrow bandwidth γ excitation may make use of the fine structure of the Pygmy Dipole Resonance (PDR) or fluctuations in γ-width leading to increased cross sections. Within a rather short period compared to the isotopic half-life, a target area of the order of (100 μm)2 can be highly transmuted, resulting in a very high specific activity. ( γ, γ') isomer production via specially selected γ cascades allows to produce high specific activity in multiple excitations, where no back-pumping of the isomer to the ground state occurs. We discuss in detail many specific radioisotopes for diagnostics and therapy applications. Photonuclear reactions with γ-beams allow to produce certain radioisotopes, e.g. 47Sc, 44Ti, 67Cu, 103Pd, 117 m Sn, 169Er, 195 m Pt or 225Ac, with higher specific activity

  8. [Nuclear transfer and therapeutic cloning].

    Science.gov (United States)

    Xu, Xiao-Ming; Lei, An-Min; Hua, Jin-Lian; Dou, Zhong-Ying

    2005-03-01

    Nuclear transfer and therapeutic cloning have widespread and attractive prospects in animal agriculture and biomedical applications. We reviewed that the quality of oocytes and nuclear reprogramming of somatic donor cells were the main reasons of the common abnormalities in cloned animals and the low efficiency of cloning and showed the problems and outlets in therapeutic cloning, such as some basic problems in nuclear transfer affected clinical applications of therapeutic cloning. Study on isolation and culture of nuclear transfer embryonic stem (ntES) cells and specific differentiation of ntES cells into important functional cells should be emphasized and could enhance the efficiency. Adult stem cells could help to cure some great diseases, but could not replace therapeutic cloning. Ethics also impeded the development of therapeutic cloning. It is necessary to improve many techniques and reinforce the research of some basic theories, then somatic nuclear transfer and therapeutic cloning may apply to agriculture reproduction and benefit to human life better.

  9. Therapeutic vaccines for leishmaniasis.

    Science.gov (United States)

    Khamesipour, Ali

    2014-11-01

    Numerous therapeutic strategies are used to treat leishmaniasis. The treatment of cutaneous leishmaniasis (CL) is solely depends on antimonate derivatives with safety issues and questionable efficacy and there is no fully effective modality to treat CL caused by Leishmania tropica and Leishmania braziliensis. There is no prophylactic vaccine available against any form of leishmaniasis. Immunotherapy for CL has a long history; immunotherapy trials of first and second generation vaccines showed promising results. The current article briefly covers the prophylactic vaccines and explains different immunotherapy strategies that have been used to treat leishmaniasis. This paper does not include experimental vaccines and only lays emphasis on human trials and those vaccines which reached human trials. Immunotherapy is currently used to successfully treat several disorders; Low cost, limited side effects and no possibility to develop resistance make immunotherapy a valuable choice especially for infectious disease with chemotherapy problems. Efforts are needed to explore the immunological surrogate marker(s) of cure and protection in leishmaniasis and overcome the difficulties in standardization of crude Leishmania vaccines. One of the reasons for anti-leishmaniasis vaccine failure is lack of an appropriate adjuvant. So far, not enough attention has been paid to develop vaccines for immunotherapy of leishmaniasis.

  10. Kinetoplastida: new therapeutic strategies

    Directory of Open Access Journals (Sweden)

    Croft S.L.

    2008-09-01

    Full Text Available New formulations and therapeutic switching of the established drugs, amphotericin B and paromomycin, together with the discovery of miltefosine, have significantly improved the opportunities for treatment of visceral leishmaniasis (VL chemotherapy. However, for human African trypanosomiasis (HAT, Chagas disease and cutaneous leishmaniases there has been limited progress. For HAT, a novel diamidine, parfuramidine, is in phase III clinical trial for early-stage disease, but for the treatment of late-stage disease there are no new drugs and combinations of eflornithine with melarsoprol or nifurtimox have been the focus of clinical studies. For Chagas disease, different classes of compounds that have validated biochemical targets, sterol biosynthesis methylases and cysteine proteases, are in various stages of development. The genome sequences that are now available for the pathogens that cause the leishmaniases and trypanosomiases, and new methods for rapid validation of targets, are part of the solution to discover new drugs. The integration of medicinal chemistry, pharmacokinetics, project planning and interaction with the pharma/biotech sector are essential if progress is to be made. Although there are financial constraints, the appearance of new funding sources and not-for-profit product development partnerships offers hope for drug development.

  11. Therapeutic uses of magnesium.

    Science.gov (United States)

    Guerrera, Mary P; Volpe, Stella Lucia; Mao, Jun James

    2009-07-15

    Magnesium is an essential mineral for optimal metabolic function. Research has shown that the mineral content of magnesium in food sources is declining, and that magnesium depletion has been detected in persons with some chronic diseases. This has led to an increased awareness of proper magnesium intake and its potential therapeutic role in a number of medical conditions. Studies have shown the effectiveness of magnesium in eclampsia and preeclampsia, arrhythmia, severe asthma, and migraine. Other areas that have shown promising results include lowering the risk of metabolic syndrome, improving glucose and insulin metabolism, relieving symptoms of dysmenorrhea, and alleviating leg cramps in women who are pregnant. The use of magnesium for constipation and dyspepsia are accepted as standard care despite limited evidence. Although it is safe in selected patients at appropriate dosages, magnesium may cause adverse effects or death at high dosages. Because magnesium is excreted renally, it should be used with caution in patients with kidney disease. Food sources of magnesium include green leafy vegetables, nuts, legumes, and whole grains.

  12. Leech Therapeutic Applications

    Science.gov (United States)

    Abdualkader, A. M.; Ghawi, A. M.; Alaama, M.; Awang, M.; Merzouk, A.

    2013-01-01

    Hematophagous animals including leeches have been known to possess biologically active compounds in their secretions, especially in their saliva. The blood-sucking annelids, leeches have been used for therapeutic purposes since the beginning of civilization. Ancient Egyptian, Indian, Greek and Arab physicians used leeches for a wide range of diseases starting from the conventional use for bleeding to systemic ailments, such as skin diseases, nervous system abnormalities, urinary and reproductive system problems, inflammation, and dental problems. Recently, extensive researches on leech saliva unveiled the presence of a variety of bioactive peptides and proteins involving antithrombin (hirudin, bufrudin), antiplatelet (calin, saratin), factor Xa inhibitors (lefaxin), antibacterial (theromacin, theromyzin) and others. Consequently, leech has made a comeback as a new remedy for many chronic and life-threatening abnormalities, such as cardiovascular problems, cancer, metastasis, and infectious diseases. In the 20th century, leech therapy has established itself in plastic and microsurgery as a protective tool against venous congestion and served to salvage the replanted digits and flaps. Many clinics for plastic surgery all over the world started to use leeches for cosmetic purposes. Despite the efficacious properties of leech therapy, the safety, and complications of leeching are still controversial. PMID:24019559

  13. Therapeutic cloning in the mouse

    Science.gov (United States)

    Mombaerts, Peter

    2003-01-01

    Nuclear transfer technology can be applied to produce autologous differentiated cells for therapeutic purposes, a concept termed therapeutic cloning. Countless articles have been published on the ethics and politics of human therapeutic cloning, reflecting the high expectations from this new opportunity for rejuvenation of the aging or diseased body. Yet the research literature on therapeutic cloning, strictly speaking, is comprised of only four articles, all in the mouse. The efficiency of derivation of embryonic stem cell lines via nuclear transfer is remarkably consistent among these reports. However, the efficiency is so low that, in its present form, the concept is unlikely to become widespread in clinical practice. PMID:12949262

  14. Estimation of groundwater residence time using environmental radioisotopes (14C,T) in carbonate aquifers, southern Poland.

    Science.gov (United States)

    Samborska, Katarzyna; Różkowski, Andrzej; Małoszewski, Piotr

    2013-01-01

    Triassic carbonate aquifers in the Upper Silesia region, affected by intense withdrawal, have been investigated by means of isotopic analyses of (14)C, δ(13)C, δ(2)H, δ(18)O and (3)H. The isotopic examinations were carried out in the 1970s and in the early 1980s, and it was the first application of tracers to estimate age and vulnerability for the contamination of groundwater in this region. Similar isotopic analyses were conducted in 2007 and 2008 with the same Triassic carbonate formation. The isotopic examinations were performed within the confined part of the carbonate formation, wherein aquifers are covered by semi-permeable deposits. The direct recharge of the aquifer occurs in the outcrop areas, but it mainly takes place due to percolation of the water through aquitards and erosional windows. The Triassic aquifer has been intensively drained by wells and by lead-zinc mines. Nowadays, the declining water demand and closure of some mines have induced a significant increase in the water table level. The detailed analysis of the results, including the radiocarbon age corrections and the comparison of radioisotope activities, has made it possible to estimate the range of residence time within the carbonate Triassic aquifer. This range from several tens to several tens of thousands indicates that the recharge of aquifers might have occurred between modern times and the Pleistocene. The apparent age of the water estimated on the basis of (14)C activity was corrected considering the carbon isotope exchange and the diffusion between mobile water in fractures and stagnant water in micropores. The obtained corrected period of recharge corresponds to the result of investigations of noble gases, which were carried out in the 1990s. In almost half of the cases, groundwater is a mixture of young and old water. The mixing processes occur mainly in areas of heavy exploitation of the aquifer.

  15. Radioisotopic, Culture-Based, and Oligonucleotide Microchip Analyses of Thermophilic Microbial Communities in a Continental High-Temperature Petroleum Reservoir†

    Science.gov (United States)

    Bonch-Osmolovskaya, Elizaveta A.; Miroshnichenko, Margarita L.; Lebedinsky, Alexander V.; Chernyh, Nikolai A.; Nazina, Tamara N.; Ivoilov, Valery S.; Belyaev, Sergey S.; Boulygina, Eugenia S.; Lysov, Yury P.; Perov, Alexander N.; Mirzabekov , Andrei D.; Hippe, Hans; Stackebrandt, Erko; L'Haridon, Stéphane; Jeanthon, Christian

    2003-01-01

    Activity measurements by radioisotopic methods and cultural and molecular approaches were used in parallel to investigate the microbial biodiversity and its physiological potential in formation waters of the Samotlor high-temperature oil reservoir (Western Siberia, Russia). Sulfate reduction with rates not exceeding 20 nmol of H2S liter−1 day−1 occurred at 60 and 80°C. In upper horizons (AB, A, and B), methanogenesis (lithotrophic and/or acetoclastic) was detected only in wells in which sulfate reduction did not occur. In some of the wells from deeper (J) horizons, high-temperature sulfate reduction and methanogenesis occurred simultaneously, the rate of lithotrophic methanogenesis exceeding 80 nmol of CH4 liter−1 day−1. Enrichment cultures indicated the presence of diverse physiological groups representing aerobic and anaerobic thermophiles and hyperthermophiles; fermentative organotrophs were predominant. Phylogenetic analyses of 15 isolates identified representatives of the genera Thermotoga, Thermoanaerobacter, Geobacillus, Petrotoga, Thermosipho, and Thermococcus, the latter four being represented by new species. Except for Thermosipho, the isolates were members of genera recovered earlier from similar habitats. DNA obtained from three samples was hybridized with a set of oligonucleotide probes targeting selected microbial groups encompassing key genera of thermophilic bacteria and archaea. Oligonucleotide microchip analyses confirmed the cultural data but also revealed the presence of several groups of microorganisms that escaped cultivation, among them representatives of the Aquificales/Desulfurobacterium-Thermovibrio cluster and of the genera Desulfurococcus and Thermus, up to now unknown in this habitat. The unexpected presence of these organisms suggests that their distribution may be much wider than suspected. PMID:14532074

  16. Purinergic Signalling: Therapeutic Developments

    Directory of Open Access Journals (Sweden)

    Geoffrey Burnstock

    2017-09-01

    Full Text Available Purinergic signalling, i.e., the role of nucleotides as extracellular signalling molecules, was proposed in 1972. However, this concept was not well accepted until the early 1990’s when receptor subtypes for purines and pyrimidines were cloned and characterised, which includes four subtypes of the P1 (adenosine receptor, seven subtypes of P2X ion channel receptors and 8 subtypes of the P2Y G protein-coupled receptor. Early studies were largely concerned with the physiology, pharmacology and biochemistry of purinergic signalling. More recently, the focus has been on the pathophysiology and therapeutic potential. There was early recognition of the use of P1 receptor agonists for the treatment of supraventricular tachycardia and A2A receptor antagonists are promising for the treatment of Parkinson’s disease. Clopidogrel, a P2Y12 antagonist, is widely used for the treatment of thrombosis and stroke, blocking P2Y12 receptor-mediated platelet aggregation. Diquafosol, a long acting P2Y2 receptor agonist, is being used for the treatment of dry eye. P2X3 receptor antagonists have been developed that are orally bioavailable and stable in vivo and are currently in clinical trials for the treatment of chronic cough, bladder incontinence, visceral pain and hypertension. Antagonists to P2X7 receptors are being investigated for the treatment of inflammatory disorders, including neurodegenerative diseases. Other investigations are in progress for the use of purinergic agents for the treatment of osteoporosis, myocardial infarction, irritable bowel syndrome, epilepsy, atherosclerosis, depression, autism, diabetes, and cancer.

  17. Therapeutical aspect of trichomoniasis

    Directory of Open Access Journals (Sweden)

    Vukićević Jelica

    2003-01-01

    Full Text Available Trichomoniasis is frequent, parasitic and sexually transmitted infection of genitourinary tract. It is treated by metronidazole (5-nitroimidazole according to protocol recommended by Center for Disease Control (CDC formerly called: Communicable Disease Center [19]. The resistance of Trichomonas vaginalis (TV strains to metronidazole (MND was described in USA in 1960, and later on in many European countries [8, 9, 10, 11, 12, 13]. In these cases, due to persistent trichomonas infection, it is necessary to repeat MND treatment with moderate modification of dose and/or length of its application. Nevertheless, oncogenic and toxic effects of MND have to be taken into consideration. OBJECT The aim of this study was to investigate and analyze the incidence of TV in STD and lower susceptibility of certain TV strains to MND were analyzed. MATERIAL AND METHODS In three-year period (1999-2001 612 patients (244 females and 368 males suspected of STD were examined clinically and microbiologically at the Institute of Dermatovenereology in Belgrade. The patients detected for TV were treated according to CDC protocol. The affected were considered cured if there was no manifest clinical infection, and no TV verified by microbiological test. Results TV was isolated in 216 patients (35.29 % of all subjects. Trichomonas infection was found in 90 (36.88 % out of 244 tested females and in 126 (32.34 % of 368 males. Clinically manifested infection, with extensive urethral and vaginal secretion, was recorded in 161 patients, while the asymptomatic form was found in 55 subjects. This result indicates the predominance of manifested trichomonas infections (75.54 % of cases. The difference of distribution of clinical forms of trichomoniasis, in relation to sex, was not statistically significant (c2=0.854; p>0.05. The patients with verified trichomonas infection were treated by metronidazole according to CDC protocol. The recommended therapeutical scheme consisted of three

  18. READING PHILEMON AS THERAPEUTIC NARRATIVE

    African Journals Online (AJOL)

    2010-03-29

    Mar 29, 2010 ... Contrary to an initial impression, the narrative therapeutic approach does not emerge from a completely psychological ... Furthermore, a narrative therapeutic reading does not exist in a vacuum, therefore this investigation ..... converted to Christianity, Philemon supported other believers in various ways ...

  19. Clinical applications of therapeutic phlebotomy

    Directory of Open Access Journals (Sweden)

    Kim KH

    2016-07-01

    Full Text Available Kyung Hee Kim,1 Ki Young Oh,2 1Department of Laboratory Medicine, Gachon University Gil Medical Center, Incheon, 2Department of Physical Medicine and Rehabilitation, Soonchunhyang University, Cheonan Hospital, Cheonan, South Korea Abstract: Phlebotomy is the removal of blood from the body, and therapeutic phlebotomy is the preferred treatment for blood disorders in which the removal of red blood cells or serum iron is the most efficient method for managing the symptoms and complications. Therapeutic phlebotomy is currently indicated for the treatment of hemochromatosis, polycythemia vera, porphyria cutanea tarda, sickle cell disease, and nonalcoholic fatty liver disease with hyperferritinemia. This review discusses therapeutic phlebotomy and the related disorders and also offers guidelines for establishing a therapeutic phlebotomy program. Keywords: therapeutic phlebotomy, hemochromatosis, polycythemia vera, porphyria cutanea tarda, sickle cell disease, nonalcoholic fatty liver disease

  20. Rethinking Therapeutic Misconception in Biobanking

    DEFF Research Database (Denmark)

    Tupasela, Aaro; Snell, Karoliina; Cañada, Jose

    2017-01-01

    Some authors have noted that in biobank research participants may be guided by what is called therapeutic misconception, whereby participants attribute therapeutic intent to research procedures.This article argues that the notion of therapeutic misconception is increasingly less justified when...... evaluating biobanks. We present four examples taken from recent developments in biobanking to argue why the notion of therapeutic misconception is problematic in that biobanking practices are increasingly seeking to bridge research and treatment in diff erent ways. In this article we explore examples where...... underpinnings for the need to separate research and treatment, and thus the notion of therapeutic misconception in the fi rst place. We call this tension between research and treatment ambivalent research advancement to highlight the difficulties that various actors have in managing such shifts within...

  1. From 1962 the teaching of Methodology of Radioisotopes is continuous in the University of Buenos Aires of the Argentine Republic; Desde 1962 la ensenanza de Metodologia de Radioisotopos es continua en la Universidad de Buenos Aires de la Republica Argentina

    Energy Technology Data Exchange (ETDEWEB)

    Rivera, E.; Cremaschi, G.; Martin, G.; Zubillaga, M.; Cricco, G.; Davio, C.; Genaro, A.; Bianchin, A.; Mohamad, N.; Klecha, A.; Calmanovici, G.; Goldman, G.; Salgueiro, J.; Nunez, M.; Medina, V.; Gutierrez, A.; Leonardi, N.; Bergoc, R. [Laboratorio de Radioisotopos, Facultad de Farmacia y Bioquimica, Universidad de Buenos Aires, Junin 956, 1113- Buenos Aires (Argentina)]. e-mail: rmbergoc@arnet.com.ar

    2006-07-01

    In the Faculty of Pharmacy and Biochemistry of the University of Buenos Aires the teaching of the radioisotopes began in 1960 and uninterruptedly continuous. The application of the radioisotopes and the radiations in different professional activities it is acceptable only in a context of radiological safety and with personal appropriately trained. Conscious of it, the training in grade, postgraduate and technicature, has more of 40% of the thematic one guided to the formation in radiological protection. The courses dictated at the moment in the Laboratory of Radioisotopes they include: Grade formation: to) Subject grade 'Methodology of Radioisotopes' in the Career of Biochemistry: it began to be dictated in 1960 and until the present, more of 6500 students they have gone by our classrooms. b) Grade subject 'Radiopharmacy' in the Career of Pharmacy: guided to the formation of a modern pharmacist, with necessary knowledge to be developed as professional in the Radiopharmaceutical area. Postgraduate formation: c) Postgraduate course of Methodology of Radioisotopes specially directed to biochemical, biologists, veterinarians, chemical. It is dictated uninterruptedly from 1962. d) Postgraduate course in Methodology of Radioisotopes for medical professionals, specially directed to professionals of the medicine that want to specialize in different branches of the Nuclear Medicine. Both courses have 220 present hours and it stops their approval the assistants they should surrender a final exam at open book that consists on the resolution of a practical exercise adapted to their professional practices. Until the present they have surrendered their exams satisfactorily approximately 2000 professionals coming from different areas of the Argentina and of several countries of Hispanic speech. e) Starting from 1992 the Course of Upgrade in Methodology of Radioisotopes directed to professionals that want to upgrade its knowledge in new radioisotopic

  2. Modeling non-steady state radioisotope transport in the vadose zone - A case study using uranium isotopes at Peña Blanca, Mexico

    Science.gov (United States)

    Ku, T. L.; Luo, S.; Goldstein, S. J.; Murrell, M. T.; Chu, W. L.; Dobson, P. F.

    2009-10-01

    Current models using U- and Th-series disequilibria to study radioisotope transport in groundwater systems mostly consider a steady-state situation. These models have limited applicability to the vadose zone (UZ) where the concentration and migratory behavior of radioisotopes in fluid are often transitory. We present here, as a first attempt of its kind, a model simulating the non-steady state, intermittent fluid transport in vadose layers. It provides quantitative constraints on in-situ migration of dissolved and colloidal radioisotopes in terms of retardation factor and rock-water interaction (or water transit) time. For uranium, the simulation predicts that intermittent flushing in the UZ leads to a linear relationship between reciprocal U concentration and 234U/ 238U ratio in percolating waters, with the intercept and slope bearing information on the rates of dissolution and α-recoil of U isotopes, respectively. The general validity of the model appears to be borne out by the measurement of uranium isotopes in UZ waters collected at various times over a period during 1995-2006 from a site in the Peña Blanca mining district, Mexico, where the Nopal I uranium deposit is located. Enhanced 234U/ 238U ratios in vadose-zone waters resulting from lengthened non-flushing time as prescribed by the model provide an interpretative basis for using 234U/ 238U in cave calcites to reconstruct the regional changes in hydrology and climate. We also provide a theoretical account of the model's potential applications using radium isotopes.

  3. Modeling non-steady state radioisotope transport in the vadose zone--A case study using uranium isotopes at Pena Blanca, Mexico

    Energy Technology Data Exchange (ETDEWEB)

    Ku, T. L.; Luo, S.; Goldstein, S. J.; Murrell, M. T.; Chu, W. L.; Dobson, P. F.

    2009-06-01

    Current models using U- and Th-series disequilibria to study radioisotope transport in groundwater systems mostly consider a steady-state situation. These models have limited applicability to the vadose zone (UZ) where the concentration and migratory behavior of radioisotopes in fluid are often transitory. We present here, as a first attempt of its kind, a model simulating the non-steady state, intermittent fluid transport in vadose layers. It provides quantitative constraints on in-situ migration of dissolved and colloidal radioisotopes in terms of retardation factor and rock-water interaction (or water transit) time. For uranium, the simulation predicts that intermittent flushing in the UZ leads to a linear relationship between reciprocal U concentration and {sup 234}U/{sup 238}U ratio in percolating waters, with the intercept and slope bearing information on the rates of dissolution and {alpha}-recoil of U isotopes, respectively. The general validity of the model appears to be borne out by the measurement of uranium isotopes in UZ waters collected at various times over a period during 1995-2006 from a site in the Pena Blanca mining district, Mexico, where the Nopal I uranium deposit is located. Enhanced {sup 234}U/{sup 238}U ratios in vadose-zone waters resulting from lengthened non-flushing time as prescribed by the model provide an interpretative basis for using {sup 234}U/{sup 238}U in cave calcites to reconstruct the regional changes in hydrology and climate. We also provide a theoretical account of the model's potential applications using radium isotopes.

  4. 182Hf-182W age dating of a 26Al-poor inclusion and implications for the origin of short-lived radioisotopes in the early Solar System.

    Science.gov (United States)

    Holst, Jesper C; Olsen, Mia B; Paton, Chad; Nagashima, Kazuhide; Schiller, Martin; Wielandt, Daniel; Larsen, Kirsten K; Connelly, James N; Jørgensen, Jes K; Krot, Alexander N; Nordlund, Ake; Bizzarro, Martin

    2013-05-28

    Refractory inclusions [calcium-aluminum-rich inclusions, (CAIs)] represent the oldest Solar System solids and provide information regarding the formation of the Sun and its protoplanetary disk. CAIs contain evidence of now extinct short-lived radioisotopes (e.g., (26)Al, (41)Ca, and (182)Hf) synthesized in one or multiple stars and added to the protosolar molecular cloud before or during its collapse. Understanding how and when short-lived radioisotopes were added to the Solar System is necessary to assess their validity as chronometers and constrain the birthplace of the Sun. Whereas most CAIs formed with the canonical abundance of (26)Al corresponding to (26)Al/(27)Al of ∼5 × 10(-5), rare CAIs with fractionation and unidentified nuclear isotope effects (FUN CAIs) record nucleosynthetic isotopic heterogeneity and (26)Al/(27)Al of Solar System, including the origin of short-lived radioisotopes. However, their chronology is unknown. Using the (182)Hf-(182)W chronometer, we show that a FUN CAI recording a condensation origin from a solar gas formed coevally with canonical CAIs, but with (26)Al/(27)Al of ∼3 × 10(-6). The decoupling between (182)Hf and (26)Al requires distinct stellar origins: steady-state galactic stellar nucleosynthesis for (182)Hf and late-stage contamination of the protosolar molecular cloud by a massive star(s) for (26)Al. Admixing of stellar-derived (26)Al to the protoplanetary disk occurred during the epoch of CAI formation and, therefore, the (26)Al-(26)Mg systematics of CAIs cannot be used to define their formation interval. In contrast, our results support (182)Hf homogeneity and chronological significance of the (182)Hf-(182)W clock.

  5. Lead shielded cells for the spectrographic analysis of radioisotope solutions; Descripcion de un equipo, con recintos blindados, para el analisis espectrografico de soluciones de radioisotopos

    Energy Technology Data Exchange (ETDEWEB)

    Roca, M.; Capdevila, C.; Cruz, F. de la

    1967-07-01

    Two lead shielded cells for the spectrochemical analysis of radioisotope samples are described. One of them is devoted to the evaporation of samples before excitation and the other one contains a suitable spectrographic excitation stand for the copper spark technique. A special device makes it possible the easy displacement of the excitation cell on wheels and rails for its accurate and reproducible position as well as its replacement by a glove box for plutonium analysis. In order to guarantee safety the room in which the spectrograph and the source are set up in separated from the active laboratory by a wall with a suitable window. (Author) 1 refs.

  6. Calculation of excitation functions of proton, alpha and deuteron induced reactions for production of medical radioisotopes {sup 122–125}I

    Energy Technology Data Exchange (ETDEWEB)

    Artun, Ozan, E-mail: ozanartun@yahoo.com; Aytekin, Hüseyin, E-mail: huseyinaytekin@gmail.com

    2015-02-15

    In this work, the excitation functions for production of medical radioisotopes {sup 122–125}I with proton, alpha, and deuteron induced reactions were calculated by two different level density models. For the nuclear model calculations, the Talys 1.6 code were used, which is the latest version of Talys code series. Calculations of excitation functions for production of the {sup 122–125}I isotopes were carried out by using the generalized superfluid model (GSM) and Fermi-gas model (FGM). The results have shown that generalized superfluid model is more successful than Fermi-gas model in explaining the experimental results.

  7. Dose Calibrator Linearity Testing: Radioisotope (99m)Tc or (18)F? An Alternative for Reducing Costs in Nuclear Medicine Quality Control.

    Science.gov (United States)

    Willegaignon, José; Sapienza, Marcelo T; Coura-Filho, George Barberio; Garcez, Alexandre T; Alves, Carlos E; Cardona, Marissa R; Gutterres, Ricardo F; Buchpiguel, Carlos A

    2015-01-01

    Dose calibrator linearity testing is indispensable for evaluating the capacity of this equipment in measuring radioisotope activities at different magnitudes, a fundamental aspect of the daily routine of a nuclear medicine department, and with an impact on patient exposure. The main aims of this study were to evaluate the feasibility of substituting the radioisotope Fluorine-18 ((18)F) with Technetium-99m ((99m)Tc) in this test, and to indicate it with the lowest operational cost. The test was applied with sources of (99m)Tc (62 GBq) and (18)F (12 GBq), the activities of which were measured at different times, with the equipment preadjusted to measuring sources of (99m)Tc, (18)F, Gallium-67 ((67)Ga), and Iodine-131 ((131)I). Over time, the average deviation between measured and expected activities from (99m)Tc and (18)F were, respectively, 0.56 (±1.79)% and 0.92 (±1.19)%. The average ratios for 99(m)Tc source experimental activity, when measured with the equipment adjusted for measuring (18)F, (67)Ga, and (131)I sources, in real values, were, respectively, 3.42 (±0.06), 1.45 (±0.03), and 1.13 (±0.02), and those for the (18)F source experimental activity, measured through adjustments of (99m)Tc, (67)Ga, and (131)I, were, respectively, 0.295 (±0.004), 0.335 (±0.007), and 0.426 (±0.006). The adjustment of a simple exponential function for describing (99m)Tc and (18)F experimental activities facilitated the calculation of the physical half-lives of the radioisotopes, with a difference of about 1% in relation to the values described in the literature. Linearity test results, when using (99m)Tc, through being compatible with those acquired with (18)F, imply the possibility of using both radioisotopes during linearity testing. Nevertheless, this information, along with the high potential of exposure and the high cost of (18)F, implies that (99m)Tc should preferably be employed for linearity testing in clinics that normally use (18)F, without the risk of

  8. Therapeutic hypothermia for acute stroke

    DEFF Research Database (Denmark)

    Olsen, Tom Skyhøj; Weber, Uno Jakob; Kammersgaard, Lars Peter

    2003-01-01

    Experimental evidence and clinical experience show that hypothermia protects the brain from damage during ischaemia. There is a growing hope that the prevention of fever in stroke will improve outcome and that hypothermia may be a therapeutic option for the treatment of stroke. Body temperature...... obvious therapeutic potential, hypothermia as a form of neuroprotection for stroke has been investigated in only a few very small studies. Therapeutic hypothermia is feasible in acute stroke but owing to serious side-effects--such as hypotension, cardiac arrhythmia, and pneumonia--it is still thought...

  9. Frontiers in nano-therapeutics

    CERN Document Server

    Tasnim, Nishat; Sai Krishna, Katla; Kalagara, Sudhakar; Narayan, Mahesh; Noveron, Juan C; Joddar, Binata

    2017-01-01

    This brief highlights recent research advances in the area of nano-therapeutics. Nanotechnology holds immense potential for application in a wide range of biological and engineering applications such as molecular sensors for disease diagnosis, therapeutic agents for the treatment of diseases, a vehicle for delivering therapeutics and imaging agents for theranostic applications, both in-vitro and in-vivo. The brief is grouped into the following sections namely, A) Discrete Nanosystems ; B) Anisotropic Nanoparticles; C) Nano-films/coated/layered and D) Nano-composites.

  10. [Therapeutic management of neurodermatitis atopica].

    Science.gov (United States)

    Kägi, M K

    1998-08-01

    The therapy of atopic dermatitis remains a challenge. The success of any therapeutic concept is based on a broad and early diagnostic approach which allows to rule out relevant provocation factors and allergens. During remission periods the regular use of a topical basic therapy consisting of drug-free emolients is recommended. Topical corticosteroids as well as systemic or local antimicrobial therapy and antihistamines are essential during periods of acute exacerbations. Although during the last years a great number of new therapeutic approaches have been published, data of most of these therapeutic modalities are not sufficient to allow an unrestricted use in all patients with atopic dermatitis.

  11. [Current Therapeutic Approaches to Sarcoidosis].

    Science.gov (United States)

    Pizarro, Carmen; Skowasch, Dirk; Grohé, Christian

    2017-01-01

    Sarcoidosis represents a non-caseating, granulomatous disorder of unknown aetiology whose clinical manifestation is heterogeneous and frequently multisystemic. The portion of patients needing systemic treatment varies: though many patients may undergo spontaneous remission, organ-threatening courses demand systemic therapy. Corticosteroids are the first-line treatment option; however, disease´s progression and/or major corticosteroid side effects may require second- and third-line therapeutics. A current stepwise therapeutic algorithm to sarcoidosis that characterizes additive and alternative therapeutic agents is given in the following review. © Georg Thieme Verlag KG Stuttgart · New York.

  12. Probabilistic Prognosis of Environmental Radioactivity Concentrations due to Radioisotopes Discharged to Water Bodies from Nuclear Power Plants.

    Science.gov (United States)

    Tomás Zerquera, Juan; Mora, Juan C; Robles, Beatriz

    2017-11-15

    Due to their very low values, the complexity of comparing the contribution of nuclear power plants (NPPs) to environmental radioactivity with modeled values is recognized. In order to compare probabilistic prognosis of radioactivity concentrations with environmental measurement values, an exercise was performed using public data of radioactive routine discharges from three representative Spanish nuclear power plants. Specifically, data on liquid discharges from three Spanish NPPs: Almaraz, Vandellós II, and Ascó to three different aquatic bodies (river, lake, and coast) were used. Results modelled using generic conservative models together with Monte Carlo techniques used for uncertainties propagation were compared with values of radioactivity concentrations in the environment measured in the surroundings of these NPPs. Probability distribution functions were inferred for the source term, used as an input to the model to estimate the radioactivity concentrations in the environment due to discharges to the water bodies. Radioactivity concentrations measured in bottom sediments were used in the exercise due to their accumulation properties. Of all the radioisotopes measured in the environmental monitoring programs around the NPPs, only Cs-137, Sr-90, and Co-60 had positive values greater than their respective detection limits. Of those, Sr-90 and Cs-137 are easily measured in the environment, but significant contribution from the radioactive fall-out due to nuclear explosions in the atmosphere exists, and therefore their values cannot be attributed to the NPPs. On the contrary, Co-60 is especially useful as an indicator of the radioactive discharges from NPPs because its presence in the environment can solely be attributed to the impact of the closer nuclear facilities. All the modelled values for Co-60 showed a reasonable correspondence with measured environmental data in all cases, being conservative in two of them. The more conservative predictions obtained with

  13. Probabilistic Prognosis of Environmental Radioactivity Concentrations due to Radioisotopes Discharged to Water Bodies from Nuclear Power Plants

    Directory of Open Access Journals (Sweden)

    Juan Tomás Zerquera

    2017-11-01

    Full Text Available Due to their very low values, the complexity of comparing the contribution of nuclear power plants (NPPs to environmental radioactivity with modeled values is recognized. In order to compare probabilistic prognosis of radioactivity concentrations with environmental measurement values, an exercise was performed using public data of radioactive routine discharges from three representative Spanish nuclear power plants. Specifically, data on liquid discharges from three Spanish NPPs: Almaraz, Vandellós II, and Ascó to three different aquatic bodies (river, lake, and coast were used. Results modelled using generic conservative models together with Monte Carlo techniques used for uncertainties propagation were compared with values of radioactivity concentrations in the environment measured in the surroundings of these NPPs. Probability distribution functions were inferred for the source term, used as an input to the model to estimate the radioactivity concentrations in the environment due to discharges to the water bodies. Radioactivity concentrations measured in bottom sediments were used in the exercise due to their accumulation properties. Of all the radioisotopes measured in the environmental monitoring programs around the NPPs, only Cs-137, Sr-90, and Co-60 had positive values greater than their respective detection limits. Of those, Sr-90 and Cs-137 are easily measured in the environment, but significant contribution from the radioactive fall-out due to nuclear explosions in the atmosphere exists, and therefore their values cannot be attributed to the NPPs. On the contrary, Co-60 is especially useful as an indicator of the radioactive discharges from NPPs because its presence in the environment can solely be attributed to the impact of the closer nuclear facilities. All the modelled values for Co-60 showed a reasonable correspondence with measured environmental data in all cases, being conservative in two of them. The more conservative

  14. American Society for Therapeutic Radiology and Oncology (ASTRO) Emerging Technology Committee report on electronic brachytherapy.

    Science.gov (United States)

    Park, Catherine C; Yom, Sue S; Podgorsak, Matthew B; Harris, Eleanor; Price, Robert A; Bevan, Alison; Pouliot, Jean; Konski, Andre A; Wallner, Paul E

    2010-03-15

    The development of novel technologies for the safe and effective delivery of radiation is critical to advancing the field of radiation oncology. The Emerging Technology Committee of the American Society for Therapeutic Radiology and Oncology appointed a Task Group within its Evaluation Subcommittee to evaluate new electronic brachytherapy methods that are being developed for, or are already in, clinical use. The Task Group evaluated two devices, the Axxent Electronic Brachytherapy System by Xoft, Inc. (Fremont, CA), and the Intrabeam Photon Radiosurgery Device by Carl Zeiss Surgical (Oberkochen, Germany). These devices are designed to deliver electronically generated radiation, and because of their relatively low energy output, they do not fall under existing regulatory scrutiny of radioactive sources that are used for conventional radioisotope brachytherapy. This report provides a descriptive overview of the technologies, current and future projected applications, comparison of competing technologies, potential impact, and potential safety issues. The full Emerging Technology Committee report is available on the American Society for Therapeutic Radiology and Oncology Web site. Copyright 2010. Published by Elsevier Inc.

  15. [Therapeutic drug monitoring of antimicrobials

    NARCIS (Netherlands)

    Mouton, J.W.; Aarnoutse, R.E.

    2014-01-01

    The importance of dose adjustments of antimicrobials based on measured concentrations in an individual ('therapeutic drug monitoring', TDM) is increasingly recognized. There are several reasons for this. First, there is a better understanding of the relationships between doses administered,

  16. Accelerated Decay of Radioisotopes

    Science.gov (United States)

    2013-01-01

    controllable and varied to access reactions of interest (primarily (n,n’) inelastic scattering). Theory and analysis using Monte Carlo codes (MCNPX) is still...performance and p-7Li neutron production: The Mercury pulsed power generator was operated in positive polarity at 2/3 Marx charge. Positive polarity...was achieved by reversing the normal Marx charging polarity, which can be easily done at the lower 50 kV (out of 75 kV) charge. The ion diode produced

  17. Therapeutic Vaccines for Chronic Infections

    Science.gov (United States)

    Autran, Brigitte; Carcelain, Guislaine; Combadiere, Béhazine; Debre, Patrice

    2004-07-01

    Therapeutic vaccines aim to prevent severe complications of a chronic infection by reinforcing host defenses when some immune control, albeit insufficient, can already be demonstrated and when a conventional antimicrobial therapy either is not available or has limited efficacy. We focus on the rationale and challenges behind this still controversial strategy and provide examples from three major chronic infectious diseases-human immunodeficiency virus, hepatitis B virus, and human papillomavirus-for which the efficacy of therapeutic vaccines is currently being evaluated.

  18. Annual Technical Progress Report of Radioisotope Power Systems Materials Production and Technology Program Tasks for October 1, 2007 Through September 30,2008

    Energy Technology Data Exchange (ETDEWEB)

    King, James F [ORNL

    2009-04-01

    The Office of Radioisotope Power Systems (RPS) of the Department of Energy (DOE) provides RPS for applications where conventional power systems are not feasible. For example, radioisotope thermoelectric generators were supplied by the DOE to the National Aeronautics and Space Administration (NASA) for deep space missions including the Cassini Mission launched in October of 1997 to study the planet Saturn. For the Cassini Mission, ORNL produced carbon-bonded carbon fiber (CBCF) insulator sets, iridium alloy blanks and foil, and clad vent sets (CVS) used in the generators. The Oak Ridge National Laboratory (ORNL) has been involved in developing materials and technology and producing components for the DOE for more than three decades. This report reflects program guidance from the Office of RPS for fiscal year (FY) 2008. Production activities for prime quality (prime) CBCF insulator sets, iridium alloy blanks and foil, and CVS are summarized in this report. Technology activities are also reported that were conducted to improve the manufacturing processes, characterize materials, or to develop information for new RPS.

  19. Dandy-walker malformation and the contribution of radioisotopic studies of cerebral spinal fluid dynamics to its diagnosis. Case report

    Energy Technology Data Exchange (ETDEWEB)

    Palma, A.; Nazar, N.; Castro, M.; Olea, E.; Guzmann, G. (Inst. of Neurosurgery, Santiago (Chile))

    1982-01-01

    One case of Dandy-Walker malformation is described. The diagnosis was mainly reached by dynamic isotope studies of CSF, and was confirmed by axial computerized tomography. The importance of these examinations is discussed, not only as a means of understanding the aetiopathology, but especially because of the functional information they give and the therapeutic consequences they have.

  20. Design, Analyses, and Fabrication Procedure of Amtec Cell, Test Assembly, and Radioisotope Power System for Outer-Planet Missions

    Science.gov (United States)

    Schock, A.; Noravian, H.; Or, C.; Kumar, V.

    2002-04-01

    interim cell design, which is being implemented by AMPS, Inc., for a DOE-sponsored technology development program. It then describes the extension of that analytical procedure to a variety of OSC-designed radioisotope-heated generators employing the recommended cell design, with particular attention to the thermal insulation between the outside of the 16 cells and the inside of the generator housing. The studies found that the performance of the generator is optimized by employing a hybrid insulation system, in which the space between the cells is filled with fibrous Min-K insulation, and the generator walls are lined with tapered (i.e., graded-length) multifoil insulation. The paper then examines the performance of the OSC generator designs for various fuel loadings, output voltages, and mission phases, and assesses their ability to meet the stipulated temperature constraints and power demands of the Europa Orbiter and Pluto Express missions under consideration by NASA. Finally, it presents an OSC-recommended design and fabrication procedure of an electrically heated four-cell test assembly with hybrid insulation to simulate the prototypic 16-cell generator. That test assembly will be analyzed by OSC, built by AMPS, and tested by the Air Force Phillips Laboratory (AFPL), to check the validity of the analytical predictions. The reason for basing the recommended test assembly on the interim rather than the ultimate refractory metal cell design is to avoid the delays required to develop the new technology for the latter.

  1. Bone-seeking therapeutic radiopharmaceuticals

    Directory of Open Access Journals (Sweden)

    Srivastava Suresh C.

    2002-01-01

    Full Text Available Bone-seeking therapeutic radiopharmaceuticals are utilized on the basis of the radionuclide?s particulate emissions (primarily low to intermediate beta emission. The requirements therefore are different from those of bone imaging agents that consist mainly of short-lived single photon emitters. Lately, the therapeutic bone seeking radiopharmaceuticals have attained increasing importance due to their potential role in alleviating pain from osseous metastases in cancer patients, for the treatment of joint pain resulting from inflamed synovium (radiosynoviorthesis, or radiosynovectomy, or from various other forms of arthritic disease. There is, however, a paucity of published data on the bio-pharmacokinetics of these agents when used following intravenous administration for bone pain palliation. This paper will briefly review and summarize the presently available chemical and biopharmacokinetic information on the various clinically approved as well as experimental bone-localizing therapeutic radiopharmaceuticals, and make projections on their clinical application for the treatment of primary/metastatic cancer in bone.

  2. Therapeutic hypothermia for acute stroke

    DEFF Research Database (Denmark)

    Olsen, Tom Skyhøj; Weber, Uno Jakob; Kammersgaard, Lars Peter

    2003-01-01

    Experimental evidence and clinical experience show that hypothermia protects the brain from damage during ischaemia. There is a growing hope that the prevention of fever in stroke will improve outcome and that hypothermia may be a therapeutic option for the treatment of stroke. Body temperature...... is directly related to stroke severity and outcome, and fever after stroke is associated with substantial increases in morbidity and mortality. Normalisation of temperature in acute stroke by antipyretics is generally recommended, although there is no direct evidence to support this treatment. Despite its...... obvious therapeutic potential, hypothermia as a form of neuroprotection for stroke has been investigated in only a few very small studies. Therapeutic hypothermia is feasible in acute stroke but owing to serious side-effects--such as hypotension, cardiac arrhythmia, and pneumonia--it is still thought...

  3. Conflicts in the therapeutic field

    Directory of Open Access Journals (Sweden)

    Antonino Aprea

    2012-06-01

    Full Text Available How the analytical knowledge that compare human consciousness with that, even more disturbing, moving behind his fifth can be said to be “for peace”? It can be - and this will be the contribution of the proposal - the same tortuous and enigmatic of therapeutic practice, with its hesitations and his impulses, to outline a path crossing and overcoming the conflict? May, finally, peace, in the sense of feasibility of intra-and interpersonal dialectic instead of tearing and hostileconfrontation with oneself and with the other, to be a reference in some crucial pivot of ethical therapeutic work? To these questions the intervention seeks to answer retracing some of the highlights of almost three years of therapeutic work with a young woman and her family.

  4. Oligonucleotide conjugates for therapeutic applications.

    Science.gov (United States)

    Winkler, Johannes

    2013-07-01

    Insufficient pharmacokinetic properties and poor cellular uptake are the main hurdles for successful therapeutic development of oligonucleotide agents. The covalent attachment of various ligands designed to influence the biodistribution and cellular uptake or for targeting specific tissues is an attractive possibility to advance therapeutic applications and to expand development options. In contrast to advanced formulations, which often consist of multiple reagents and are sensitive to a variety of preparation conditions, oligonucleotide conjugates are defined molecules, enabling structure-based analytics and quality control techniques. This review gives an overview of current developments of oligonucleotide conjugates for therapeutic applications. Attached ligands comprise peptides, proteins, carbohydrates, aptamers and small molecules, including cholesterol, tocopherol and folic acid. Important linkage types and conjugation methods are summarized. The distinct ligands directly influence biochemical parameters, uptake mechanisms and pharmacokinetic properties.

  5. [Therapeutic touch and anorexia nervosa].

    Science.gov (United States)

    Satori, Nadine

    2016-01-01

    An innovative practice, therapeutic touch has been used for around ten years in the treatment of eating disorders. Delivered by nurse clinicians having received specific training, this approach is based on nursing diagnoses which identify the major symptoms of this pathology. The support is built around the body and its perceptions. Through the helping relationship, it mobilises the patient's resources to favour a relationship of trust, a letting-go, physical, psychological and emotional relaxation, and improves the therapeutic alliance. Copyright © 2016. Published by Elsevier Masson SAS.

  6. Therapeutic options for visceral leishmaniasis.

    Science.gov (United States)

    Monge-Maillo, Begoña; López-Vélez, Rogelio

    2013-11-01

    Visceral leishmaniasis (VL), also known as Kala-Azar, is a disseminated protozoal infection caused principally by Leishmania donovani and Leishmania infantum (known as Leishmania chagasi in South America). The therapeutic options for VL are diverse and depend on different factors, such as the geographical area of the infection, development of resistance to habitual treatments, HIV co-infection, malnourishment and other concomitant infections. This article provides an exhaustive review of the literature regarding studies published on the treatment of VL, and gives therapeutic recommendations stratified according to their level of evidence, the species of Leishmania implicated and the geographical location of the infection.

  7. Therapeutic Adherence in Smoking Therapy

    Directory of Open Access Journals (Sweden)

    María Salvador Manzano

    2010-02-01

    Full Text Available Therapeutic adherence is a complex and multidimensional concept. The percentage of adherence to treatments involving a change in lifestyle, such as quitting smoking, is lower than in other disorders, a fact which has relevant clinical, psychological and economic consequences. This paper aims to review the associated factors with adherence to therapy in smoking treatment. Strategies to enhance therapeutic adherence involve the adequate choice of treatment, to know the smoker´s characteristics, breaking down organizational barriers in health system and the training of health professionals in communication skills with patients.

  8. Therapeutics for Equine Endocrine Disorders.

    Science.gov (United States)

    Durham, Andy E

    2017-04-01

    Equine endocrine disease is commonly encountered by equine practitioners. Pituitary pars intermedia dysfunction (PPID) and equine metabolic syndrome (EMS) predominate. The most logical therapeutic approach in PPID uses dopamine agonists; pergolide mesylate is the most common. Bromocryptine and cabergoline are alternative drugs with similar actions. Drugs from other classes have a poor evidence basis, although cyproheptadine and trilostane might be considered. EMS requires management changes as the primary approach; reasonable justification for use of drugs such as levothyroxine and metformin may apply. Therapeutic options exist in rare cases of diabetes mellitus, diabetes insipidus, hyperthyroidism, and critical illness-related corticosteroid insufficiency. Copyright © 2016 Elsevier Inc. All rights reserved.

  9. 182Hf-182W age dating of a 26Al-poor inclusion and implications for the origin of short-lived radioisotopes in the early Solar System

    DEFF Research Database (Denmark)

    Holst, Jesper Christian; Olsen, Mia Bjørg Stolberg; Paton, Chad

    2013-01-01

    Refractory inclusions [calcium–aluminum-rich inclusions, (CAIs)] represent the oldest Solar System solids and provide information regarding the formation of the Sun and its protoplanetary disk. CAIs contain evidence of now extinct short-lived radioisotopes (e.g., 26Al, 41Ca, and 182Hf) synthesize...

  10. The renaissance of complement therapeutics.

    Science.gov (United States)

    Ricklin, Daniel; Mastellos, Dimitrios C; Reis, Edimara S; Lambris, John D

    2018-01-01

    The increasing number of clinical conditions that involve a pathological contribution from the complement system - many of which affect the kidneys - has spurred a regained interest in therapeutic options to modulate this host defence pathway. Molecular insight, technological advances, and the first decade of clinical experience with the complement-specific drug eculizumab, have contributed to a growing confidence in therapeutic complement inhibition. More than 20 candidate drugs that target various stages of the complement cascade are currently being evaluated in clinical trials, and additional agents are in preclinical development. Such diversity is clearly needed in view of the complex and distinct involvement of complement in a wide range of clinical conditions, including rare kidney disorders, transplant rejection and haemodialysis-induced inflammation. The existing drugs cannot be applied to all complement-driven diseases, and each indication has to be assessed individually. Alongside considerations concerning optimal points of intervention and economic factors, patient stratification will become essential to identify the best complement-specific therapy for each individual patient. This Review provides an overview of the therapeutic concepts, targets and candidate drugs, summarizes insights from clinical trials, and reflects on existing challenges for the development of complement therapeutics for kidney diseases and beyond.

  11. READING PHILEMON AS THERAPEUTIC NARRATIVE

    African Journals Online (AJOL)

    2010-03-29

    Mar 29, 2010 ... harsh treatment of slaves in the early Christian environment) and a challenging narrative (a more humane conduct of ... therapeutic, it has also proved to be a useful perspective from which to conduct a literary analysis, because it can ...... The Cambridge companion to postmodern theology, pp. 186−202,.

  12. Therapeutic approaches to genetic disorders

    African Journals Online (AJOL)

    salah

    Although prevention is the ideal goal for genetic disorders, various types of therapeutic management are available. Such management approaches depend on the nature of the defect, how well it is understood at the genetic and bio- chemical levels and the practical feasibility of correction. In some conditions.

  13. Therapeutic balloon-assisted enteroscopy

    NARCIS (Netherlands)

    H. Aktas (Huseyin); P.B.F. Mensink (Peter)

    2009-01-01

    textabstractSince the introduction of the first balloon-based enteroscopic technique in 2001, therapeutic balloon-assisted enteroscopy (BAE) using either the single or double balloon enteroscopy technique (respectively SBE and DBE) has evolved rapidly. Argon plasma coagulation (APC), polypectomy,

  14. The renaissance of complement therapeutics

    Science.gov (United States)

    Ricklin, Daniel; Mastellos, Dimitrios C.; Reis, Edimara S.; Lambris, John D.

    2018-01-01

    The increasing number of clinical conditions that involve a pathological contribution from the complement system — many of which affect the kidneys — has spurred a regained interest in therapeutic options to modulate this host defence pathway. Molecular insight, technological advances, and the first decade of clinical experience with the complement-specific drug eculizumab, have contributed to a growing confidence in therapeutic complement inhibition. More than 20 candidate drugs that target various stages of the complement cascade are currently being evaluated in clinical trials, and additional agents are in preclinical development. Such diversity is clearly needed in view of the complex and distinct involvement of complement in a wide range of clinical conditions, including rare kidney disorders, transplant rejection and haemodialysis-induced inflammation. The existing drugs cannot be applied to all complement-driven diseases, and each indication has to be assessed individually. Alongside considerations concerning optimal points of intervention and economic factors, patient stratification will become essential to identify the best complement-specific therapy for each individual patient. This Review provides an overview of the therapeutic concepts, targets and candidate drugs, summarizes insights from clinical trials, and reflects on existing challenges for the development of complement therapeutics for kidney diseases and beyond. PMID:29199277

  15. A radioisotope-nondependent high-sensitivity method for measuring the activity of glioblastoma-related O(6)-methylguanine DNA methyltransferase.

    Science.gov (United States)

    Hongo, Aya; Gu, Ran; Suzuki, Miho; Nemoto, Naoto; Nishigaki, Koichi

    2015-07-01

    O(6)-Methylguanine DNA methyltransferase (MGMT) cancels the anticancer effect of temozolomide (drug for glioblastoma), which introduces methylation to DNA. Therefore, developing an MGMT inhibitor is a promising strategy for the treatment of this cancer. For this purpose, a sensitive detection method that does not depend on the conventional radioisotope (RI) method was developed. This was realized by a fluorescence-based method that measured the amount of cleavable restriction sites demethylated by the action of MGMT; this method was enhanced by introducing a polymerase chain reaction (PCR) amplification step. As an assay of enzyme activity, 20-fold higher sensitivity (subnanomolar) was attained compared with our and others' fluorescence-based approaches. Copyright © 2014 Elsevier Inc. All rights reserved.

  16. Radioisotopic Purity of Sodium Pertechnetate 99mTc Produced with a Medium-Energy Cyclotron: Implications for Internal Radiation Dose, Image Quality, and Release Specifications.

    Science.gov (United States)

    Selivanova, Svetlana V; Lavallée, Éric; Senta, Helena; Caouette, Lyne; Sader, Jayden A; van Lier, Erik J; Zyuzin, Alexander; van Lier, Johan E; Guérin, Brigitte; Turcotte, Éric; Lecomte, Roger

    2015-10-01

    Cyclotron production of 99mTc is a promising route to supply 99mTc radiopharmaceuticals. Higher 99mTc yields can be obtained with medium-energy cyclotrons in comparison to those dedicated to PET isotope production. To take advantage of this capability, evaluation of the radioisotopic purity of 99mTc produced at medium energy (20-24 MeV) and its impact on image quality and dosimetry was required. Thick 100Mo (99.03% and 99.815%) targets were irradiated with incident energies of 20, 22, and 24 MeV for 2 or 6 h. The targets were processed to recover an effective thickness corresponding to approximately 5-MeV energy loss, and the resulting sodium pertechnetate 99mTc was assayed for chemical, radiochemical, and radionuclidic purity. Radioisotopic content in final formulation was quantified using γ-ray spectrometry. The internal radiation dose for 99mTc-pertechnetate was calculated on the basis of experimentally measured values and biokinetic data in humans. Planar and SPECT imaging were performed using thin capillary and water-filled Jaszczak phantoms. Extracted sodium pertechnetate 99mTc met all provisional quality standards. The formulated solution for injection had a pH of 5.0-5.5, contained greater than 98% of radioactivity in the form of pertechnetate ion, and was stable for at least 24 h after formulation. Radioisotopic purity of 99mTc produced with 99.03% enriched 100Mo was greater than 99.0% decay corrected to the end of bombardment (EOB). The radioisotopic purity of 99mTc produced with 99.815% enriched 100Mo was 99.98% or greater (decay corrected to the EOB). The estimated dose increase relative to 99mTc without any radionuclidic impurities was below 10% for sodium pertechnetate 99mTc produced from 99.03% 100Mo if injected up to 6 h after the EOB. For 99.815% 100Mo, the increase in effective dose was less than 2% at 6 h after the EOB and less than 4% at 15 h after the EOB when the target was irradiated at an incident energy of 24 MeV. Image spatial resolution

  17. Light-Weight Radioisotope Heater Unit final safety analysis report (LWRHU-FSAR): Volume 1: A. Introduction and executive summary: B. Reference Design Document (RDD)

    Energy Technology Data Exchange (ETDEWEB)

    Johnson, E.W.

    1988-10-01

    The orbiter and probe portions of the National Aeronautics and Space Administration (NASA) Galileo spacecraft contain components which require auxiliary heat during the mission. To meet these needs, the Department of Energy's (DOE's) Office of Special Applications (OSA) has sponsored the design, fabrication, and testing of a one-watt encapsulated plutonium dioxide-fueled thermal heater named the Light-Weight Radioisotope Heater Unit (LWRHU). This report, prepared by Monsanto Research Corporation (MRC), addresses the radiological risks which might be encountered by people both at the launch area and worldwide should postulated mission failures or malfunctions occur, resulting in the release of the LWRHUs to the environment. Included are data from the design, mission descriptions, postulated accidents with their consequences, test data, and the derived source terms and personnel exposures for the various events. 11 refs., 44 figs., 11 tabs.

  18. An approach to design a 90Sr radioisotope thermoelectric generator using analytical and Monte Carlo methods with ANSYS, COMSOL, and MCNP.

    Science.gov (United States)

    Khajepour, Abolhasan; Rahmani, Faezeh

    2017-01-01

    In this study, a 90Sr radioisotope thermoelectric generator (RTG) with power of milliWatt was designed to operate in the determined temperature (300-312K). For this purpose, the combination of analytical and Monte Carlo methods with ANSYS and COMSOL software as well as the MCNP code was used. This designed RTG contains 90Sr as a radioisotope heat source (RHS) and 127 coupled thermoelectric modules (TEMs) based on bismuth telluride. Kapton (2.45mm in thickness) and Cryotherm sheets (0.78mm in thickness) were selected as the thermal insulators of the RHS, as well as a stainless steel container was used as a generator chamber. The initial design of the RHS geometry was performed according to the amount of radioactive material (strontium titanate) as well as the heat transfer calculations and mechanical strength considerations. According to the Monte Carlo simulation performed by the MCNP code, approximately 0.35 kCi of 90Sr is sufficient to generate heat power in the RHS. To determine the optimal design of the RTG, the distribution of temperature as well as the dissipated heat and input power to the module were calculated in different parts of the generator using the ANSYS software. Output voltage according to temperature distribution on TEM was calculated using COMSOL. Optimization of the dimension of the RHS and heat insulator was performed to adapt the average temperature of the hot plate of TEM to the determined hot temperature value. This designed RTG generates 8mW in power with an efficiency of 1%. This proposed approach of combination method can be used for the precise design of various types of RTGs. Copyright © 2016 Elsevier Ltd. All rights reserved.

  19. Estimation of the contribution of gamma-emission of incorporated cesium radioisotopes in interpretation of the results of the public survey to assess the thyroidal iodine content following a radiation accident at the nuclear power plant

    Directory of Open Access Journals (Sweden)

    Shinkarev S.M.

    2014-12-01

    Full Text Available Aim. A detail consideration has been done to assess an importance of the contribution of gamma-emission of incorporated cesium radioisotopes to the exposure rate measured near the thyroid by the public survey for following the Chernobyl accident. Empirical ratios have been derived to take into account that contribution under interpretation of the results of survey meter monitoring of the public. Materials and methods. Model calculations for typical radionuclide intake by the residents living in contaminated territories after the Chernobyl accident have been carried out in order to assess the contribution of gamma-emission of incorporated cesium radioisotopes to the exposure rate measured near the thyroid by the survey. Under such calculations two the most important modes of intake have been considered: 1 inhalation and 2 ingestion with cow milk. Results. According to the estimates received the contribution of gamma-emission of incorporated cesium radioisotopes to the exposure rate measured near the thyroid during the first 20 days does not exceed 20% for the residents of southern areas of Gomel region and 30% for the residents of Mogil'yov region. During 60 days following the accident that contribution is estimated to be within (50-80 % for the residents of southern areas of Gomel region and (80-95 % for the residents of Mogil'yov region. Conclusion. For the period of intensive thyroid measuring in the southern areas of Gomel region (the second part of May account of the contribution of gamma-emission of incorporated cesium radioisotopes is relatively unimportant, but for Mogil'yov region (the end of May — it is important to account for. For the thyroid measurements conducted in June of 1986 it is important for all residents living in Belarus to take into account the contribution of gamma-emission of incorporated cesium radioisotopes.

  20. Therapeutic approaches for celiac disease

    Science.gov (United States)

    Plugis, Nicholas M.; Khosla, Chaitan

    2015-01-01

    Celiac disease is a common, lifelong autoimmune disorder for which dietary control is the only accepted form of therapy. A strict gluten-free diet is burdensome to patients and can be limited in efficacy, indicating there is an unmet need for novel therapeutic approaches to supplement or supplant dietary therapy. Many molecular events required for disease pathogenesis have been recently characterized and inspire most current and emerging drug-discovery efforts. Genome-wide association studies (GWAS) confirm the importance of human leukocyte antigen genes in our pathogenic model and identify a number of new risk loci in this complex disease. Here, we review the status of both emerging and potential therapeutic strategies in the context of disease pathophysiology. We conclude with a discussion of how genes identified during GWAS and follow-up studies that enhance susceptibility may offer insight into developing novel therapies. PMID:26060114

  1. Therapeutic Dancing for Parkinson's Disease

    Directory of Open Access Journals (Sweden)

    Lorenna Pryscia Carvalho Aguiar

    2016-06-01

    Full Text Available Therapeutic dancing has been advocated as an effective adjunct to conventional physical therapies for people living with Parkinson's disease (PD. This systematic review evaluates studies on the outcomes of different dance genres on mobility and quality of life in PD. We searched databases including CINHAL (1982–2015, Medline (1922–2015, Scopus (1996–2015, Web of Science (2002–2015, Embase (2007–2015, PEDro (1999–2015 and the Cochrane Library (1996–2015. The key words were: Parkinson's disease, Parkinson*, Parkinsonism, dance, dance therapy, dance genres, safety, feasibility, and quality of life. Two independent investigators reviewed the texts. Only randomized controlled trials, quasirandomized controlled trials, and case series studies were included. There was emerging evidence that therapeutic dance can be safe and feasible for people with mild to moderately severe PD, with beneficial effects on walking, freezing of gait, and health related quality of life.

  2. Therapeutic drug monitoring: antiarrhythmic drugs

    OpenAIRE

    Campbell, T. J.; Williams, K. M.(Virginia Polytechnic Institute and State University, 24061, Blacksburg, VA, USA)

    1998-01-01

    Antiarrhythmic agents are traditionally classified according to Vaughan Williams into four classes of action. Class I antiarrhythmic agents include most of the drugs traditionally thought of as antiarrhythmics, and have as a common action, blockade of the fast-inward sodium channel on myocardium. These agents have a very significant toxicity, and while they are being used less, therapeutic drug monitoring (TDM) does significantly increase the safety with which they can be administered. Class ...

  3. Potential Therapeutic Effects of Psilocybin.

    Science.gov (United States)

    Johnson, Matthew W; Griffiths, Roland R

    2017-07-01

    Psilocybin and other 5-hydroxytryptamine2A agonist classic psychedelics have been used for centuries as sacraments within indigenous cultures. In the mid-twentieth century they were a focus within psychiatry as both probes of brain function and experimental therapeutics. By the late 1960s and early 1970s these scientific inquires fell out of favor because classic psychedelics were being used outside of medical research and in association with the emerging counter culture. However, in the twenty-first century, scientific interest in classic psychedelics has returned and grown as a result of several promising studies, validating earlier research. Here, we review therapeutic research on psilocybin, the classic psychedelic that has been the focus of most recent research. For mood and anxiety disorders, three controlled trials have suggested that psilocybin may decrease symptoms of depression and anxiety in the context of cancer-related psychiatric distress for at least 6 months following a single acute administration. A small, open-label study in patients with treatment-resistant depression showed reductions in depression and anxiety symptoms 3 months after two acute doses. For addiction, small, open-label pilot studies have shown promising success rates for both tobacco and alcohol addiction. Safety data from these various trials, which involve careful screening, preparation, monitoring, and follow-up, indicate the absence of severe drug-related adverse reactions. Modest drug-related adverse effects at the time of medication administration are readily managed. US federal funding has yet to support therapeutic psilocybin research, although such support will be important to thoroughly investigate efficacy, safety, and therapeutic mechanisms.

  4. Thermodynamic aspects of therapeutic hypothermia.

    Science.gov (United States)

    Vanlandingham, Sean C; Kurz, Michael C; Wang, Henry E

    2015-01-01

    Therapeutic hypothermia (TH) is an important treatment for post-cardiac arrest syndrome. Despite its widespread practice, only limited data describe the thermodynamic aspects of heat transfer during TH. This paper reviews the principles of human body heat balance and provides a conceptual model for characterizing heat exchange during TH. The model may provide a framework for computer simulation for improving training in or clinical methods of TH. Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

  5. Therapeutic advances in muscular dystrophy

    OpenAIRE

    Leung, Doris G; Wagner, Kathryn R

    2013-01-01

    The muscular dystrophies comprise a heterogeneous group of genetic disorders that produce progressive skeletal muscle weakness and wasting. There has been rapid growth and change in our understanding of these disorders in recent years, and advances in basic science are being translated into increasing numbers of clinical trials. This review will discuss therapeutic developments in 3 of the most common forms of muscular dystrophy: Duchenne muscular dystrophy, facioscapulohumeral muscular dystr...

  6. Conotoxins that Confer Therapeutic Possibilities

    Directory of Open Access Journals (Sweden)

    John A. C. Archer

    2012-06-01

    Full Text Available Cone snails produce a distinctive repertoire of venom peptides that are used both as a defense mechanism and also to facilitate the immobilization and digestion of prey. These peptides target a wide variety of voltage- and ligand-gated ion channels, which make them an invaluable resource for studying the properties of these ion channels in normal and diseased states, as well as being a collection of compounds of potential pharmacological use in their own right. Examples include the United States Food and Drug Administration (FDA approved pharmaceutical drug, Ziconotide (Prialt®; Elan Pharmaceuticals, Inc. that is the synthetic equivalent of the naturally occurring ω-conotoxin MVIIA, whilst several other conotoxins are currently being used as standard research tools and screened as potential therapeutic drugs in pre-clinical or clinical trials. These developments highlight the importance of driving conotoxin-related research. A PubMed query from 1 January 2007 to 31 August 2011 combined with hand-curation of the retrieved articles allowed for the collation of 98 recently identified conotoxins with therapeutic potential which are selectively discussed in this review. Protein sequence similarity analysis tentatively assigned uncharacterized conotoxins to predicted functional classes. Furthermore, conotoxin therapeutic potential for neurodegenerative disorders (NDD was also inferred.

  7. Avian Diagnostic and Therapeutic Antibodies

    Energy Technology Data Exchange (ETDEWEB)

    Bradley, David Sherman [UND SMHS

    2012-12-31

    A number of infectious agents have the potential of causing significant clinical symptomology and even death, but dispite this, the number of incidence remain below the level that supports producing a vaccine. Therapeutic antibodies provide a viable treatment option for many of these diseases. We proposed that antibodies derived from West Nile Virus (WNV) immunized geese would be able to treat WNV infection in mammals and potential humans. We demonstrated that WNV specific goose antibodies are indeed successful in treating WNV infection both prophylactically and therapeutically in a golden hamster model. We demonstrated that the goose derived antibodies are non-reactogenic, i.e. do not cause an inflammatory response with multiple exposures in mammals. We also developed both a specific pathogen free facility to house the geese during the antibody production phase and a patent-pending purification process to purify the antibodies to greater than 99% purity. Therefore, the success of these study will allow a cost effective rapidly producible therapeutic toward clinical testing with the necessary infrastructure and processes developed and in place.

  8. Therapeutic Applications of Carbon Monoxide

    Science.gov (United States)

    Knauert, Melissa; Vangala, Sandeep; Haslip, Maria; Lee, Patty J.

    2013-01-01

    Heme oxygenase-1 (HO-1) is a regulated enzyme induced in multiple stress states. Carbon monoxide (CO) is a product of HO catalysis of heme. In many circumstances, CO appears to functionally replace HO-1, and CO is known to have endogenous anti-inflammatory, anti-apoptotic, and antiproliferative effects. CO is well studied in anoxia-reoxygenation and ischemia-reperfusion models and has advanced to phase II trials for treatment of several clinical entities. In alternative injury models, laboratories have used sepsis, acute lung injury, and systemic inflammatory challenges to assess the ability of CO to rescue cells, organs, and organisms. Hopefully, the research supporting the protective effects of CO in animal models will translate into therapeutic benefits for patients. Preclinical studies of CO are now moving towards more complex damage models that reflect polymicrobial sepsis or two-step injuries, such as sepsis complicated by acute respiratory distress syndrome. Furthermore, co-treatment and post-treatment with CO are being explored in which the insult occurs before there is an opportunity to intervene therapeutically. The aim of this review is to discuss the potential therapeutic implications of CO with a focus on lung injury and sepsis-related models. PMID:24648866

  9. Conotoxins that confer therapeutic possibilities

    KAUST Repository

    Essack, Magbubah

    2012-06-04

    Cone snails produce a distinctive repertoire of venom peptides that are used both as a defense mechanism and also to facilitate the immobilization and digestion of prey. These peptides target a wide variety of voltage- and ligand-gated ion channels, which make them an invaluable resource for studying the properties of these ion channels in normal and diseased states, as well as being a collection of compounds of potential pharmacological use in their own right. Examples include the United States Food and Drug Administration (FDA) approved pharmaceutical drug, Ziconotide (Prialt; Elan Pharmaceuticals, Inc.) that is the synthetic equivalent of the naturally occurring ?-conotoxin MVIIA, whilst several other conotoxins are currently being used as standard research tools and screened as potential therapeutic drugs in pre-clinical or clinical trials. These developments highlight the importance of driving conotoxin-related research. A PubMed query from 1 January 2007 to 31 August 2011 combined with hand-curation of the retrieved articles allowed for the collation of 98 recently identified conotoxins with therapeutic potential which are selectively discussed in this review. Protein sequence similarity analysis tentatively assigned uncharacterized conotoxins to predicted functional classes. Furthermore, conotoxin therapeutic potential for neurodegenerative disorders (NDD) was also inferred. 2012 by the authors; licensee MDPI.

  10. Conotoxins: Therapeutic Potential and Application

    Directory of Open Access Journals (Sweden)

    Richard T. Layer

    2006-04-01

    Full Text Available The pharmacological variety of conotoxins, diverse peptides found in the venoms of marine cone snails, is well recognized. Venoms from each of the estimated 500 species of cone snails contain 50 to 200 distinct biologically active peptides. Most conotoxins characterized to date target receptors and ion channels of excitable tissues, such as ligandgated nicotinic acetylcholine, N-methyl-D-aspartate, and type 3 serotonin receptors, as well as voltage-gated calcium, sodium, and potassium channels, and G-protein-coupled receptors including α-adrenergic, neurotensin, and vasopressin receptors, and the norepinephrine transporter. Several conotoxins have shown promise in preclinical models of pain, convulsive disorders, stroke, neuromuscular block, and cardioprotection. The pharmacological selectivity of the conotoxins, coupled with the safety and efficacy demonstrated in preclinical models, has led to their investigation as human therapeutic agents. In the following review, we will survey the pharmacology and therapeutic rationale of those conotoxins with potential clinical application, and discuss the unique challenges that each will face in the course of their transition from venom component to human therapeutic.

  11. Zircon Geochronology (U-Pb, Petrography, Geochemistry and Radioisotopes of Bornaward Metarhyolites (Central Taknar Zone-Northwest of Bardaskan

    Directory of Open Access Journals (Sweden)

    Reza Monazzami Bagherzadeh

    2016-07-01

    Full Text Available Introduction The Bornaward area is located in the Northeastern Iran (in the Khorasan Razavi province 28 km northwest of the city of Bardaskan at 57˚ 46΄ to 57˚ 52΄ N latitude and 35˚ 21΄ to 35˚ 24΄E longitude. The Taknar structural zone, situated in the North central Iranian micro continent, is part of the Lut block (Forster, 1978. The Taknar zone is an allochthonous block bounded by the Darouneh and Taknar major faults. Much of this zone consists of metarhyolite-rhyodacite volcanic rocks, and rhyolitic tuff with interlayers of sandstone and dolomite (Taknar Formation. Analytical Results ICP-MS analysis of REE and minor elements of samples of the Bornaward metarhyolites was carried out at the ACME Laboratory in Vancouver, Canada. U-Pb dating of the metarhyolites was performed on isolated zircons in Crohn's Laser Lab, in Arizona (Gehrels et al., 2008. Measurement of Rb, Sr, Sm and Nd isotopes and (143Nd/144Ndi and (87Sr/86Sri ratios took place in the radioisotope laboratory of the University of Aveiro in Portugal. Petrography The volcanic rocks are porphyritic, commonly containing phenocrysts of orthoclase and rarely sanidine, quartz and intermediate plagioclase in a groundmass of fine-grained quartz and feldspar. An alteration has produced oriented needles of sericite and clay minerals, clusters of fine-grained green biotite and clots of epidote and chlorite. Geochemistry The compositions of the volcanic rocks are calc alkaline and high K- calc alkaline. The obtained Shand index (Al2O3/( CaO+Na2O+K2O is above 1.1, in the peraluminous S-type granite field (Chappell and White, 2001. Plotted on the TAS diagram (Middlemost, 1994, all the metarhyolite-rhyodacite samples are located in the sub-alkaline field and the majority fall into the rhyolite group. The metarhyolite-rhyodacites show enrichment of LREE with a moderately ascending pattern ((La/YbN=2.51-10.11 and La=46.45-145.48. Europium shows a negative anomaly (Eu/Eu*=0.23-0.71. U

  12. Individualised cancer therapeutics: dream or reality? Therapeutics construction.

    Science.gov (United States)

    Shen, Yuqiao; Senzer, Neil; Nemunaitis, John

    2005-11-01

    The analysis of DNA microarray and proteomic data, and the subsequent integration into functional expression sets, provides a circuit map of the hierarchical cellular networks responsible for sustaining the viability and environmental competitiveness of cancer cells, that is, their robust systematics. These technologies can be used to 'snapshot' the unique patterns of molecular derangements and modified interactions in cancer, and allow for strategic selection of therapeutics that best match the individual profile of the tumour. This review highlights technology that can be used to selectively disrupt critical molecular targets and describes possible vehicles to deliver the synthesised molecular therapeutics to the relevant cellular compartments of the malignant cells. RNA interference (RNAi) involves a group of evolutionarily conserved gene silencing mechanisms in which small sequences of double-stranded RNA or intrinsic antisense RNA trigger mRNA cleavage or translational repression, respectively. Although RNAi molecules can be synthesised to 'silence' virtually any gene, even if upregulated, a mechanism for selective delivery of RNAi effectors to sites of malignant disease remains challenging. The authors will discuss gene-modified conditionally replicating viruses as candidate vehicles for the delivery of RNAi.

  13. [Therapeutic possibilities after traumatic experiences].

    Science.gov (United States)

    Kapfhammer, Hans-Peter

    2008-12-01

    Acute stress disorder (ASD) and posttraumatic stress disorder (PTSD) are frequent, but not obligatory psychological sequelae following trauma. A major subgroup of patients face a chronic course of illness associated with an increased psychiatric comorbidity and significant impairments in psychosocial adaptation. The typical psychopathological symptoms of ASD and PTSD are best described within a multifactorial model integrating both neurobiological and psychosocial influences. The complex etiopathogenesis of acute and posttraumatic stress disorder favours multimodal approaches in the treatment. Differential psychotherapeutic and pharmacological strategies are available. In a critical survey on empirical studies, psychological debriefing cannot be considered as a positive approach to be recommended as general preventive measure during the immediate posttraumatic phase. Positive effects of cognitive-behavioral interventions can be established for ASD. Psychodynamic psychotherapy, cognitive-behavioral therapy and EMDR show promising results in the treatment of PTSD. Major clinical restrictions of patient sampling within special research facilities, however, do not allow an unconditional generalization of these data to psychiatric routine care. In an empirical analysis the SSRIs are the most and best studied medications for ASD and PTSD. In comparison to tricyclic antidepressants SSRIs demonstrate a broader spectrum of therapeutic effects and are better tolerated. The substance classes of SSNRI, DAS, SARI and NaSSA are to be considered as drugs of second choice. They promise a therapeutic efficacy equivalent to the SSRIs, being investigated so far only in open studies. MAO-inhibitors may dispose of a positive therapeutic potential, their profile of side effects must be respected, however. Mood stabilizers and atypical neuroleptics may be used first and foremost in add-on strategies. Benzodiazepines should be used only with increased caution for a short time in states of

  14. Enactments in Psychoanalysis: Therapeutic Benefits.

    Science.gov (United States)

    Stern, Stanley

    The therapeutic benefits of enactments are addressed. Relevant literature reveals disparate conceptions about the nature and use of enactments. Clarification of the term is discussed. This analyst's theoretical and technical evolution is addressed; it is inextricably related to using enactments. How can it not be? A taxonomy of enactments is presented. The article considers that enactments may be fundamental in the evolution from orthodox to contemporary analytic technique. Assumptions underlying enactments are explored, as are guidelines for using enactments. Finally, the article posits that enactments have widened the scope of analysis and contributed to its vitality.

  15. Imaging of prehospital stroke therapeutics

    Science.gov (United States)

    Lin, Michelle P; Sanossian, Nerses; Liebeskind, David S

    2016-01-01

    Despite significant quality improvement efforts to streamline in-hospital acute stroke care in the conventional model, there remain inherent layers of treatment delays, which could be eliminated with prehospital diagnostics and therapeutics administered in a mobile stroke unit. Early diagnosis using Telestroke and neuroimaging while in the ambulance may enable targeted routing to hospitals with specialized care, which will likely improve patient outcomes. Key clinical trials in Telestroke, mobile stroke units with prehospital neuroimaging capability, prehospital ultrasound and co-administration of various classes of neuroprotectives, antiplatelets and antithrombin agents with intravenous thrombolysis are discussed in this article. PMID:26308602

  16. Bioengineering lantibiotics for therapeutic success

    Directory of Open Access Journals (Sweden)

    Des eField

    2015-11-01

    Full Text Available Several examples of highly modified antimicrobial peptides have been described. While many such peptides are non-ribosomally synthesized, ribosomally synthesised equivalents are being discovered with increased frequency. Of the latter group, the lantibiotics continue to attract most attention. In the present review, we discuss the implementation of in vivo and in vitro engineering systems to alter, and even enhance, the antimicrobial activity, antibacterial spectrum and physico-chemical properties, including heat stability, solubility, diffusion and protease resistance, of these compounds. Additionally, we discuss the potential applications of these lantibiotics for use as therapeutics.

  17. Therapeutic modality: rehabilitation of the injured athlete.

    Science.gov (United States)

    Nyland, John; Nolan, Michael F

    2004-04-01

    Traditional therapeutic modalities include cryotherapy, sonotherapy, pulsed electrical stimulation, transcutaneous electrical nerve stimulation, high-volt pulsed current, and iotopheresis. Alternative modalities include acupuncture, magnetic field therapy, biofeedback,and massage. All therapeutic modalities should be considered adjuncts to progressive functional exercise. Controlled studies rarely reach consensus regarding the efficacy of therapeutic modalities,so their use should be individualized to the patient.

  18. Therapeutic drug monitoring, a practical application

    NARCIS (Netherlands)

    Kees Neef, C.; Touw, D.J.

    Therapeutic Drug Monitoring (TDM) is an indispensable tool in therapeutic handling and medication safety. A definition of TDM is: Therapeutic drug monitoring is a system of quality assurance of a drug management system, aiming that the right drug is given tot the right patient in the right dose in

  19. Therapeutic Robotics: A Technology Push

    Science.gov (United States)

    Krebs, Hermano Igo; Hogan, Neville

    2009-01-01

    In this paper, we present a retrospective and chronological review of our efforts to revolutionize the way physical medicine is practiced by developing and deploying therapeutic robots. We present a sample of our clinical results with well over 300 stroke patients, both inpatients and outpatients, proving that movement therapy has a measurable and significant impact on recovery following brain injury. Bolstered by this result, we embarked on a two-pronged approach: 1) to determine what constitutes best therapy practice and 2) to develop additional therapeutic robots. We review our robots developed over the past 15 years and their unique characteristics. All are configured both to deliver reproducible therapy but also to measure outcomes with minimal encumbrance, thus providing critical measurement tools to help unravel the key question posed under the first prong: what constitutes “best practice”? We believe that a “gym” of robots like these will become a central feature of physical medicine and the rehabilitation clinic within the next ten years. PMID:19779587

  20. [Therapeutic Aggressiveness and Liquid Oncology].

    Science.gov (United States)

    Barón Duarte, F J; Rodríguez Calvo, M S; Amor Pan, J R

    2017-01-01

    Aggressiveness criteria proposed in the scientific literature a decade ago provide a quality judgment and are a reference in the care of patients with advanced cancer, but their use is not generalized in the evaluation of Oncology Services. In this paper we analyze the therapeutic aggressiveness, according to standard criteria, in 1.001 patients with advanced cancer who died in our Institution between 2010 and 2013. The results seem to show that aggressiveness at the end of life is present more frequently than experts recommend. About 25% of patients fulfill at least one criterion of aggressiveness. This result could be explained by a liquid Oncology which does not prioritize the patient as a moral subject in the clinical appointment. Medical care is oriented to necessities and must be articulated in a model focused on dignity and communication. Its implementation through Advanced Care Planning, consideration of patient's values and preferences, and Limitation of therapeutic effort are ways to reduce aggressiveness and improve clinical practice at the end of life. We need to encourage synergic and proactive attitudes, adding the best of cancer research with the best clinical care for the benefit of human being, moral subject and main goal of Medicine.

  1. Clinical results in cachexia therapeutics.

    Science.gov (United States)

    Crawford, Jeffrey

    2016-05-01

    This article highlights recent developments in the area of cancer cachexia and therapeutic interventions. Therapeutic interventions in cancer cachexia have been guided by clinical studies focused on the central role of muscle and the increased use of CT imaging to measure the impact of skeletal muscle loss on clinical outcomes. At the translational level, a number of different model systems have emphasized the importance of blockade of tumor-induced inflammation and its potential impact on reversing the cachexia phenotype, including FN14, a receptor in the TNF pathway, as well as the parathyroid hormone-related protein. Clinical studies continue to demonstrate the importance of nutrition and exercise as part of a multimodality approach. Although a number of promising agents are being evaluated, both enobosarm, a selected androgen receptor modulator, and anamorelin, a ghrelin agonist have completed phase III trials. Both agents have shown significant impact on reversal of skeletal muscle loss, but inconsistent effect on physical function improvement. Anamorelin also has a positive effect on appetite and weight gain. Further analysis of these studies, along with regulatory guidance, will be critical in the further development of these and other promising agents in the clinical management of patients with cancer cachexia.

  2. Neonatal Encephalopathy: Update on Therapeutic Hypothermia and Other Novel Therapeutics.

    Science.gov (United States)

    McAdams, Ryan M; Juul, Sandra E

    2016-09-01

    Neonatal encephalopathy (NE) is a major cause of neonatal mortality and morbidity. Therapeutic hypothermia (TH) is standard treatment for newborns at 36 weeks of gestation or greater with intrapartum hypoxia-related NE. Term and late preterm infants with moderate to severe encephalopathy show improved survival and neurodevelopmental outcomes at 18 months of age after TH. TH can increase survival without increasing major disability, rates of an IQ less than 70, or cerebral palsy. Neonates with severe NE remain at risk of death or severe neurodevelopmental impairment. This review discusses the evidence supporting TH for term or near term neonates with NE. Copyright © 2016 Elsevier Inc. All rights reserved.

  3. SU-E-CAMPUS-I-03: Dosimetric Comparison of the Hypoxia Agent Iodoazomycin Arabinoside (IAZA) Labeled with the Radioisotopes I-123, I-131 and I-124

    Energy Technology Data Exchange (ETDEWEB)

    Jans, H-S [Cross Cancer Institute, Edmonton, AB (Canada); Dept. of Oncology, University of Alberta, Edmonton, AB (Canada); Stypinski, D [Celerion Inc., Lincoln, NE (United States); Mcquarrie, S; Kumar, P; Mercer, J; McEwan, S [Dept. of Oncology, University of Alberta, Edmonton, AB (Canada); Wiebe, L [Cross Cancer Institute, Edmonton, AB (Canada)

    2014-06-15

    Purpose: To compare the radiation dose to normal organs from the radio-iodinated, hypoxia-binding radiosensitizer iodoazomycin arabinoside (IAZA) for three different isotopes of iodine. Methods: Dosimety studies with normal volunteers had been carried out with [{sup 123}I]IAZA, a drug binding selectively to hypoxic sites. Two other isotopes of iodine, {sup 131}I and {sup 124}I, offer the opportunity to use IAZA as an agent for radioisotope therapy and as an imaging tracer for Positron Emission Tomography. Radioisotope dosimetry for {sup 131}I and {sup 124}I was performed by first deriving from the [{sup 123}I]IAZA studies biological uptake and excretion data. The cumulated activities for {sup 131}I or {sup 124}I where obtained by including their half-lives when integrating the biological data and then extrapolating to infinite time points considering a) physical decay only or b) physical and biological excretion. Doses were calculated using the Medical Internal Radiation Dose (MIRD) schema (OLINDA1.1 code, Vanderbilt 2007). Results: Compared to {sup 123}I, organ doses were elevated on average by a factor 6 and 9 for {sup 131}I and {sup 124}I, respectively, if both physical decay and biological excretion were modeled. If only physical decay is considered, doses increase by a factor 18 ({sup 131}I) and 19 ({sup 124}I). Highest organ doses were observed in intestinal walls, urinary bladder and thyroid. Effective doses increased by a factor 11 and 14 for {sup 131}I and {sup 124}I, respectively, if biological and physical decay are present. Purely physical decay yields a 23-fold increase over {sup 123}I for both, {sup 131}I and {sup 124}I. Conclusion: Owing to the significant dose increase, caused by their longer half life and the approximately 10 times larger electronic dose deposited in tissue per nuclear decay, normal tissue doses of IAZA labeled with {sup 131}I and {sup 124}I need to be carefully considered when designing imaging and therapy protocols for clinical

  4. The therapeutic relationship after psychiatric admission.

    LENUS (Irish Health Repository)

    Roche, Eric

    2014-03-01

    The therapeutic relationship is one of the most central and important factors in the treatment of mental health disorders. A better therapeutic relationship is associated with service engagement, medication adherence, and satisfaction with services. This study aimed to compare the demographic and clinical factors associated with the therapeutic relationship in voluntarily and involuntarily admitted psychiatric service users. We found that individuals who had been admitted involuntarily, who had a diagnosis of a psychotic disorder, and who reported higher levels of perceived pressures on admission were more likely to have a poorer therapeutic relationship with their consultant psychiatrist. Greater levels of insight and treatment satisfaction, together with higher levels of procedural justice experienced on admission, were associated with a better therapeutic relationship. We found that the level of perceived coercion on admission was not related to the therapeutic relationship. Targeted interventions to improve the therapeutic relationship, particularly for involuntarily admitted service users, are discussed.

  5. Therapeutic Plasmapheresis in Kidney Transplantation

    Directory of Open Access Journals (Sweden)

    Zeynep Kendi Celebi

    2013-02-01

    Full Text Available In 1960's, with succesfully renal transplantations, acute rejection became to be a serious problem for graft survival. From 1965 to 2010, with the introduction of new immunosuppressant agents such as cyclosporine, mycophenolate mofetile and tacrolimus, the acute rejection rates declined from 80% to 10% . There is an ongoing gradual improvement in allograft survival. Use of Therapeutic plasma exchange (TPE is not evidence based treatment, but TPE is necessary for pre- and also post transplantation in patients with DSA. TPE is also a main treatment for antibody mediated rejection (AMR , but in clinical practice the duration and frequency of TPE and individual difference of antibody production is unclear. There is a requirement for more specific antibody elimination. Further randomised controlled studies are needed to elucidate TPE use before and after kidney transplantation. [Dis Mol Med 2013; 1(1.000: 8-10

  6. Angiogenesis and Its Therapeutic Opportunities

    Directory of Open Access Journals (Sweden)

    So Young Yoo

    2013-01-01

    Full Text Available Angiogenesis plays critical roles in human physiology that range from reproduction and fetal growth to wound healing and tissue repair. The sophisticated multistep process is tightly regulated in a spatial and temporal manner by “on-off switch signals” between angiogenic factors, extracellular matrix components, and endothelial cells. Uncontrolled angiogenesis may lead to several angiogenic disorders, including vascular insufficiency (myocardial or critical limb ischemia and vascular overgrowth (hemangiomas, vascularized tumors, and retinopathies. Thus, numerous therapeutic opportunities can be envisaged through the successful understanding and subsequent manipulation of angiogenesis. Here, we review the clinical implications of angiogenesis and discuss pro- and antiangiogenic agents that offer potential therapy for cancer and other angiogenic diseases.

  7. [New therapeutic options in obesity].

    Science.gov (United States)

    Heufelder, A E

    2003-10-16

    The basis for a therapeutic concept for obesity comprises specific measures aimed at changing inappropriate lifestyle habits (overeating, unsuitable diet, sedentary lifestyle) and psychological counseling (identification of bad eating habits, motivation, intensive coaching). Education by a physician on an individual or small-group basis, with emphasis on the practical implementation of fitness training (endurance and muscle building!), together with modification of the diet, has proved successful. In parallel with this, supportive anti-obesity medication makes a useful contribution to weight reduction and the control of risk factors. Evidence-based anti-obesity drugs such as sibutramine and orlistat facilitate the start of weight reduction, thus providing additional motivation of success, and support the long-term effect by stabilizing the weight loss. Health insurance carriers should, in future, selectively support evaluated and approved medication-based and non-medication-based weight-reduction programs, and reimburse the patient who has successfully participated in one.

  8. Therapeutic Drug Monitoring of Lithium

    DEFF Research Database (Denmark)

    Mose, Tina; Damkier, Per; Petersen, Magnus

    2015-01-01

    BACKGROUND: Serum lithium is monitored to ensure levels within the narrow therapeutic window. This study examines the interlaboratory variation and inaccuracy of lithium monitoring in Denmark. METHODS: In 16 samples consisting of (1) control materials (n = 4), (2) pooled patient serum (n = 5......), and (3) serum from individual patients (n = 7), lithium was measured in 19 laboratories using 20 different instruments. The lithium concentrations were targeted by a reference laboratory. Ion-selective electrode (n = 5), reflective spectrophotometric (RSM, n = 5), and spectrophotometric (n = 10) methods...... of >12%. Seven of these instruments had a systematic positive or negative bias and more so at lower lithium concentrations. Three poorly calibrated instruments were found in the ion-selective electrode group, 3 in the spectrophotometric group, and 2 in the RSM group. The instruments using reflectance...

  9. Brain plasticity-based therapeutics

    Science.gov (United States)

    Merzenich, Michael M.; Van Vleet, Thomas M.; Nahum, Mor

    2014-01-01

    The primary objective of this review article is to summarize how the neuroscience of brain plasticity, exploiting new findings in fundamental, integrative and cognitive neuroscience, is changing the therapeutic landscape for professional communities addressing brain-based disorders and disease. After considering the neurological bases of training-driven neuroplasticity, we shall describe how this neuroscience-guided perspective distinguishes this new approach from (a) the more-behavioral, traditional clinical strategies of professional therapy practitioners, and (b) an even more widely applied pharmaceutical treatment model for neurological and psychiatric treatment domains. With that background, we shall argue that neuroplasticity-based treatments will be an important part of future best-treatment practices in neurological and psychiatric medicine. PMID:25018719

  10. Therapeutic interventions in cerebral palsy.

    Science.gov (United States)

    Patel, Dilip R

    2005-11-01

    Various therapeutic interventions have been used in the management of children with cerebral palsy. Traditional physiotherapy and occupational therapy are widely used interventions and have been shown to be of benefit in the treatment of cerebral palsy. Evidence in support of the effectiveness of the neurodevelopmental treatment is equivocal at best. There is evidence to support the use and effectiveness of neuromuscular electrical stimulation in children with cerebral palsy. The effectiveness of many other interventions used in the treatment of cerebral palsy has not been clearly established based on well-controlled trials. These include: sensory integration, body-weight support treadmill training, conductive education, constraint-induced therapy, hyperbaric oxygen therapy, and the Vojta method. This article provides an overview of salient aspects of popular interventions used in the management of children with cerebral palsy.

  11. Novel therapeutic approaches in chondrosarcoma.

    Science.gov (United States)

    Polychronidou, Genovefa; Karavasilis, Vasilios; Pollack, Seth M; Huang, Paul H; Lee, Alex; Jones, Robin L

    2017-03-01

    Chondrosarcoma is a malignant tumor of bones, characterized by the production of cartilage matrix. Due to lack of effective treatment for advanced disease, the clinical management of chondrosarcomas is exceptionally challenging. Current research focuses on elucidating the molecular events underlying the pathogenesis of this rare bone malignancy, with the goal of developing new molecularly targeted therapies. Signaling pathways suggested to have a role in chondrosarcoma include Hedgehog, Src, PI3k-Akt-mTOR and angiogenesis. Mutations in IDH1/2, present in more than 50% of primary conventional chondrosarcomas, make the development of IDH inhibitors a promising treatment option. The present review discusses the preclinical and early clinical data on novel targeted therapeutic approaches in chondrosarcoma.

  12. Host modulation by therapeutic agents

    Directory of Open Access Journals (Sweden)

    Sugumari Elavarasu

    2012-01-01

    Full Text Available Periodontal disease susceptible group present advanced periodontal breakdown even though they achieve a high standard of oral hygiene. Various destructive enzymes and inflammatory mediators are involved in destruction. These are elevated in case of periodontal destruction. Host modulation aims at bringing these enzymes and mediators to normal level. Doxycycline, nonsteroidal anti-inflammatory drugs (NSAIDs, bisphosphonates, nitrous oxide (NO synthase inhibitors, recombinant human interleukin-11 (rhIL-11, omega-3 fatty acid, mouse anti-human interleukin-6 receptor antibody (MRA, mitogen-activated protein kinase (MAPK inhibitors, nuclear factor-kappa B (NF-kb inhibitors, osteoprotegerin, and tumor necrosis factor antagonist (TNF-α are some of the therapeutic agents that have host modulation properties.

  13. Brain Plasticity-Based Therapeutics

    Directory of Open Access Journals (Sweden)

    Michael eMerzenich

    2014-06-01

    Full Text Available The primary objective of this review article is to summarize how the neuroscience of brain plasticity, exploiting new findings in fundamental, integrative and cognitive neuroscience, is changing the therapeutic landscape for professional communities addressing brain-based disorders and disease. After considering the neurological bases of training-driven neuroplasticity, we shall describe how this neuroscience-guided perspective distinguishes this new approach from a the more-behavioral, traditional clinical strategies of professional therapy practitioners, and b an even more widely applied pharmaceutical treatment model for neurological and psychiatric treatment domains. With that background, we shall argue that neuroplasticity-based treatments will be an important part of future best-treatment practices in neurological and psychiatric medicine.

  14. Guidelines for Rational Cancer Therapeutics

    Directory of Open Access Journals (Sweden)

    Byunghee Yoo

    2017-12-01

    Full Text Available Traditionally, cancer therapy has relied on surgery, radiation therapy, and chemotherapy. In recent years, these interventions have become increasingly replaced or complemented by more targeted approaches that are informed by a deeper understanding of the underlying biology. Still, the implementation of fully rational patient-specific drug design appears to be years away. Here, we present a vision of rational drug design for cancer that is defined by two major components: modularity and image guidance. We suggest that modularity can be achieved by combining a nanocarrier and an oligonucleotide component into the therapeutic. Image guidance can be incorporated into the nanocarrier component by labeling with a specific imaging reporter, such as a radionuclide or contrast agent for magnetic resonance imaging. While limited by the need for additional technological advancement in the areas of cancer biology, nanotechnology, and imaging, this vision for the future of cancer therapy can be used as a guide to future research endeavors.

  15. Harsh humour: a therapeutic discourse.

    Science.gov (United States)

    McCreaddie, May

    2010-11-01

    Humour research in healthcare has tended to focus on rehearsed as opposed to spontaneous humour. This paper reports an empirical example of spontaneous humour in healthcare interactions: a negative case analysis from a constructivist grounded theory study. Twenty Clinical Nurse Specialist (CNS)-patient interactions and CNS pre- and postinteraction audio diaries provided the baseline data corpus. Follow-up interviews, field notes, focus groups and observations serviced theory generation with a constant comparison approach to data collection and analyses. Interpretative and illustrative frameworks incorporating humour theories, non-laughter humour support, discursive features and prosodical features of speech were applied to all data. This paper is based upon the negative case comprising a 90-minute follow-up interview and 10 hours of field note observations. The negative case - a CNS working with female drug users' sexual and reproductive health needs - contradicted emerging findings from the baseline data corpus. First, the negative case had greater awareness of humour, deliberately initiated humour and recognised parameters and exclusion zones. Second, a good patient personal was evident in the baseline data corpus but the negative case worked with 'bad' patients. Accordingly, a specific type of humour - harsh humour - was evident in the negative case. Harsh humour used areas of potential discord (e.g. drug use) as a focus of humour creation and maintenance. The deliberate initiation of harsh humour enabled the negative case and her colleagues to achieve their aims by engaging effectively with unpredictable, reluctant and recalcitrant patients. The negative case demonstrates how humour can be used to therapeutically enhance healthcare interactions with disenfranchised individuals. Humour is not superficial but integral to the accomplishment of key aspects of interactions. Health and social care workers should consider the potential for therapeutic humour to engage

  16. Estimation of whole body bone resorption rate: a comparison of urinary total hydroxyproline excretion with two radioisotopic tracer methods in osteoporosis.

    Science.gov (United States)

    Deacon, A C; Hulme, P; Hesp, R; Green, J R; Tellez, M; Reeve, J

    1987-07-15

    In 37 female patients with primary osteoporosis, urinary hydroxyproline excretion, determined in 18 24-h consecutive complete urine collections was compared with two radioisotopic measurements of bone resorption rate measured simultaneously using 85Sr. A somewhat better fit was obtained when the kinetically determined bone resorption rate was corrected for long-term exchange processes within bone. Regression analysis showed that the intercept of the regression of hydroxyproline excretion on resorption rate, corrected or uncorrected for exchange, was significantly higher than zero at about 100 mumol/day. This is consistent with a substantial fraction of urinary hydroxyproline arising from non-bony sources. Fifteen paired studies were analysed and the results suggested that intra-individual variability in these relationships (when studies were separated by a year or more) were similar to inter-individual variability. We calculated the precision with which an estimate of bone resorption could be determined based on the calculated regressions. As a means of non-invasive quantitation of whole body bone resorption rate, the excretion rate of hydroxyproline, measured over 5 days, for example, appeared competitive with isotopic methods making no correction for exchange and relatively little worse than our exchange corrected method.

  17. Monte Carlo simulation for radioisotope production yields calculation and radiation shielding for Rh, RbCl, ZnO, and ga target

    Energy Technology Data Exchange (ETDEWEB)

    Ra, Se Jin; Jung, Myung Hwan; Kim, Kye Ryung [Korea Atomic Energy Research Institute, Daejeon (Korea, Republic of)

    2012-10-15

    The 100 MeV linear accelerator at the proton engineering frontier project (PEFP) will be operated with average current of 300 {mu}A for 100 MeV beam line and 600 {mu}A for 20 MeV beam line. With this high current proton beam, all proton beam irradiated targets may be highly radio-activated, so we will install hot cell for radiation work. In this paper, we simulated production yield of radioisotopes such as {sup 109}Pd, {sup 82}Sr, {sup 67}Cu, and {sup 68}Ge, so we used natural Rh, RbCl, ZnO, and Ga prototype target of 2-mm thickness. Proton beam irradiation condition is 1-{mu}A current and 1-hour irradiation at all target cases. Also we simulated radiation shielding calculation for 10 cm thickness lead plate. The Monte Carlo codes, MCNPX and PHITS, and the analyzing decay and build-up code, DCHAIN-SP were used to these calculations.

  18. Project and implantation of automation in irradiation systems for solid, liquid and gaseous targets in cyclotrons aiming the production of radioisotopes

    CERN Document Server

    Araujo, S G D

    2001-01-01

    Nowadays, two cyclotron are being operated at IPEN-CNEN/SP: one model CV-28, capable of accelerating p, d sup 3 He sub 4 and alpha, with energies of 24, 14, 36 and 28 MeV, respectively, and beam currents up to 30 mu A; the other one, model Cyclone 30, accelerates protons with energy of 30 MeV and currents up to 350 mu A. Both have the objective of irradiating targets both for radioisotopes production for use in nuclear medicine, such as sup 6 sup 7 Ga, sup 2 sup 0 sup 1 Tl, sup 1 sup 2 sup 3 I, sup 1 sup 8 F and general research. The development of irradiating systems completely automatic was the objective of this work, always aiming to reduce the radiation exposition dose to the workers and to increase the reliability of use of these systems, because very high activities are expected in these processes. In the automation, a Programmable Logical Controller (PCL) was used connected to a feedback net, to manage all the variables involved in the irradiation processes. The program of the PCL was developed using S...

  19. Prevention of significant deterioration permit application for the Fueled Clad Fabrication System, the Radioisotope Power Systems Facility, and the Fuel Assembly Area

    Energy Technology Data Exchange (ETDEWEB)

    1989-08-01

    This New Source Review'' has been submitted by the US Department of Energy-Richland Operations Office (PO Box 550, Richland, Washington 99352), pursuant to WAC 173-403-050 and in compliance with the Department of Ecology Guide to Processing A Prevention Of Significant Deterioration (PSD) Permit'' for three new sources of radionuclide emissions at the Hanford Site in Washington State. The three new sources, the Fueled Clad Fabrication System (FCFS), the Radioisotope Power Systems Facility (RPSF), and the Fuel Assembly Area (FAA), will be located in one facility, the Fuels and Materials Examination Facility (FMEF) of the 400 Area. The FMEF was originally designed to provide for post-irradiation examination and fabrication of breeder reactor fuels. These FMEF missions were cancelled before the introduction of any fuel materials or any irradiated material. The current plans are to use the facility to fabricate power supplies for use in space applications and to produce Fast Flux Test Facility (FFTF) fuel and target assemblies. The FCFS and the RPSF will produce materials and assemblies for application in space. The FAA project will produce FFTF fuel and target assemblies. The FCFS and the RPSF will share the same building, stack, and, in certain cases, the same floor space. Given this relationship, these systems will be dealt with separately to the extent possible. The FAA is a comparatively independent operation though it will share the FMEF complex.

  20. Triggering Collapse of the Presolar Dense Cloud Core and Injecting Short-lived Radioisotopes with a Shock Wave. V. Nonisothermal Collapse Regime

    Energy Technology Data Exchange (ETDEWEB)

    Boss, Alan P., E-mail: aboss@carnegiescience.edu [Department of Terrestrial Magnetism, Carnegie Institution for Science, 5241 Broad Branch Road, NW, Washington, DC 20015-1305 (United States)

    2017-08-01

    Recent meteoritical analyses support an initial abundance of the short-lived radioisotope (SLRI) {sup 60}Fe that may be high enough to require nucleosynthesis in a core-collapse supernova, followed by rapid incorporation into primitive meteoritical components, rather than a scenario where such isotopes were inherited from a well-mixed region of a giant molecular cloud polluted by a variety of supernovae remnants and massive star winds. This paper continues to explore the former scenario, by calculating three-dimensional, adaptive mesh refinement, hydrodynamical code (FLASH 2.5) models of the self-gravitational, dynamical collapse of a molecular cloud core that has been struck by a thin shock front with a speed of 40 km s{sup −1}, leading to the injection of shock front matter into the collapsing cloud through the formation of Rayleigh–Taylor fingers at the shock–cloud intersection. These models extend the previous work into the nonisothermal collapse regime using a polytropic approximation to represent compressional heating in the optically thick protostar. The models show that the injection efficiencies of shock front materials are enhanced compared to previous models, which were not carried into the nonisothermal regime, and so did not reach such high densities. The new models, combined with the recent estimates of initial {sup 60}Fe abundances, imply that the supernova triggering and injection scenario remains a plausible explanation for the origin of the SLRIs involved in the formation of our solar system.

  1. Reliability of radioisotope-guided sentinel lymph node biopsy in penile cancer: verification in consideration of the European guidelines.

    Science.gov (United States)

    Schubert, Tim; Uphoff, Jens; Henke, Rolf-Peter; Wawroschek, Friedhelm; Winter, Alexander

    2015-09-28

    these circumstances, patients can be spared from higher morbidity without compromising the detection of LN metastases or therapeutic implications. Improvement of the methodology used to perform DSNB should be developed further to decrease the risk of missing LN metastases and to simplify the procedure.

  2. Translational nanomedicine--through the therapeutic window.

    Science.gov (United States)

    Pierce, Robin L

    2015-01-01

    Translational nanomedicine occurs only through the successful integration of multiple inputs and iterative modifications. The therapeutic window plays a pivotal role in the trajectory of translational nanomedicine. Often defined in terms of the range of dosage for safe and effective therapeutic effect, a second definition of the therapeutic window refers to the often narrow temporal window in which a therapeutic effect can be obtained. Expanding the second definition to explicitly include the spatial dimension, this article explores aspects of the therapeutic spaces created by nanomedicine that shift the traditional dimensions of symptom, sign and pathology. This article analyzes three aspects of the therapeutic window in nanomedicine - temporal, spatial and manner of construction and their impact on the dimensions of modern medicine.

  3. Novel therapeutics for Stargardt disease.

    Science.gov (United States)

    Lu, Louise J; Liu, Ji; Adelman, Ron A

    2017-06-01

    Stargardt disease, an inherited macular dystrophy caused by mutations in the ABCA4 gene encoding a retinal transporter protein, is the most prevalent form of macular degeneration in children. Patients with Stargardt disease develop severe vision loss within their first or second decades of life, which progresses to irreversible decreased visual acuity in almost all cases. Presently, there are no standard treatments for Stargardt disease. However, encouraging progress has been made in the development of innovative approaches to preventing vision loss in Stargardt patients. Among the promising treatment candidates include ALK-001, fenretinide, and A1120 as pharmacological agents to modulate the visual cycle, StarGen(TM) as a vector for supplementation of a functional ABCA4 gene, and stem-cell transplantation of hESC-RPE cells for regeneration of the retinal pigment epithelium. This study aims to systematically review and summarize evidence concerning the most up-to-date developments in pharmacologic, gene, and stem-cell therapies as novel therapeutic strategies to improve vision for patients with Stargardt disease.

  4. Therapeutic plasma exchange in Casablanca.

    Science.gov (United States)

    Tazi, I; Merimi, F; Majd, A; Benchemsi, N

    2008-08-01

    Therapeutic plasma exchange (TPE) is an extracorporeal blood purification method for the treatment of diseases in which pathological proteins have to be eliminated. In the aim to demonstrate our single center activity, we analyzed our data since 2 years. Between years 2002 and 2005, 104 TPE procedures were performed on 42 patients. Median age and male/female ratio were 32 (range, 17-56) and 24/18, respectively. Departments those referred the majority of the TPE were neurology (n=32), nephrology (n=5) and intensive care unit (n=5). The most common indications were: polyradiculoneuropathies (53%), myasthenia gravis (17%) and Guillain-Barré syndrome (12%). The median TPE procedure per patient was 2.3 (range, 1-10). In the majority of patients, vascular access was provided by puncture of two large, durable peripheral antecubital veins. The procedures were performed with the "Haemonetic Ultralight" discontinuous flow cell separator devices. Citrate solution was used as an anticoagulant in all cases. The substitution fluids most often used in our unit are Albumin 20% solution (92 times), Albumin 4% (10 times) and fresh frozen plasma (twice). Seventy five percent of the patients showed improvement, 7% remained the same and 18% worsened. Thirteen adverse reactions were recorded. The creation of a national registry by the local society is a vital move to improve TPE practice in our country.

  5. Therapeutic drug monitoring: antiarrhythmic drugs

    Science.gov (United States)

    Campbell, T J; Williams, K M

    1998-01-01

    Antiarrhythmic agents are traditionally classified according to Vaughan Williams into four classes of action. Class I antiarrhythmic agents include most of the drugs traditionally thought of as antiarrhythmics, and have as a common action, blockade of the fast-inward sodium channel on myocardium. These agents have a very significant toxicity, and while they are being used less, therapeutic drug monitoring (TDM) does significantly increase the safety with which they can be administered. Class II agents are antisympathetic drugs, particularly the β-adrenoceptor blockers. These are generally safe agents which do not normally require TDM. Class III antiarrhythmic agents include sotalol and amiodarone. TDM can be useful in the case of amiodarone to monitor compliance and toxicity but is generally of little value for sotalol. Class IV antiarrhythmic drugs are the calcium channel blockers verapamil and diltiazem. These are normally monitored by haemodynamic effects, rather than using TDM. Other agents which do not fall neatly into the Vaughan Williams classification include digoxin and perhexiline. TDM is very useful for monitoring the administration (and particularly the safety) of both of these agents. PMID:9803978

  6. Therapeutic outcomes of retinal hemangioblastomas.

    Science.gov (United States)

    Kim, Hyesun; Yi, Jeong H; Kwon, Hee J; Lee, Christopher S; Lee, Sung C

    2014-12-01

    To report the results of treatments and therapeutic complications of retinal hemangioblastomas (RH). Retrospective consecutive case series. Data from 32 patients (37 eyes) with RH were reviewed for characteristics of RH and treatment outcomes. Among 32 patients, we identified 73 RHs in 37 eyes. At baseline, 24 of 37 eyes (65%) had 20/50 visual acuity or better, 8 eyes (22%) had intermediate vision (20/400-20/50), and 5 eyes (13%) had poor vision (≤20/400). Seven RHs (9.6%) were located in the juxtapapillary area, and 66 RHs (90.4%) were located in peripheral area. Small RHs (54.8%; thermotherapy, and large RHs (20.5%; >3.0 mm in size) were treated with a combination of transpupillary thermotherapy and cryotherapy. After treatment, 90% of small RHs regressed, whereas only 67% of large RHs regressed (P = 0.044). Peripheral RHs showed better response to treatment than juxtapapillary RHs (P = 0.010). Treatment-related complications occurred in 5 eyes (14%), and 1-step combination therapy was applied more frequently in the complication group (P = 0.048). Small RHs in peripheral areas may require aggressive treatment because they respond well to treatment. In larger RHs, staged treatment could reduce treatment-related complications. Transpupillary thermotherapy could be an effective method in tumor regression for moderate-to-large-sized RHs showing tumor regression rate of 70%.

  7. [Probiotics and their therapeutic properties].

    Science.gov (United States)

    Ochmański, W; Barabasz, W

    1999-01-01

    Probiotics are specific products of microorganisms, and by being biologically active positively act on stabilizing the bacteriological flora of the gastrointestinal tract. They are live or lyophilized bacterial cultures, especially those derived from lactic fermentation (Lactobacillacea and Streptococcacea). The first to use the term probiotics were Lilly and Stillwell in 1965 when referring to substances produced by protozoa, which in turn stimulated the growth of other organisms. Probiotics are devoid of side affects and do not cause accumulation of toxic substances in the body. They are administered for therapeutic, prophylactic and nutritional purposes both in humans and in animals. Interest into probiotics has been spurred on by the growing abundance of civilization disorders such as neoplasms, atherosclerosis, heart disease, hypertension and HIV infection. Probiotics are potentially capable of annihilating these disorders. Starter cultures are pure mixed bacterial, fungal or mold cultures which by transformation of their metabolism faciliate favourable changes in apperance, aroma, consistency, and durability of foodstuffs. Contemporary knowledge concerning probiotics and their action is derived from many years of tradition in consumption of fermented milk products and the documentation of much research into strains of lactic bacteria, their harmless action on health and overall beneficial effect.

  8. Recent advances in rhinovirus therapeutics.

    Science.gov (United States)

    Charles, Catherine H; Yelmene, Michele; Luo, Guang X

    2004-12-01

    Human rhinoviruses are the major causative agents of the common cold. Because there are greater than 100 viral serotypes, little immunological protection is afforded to humans by prior rhinovirus exposure, which accounts for the high incidence of infection. In most cases, rhinovirus leads to a short self-limiting illness. However, for asthmatics, the elderly and immunocompromised patients, rhinovirus infection can lead to life-threatening complications. This has spurred a consistent effort over recent decades to identify effective treatments and preventions for rhinovirus infection. While some work has focused on alleviating the symptoms induced as a result of inflammatory pathways stimulated by rhinoviruses, the majority of the research has been focused on limiting or preventing viral infection altogether. Various approaches have been taken to halt rhinovirus infection. Prevention of virus-cell interaction has been the aim of research on viral capsid binders and cell receptor blockers. Interference with correct viral protein processing is the goal of the design and testing of protease inhibitors. Current work is attempting to interfere with viral RNA replication by testing silencing RNA molecules. In this review, we will discuss recent advances in the development and testing of human rhinovirus therapeutics.

  9. Melasma. Etiologic and therapeutic considerations.

    Science.gov (United States)

    Grimes, P E

    1995-12-01

    Melasma is a common acquired symmetric hypermelanosis characterized by irregular light- to gray-brown macules and patches involving sun-exposed areas of skin. Etiologic factors in the pathogenesis of melasma include genetic influences, exposure to UV radiation, pregnancy, hormonal therapies, cosmetics, phototoxic drugs, and antiseizure medications. Melasma is often a therapeutically challenging disease, and current treatments include hypopigmenting agents, chemical peels, and lasers. Hypopigmenting agents include phenolic and nonphenolic derivatives. Phenolic agents include hydroquinone and hydroquinone combination preparations. Despite controversies regarding the issue of hydroquinone-induced ochronosis, hydroquinone remains the most effective topically applied bleaching agent approved by the Food and Drug Administration for the treatment of melasma. Nonphenolic bleaching agents include tretinoin and azelaic acid. Superficial, medium, and deep chemical peels are more often used in lighter-complexioned patients. Such peels should be used with caution in blacks. Although lasers have demonstrated significant efficacy in the treatment of a variety of hyperpigmentary disorders, their precise efficacy and place in the therapy of melasma have yet to be established. In the hierarchy of therapies for melasma, the treating physician must consider the devastating psychosocial impact of pigmentary imperfections within the realm of the benefits and risks associated with each treatment.

  10. Therapeutic targeting of replicative immortality.

    Science.gov (United States)

    Yaswen, Paul; MacKenzie, Karen L; Keith, W Nicol; Hentosh, Patricia; Rodier, Francis; Zhu, Jiyue; Firestone, Gary L; Matheu, Ander; Carnero, Amancio; Bilsland, Alan; Sundin, Tabetha; Honoki, Kanya; Fujii, Hiromasa; Georgakilas, Alexandros G; Amedei, Amedeo; Amin, Amr; Helferich, Bill; Boosani, Chandra S; Guha, Gunjan; Ciriolo, Maria Rosa; Chen, Sophie; Mohammed, Sulma I; Azmi, Asfar S; Bhakta, Dipita; Halicka, Dorota; Niccolai, Elena; Aquilano, Katia; Ashraf, S Salman; Nowsheen, Somaira; Yang, Xujuan

    2015-12-01

    One of the hallmarks of malignant cell populations is the ability to undergo continuous proliferation. This property allows clonal lineages to acquire sequential aberrations that can fuel increasingly autonomous growth, invasiveness, and therapeutic resistance. Innate cellular mechanisms have evolved to regulate replicative potential as a hedge against malignant progression. When activated in the absence of normal terminal differentiation cues, these mechanisms can result in a state of persistent cytostasis. This state, termed "senescence," can be triggered by intrinsic cellular processes such as telomere dysfunction and oncogene expression, and by exogenous factors such as DNA damaging agents or oxidative environments. Despite differences in upstream signaling, senescence often involves convergent interdependent activation of tumor suppressors p53 and p16/pRB, but can be induced, albeit with reduced sensitivity, when these suppressors are compromised. Doses of conventional genotoxic drugs required to achieve cancer cell senescence are often much lower than doses required to achieve outright cell death. Additional therapies, such as those targeting cyclin dependent kinases or components of the PI3K signaling pathway, may induce senescence specifically in cancer cells by circumventing defects in tumor suppressor pathways or exploiting cancer cells' heightened requirements for telomerase. Such treatments sufficient to induce cancer cell senescence could provide increased patient survival with fewer and less severe side effects than conventional cytotoxic regimens. This positive aspect is countered by important caveats regarding senescence reversibility, genomic instability, and paracrine effects that may increase heterogeneity and adaptive resistance of surviving cancer cells. Nevertheless, agents that effectively disrupt replicative immortality will likely be valuable components of new combinatorial approaches to cancer therapy. Copyright © 2015 The Authors

  11. Emerging therapeutic strategies for obesity.

    Science.gov (United States)

    Foster-Schubert, Karen E; Cummings, David E

    2006-12-01

    The rising tide of obesity is one of the most pressing health issues of our time, yet existing medicines to combat the problem are disappointingly limited in number and effectiveness. Fortunately, a recent burgeoning of mechanistic insights into the neuroendocrine regulation of body weight provides an expanding list of molecular targets for novel, rationally designed antiobesity pharmaceuticals. In this review, we articulate a set of conceptual principles that we feel could help prioritize among these molecules in the development of obesity therapeutics, based on an understanding of energy homeostasis. We focus primarily on central targets, highlighting selected strategies to stimulate endogenous catabolic signals or inhibit anabolic signals. Examples of the former approach include methods to enhance central leptin signaling through intranasal leptin delivery, use of superpotent leptin-receptor agonists, and mechanisms to increase leptin sensitivity by manipulating SOCS-3, PTP-1B, ciliary neurotrophic factor, or simply by first losing weight with traditional interventions. Techniques to augment signaling by neurochemical mediators of leptin action that lie downstream of at least some levels of obesity-associated leptin resistance include activation of melanocortin receptors or 5-HT2C and 5-HT1B receptors. We also describe strategies to inhibit anabolic molecules, such as neuropeptide Y, melanin-concentrating hormone, ghrelin, and endocannabinoids. Modulation of gastrointestinal satiation and hunger signals is discussed as well. As scientists continue to provide fundamental insights into the mechanisms governing body weight, the future looks bright for development of new and better antiobesity medications to be used with diet and exercise to facilitate substantial weight loss.

  12. Therapeutic strategies in pulmonary hypertension

    Directory of Open Access Journals (Sweden)

    Leonello eFuso

    2011-04-01

    Full Text Available Pulmonary hypertension (PH is a life-threatening condition characterized by elevated pulmonary arterial pressure. It is clinically classified into five groups: patients in the first group are considered to have pulmonary arterial hypertension (PAH whereas patients of the other groups have PH that is due to cardiopulmonary or other systemic diseases. The management of patients with PH has advanced rapidly over the last decade and the introduction of specific treatments especially for PAH has lead to an improved outcome. However, despite the progress in the treatment, the functional limitation and the survival of these patients remain unsatisfactory and there is no cure for PAH. Therefore the search for an ideal therapy still goes on. At present, two levels of treatment can be identified: primary and specific therapy. Primary therapy is directed at the underlying cause of the PH. It also includes a supportive therapy consisting in oxygen supplementation, diuretics, and anticoagulation which should be considered in all patients with PH. Specific therapy is directed at the PH itself and includes treatment with vasodilatators such as calcium channel blockers and with vasodilatator and pathogenetic drugs such as prostanoids, endothelin receptor antagonists and phosphodiesterase type-5 inhibitors. These drugs act in several pathogenetic mechanisms of the PH and are specific for PAH although they might be used also in the other groups of PH. Finally, atrial septostomy and lung transplantation are reserved for patients refractory to medical therapy. Different therapeutic approaches can be considered in the management of patients with PH. Therapy can be established on the basis of both the clinical classification and the functional class. It is also possible to adopt a goal-oriented therapy in which the timing of treatment escalation is determined by inadequate response to known prognostic indicators.

  13. Changes in microvascular permeability of the middle ear mucosa following the occulsion of the eustachian tube of rabbits. The functional investigation using radioisotope

    Energy Technology Data Exchange (ETDEWEB)

    Kikuchi, Yasutaka

    1988-12-01

    Serial changes in submucosal microvascular permeability of the middle ear and the response to histamine after occlusion of the eustachian tube were functionally investigated using radioisotope in rabbits with experimentally induced otitis media with effusion. Tritium water was administered through intravenous injection and transference of tritium water into the middle ear cavity was measured by radioactivity of the middle ear perfusate. Morphological changes were concurrently examined for comparison. Vascular permeability, as measured one, 7, and 14 days after occlusion of the eustachian tube, increased with time. A histological study showed an edematous hypertrophy of the submucosal tissue of the middle ear, suggesting a noticeable increase in microvascular permeability. The response of the middle ear mucosa to histamine, which was added to the fluid for perfusion, gradually decreased after occlusion of the eustachian tube, although the effect of histamine tended to persist for a long time, irrespective of the amount of administration. The results indicated that the mucosal membrane of the middle ear has a noticeable permeability at least up to 14 days after occlusion, and that histamine may be responsible for the increase of submucosal microvascular permeability not only in the normal middle ear cavity but also in otitis media with effusion which results in the persistance of the disease. The presence of factors permeable to the blood, other than histamine, caused microvascular peameability to increase, probably resulting in chronic or irreversible inflammation. This may be explained by markedly proliferative or parenchymatous connective tissues observed 7 and l0 weeks after occlusion. It should be noted that surgical treatment be performed as early as possible in the case of otitis media with effusion. (Namekawa, K) 80 refs.

  14. Reentry response of the lightweight radioisotope heater unit resulting from a Cassini Venus-Venus-Earth-Jupiter gravity assist maneuver accident

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-12-01

    Reentry analyses consisting of ablation response, thermal response and thermal stress response have been conducted on the Lightweight Radioisotope Heater Unit (LWRHU) for Cassini/Venus-Venus-Earth-Jupiter-Gravity-Assist (VVEJGA) reentry conditions. Sequential ablation analyses of the LWRHU aeroshell, and the fuel pellet have been conducted in reentry regimes where the aeroshell has been deemed to fail. The failure criterion for ablation is generally assumed to be recession corresponding to 75% and 100% of the wall thickness. The 75% recession failure criteria allows for uncertainties that result mainly because of the high energies involved in the VVEJGA reentries compared to orbital decay reentries. Risk evaluations should consider the fact that for shallow flight paths the unit may disassemble at high-altitude as a result of ablation or may remain intact with a clad that had been molten. Within the limitations of the methodologies and assumptions of the analyses, the results indicate that: (1) For a side-on stable LWRHU reentry, aeroshell ablation failures occur for all reentry angles. (2)For a side-on spinning LWRHU reentry, aeroshell ablation failures are minimal. (3) For the tumbling LWRHU reentry, the aeroshell survives for most angles. (4) For the thermostructural analyses, using both a 1% and 5% allowable strain, all reentry angles and orientations examined resulted in small localized failures, but aeroshell breach is not predicted for any case. The analyses included in this report concentrate on VVEJGA reentry scenarios. Analyses reported previously have demonstrated that the LWRHU has adequate design margin to survive reentry from orbital decay scenarios and most injection scenarios at speeds up to escape speeds. The exception is a narrow range of flight path angles that produce multiple skip trajectories which may have excessive ablation.

  15. Productivity of a nuclear chemical reactor with gamma radioisotopic sources; Rendimiento de un reactor quimico-nuclear con fuentes radioisotopicas gamma

    Energy Technology Data Exchange (ETDEWEB)

    Anguis T, C

    1975-07-01

    According to an established mathematical model of successive Compton interaction processes the made calculations for major distances are extended checking the acceptability of the spheric geometry model for the experimental data for radioisotopic sources of Co-60 and Cs-137. Parameters such as the increasing factor and the absorbed dose served as comparative base. calculations for the case of a punctual source succession inside a determined volume cylinder are made to obtain the total dose, the deposited energy by each photons energetic group and the total absorbed energy inside the reactor. Varying adequately the height/radius relation for different cylinders, the distinct energy depositions are compared in each one of them once a time standardized toward a standard value of energy emitted by the reactor volume. A relation between the quantity of deposited energy in each point of the reactor and the conversion values of chemical species is established. They are induced by electromagnetic radiation and that are reported as ''G'' in the scientific literature (number of molecules formed or disappeared by each 100 e.v. of energy). Once obtained the molecular performance inside the reactor for each type of geometry, it is optimized the height/radius relation according to the maximum production of molecules by unity of time. It is completed a bibliographical review of ''G'' values reported by different types of aqueous solutions with the purpose to determine the maximum performance of molecular hydrogen as a function of pH of the solution and of the used type of solute among other factors. Calculations for the ethyl bromide production as an example of one of the industrial processes which actually work using the gamma radiation as reactions inductor are realized. (Author)

  16. Therapeutic Work with Children: A Contextual Overview

    Science.gov (United States)

    Robson, Maggie

    2010-01-01

    This overview sets therapeutic work with children in context. It begins with a rationale for why this work is necessary and describes and explores the needs and rights of children and young people. Resilience as a factor in mitigating the effects of distress is discussed and an overview of the history of therapeutic work is offered. Different…

  17. [A therapeutic education tool in paediatric dentistry].

    Science.gov (United States)

    Marquillier, Thomas; Trentesaux, Thomas; Catteau, Céline; Delfosse, Caroline

    Therapeutic education for children is developing in the treatment of dental caries. The Elmy pathway, a pedagogical game aiming to improve children's oral health skills, has been designed. The qualitative assessment of this tool seems to confirm its benefit for use in therapeutic education sessions. Copyright © 2016 Elsevier Masson SAS. All rights reserved.

  18. Translational nanomedicine : Through the therapeutic window

    NARCIS (Netherlands)

    Pierce, Robin

    2015-01-01

    Translational nanomedicine occurs only through the successful integration of multiple inputs and iterative modifications. The therapeutic window plays a pivotal role in the trajectory of translational nanomedicine. Often defined in terms of the range of dosage for safe and effective therapeutic

  19. Poetry and Therapeutic Factors in Group Therapy.

    Science.gov (United States)

    Goldstein, Marion

    1989-01-01

    Describes the ways in which the use of poetry in group therapy facilitates therapeutic goals consistent with interpersonal theory. Discusses the relationship between poetic interventions and I. D. Yalom's therapeutic factors, and offers a case example of an in-patient therapy group. (SR)

  20. Woodland in Practical Skills Therapeutic Education

    Science.gov (United States)

    Mata, Paula; Gibons, Kenneth; Mata, Fernando

    2016-01-01

    Modern urban life provides less opportunities to contact with nature, which is a potential cause of developmental deviances in children. We investigated the potential therapeutic effect of woodlands, within the context of Practical Skills Therapeutic Education at the Ruskin Mill College, UK. Data on physical and emotional perceptions were…

  1. The effects of therapeutic touch on pain.

    Science.gov (United States)

    Monroe, Carolyn Magdalen

    2009-06-01

    To better understand how Therapeutic Touch can be used in today's health care arena, this integrative literature review will examine current research that will help answer the question, Does Therapeutic Touch reduce pain? An extensive search was conducted of the online databases MEDLINE, CINAHL, Cochrane Library, EMBASE, PsychLIT, and PubMed to retrieve research articles published from 1997 to 2007. Seven studies that were conducted between 1997 and 2004 were found and only five of the seven were included as pertinent evidence to answer the question. All of the research that was reviewed to answer whether Therapeutic Touch could significantly reduce pain revealed a majority of statistically significant positive results for implementing this intervention. Because there are no identified risks to Therapeutic Touch as a pain relief measure, it is safe to recommend despite the limitations of current research. Therapeutic Touch should be considered among the many possible nursing interventions for the treatment of pain.

  2. [Health security--GMOs in therapeutics].

    Science.gov (United States)

    Trouvin, J-H

    2003-03-01

    The recent progress in human therapeutics has been made possible thanks to molecular biology and its use in producing proteins having the same sequence and structure as that of human proteins. The use of GMOs allows production of proteins with high added value in therapeutics, which are of satisfactory quality. GMOs may also be directly administered to patients as gene therapy vectors. However, the use of GMOs in therapeutics must take into consideration some risks, particularly those of microbiological contamination, of neo-antigenicity as well as environmental risks with regard to the way of use of the GMO. Nevertheless, those risks are taken in due consideration in the development of these new medicinal products; solutions have been found to allow their use in therapeutics with a very positive benefit/risk ratio. Medicinal products from biotechnology have enabled considerable therapeutic progress without compromising health security.

  3. [Therapeutic measures in tardive dyskinesia].

    Science.gov (United States)

    Tegeler, J; Wöller, W

    1983-06-01

    is also present, small doses of thioridazine, clozapine or tiapride can be administered. If this practice is not successful cholinergic or GABA-ergic agents may be useful. Because no currently available therapeutic agents satisfies the criteria of safety, marked effectiveness and prolonged efficacy in the treatment of tardive dyskinesia, prevention becomes more important. Prolonged use of a neuroleptic medication requires careful evaluation of indications and risks. The doses of neuroleptic drugs during the maintenance treatment of schizophrenia should be as small as possible.

  4. Oncolytic Viruses: Therapeutics With an Identity Crisis.

    Science.gov (United States)

    Breitbach, Caroline J; Lichty, Brian D; Bell, John C

    2016-07-01

    Oncolytic viruses (OV) are replicating viral therapeutics for the treatment of cancer and have been in laboratory development for about twenty years. Recently, the FDA approved Imlygic, a herpes virus based therapeutic for the treatment of melanoma and thus OVs have entered a new era where they are a weapon in the armament of the oncologist. OVs are unique therapeutics with multiple mechanisms of therapeutic activity. The exact path for their development and eventual uptake by pharmaceutical companies is somewhat clouded by an uncertain identity. Are they vaccines, tumour lysing therapeutics, inducers of innate immunity, gene therapy vectors, anti-vascular agents or all of the above? Should they be developed as stand-alone loco-regional therapeutics, systemically delivered tumour hunters or immune modulators best tested as combination therapeutics? We summarize data here supporting the idea, depending upon the virus, that OVs can be any or all of these things. Pursuing a "one-size fits all" approach is counter-productive to their clinical development and instead as a field we should build on the strengths of individual virus platforms. Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.

  5. Oncolytic Viruses: Therapeutics With an Identity Crisis

    Directory of Open Access Journals (Sweden)

    Caroline J. Breitbach

    2016-07-01

    Full Text Available Oncolytic viruses (OV are replicating viral therapeutics for the treatment of cancer and have been in laboratory development for about twenty years. Recently, the FDA approved Imlygic, a herpes virus based therapeutic for the treatment of melanoma and thus OVs have entered a new era where they are a weapon in the armament of the oncologist. OVs are unique therapeutics with multiple mechanisms of therapeutic activity. The exact path for their development and eventual uptake by pharmaceutical companies is somewhat clouded by an uncertain identity. Are they vaccines, tumour lysing therapeutics, inducers of innate immunity, gene therapy vectors, anti-vascular agents or all of the above? Should they be developed as stand-alone loco-regional therapeutics, systemically delivered tumour hunters or immune modulators best tested as combination therapeutics? We summarize data here supporting the idea, depending upon the virus, that OVs can be any or all of these things. Pursuing a “one-size fits all” approach is counter-productive to their clinical development and instead as a field we should build on the strengths of individual virus platforms.

  6. On the use of iron radio-isotopes to study iron speciation kinetics in seawater: A column separation and off-line counting approach

    Energy Technology Data Exchange (ETDEWEB)

    Fischer, A.C. [Interfaculty Reactor Institute, Delft University of Technology, Mekelweg 15, 2629 JB Delft (Netherlands)]. E-mail: science@astrid.thatsme.nl; Wolterbeek, H.Th. [Interfaculty Reactor Institute, Delft University of Technology, Mekelweg 15, 2629 JB Delft (Netherlands); Kroon, J.J. [Interfaculty Reactor Institute, Delft University of Technology, Mekelweg 15, 2629 JB Delft (Netherlands); Gerringa, L.J.A. [Royal Netherlands Institute for Sea Research (NIOZ), Department of Marine Chemistry and Geology, P.O. Box 59, 1790 AB Den Burg, Texel (Netherlands); Timmermans, K.R. [Royal Netherlands Institute for Sea Research (NIOZ), Department of Marine Chemistry and Geology, P.O. Box 59, 1790 AB Den Burg, Texel (Netherlands); Elteren, J.T. van [National Institute of Chemistry, Hajdrihova 19, SI-1000 Ljubljana (Slovenia); Teunissen, T. [Interfaculty Reactor Institute, Delft University of Technology, Mekelweg 15, 2629 JB Delft (Netherlands)

    2006-06-01

    The determination of unidirectional fluxes of Fe in the seawater Fe-pools requires the use of Fe (radio)isotopes, which in turn necessitates off-line iron counting. To implement new off-line counting approaches, methods by King et al. (1991) [King DW, Lin J, Kester DR. Spectrophotometric determination of iron(II) in seawater at nanomolar concentrations. Anal Chim Acta 1991;247:125-32] were adapted for use with radio-iron for Fe(II) and total Fe analysis. The approach consists of passing samples through preloaded SepPak (registered) C{sub 18} cartridges with either ferrozine (FZ) for Fe(II) measurement or 1-nitroso-2-naphthol (1N2N) for total iron analysis. Cartridges are afterwards eluted with methanol and the eluate subsequently counted for radio-iron. A series of experiments was carried out to investigate the new method's applicability. This included loading and extraction behaviour, selectivity for the targeted iron species, iron species recovery, memory effects and the influence of iron concentration. The FZ-preloaded cartridge showed 85% Fe(II) recovery in seawater by direct determination. Recoveries of about 60% for Fe(II) in seawater were found when including 10-15 min waiting time and sample loops, which was probably caused by the instability of Fe(II) due to oxidation. Using 1N2N cartridges for total dissolved iron measurement, recovery was obtained as nearly 100%, but with high variability which was probably caused by the interaction time of Fe with the 1N2N-preloaded cartridges. The cartridges showed only small memory effects. Remaining radio-iron could only be removed from the cartridges with 0.5 M HCl, which destroyed the functionality of the cartridge. This result suggests that the Fe fraction, which could not be eluted by methanol, was irreversibly bound to the cartridge. Desferrioxamine B was applied as a model ligand to test for interference from naturally occurring organic ligands; the results indicate that interferences may occur and should

  7. Therapeutic drug monitoring of aminoglycosides in neonates

    NARCIS (Netherlands)

    Touw, Daniël J; Westerman, Elsbeth M; Sprij, Arwen J

    2009-01-01

    The efficacy and toxicity of aminoglycosides show a strong direct positive relationship with blood drug concentrations, therefore, therapy with aminoglycosides in adults is usually guided by therapeutic drug monitoring. Dosing regimens in adults have evolved from multiple daily dosing to

  8. FAQ about Recreational Therapy/Therapeutic Recreation

    Science.gov (United States)

    ... biological, and behavioral sciences and recreation and leisure theory. How can I get RT/TR services? Many ... facilities, as was daycare programs for individuals with disabilities." About the American Therapeutic Recreation Association: The American ...

  9. MicroRNA therapeutics in cardiovascular medicine

    National Research Council Canada - National Science Library

    Thum, Thomas

    2012-01-01

    Cardiovascular diseases are the most common causes of human morbidity and mortality despite significant therapeutic improvements by surgical, interventional and pharmacological approaches in the last decade. MicroRNAs (miRNAs...

  10. The Diagnostic/Therapeutic Preabortion Interview.

    Science.gov (United States)

    Boekelheide, Priscilla Day

    1978-01-01

    The therapeutic and diagnostic aspect of the preabortion interview are discussed with attention to specifics that will identify students with the greatest likelihood for psychological problems and/or repeat abortions. (JD)

  11. Towards new therapeutic strategies in chondrosarcoma

    NARCIS (Netherlands)

    Schrage, Yvonne Maria

    2009-01-01

    This thesis presents the identification of new targets for therapeutic treatment of chondrosarcoma, tumours that are highly insensitive to conventional chemo- and radiation thearapy. A relatively new array technique to identify active kinases in chondrosarcoma cell cultures was used, which

  12. Therapeutic radionuclides: Making the right choice

    Energy Technology Data Exchange (ETDEWEB)

    Srivastava, S.C.

    1996-08-01

    Recently, there has been a resurgence of interest in nuclear medicine therapeutic procedures. Using unsealed sources for therapy is not a new concept; it has been around since the beginnings of nuclear medicine. Treatment of thyroid disorders with radioiodine is a classic example. The availability of radionuclides with suitable therapeutic properties for specific applications, as well as methods for their selective targeting to diseased tissue have, however, remained the main obstacles for therapy to assume a more widespread role in nuclear medicine. Nonetheless, a number of new techniques that have recently emerged, (e.g., tumor therapy with radiolabeled monoclonal antibodies, treatment of metastatic bone pain, etc.) appear to have provided a substantial impetus to research on production of new therapeutic radionuclides. Although there are a number of new therapeutic approaches requiring specific radionuclides, only selected broad areas will be used as examples in this article.

  13. Therapeutic potential of fecal microbiota transplantation

    NARCIS (Netherlands)

    Smits, Loek P.; Bouter, Kristien E. C.; de Vos, Willem M.; Borody, Thomas J.; Nieuwdorp, Max

    2013-01-01

    There has been growing interest in the use of fecal microbiota for the treatment of patients with chronic gastrointestinal infections and inflammatory bowel diseases. Lately, there has also been interest in its therapeutic potential for cardiometabolic, autoimmune, and other extraintestinal

  14. [Therapeutic baths and relaxation in neurosurgery].

    Science.gov (United States)

    Leseigneur, Matthieu

    2017-03-01

    A neurosurgical nursing and nursing auxiliaries team has started using therapeutic baths. The wellbeing procured favours a re-appropriation of body awareness and a reduction in anxiety. Copyright © 2016 Elsevier Masson SAS. All rights reserved.

  15. [Relationship between defense mechanism and therapeutic alliance].

    Science.gov (United States)

    Laconi, S; Cailhol, L; Pourcel, L; Thalamas, C; Lapeyre-Mestre, M; Chabrol, H

    2015-10-01

    The therapeutic alliance can be defined as a collaborative relationship between the patient and the practitioner. It represents an essential component of the psychotherapeutic process (Ambresin et al., 2007; Cungi, 2006; Martin et al., 2000). Some authors suggest that a good alliance can have a favorable impact on the therapeutic success (Barber et al., 2000; Hubble, Duncan, & Miller 1999; Horvath & Luborsky, 1993; Horvath & Symonds, 1991). This alliance can be influenced by psychological and behavioral factors (Cungi, 2006) Thus, some defense mechanisms could prevent change or, on the contrary could facilitate adaptation (Ambresin et al., 2007) and have an impact on the therapeutic success (Muris & Merckelbach, 1996). However, the relationship between therapeutic alliance and defense mechanisms represents an insufficiently explored field (Ambresin et al., 2007; Cungi, 2006). The aim of the present study was to examine the relationship between therapeutic alliance and twenty defense mechanisms in a sample of French psychiatric patients, by differentiating results in men and women. We also examined the positive and the negative therapeutic alliance. Sixty patients aged from 18 to 58 (M=41.50; SD=11.03) completed the French versions of the Defense Style Questionnaire-40 (DSQ-40) and the Helping Alliance questionnaire-II (HAq-II). Therapeutic alliance was significantly associated with each defense style: mature (0.62), neurotic (0.45) Ptherapeutic alliance (R(2) adj=36, F=12.39, β=0.65, Ptherapeutic alliance (R(2) adj=36, F=12.34, β=0.62, Ptherapeutic alliance was significantly associated with all mature defenses, three neurotic defenses (reaction formation, pseudo-altruism, idealization) and four immature defenses (splitting, denial, somatization, passive aggression). Among men, three mature defenses were associated (anticipation, humor, sublimation), four neurotic (reaction formation, pseudo-altruism, idealization and undoing) and two immature (somatization and

  16. Therapeutic applications of ultrasonography in dentistry

    OpenAIRE

    Jyoti Mago; Soheyl Sheikh; Shambulingappa Pallagatti; Amit Aggarwal

    2014-01-01

    Ultrasonography is one of the most common imaging modality used in dental as well as medical sciences. The use of ultrasonography when discovered was as a therapeutic aid, but in recent times, it has become one of the most common imaging modality next to conventional radiology. Currently, its use as a therapeutic aid has been rediscovered along with its association with other specialized imaging. The aim of this paper is to highlight such advancements in the field of ultrasonography.

  17. Therapeutic applications of ultrasonography in dentistry

    Directory of Open Access Journals (Sweden)

    Jyoti Mago

    2014-01-01

    Full Text Available Ultrasonography is one of the most common imaging modality used in dental as well as medical sciences. The use of ultrasonography when discovered was as a therapeutic aid, but in recent times, it has become one of the most common imaging modality next to conventional radiology. Currently, its use as a therapeutic aid has been rediscovered along with its association with other specialized imaging. The aim of this paper is to highlight such advancements in the field of ultrasonography.

  18. Ultrasound: A Revenant Therapeutic Modality in Dentistry

    OpenAIRE

    Karumuri, Sunil Kumar; Rastogi, Trisha; Beeraka, Kartheeki; Penumatcha, Mohan Raju; Olepu, Sanjeeva Rao

    2016-01-01

    An ultrasound (US) gives a visible image of the organs that are present inside the body. In medicine it serves for diagnosing and also its therapeutic benefits are well established for bone healing, osteointegration and soft tissue healing. In dentistry it is widely used for diagnostic purposes. When it was discovered it was introduced for therapeutic purposes, but due to lack of clinical studies its use as therapy was remittent in dentistry. The aim of the present paper was to establish the ...

  19. [Therapeutic approaches in court-ordered therapy].

    Science.gov (United States)

    Floris, Emmanuelle; De Jésus, Arnaud; Cano, Jean-Philippe; Raymondaud, Séverine; Rouveyrol, Éric; Bouchard, Jean-Pierre

    As is the case with other contexts of mental health treatments, the therapeutic approaches to court-ordered therapy are varied. They are based on the principle of their clinical indication and must be delivered by therapists trained in the specific area. The classic therapeutic approaches are used: medication, psychoanalysis and psychoanalytically inspired therapies, cognitive behavioural therapies, group therapies and body-oriented approach. Copyright © 2017. Published by Elsevier Masson SAS.

  20. Viral Oncolytic Therapeutics for Neoplastic Meningitis

    Science.gov (United States)

    2014-09-01

    Award Number: W81XWH-11-1-0387 TITLE: Viral Oncolytic Therapeutics for Neoplastic Meningitis PRINCIPAL INVESTIGATOR: Mikhail Papisov, PhD...SUBTITLE Viral Oncolytic Therapeutics for Neoplastic Meningitis 5a. CONTRACT NUMBER 5b. GRANT NUMBER W81XWH-11-1-0387 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR...for neoplastic meningitis ( meningeal metastasis of breast cancer). The proposed therapy will be based on direct (intrathecal) administration of

  1. Therapeutic Strategy for Chronic Headache in Children

    Directory of Open Access Journals (Sweden)

    H.O. Lezhenko

    2016-05-01

    Full Text Available The therapeutic efficacy of a combined homeopathic preparation Cefavora, which consists of alcoholic extracts of Ginkgo biloba, hawthorn (Crataegus and white mistletoe (Viscum album, has been studied in the treatment of chronic tension-type headache in children. It has been shown that alongside with elimination of headache manifestations, the use of homeopathic medicine has contributed to the normalization of adaptive mechanisms of autonomic regulation in children indicating its high therapeutic efficacy.

  2. [Therapeutic education for recurrent depressive disorder].

    Science.gov (United States)

    Carde, Soufiane; Hatif, Séverine; Samama, Diane; Charbonnel, Patricia; Jouvent, Roland

    2016-01-01

    Depression is a serious and recurrent condition which can become chronic. As a complement to other therapeutic approaches, therapeutic patient education (TPE) or psychoeducation is effective. TPE groups led by a multidisciplinary hospitalisation team in a psychiatric department are thereby integrated into the global care in order to reduce relapses and improve patients' quality of life. Copyright © 2015 Elsevier Masson SAS. All rights reserved.

  3. Preconception care in therapeutic abortion applicants.

    Science.gov (United States)

    Shirmohammadi, Farzaneh; Nekuei, Nafisehsadat; Bahadoran, Parvin; Montazery, Gita

    2017-01-01

    Some risk factors that would lead to therapeutic abortion do even exist before pregnancy and could be resolved or corrected through appropriate interventions. The present study was conducted to evaluate the condition of preconception care among therapeutic abortion applicants. This research was a descriptive, cross-sectional study that was conducted on 200 applicants for therapeutic abortion at the Forensics Medicine Center of Isfahan (Iran) who were selected convenience sampling from October 2014 to March 2015. Data were gathered using a researcher made checklist. Data were analyzed using SPSS version 16 through descriptive statistics and Chi-square and independent t-test. Eighty-five percent of the participants were applicants for therapeutic abortion due to fetal problems, and the other 15% were due to maternal issues. About 41.7% of participants with fetal problems and all of the participants with maternal issues had not received preconception care. In 93.3% of the applicants with maternal issues, the disease existed before the pregnancy. About 48.2% of participants needed genetic counseling, but 28.6% had not received any. Results showed that in most of the participants, the risk factor for therapeutic abortion existed before the pregnancy. Providing preconception care along with the elimination of risk factors before the pregnancy could prevent some of the pregnancies with the indication of therapeutic abortion.

  4. Therapeutic angiogenesis: a fantastic new adventure.

    Science.gov (United States)

    Harjai, Kishore J; Chowdhury, Pertha; Grines, Cindy L

    2002-06-01

    A significant proportion of patients with coronary artery disease have symptoms refractory to medical treatment, yet are unsuitable for conventional revascularization techniques, like percutaneous coronary intervention and coronary artery bypass surgery. Such patients are potential candidates for alternative forms of coronary revascularization, like therapeutic angiogenesis. This strategy is designed to promote the development of supplemental collateral blood vessels that will act as endogenous bypass conduits. Two major avenues for achieving therapeutic angiogenesis are currently under intense investigation: gene therapy (the introduction of new genetic material into somatic cells to synthesize proteins that are missing, defective, or desired for specific therapeutic purposes) and protein-based therapy (administration of the growth factors, instead of the genes encoding for the growth factors responsible for angiogenesis). This article provides a concise review of the "components" of gene and protein-based therapy, namely, the growth factors, the vector (for gene therapy), the route of delivery, the therapeutic target, the desired therapeutic effect, and quantifiable clinical end points for trials of angiogenesis. Based on preliminary studies, the authors believe that therapeutic angiogenesis represents a promising novel therapy for treatment of the ischemic heart. In the future, angiogenesis will likely be offered as an adjunct to conventional revascularization strategies in subsets of patients who are only "suboptimally" revascularized with conventional techniques, and might evolve into a stand-alone treatment for some patients with nonrevascularizable disease.

  5. Radioisotopes and Life Processes (Rev.)

    Energy Technology Data Exchange (ETDEWEB)

    Kisieleski, Walter E. [Argonne National Laboratory; Baserga, Renato [Fels Research Institute

    1967-01-01

    This booklet gives an account, in chemical terms, of the materials from which living matter is made and some of the chemical reactions that underlie the manifestations and the maintenance of life. DNA, RNA and proteins are described. How radioactive isotopes can be used to pry into the innermost secrets of these substances are shown.

  6. Radioisotopic Thermoelectric Generator (RTG) Surveillance

    Energy Technology Data Exchange (ETDEWEB)

    Mulford, Roberta Nancy [Los Alamos National Lab. (LANL), Los Alamos, NM (United States)

    2016-09-29

    This lecture discusses stockpile stewardship efforts and the role surveillance plays in the process. Performance of the RTGs is described, and the question of the absence of anticipated He is addressed.

  7. Milliwatt Radioisotope Stirling Convertor Project

    Data.gov (United States)

    National Aeronautics and Space Administration — Sest, Inc. proposes to perform a detailed evaluation at the both convertor and component levels of a small, low electrical output power (50 to 500 mW) Stirling cycle...

  8. Potential therapeutic roles for antibody mixtures.

    Science.gov (United States)

    Raju, T Shantha; Strohl, William R

    2013-10-01

    With the enormous success of recombinant monoclonal antibodies (rMAbs) as human therapeutics, there are increasing efforts underway to explore new molecular entities that mimic rMAbs to replicate this huge success. In addition to naked intact rMAbs, antibody drug conjugates (ADCs), FAb and F(ab')2 fragments and also Fc fusion proteins have been developed and/or marketed as human therapeutics to treat different human diseases, including life-threatening diseases such as cancer. Several hundreds more intact rMAbs, ADCs, FAb, F(ab')2 fragments and Fc fusion proteins are currently undergoing human clinical trials. In addition to these molecules, new type of antibody fragments such as single-chain Fvs (scFvs), VH, scFv-Fc, scFv-CH, scFAb, scFv-zipper, diabodies, bispecific antibodies and similar types of constructs are also being investigated to be developed as human monotherapeutics. Further, there are quite a few current examples of combinations of biologics being developed. For example, currently, several biopharmaceutical companies are developing combinations of antibody mixtures as human therapeutics. Accordingly, the question posed here is whether it is time to consider the possibility of developing a broader range of combinations of therapeutic biologics. Combinations of small organic molecules have been successfully used as therapeutics for many years to treat many diseases, so the context of using polypharmacology to treat human diseases is not novel. For the past several decades, intravenous immunoglobulins have successfully been used in treating various autoimmune diseases. In this context, several biotechnology companies are exploring the use of combinations of antibody mixtures as human therapeutics. This editorial discusses these current efforts and the potential future role of antibody mixtures as human therapeutics.

  9. Therapeutic Vaccination for HPV Induced Cervical Cancers

    Directory of Open Access Journals (Sweden)

    Joeli A. Brinkman

    2007-01-01

    Full Text Available Cervical Cancer is the second leading cause of cancer–related deaths in women worldwide and is associated with Human Papillomavirus (HPV infection, creating a unique opportunity to treat cervical cancer through anti-viral vaccination. Although a prophylactic vaccine may be available within a year, millions of women, already infected, will continue to suffer from HPV-related disease, emphasizing the need to develop therapeutic vaccination strategies. A majority of clinical trials examining therapeutic vaccination have shown limited efficacy due to examining patients with more advanced-stage cancer who tend to have decreased immune function. Current trends in clinical trials with therapeutic agents examine patients with pre-invasive lesions in order to prevent invasive cervical cancer. However, longer follow-up is necessary to correlate immune responses to lesion regression. Meanwhile, preclinical studies in this field include further exploration of peptide or protein vaccination, and the delivery of HPV antigens in DNA-based vaccines or in viral vectors. As long as pre-clinical studies continue to advance, the prospect of therapeutic vaccination to treat existing lesions seem good in the near future. Positive consequences of therapeutic vaccination would include less disfiguring treatment options and fewer instances of recurrent or progressive lesions leading to a reduction in cervical cancer incidence.

  10. Nanotechnology—novel therapeutics for CNS disorders

    Science.gov (United States)

    Srikanth, Maya; Kessler, John A.

    2013-01-01

    Research into treatments for diseases of the CNS has made impressive strides in the past few decades, but therapeutic options are limited for many patients with CNS disorders. Nanotechnology has emerged as an exciting and promising new means of treating neurological disease, with the potential to fundamentally change the way we approach CNS-targeted therapeutics. Molecules can be nanoengineered to cross the blood–brain barrier, target specific cell or signalling systems, respond to endogenous stimuli, or act as vehicles for gene delivery, or as a matrix to promote axon elongation and support cell survival. The wide variety of available nanotechnologies allows the selection of a nanoscale material with the characteristics best suited to the therapeutic challenges posed by an individual CNS disorder. In this Review, we describe recent advances in the development of nanotechnology for the treatment of neurological disorders—in particular, neurodegenerative disease and malignant brain tumours—and for the promotion of neuroregeneration. PMID:22526003

  11. Playing and therapeutic action in child analysis.

    Science.gov (United States)

    Mayes, L C; Cohen, D J

    1993-12-01

    From its inception, child psychoanalysis has used fantasy play as a window to both the content and process of children's inner worlds. Because of the link to action and primary process, young children's imaginary play is rich in symbolic expressions that facilitate analytic interpretive interventions addressing the conflicts impeding development. There are inevitable tensions between allowing play to emerge as a therapeutic process in its own right and the usual psychoanalytic emphasis on clarification, verbalisation and, above all, interpretation within and about the transference. For many children, the very act of playing carries much of the therapeutic work aimed toward facilitating their return to developmentally appropriate and adaptive psychic functioning. The mobilisation of capacities for play in the analysis allows children to do what is needed for their development to continue and makes use of the developmentally restorative functions of play in the service of therapeutic action.

  12. Current Therapeutic Approach to Hypertrophic Scars

    Directory of Open Access Journals (Sweden)

    Zrinka Bukvić Mokos

    2017-06-01

    Full Text Available Abnormal scarring and its accompanying esthetic, functional, and psychological sequelae still pose significant challe nges. To date, there is no satisfactory prevention or treatment option for hypertrophic scars (HSs, which is mostly due to not completely comprehending the mechanisms underlying their formation. That is why the apprehension of regular and controlled physiological processes of scar formation is of utmost importance when facing hypertrophic scarring, its pathophysiology, prevention, and therapeutic approach. When treating HSs and choosing the best treatment and prevention modality, physicians can choose from a plethora of therapeutic options and many commercially available products, among which currently there is no efficient option that can successfully overcome impaired skin healing. This article reviews current therapeutic approach and emerging therapeutic strategies for the management of HSs, which should be individualized, based on an evaluation of the scar itself, patients’ expectations, and practical, evidence-based guidelines. Clinicians are encouraged to combine various prevention and treatment modalities where combination therapy that includes steroid injections, 5-fluorouracil, and pulsed-dye laser seems to be the most effective. On the other hand, the current therapeutic options are usually empirical and their results are unreliable and unpredictable. Therefore, there is an unmet need for an effective, targeted therapy and prevention, which would be based on an action or a modulation of a particular factor with clarified mechanism of action that has a beneficial effect on wound healing. As the extracellular matrix has a crucial role in cellular and extracellular events that lead to pathological scarring, targeting its components mostly by regulating bone morphogenetic proteins may throw up new therapeutic approach for reduction or prevention of HSs with functionally and cosmetically acceptable outcome.

  13. Measuring Therapeutic Alliance with Children in Residential Treatment and Therapeutic Day Care

    Science.gov (United States)

    Roest, Jesse; van der Helm, Peer; Strijbosch, Eefje; van Brandenburg, Mariëtte; Stams, Geert Jan

    2016-01-01

    Purpose: This study examined the construct validity and reliability of a therapeutic alliance measure (Children's Alliance Questionnaire [CAQ]) for children with psychosocial and/or behavioral problems, receiving therapeutic residential care or day care in the Netherlands. Methods: Confirmatory factor analysis of a one-factor model ''therapeutic…

  14. Therapeutic Responses of Psychopathic Sexual Offenders: Treatment Attrition, Therapeutic Change, and Long-Term Recidivism

    Science.gov (United States)

    Olver, Mark E.; Wong, Stephen C. P.

    2009-01-01

    The authors examined the therapeutic responses of psychopathic sex offenders (greater than or equal to 25 Psychopathy Checklist-Revised; PCL-R) in terms of treatment dropout and therapeutic change, as well as sexual and violent recidivism over a 10-year follow-up among 156 federally incarcerated sex offenders treated in a high-intensity inpatient…

  15. Therapeutic Engagement as a Predictor of Retention in Adolescent Therapeutic Community Treatment

    Science.gov (United States)

    Abdel-Salam, Sami; Gunter, Whitney D.

    2014-01-01

    The adolescent drug problem places a huge toll on society and a heavy burden on the criminal justice system. Research regarding the benefits of therapeutic community (TC) treatment for adolescents has shown it to be effective. Despite the ability of therapeutic communities to lower drug relapse and reduce criminality, a great deal remains unknown…

  16. Cells as delivery vehicles for cancer therapeutics.

    Science.gov (United States)

    Basel, Matthew T; Shrestha, Tej B; Bossmann, Stefan H; Troyer, Deryl L

    2014-05-01

    Cell-based therapeutics have advanced significantly over the past decade and are poised to become a major pillar of modern medicine. Three cell types in particular have been studied in detail for their ability to home to tumors and to deliver a variety of different payloads. Neural stem cells, mesenchymal stem cells and monocytes have each been shown to have great potential as future delivery systems for cancer therapy. A variety of other cell types have also been studied. These results demonstrate that the field of cell-based therapeutics will only continue to grow.

  17. Therapeutic gas delivery via microbubbles and liposomes.

    Science.gov (United States)

    Fix, Samantha M; Borden, Mark A; Dayton, Paul A

    2015-07-10

    Gaseous molecules including nitric oxide, hydrogen sulfide, carbon monoxide and oxygen mediate numerous cell signaling pathways and have important physiological roles. Several noble gasses have been shown to elicit biological responses. These bioactive gasses hold great therapeutic potential, however, their controlled delivery remains a significant challenge. Recently, researchers have begun using microbubbles and liposomes to encapsulate such gasses for parenteral delivery. The resultant particles are acoustically active, and ultrasound can be used to stimulate and/or image gas release in a targeted region. This review provides a summary of recent advances in therapeutic gas delivery using microbubbles and liposomes. Copyright © 2015 Elsevier B.V. All rights reserved.

  18. [The gastroschisis: clinical and therapeutic considerations].

    Science.gov (United States)

    Sabetay, C; Jona, J Z; Maloş, Anca; Stoica, A; Zavate, A; Ciobanu, O; Kamel, J; Neamţu, Olga; Cârstoiu, E

    2006-01-01

    Gastroschisis is a severe congenital malformation of the abdominal wall, with relative low incidence. The authors are analysing different therapeutic methods, in a group of 17 cases, hospitalised and operated in Department of Pediatric Surgery, Emergency Hospital of Craiova. They are underlining the importance of the ultrasound prenatal diagnosis of the malformation, close related to different therapeutic methods applied in this period of time and also are advising secondary closure of the abdominal wall, using a synthetic material (Silo-bag) for temporary coverage of the intestine developed outside the peritoneal cavity. This method helped with the decreasing of mortality in gastroschisis but with high costs of treatment.

  19. Process Improvement for Maximized Therapeutic Innovation Outcome.

    Science.gov (United States)

    Waldman, Scott A; Terzic, Andre

    2018-01-01

    Deconvoluting key biological mechanisms forms the framework for therapeutic discovery. Strategies that enable effective translation of those insights along the development and regulatory path ultimately drive validated clinical application in patients and populations. Accordingly, parity in What vs. How we transform novel mechanistic insights into therapeutic paradigms is essential in achieving success. Aligning molecular discovery with innovations in structures and processes along the discovery-development-regulation-utilization continuum maximizes the return on public and private investments for next-generation solutions in managing health and disease. © 2017 ASCPT.

  20. Therapeutic Gene Editing Safety and Specificity.

    Science.gov (United States)

    Lux, Christopher T; Scharenberg, Andrew M

    2017-10-01

    Therapeutic gene editing is significant for medical advancement. Safety is intricately linked to the specificity of the editing tools used to cut at precise genomic targets. Improvements can be achieved by thoughtful design of nucleases and repair templates, analysis of off-target editing, and careful utilization of viral vectors. Advancements in DNA repair mechanisms and development of new generations of tools improve targeting of specific sequences while minimizing risks. It is important to plot a safe course for future clinical trials. This article reviews safety and specificity for therapeutic gene editing to spur dialogue and advancement. Copyright © 2017 Elsevier Inc. All rights reserved.

  1. Peripheral facial nerve palsy after therapeutic endoscopy.

    Science.gov (United States)

    Kim, Eun Jeong; Lee, Jun; Lee, Ji Woon; Lee, Jun Hyung; Park, Chol Jin; Kim, Young Dae; Lee, Hyun Jin

    2015-03-01

    Peripheral facial nerve palsy (FNP) is a mononeuropathy that affects the peripheral part of the facial nerve. Primary causes of peripheral FNP remain largely unknown, but detectable causes include systemic infections (viral and others), trauma, ischemia, tumor, and extrinsic compression. Peripheral FNP in relation to extrinsic compression has rarely been described in case reports. Here, we report a case of a 71-year-old man who was diagnosed with peripheral FNP following endoscopic submucosal dissection. This case is the first report of the development of peripheral FNP in a patient undergoing therapeutic endoscopy. We emphasize the fact that physicians should be attentive to the development of peripheral FNP following therapeutic endoscopy.

  2. Postoperative Ileus: Pathophysiology, Current Therapeutic Approaches.

    Science.gov (United States)

    Stakenborg, N; Gomez-Pinilla, P J; Boeckxstaens, G E

    2017-01-01

    Postoperative ileus, which develops after each abdominal surgical procedure, is an iatrogenic disorder characterized by a transient inhibition of gastrointestinal motility. Its pathophysiology is complex involving pharmacological (opioids, anesthetics), neural, and immune-mediated mechanisms. The early neural phase, triggered by activation of afferent nerves during the surgical procedure, is short lasting compared to the later inflammatory phase. The latter starts after 3-6 h and lasts several days, making it a more interesting target for treatment. Insight into the triggers and immune cells involved is of great importance for the development of new therapeutic strategies. In this chapter, the pathogenesis and the current therapeutic approaches to treat postoperative ileus are discussed.

  3. Therapeutic Residential Care for Children and Youth:

    DEFF Research Database (Denmark)

    Whittaker, James K.; Holmes, Lisa; del Valle, Jorge F.

    2016-01-01

    In many developed countries around the world, ‘group care’ interventions for children and adolescents have come under increasing scrutiny from central government, private philanthropic and child advocacy agencies desirous of (1) achieving better outcomes for vulnerable children and youth; (2) doing...... for Child and Family Research, Loughborough University in the U.K. for a Summit meeting on therapeutic residential care for children and youth funded by the Sir Halley Stewart Trust (UK). The focus centered on what is known about therapeutic residential care and what key questions should inform a priority...

  4. Antihistaminergics and inverse agonism: potential therapeutic applications

    NARCIS (Netherlands)

    Monczor, F.; Fernandez, N.; Fitzsimons, C.P.; Shayo, C.; Davio, C.

    The accurate characterization of the molecular mechanisms involved in the action of receptor ligands is important for their appropriate therapeutic use and safety. It is well established that ligands acting at the histamine system currently used in the clinic exert their actions by specifically

  5. Effect of therapeutic ultrasound on endochondral ossification

    NARCIS (Netherlands)

    Wiltink, A.; Nijweide, P.J.; Oosterbaan, W.A.; Hekkenberg, R.T.; Helders, P.J.M.

    1995-01-01

    The effect of therapeutic doses of ultrasound was tested on endochondral ossification of in vitro developing metatarsal long bone rudiments of 16- and 17-day-old fetal mice. Bone growth, calcification and resorption following exposure to several doses of pulse-wave (PW) or continuous-wave (CW)

  6. Clinically Relevant Anticancer Polymer Paclitaxel Therapeutics

    Directory of Open Access Journals (Sweden)

    Danbo Yang

    2010-12-01

    Full Text Available The concept of utilizing polymers in drug delivery has been extensively explored for improving the therapeutic index of small molecule drugs. In general, polymers can be used as polymer-drug conjugates or polymeric micelles. Each unique application mandates its own chemistry and controlled release of active drugs. Each polymer exhibits its own intrinsic issues providing the advantage of flexibility. However, none have as yet been approved by the U.S. Food and Drug Administration. General aspects of polymer and nano-particle therapeutics have been reviewed. Here we focus this review on specific clinically relevant anticancer polymer paclitaxel therapeutics. We emphasize their chemistry and formulation, in vitro activity on some human cancer cell lines, plasma pharmacokinetics and tumor accumulation, in vivo efficacy, and clinical outcomes. Furthermore, we include a short review of our recent developments of a novel poly(L-g-glutamylglutamine-paclitaxel nano-conjugate (PGG-PTX. PGG-PTX has its own unique property of forming nano-particles. It has also been shown to possess a favorable profile of pharmacokinetics and to exhibit efficacious potency. This review might shed light on designing new and better polymer paclitaxel therapeutics for potential anticancer applications in the clinic.

  7. The Fragility of a Robust Therapeutic Technique

    DEFF Research Database (Denmark)

    Vikkelsø, Signe

    2012-01-01

    How can therapeutic techniques simultaneously be tools for emancipation and act as subtle forms of control? The article investigates this seeming paradox by examining a technique for group analysis developed by Wilfred Bion aimed at surfacing the inclination of a group to prompt inexpedient leade...

  8. [Samples for therapeutic errors in cupping therapy].

    Science.gov (United States)

    Jiang, Chui-gang; Liang, Li-an

    2005-09-01

    To explore mechanisms, operating principle, indications and contraindications of cupping therapy. Analyze some examples of clinically erroneous application of cupping therapy. Erroneous application of cupping therapy for the patient of deficiency syndrome has a poor therapeutic effect, even exacerbates. Clinically, application ranges of cupping therapy should be definited.

  9. Microbial synthetic biology for human therapeutics.

    Science.gov (United States)

    Jain, Aastha; Bhatia, Pooja; Chugh, Archana

    2012-06-01

    The emerging field of synthetic biology holds tremendous potential for developing novel drugs to treat various human conditions. The current study discusses the scope of synthetic biology for human therapeutics via microbial approach. In this context, synthetic biology aims at designing, engineering and building new microbial synthetic cells that do not pre-exist in nature as well as re-engineer existing microbes for synthesis of therapeutic products. It is expected that the construction of novel microbial genetic circuitry for human therapeutics will greatly benefit from the data generated by 'omics' approaches and multidisciplinary nature of synthetic biology. Development of novel antimicrobial drugs and vaccines by engineering microbial systems are a promising area of research in the field of synthetic biology for human theragnostics. Expression of plant based medicinal compounds in the microbial system using synthetic biology tools is another avenue dealt in the present study. Additionally, the study suggest that the traditional medicinal knowledge can do value addition for developing novel drugs in the microbial systems using synthetic biology tools. The presented work envisions the success of synthetic biology for human therapeutics via microbial approach in a holistic manner. Keeping this in view, various legal and socio-ethical concerns emerging from the use of synthetic biology via microbial approach such as patenting, biosafety and biosecurity issues have been touched upon in the later sections.

  10. Emotional Readiness and Music Therapeutic Activities

    Science.gov (United States)

    Drossinou-Korea, Maria; Fragkouli, Aspasia

    2016-01-01

    The purpose of this study is to understand the children's expression with verbal and nonverbal communication in the Autistic spectrum. We study the emotional readiness and the music therapeutic activities which exploit the elements of music. The method followed focused on the research field of special needs education. Assumptions on the parameters…

  11. Therapeutic hypothermia reduces intestinal ischemia/reperfusion ...

    African Journals Online (AJOL)

    To investigate the effects of therapeutic hypothermia (TH) on the morphology and function of intestine after cardiac arrest and resuscitation, 45 male rats were randomly assigned into three groups: (1) normothermia group, animals underwent ventricular fibrillation (VF) and cardiopulmonary resuscitation (CPR) with the rectal ...

  12. Therapeutic Exercise and Hypertension | Sikiru | African Research ...

    African Journals Online (AJOL)

    Hypertension implies chronic elevation in SBP and DBP above levels considered desirable or healthy for the person\\'s age and size. The focus of this review is to discuss the therapeutic efficacy of exercise on human hypertension. The paper revealed that hypertension is common among African, also that acute exercise ...

  13. Introduction to the Therapeutic Drawing Series

    Science.gov (United States)

    Del Giacco, Maureen

    2011-01-01

    The primary purpose of Del Giacco's Neuro-Art Therapy is to help the client regenerate the sensory system at a decoding/encoding (for our purposes we use the two words interchangeably) levels in the brain while using developmental visual spatial exercises or the Therapeutic Drawing Series (TDS). The specialty of Del Giacco Neuro Art Therapy (DAT)…

  14. IgA as therapeutic antibody

    NARCIS (Netherlands)

    Leusen, Jeanette H W

    2015-01-01

    This review is focused on the promises of IgA as a new therapeutic antibody. For more than 30 years IgG molecules have been used in the clinic in the fields of oncology, hematology, auto immune diseases and infections. However, IgA might be a good alternative, since it recruits different effector

  15. Therapeutic gene editing: delivery and regulatory perspectives.

    Science.gov (United States)

    Shim, Gayong; Kim, Dongyoon; Park, Gyu Thae; Jin, Hyerim; Suh, Soo-Kyung; Oh, Yu-Kyoung

    2017-06-01

    Gene-editing technology is an emerging therapeutic modality for manipulating the eukaryotic genome by using target-sequence-specific engineered nucleases. Because of the exceptional advantages that gene-editing technology offers in facilitating the accurate correction of sequences in a genome, gene editing-based therapy is being aggressively developed as a next-generation therapeutic approach to treat a wide range of diseases. However, strategies for precise engineering and delivery of gene-editing nucleases, including zinc finger nucleases, transcription activator-like effector nuclease, and CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats-associated nuclease Cas9), present major obstacles to the development of gene-editing therapies, as with other gene-targeting therapeutics. Currently, viral and non-viral vectors are being studied for the delivery of these nucleases into cells in the form of DNA, mRNA, or proteins. Clinical trials are already ongoing, and in vivo studies are actively investigating the applicability of CRISPR/Cas9 techniques. However, the concept of correcting the genome poses major concerns from a regulatory perspective, especially in terms of safety. This review addresses current research trends and delivery strategies for gene editing-based therapeutics in non-clinical and clinical settings and considers the associated regulatory issues.

  16. Ventricular dysphonia: clinical aspects and therapeutic options.

    Science.gov (United States)

    Maryn, Youri; De Bodt, Marc S; Van Cauwenberge, Paul

    2003-05-01

    Ventricular dysphonia, also known as dysphonia plica ventricularis, refers to the pathological interference of the false vocal folds during phonation. Despite its low incidence and prevalence, Vd is a well-known phenomenon in voice clinics. The present report reviews symptoms, etiology, diagnosis, and therapeutic options regarding this voice disorder. Literature review and case studies. The literature pertaining to all clinical aspects of V(D) was reviewed to define diagnostic and therapeutic clinical decision making. Ventricular dysphonia is characterized by a typical rough, low-pitched voice quality resulting from false vocal fold vibration. Ventricular dysphonia may be compensatory when true vocal folds are affected (resection, paralysis). Noncompensatory types may be of habitual, psychoemotional, or idiopathic origin. Because perceptual symptoms may vary considerably, diagnosis should rely on a meticulous voice assessment, including laryngeal videostroboscopic, perceptual, aerodynamic, and acoustic evaluation. Various therapeutic approaches for the noncompensatory type of ventricular dysphonia may be considered: voice therapy, psychotherapy, anesthetic or botulinum toxin injections, or surgery. The study presents the state of the art with respect to ventricular dysphonia and may be helpful in diagnosis and therapeutic decision-making.

  17. Hydrogen Sulfide in Preeclampsia : Potential Therapeutic Implications

    NARCIS (Netherlands)

    Holwerda, Kim

    2015-01-01

    The thesis provide insights into the production and possible therapeutic effect of the gaseous molecule hydrogen sulfide (H2S) in preeclampsia (PE). H2S is an important molecule in the (human) body. It is among others involved in blood pressure regulation, stimulation of vascular growth and

  18. Therapeutic applications of collagenase (metalloproteases: A review

    Directory of Open Access Journals (Sweden)

    Hamzeh Alipour

    2016-11-01

    Full Text Available Non-invasive therapeutic methods have recently been used in medical sciences. Enzymes have shown high activity at very low concentrations in laboratories and pharmaceutical, enabling them to play crucial roles in different biological phenomena related to living organism, especially human medicine. Recently, using the therapeutic methods based on non-invasive approaches has been emphasized in medical society. Researchers have focused on producing medicines and tools reducing invasive procedures in medical. Collagenases are proteins which catalyze chemical processes and break the peptide bonds in collagen. Collagen may be generated more than the required amount or produced in unsuitable sites or may not degrade after a certain time. In such cases, using an injectable collagenase or its ointment can be helpful in collagen degradation. In both in vitro and in vivo tests, it has been revealed that collagenases have several therapeutic properties in wound healing, burns, nipple pain and some diseases including intervertebral disc herniation, keloid, cellulite, lipoma among others. This review describes the therapeutic application of collagenase in medical sciences and the process for its production using novel methods, paving the way for more effective and safe applications of collagenases.

  19. The Medical Ethics of Clinical Therapeutic Trials*

    African Journals Online (AJOL)

    Clinical therapeutic trials, or human experimentation with drugs, are abso- lutely necessary, because data gained from experiments on animals cannot always be directly extrapolated onto man as being applicable. Variations are also found in the different animal species. Tt is impossible to obtain data in animals regarding.

  20. Inflammatory bowel disease: potential therapeutic strategies

    DEFF Research Database (Denmark)

    Nielsen, O H; Vainer, B; Bregenholt, S

    1997-01-01

    This review deals with potential and possibly primary therapeutics that, through insight into the inflammatory cascade, result in more rational treatment principles replacing the classical therapy of inflammatory bowel disease (IBD), i.e. Crohn's disease (CD) and ulcerative colitis (UC). These ne...